Index, Symbol, Company Name, Sector, Industry, Country, Market Cap, Forward PE, PEG, Price/Sales, Price/Book, Price/FCF, EPS This Y, EPS Next Y, EPS Next 5Y, EPS Q/Q, Sales Q/Q, ROA, ROE, ROI, Current Ratio, Quick Ratio, LT Debt/Equity, Debt/Equity, Gross Margin, Operating Margin, Net Margin, Perf Month, Perf Quarter, Perf Half Y, Perf Year, Perf YTD, Volatility (Month)
2, ABBV, AbbVie Inc., Healthcare, Drug Manufacturers - General, USA, 198.38B, 8.13, 8.88, 3.95, 14.61, 20.85, -48.50%, 10.77%, 4.50%, 6.50%, 50.90%, 3.40%, 35.80%, 12.70%, 0.80, 0.70, 5.41, 6.24, 64.90%, 23.60%, 10.10%, 2.08%, 4.42%, 8.64%, 22.15%, 5.65%, 1.77%
4, ABCL, AbCellera Biologics Inc., Healthcare, Biotechnology, Canada, 7.36B, -, -, 17.06, 7.56, -, 415.00%, -100.00%, -, -, 4253.50%, -, -, 13.60%, 10.30, 10.30, 0.00, 0.00, -, -, -, -6.78%, -32.40%, -, -, -33.33%, 8.02%
6, ABEO, Abeona Therapeutics Inc., Healthcare, Biotechnology, USA, 163.40M, -, -, 16.34, 1.65, -, 40.00%, 11.60%, -, 67.30%, -, -33.80%, -48.10%, -78.10%, 2.20, 2.20, 0.01, 0.02, -, -, -, -1.79%, -29.49%, 17.02%, -50.15%, 5.10%, 10.47%
8, ABMD, Abiomed Inc., Healthcare, Medical Devices, USA, 12.95B, 54.52, 3.37, 15.28, 9.68, 58.54, 11.40%, 19.70%, 17.10%, 77.70%, 16.70%, 16.40%, 18.50%, 12.50%, 6.10, 5.50, 0.00, 0.00, 80.90%, 27.10%, 26.60%, -11.88%, -12.24%, 7.87%, 27.10%, -12.22%, 3.07%
10, ABUS, Arbutus Biopharma Corporation, Healthcare, Biotechnology, USA, 274.71M, -, -, 36.63, -, -, 65.40%, 14.60%, -, 15.70%, 40.00%, -61.40%, 147.90%, 122.00%, 20.50, 20.50, -, -, -, -, -, -19.37%, -26.30%, -24.93%, 30.41%, -20.28%, 6.59%
12, ACB, Aurora Cannabis Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 1.91B, -, -, 6.70, 0.81, -, -, -, -, -, 22.70%, -, -, -, -, -, -, -, -, -, -, 7.81%, -12.50%, 10.91%, -31.39%, 16.25%, 6.40%
14, ACER, Acer Therapeutics Inc., Healthcare, Biotechnology, USA, 42.40M, -, -, 10.60, 3.96, -, 29.40%, -27.70%, -, 78.20%, -, -87.10%, -192.80%, -, 1.10, 1.10, 0.00, 0.00, -, -, -, -1.01%, -9.85%, 12.69%, -4.56%, 11.83%, 5.67%
16, ACHC, Acadia Healthcare Company Inc., Healthcare, Medical Care Facilities, USA, 5.72B, 22.97, 3.28, 2.68, 2.47, -, 169.00%, 14.32%, 11.99%, 19.00%, 8.20%, -, -, 5.30%, 1.30, 1.30, 0.65, 0.66, -, -, -, 4.80%, 14.85%, 48.67%, 124.96%, 28.05%, 2.67%
18, ACHV, Achieve Life Sciences Inc., Healthcare, Biotechnology, Canada, 71.53M, -, -, -, 1.63, -, 86.40%, 29.50%, -, -, -, -65.80%, -72.20%, -, 8.70, 8.70, 0.00, 0.00, -, -, -, -27.58%, -31.07%, -11.69%, -1.91%, -1.11%, 7.23%
20, ACOR, Acorda Therapeutics Inc., Healthcare, Biotechnology, USA, 36.01M, -, -, 0.23, 0.17, -, 64.30%, 39.10%, 29.00%, -333.90%, 2.80%, -19.10%, -48.30%, -14.80%, 1.40, 1.20, 0.82, 1.15, 72.90%, -65.50%, -82.30%, -23.46%, -37.48%, -13.07%, -17.07%, -10.16%, 7.08%
1, A, Agilent Technologies Inc., Healthcare, Diagnostics & Research, USA, 41.91B, 30.13, 4.28, 7.20, 8.80, 72.26, -31.60%, 11.80%, 10.80%, 48.10%, 14.10%, 7.50%, 14.80%, 10.00%, 2.10, 1.60, 0.45, 0.52, 53.50%, 14.50%, 12.40%, 2.97%, 10.97%, 20.80%, 56.72%, 16.58%, 1.67%
3, ABC, AmerisourceBergen Corporation, Healthcare, Medical Distribution, USA, 23.62B, 12.51, -, 0.12, -, 25.45, -530.90%, 7.40%, 8.81%, -54.70%, 3.70%, -8.40%, -806.00%, -105.20%, 1.10, 0.70, -, -, 2.80%, -2.30%, -1.90%, -5.37%, 11.21%, 11.28%, 20.35%, 17.37%, 2.62%
5, ABCM, Abcam plc, Healthcare, Biotechnology, United Kingdom, 4.56B, -, -, 16.92, -, -, -, -, -, -55.20%, 6.70%, -, -, -, -, -, -, -, -, -, -, -5.10%, -11.02%, 8.77%, -, -6.73%, 2.32%
7, ABIO, ARCA biopharma Inc., Healthcare, Biotechnology, USA, 49.59M, -, -, -, 0.65, -, 50.20%, -, -, 59.90%, -, -27.30%, -28.90%, -, 23.90, 23.90, 0.00, 0.00, -, -, -, -0.29%, -20.14%, -16.71%, -72.30%, -12.97%, 5.21%
9, ABT, Abbott Laboratories, Healthcare, Medical Devices, USA, 205.56B, 21.55, 2.20, 5.51, 6.18, 42.06, 24.50%, 7.32%, 16.49%, 227.60%, 35.30%, 8.10%, 17.80%, 9.70%, 1.80, 1.30, 0.52, 0.55, 56.90%, 18.10%, 15.30%, -3.60%, -4.55%, 9.62%, 22.89%, 6.54%, 1.41%
11, ACAD, ACADIA Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 3.53B, -, -, 7.70, 6.15, -, -12.00%, 37.10%, 25.00%, 26.70%, 18.30%, -33.60%, -41.20%, -45.80%, 6.20, 6.10, 0.00, 0.00, 95.60%, -57.60%, -56.70%, 8.50%, -54.92%, -60.01%, -55.03%, -58.21%, 4.21%
13, ACCD, Accolade Inc., Healthcare, Health Information Services, USA, 2.99B, -, -, 19.22, 6.71, -, 9.10%, 13.10%, 24.80%, 17.40%, 29.30%, -21.40%, -348.60%, 20.50%, 6.10, 6.10, 0.00, 0.00, 43.40%, -28.40%, -32.00%, 1.08%, 7.24%, -0.10%, -, 16.07%, 7.04%
15, ACET, Adicet Bio Inc., Healthcare, Biotechnology, USA, 417.36M, -, -, 30.03, 1.48, -, 70.30%, -8.40%, 29.10%, 39.60%, 174.80%, -, -, -33.10%, 9.10, 9.10, 0.00, 0.00, -, -, -, -14.79%, -13.97%, 10.36%, -11.65%, -4.48%, 7.13%
17, ACHL, Achilles Therapeutics plc, Healthcare, Biotechnology, United Kingdom, 511.77M, -, -, -, -, -, -137.30%, -, -, -450.30%, -, -, -, -, 11.30, 11.30, 0.00, 0.00, -, -, -, -21.16%, -, -, -, -23.69%, 8.11%
19, ACIU, AC Immune SA, Healthcare, Biotechnology, Switzerland, 464.30M, -, -, 125.49, 1.90, -, -234.80%, 87.30%, -, -116.30%, -, -28.50%, -31.30%, -28.10%, 19.80, 19.80, 0.01, 0.01, -, -, -, -10.96%, -19.76%, 17.12%, -21.32%, 17.79%, 5.51%
22, ACRX, AcelRx Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 171.50M, 14.95, -, 31.18, -, -, 29.60%, 133.30%, -, 60.20%, 25.00%, -46.50%, 66.50%, 120.80%, 4.60, 4.50, -, -, -0.40%, -, -, 8.59%, -29.44%, -9.74%, 0.00%, 12.10%, 8.96%
24, ADAG, Adagene Inc., Healthcare, Biotechnology, China, 552.74M, -, -, 789.62, -, -, -207.40%, -34.80%, -, -, -18.50%, -, -, 53.10%, 4.90, 4.90, -, -, -, -, -, -4.06%, -43.23%, -, -, -52.72%, 8.99%
26, ADCT, ADC Therapeutics SA, Healthcare, Biotechnology, Switzerland, 1.71B, -, -, -, 5.58, -, -111.40%, 16.70%, 6.70%, -9.20%, -, -54.40%, -84.40%, -, 9.50, 9.50, 0.15, 0.16, -, -, -, -14.76%, -20.75%, -39.34%, -41.41%, -32.36%, 6.42%
28, ADMA, ADMA Biologics Inc., Healthcare, Biotechnology, USA, 223.11M, -, -, 4.64, 1.80, -, 1.00%, 45.60%, -, 39.10%, 56.90%, -36.30%, -85.80%, -, 8.40, 3.90, 0.83, 0.83, -29.50%, -, -, -14.63%, -27.69%, -4.37%, -46.81%, -10.26%, 6.54%
30, ADMS, Adamas Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 229.83M, -, -, 2.90, 32.53, -, 46.60%, 72.80%, -, 39.80%, 33.10%, -38.40%, 207.00%, -, 5.40, 5.20, 21.39, 22.00, 97.70%, -51.20%, -67.30%, -1.60%, 9.94%, 26.26%, 100.36%, 27.71%, 6.33%
32, ADTX, ADiTx Therapeutics Inc., Healthcare, Biotechnology, USA, 38.50M, 3.12, -, -, 3.43, -, -120.20%, 100.00%, -, -275.50%, -, -121.80%, -176.90%, -, 4.30, 4.30, 0.17, 0.28, -, -, -, 3.69%, -12.73%, 44.10%, -, 35.10%, 9.27%
34, ADVM, Adverum Biotechnologies Inc., Healthcare, Biotechnology, USA, 344.69M, -, -, 45.96, 0.82, -, -37.20%, -7.20%, -, 6.30%, -, -27.60%, -30.80%, -, 20.60, 20.60, 0.00, 0.00, -, -, -, -9.66%, -74.02%, -74.95%, -83.23%, -68.08%, 5.76%
36, ADXS, Advaxis Inc., Healthcare, Biotechnology, USA, 67.80M, -, -, 35.68, 1.06, -, 60.30%, -, -, 68.80%, 53733.30%, -53.20%, -67.10%, -88.00%, 9.90, 9.90, 0.00, 0.00, -, -, -, -2.98%, -45.82%, 66.03%, -30.32%, 37.08%, 12.00%
38, AERI, Aerie Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 781.76M, -, -, 9.11, -, -, 9.20%, 41.30%, -, 15.20%, 13.30%, -46.40%, -430.40%, -68.70%, 3.10, 2.80, -, -, 69.80%, -, -, -6.22%, -15.07%, 27.87%, 16.11%, 20.58%, 5.07%
40, AFIB, Acutus Medical Inc., Healthcare, Medical Devices, USA, 416.19M, -, -, 39.64, 4.54, -, -127.00%, 22.60%, -, -41.70%, 125.00%, -70.80%, -391.50%, -52.20%, 6.30, 5.50, 0.42, 0.45, -87.60%, -, -, 11.82%, -23.83%, -40.75%, -, -43.53%, 8.57%
21, ACRS, Aclaris Therapeutics Inc., Healthcare, Biotechnology, USA, 1.13B, -, -, 163.19, 9.97, -, 56.20%, 4.10%, -, -55.10%, 28.60%, -66.00%, -106.90%, -105.00%, 9.30, -, 0.10, 0.00, 26.10%, -, -, -10.83%, -7.56%, 571.90%, 1477.31%, 243.74%, 5.87%
23, ACST, Acasti Pharma Inc., Healthcare, Biotechnology, Canada, 99.92M, -, -, 1233.58, 3.03, -, 30.30%, 34.00%, -, -, -, -, -, -, -, -, -, -, -, -, -, 0.83%, -32.71%, 86.31%, -21.12%, 53.63%, 11.44%
25, ADAP, Adaptimmune Therapeutics plc, Healthcare, Biotechnology, United Kingdom, 785.08M, -, -, 218.08, 2.53, -, 30.10%, -4.10%, 1.00%, -6.50%, -50.00%, -30.10%, -39.00%, -39.10%, 11.50, 11.50, 0.00, 0.00, -, -, -, -12.98%, -12.22%, 9.11%, -54.56%, -6.68%, 6.85%
27, ADIL, Adial Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 42.51M, -, -, -, 7.06, -, -0.20%, 7.80%, -, -40.10%, -, -169.30%, -211.10%, -, 3.00, 3.00, 0.00, 0.00, -, -, -, 13.67%, 3.35%, 30.69%, 52.93%, 45.29%, 7.71%
29, ADMP, Adamis Pharmaceuticals Corporation, Healthcare, Drug Manufacturers - Specialty & Generic, USA, 99.86M, -, -, 6.05, 17.21, -, -23.30%, 13.00%, -, -244.90%, -34.50%, -123.70%, -226.50%, -565.70%, 0.60, 0.50, 0.26, 1.51, 9.90%, -, -, -12.69%, -38.54%, 58.43%, 39.61%, 41.91%, 11.02%
31, ADPT, Adaptive Biotechnologies Corporation, Healthcare, Biotechnology, USA, 5.31B, -, -, 45.79, 7.24, -, -100.60%, -3.10%, 4.30%, -17.40%, 83.70%, -15.00%, -22.40%, -20.60%, 7.20, 7.00, 0.00, 0.00, 76.60%, -, -, -11.74%, -34.69%, -17.50%, -2.30%, -36.06%, 5.97%
33, ADUS, Addus HomeCare Corporation, Healthcare, Medical Care Facilities, USA, 1.53B, 24.45, 3.07, 1.96, 2.85, 23.32, 14.60%, 13.57%, 15.00%, 1.70%, 7.90%, 4.30%, 6.50%, 5.00%, 2.30, 2.30, 0.37, 0.37, 29.70%, 5.90%, 4.30%, -11.44%, -6.14%, 0.11%, -2.82%, -17.87%, 3.79%
35, ADXN, Addex Therapeutics Ltd, Healthcare, Biotechnology, Switzerland, 67.90M, -, -, 17.50, -, -, -, -, -, -, 72.70%, -, -, -, -, -, -, -, -, -, -, -6.41%, -16.52%, -22.47%, -, -30.22%, 4.15%
37, AEMD, Aethlon Medical Inc., Healthcare, Medical Devices, USA, 21.59M, -, -, 26.99, 1.81, -, 63.60%, -44.30%, -, 28.80%, 50.00%, -54.30%, -59.30%, -67.80%, 10.00, 10.00, 0.00, 0.00, -, -, -, -3.87%, -24.35%, 2.35%, 18.37%, -29.55%, 6.22%
39, AEZS, Aeterna Zentaris Inc., Healthcare, Biotechnology, USA, 105.41M, -, -, 34.00, 1.32, -, 63.90%, -, -, -142.50%, -45.50%, -16.90%, -31.40%, -45.90%, 15.70, 15.70, 0.00, 0.00, 52.90%, -, -, -19.63%, -23.12%, 126.17%, -23.78%, 107.78%, 6.00%
42, AGE, AgeX Therapeutics Inc., Healthcare, Biotechnology, USA, 47.40M, -, -, 33.85, -, -, 11.60%, -, -, 33.90%, 0.00%, -243.50%, 226.20%, -876.80%, 0.50, 0.50, -, -, 91.00%, -, -, -9.28%, -41.74%, -30.22%, 12.39%, -16.45%, 5.63%
44, AGIO, Agios Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 3.52B, -, -, 30.28, 1.69, -, 30.80%, -125.00%, 40.00%, -6.60%, -, 121.50%, 170.00%, -, 24.40, -, 0.00, 0.00, 98.00%, -, -, 0.00%, 17.41%, 22.16%, 7.81%, 28.73%, 3.73%
46, AGLE, Aeglea BioTherapeutics Inc., Healthcare, Biotechnology, USA, 331.43M, -, -, -, 2.62, -, 38.10%, 10.70%, -, 34.30%, -, -49.20%, -58.20%, -, 4.70, 4.70, 0.00, 0.00, -, -, -, -19.49%, -15.15%, -23.94%, -24.97%, -16.01%, 5.47%
48, AGTC, Applied Genetic Technologies Corporation, Healthcare, Biotechnology, USA, 180.89M, -, -, -, 1.52, -, 12.00%, 19.90%, -, 19.60%, -, -62.10%, -90.60%, -58.30%, 6.80, 6.80, 0.10, 0.10, -, -, -, -6.74%, -27.22%, -6.74%, -16.46%, -1.96%, 6.65%
50, AHCO, AdaptHealth Corp., Healthcare, Medical Devices, USA, 3.45B, 19.62, -, 2.53, 1.63, 28.33, -225.50%, 85.42%, 44.20%, 95.70%, 151.90%, -7.70%, -25.40%, 6.70%, 1.00, 0.80, 0.98, 1.00, 18.80%, 5.00%, -12.20%, -11.85%, -18.00%, -12.23%, 61.87%, -30.27%, 5.94%
52, AIH, Aesthetic Medical International Holdings Group Limited, Healthcare, Medical Care Facilities, China, 217.56M, 3.48, -, 1.54, 3.32, -, -272.90%, 3.12%, -, -33.70%, 52.30%, -21.10%, -52.80%, -25.50%, 0.70, 0.60, 0.74, 1.18, 60.40%, -25.40%, -26.10%, 34.01%, 13.25%, 65.01%, 8.96%, 63.76%, 11.38%
54, AIM, AIM ImmunoTech Inc., Healthcare, Biotechnology, USA, 99.50M, -, -, 994.98, 1.34, -, 82.50%, -5.70%, 25.00%, 30.80%, -16.00%, -22.40%, -23.90%, -23.90%, 52.80, 52.80, 0.03, 0.03, -, -, -, -4.63%, -12.34%, 15.73%, -26.43%, 15.08%, 4.39%
56, AKRO, Akero Therapeutics Inc., Healthcare, Biotechnology, USA, 922.58M, -, -, -, 3.70, -, 13.30%, -11.50%, -, -4.10%, -, -34.90%, -36.80%, -, 25.20, 25.20, 0.00, 0.00, -, -, -, -19.07%, -14.42%, -9.25%, 2.99%, 1.47%, 4.83%
58, AKUS, Akouos Inc., Healthcare, Biotechnology, USA, 464.41M, -, -, -, 1.51, -, -249.40%, -7.10%, 22.10%, -46.00%, -, -16.10%, -17.20%, -, 41.20, 41.20, 0.00, 0.00, -, -, -, -12.47%, -37.93%, -32.54%, -, -34.14%, 7.36%
60, ALBO, Albireo Pharma Inc., Healthcare, Biotechnology, USA, 636.22M, -, -, 73.13, 4.33, -, -33.50%, 34.50%, -, -2.60%, 33.30%, -46.50%, -76.10%, -, 10.20, 10.20, 0.06, 0.07, -, -, -, 3.72%, -10.18%, -9.47%, 25.00%, -10.82%, 4.90%
41, AFMD, Affimed N.V., Healthcare, Biotechnology, Germany, 1.08B, -, -, 31.11, 9.34, -, 1.60%, 25.00%, -, 13.70%, 148.70%, -34.30%, -86.80%, -47.30%, 2.20, 2.20, 0.01, 0.02, -, -, -, -19.87%, 50.08%, 71.24%, 169.60%, 52.41%, 5.60%
43, AGEN, Agenus Inc., Healthcare, Biotechnology, USA, 936.52M, -, -, 11.04, -, -, -31.40%, -4.90%, -, 13.00%, -22.50%, -90.60%, 93.80%, -, 1.00, -, -, -, 95.90%, -, -, 37.86%, 7.58%, 21.37%, 14.21%, 33.96%, 6.46%
45, AGL, agilon health inc., Healthcare, Medical Care Facilities, USA, 14.36B, -, -, 11.79, -, -, 44.80%, -, -, -, 62.00%, -, -, -62.20%, 1.10, 1.10, 8.80, 8.80, -, -, -, 15.04%, -, -, -, 15.94%, 6.71%
47, AGRX, Agile Therapeutics Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 145.59M, -, -, 161.77, 4.03, -, -62.70%, 62.00%, -, -90.10%, -, -75.20%, -105.70%, -74.70%, 5.00, 4.80, 0.44, 0.44, -66.80%, -, -, -11.54%, -46.69%, -42.09%, -42.91%, -43.90%, 8.10%
49, AGTI, Agiliti Inc., Healthcare, Health Information Services, USA, 2.72B, -, -, 3.28, -, -, 36.30%, -, -, 175.70%, 31.30%, 0.00%, -0.10%, 2.50%, 1.20, 1.10, 2.90, 2.94, 39.80%, 8.10%, 0.00%, 37.89%, -, -, -, 33.35%, 6.21%
51, AHPI, Allied Healthcare Products Inc., Healthcare, Medical Devices, USA, 14.70M, -, -, 0.39, 1.67, -, -42.90%, -, -, -25.10%, -1.20%, -2.10%, -4.50%, -26.20%, 1.50, 0.40, 0.01, 0.42, 19.30%, -1.00%, -1.10%, -21.05%, -25.60%, -27.47%, -59.81%, -23.00%, 9.10%
53, AIKI, AIkido Pharma Inc., Healthcare, Biotechnology, USA, 97.59M, -, -, -, 0.62, -, 73.60%, -, -, 92.70%, -, -16.10%, -16.40%, -, 184.10, 184.10, 0.00, 0.00, -, -, -, 5.94%, -19.55%, 108.37%, 51.26%, 22.50%, 7.41%
55, AKBA, Akebia Therapeutics Inc., Healthcare, Biotechnology, USA, 560.41M, -, -, 2.16, 2.53, -, -17.20%, 37.50%, -, 4.40%, -40.90%, -58.20%, -136.50%, -109.40%, 2.10, 1.90, 0.45, 0.45, 38.50%, -, -, 8.00%, 4.31%, 6.36%, -69.85%, 25.36%, 5.89%
57, AKTX, Akari Therapeutics Plc, Healthcare, Biotechnology, United Kingdom, 71.60M, -, -, -, 4.99, -, 41.20%, -, -, 26.30%, -, -129.60%, -352.30%, -, 2.80, 2.80, 0.00, 0.00, -, -, -, -14.11%, -46.26%, 13.61%, -12.01%, -2.97%, 6.23%
59, AKYA, Akoya Biosciences Inc., Healthcare, Medical Instruments & Supplies, USA, 768.67M, -, -, 18.11, -, -, -18.90%, -, -, -, -, -, -, 79.30%, 1.20, 0.90, -, -, -, -, -, -7.43%, -, -, -, -20.08%, 10.02%
62, ALDX, Aldeyra Therapeutics Inc., Healthcare, Biotechnology, USA, 682.84M, -, -, -, 4.54, -, 50.70%, -14.00%, -, 26.80%, -, -39.90%, -50.70%, -, 13.30, 13.30, 0.08, 0.12, -, -, -, 0.12%, 2.62%, 85.76%, 154.47%, 82.51%, 5.55%
64, ALGN, Align Technology Inc., Healthcare, Medical Devices, USA, 47.47B, 46.49, 3.31, 16.86, 13.74, 65.26, 305.50%, 21.74%, 31.01%, -86.90%, 62.40%, 10.00%, 14.70%, 55.20%, 1.50, 1.40, 0.00, 0.00, 72.70%, 19.30%, 16.30%, -2.35%, 4.43%, 24.59%, 140.27%, 10.44%, 3.44%
66, ALHC, Alignment Healthcare Inc., Healthcare, Healthcare Plans, USA, 4.69B, -, -, 4.68, 13.35, -, 48.70%, 28.90%, -, -464.70%, 18.90%, -, -, -3.00%, 3.60, 3.60, 0.41, 0.41, 15.10%, -5.20%, -6.90%, -5.61%, -, -, -, 45.75%, 8.65%
68, ALKS, Alkermes plc, Healthcare, Biotechnology, Ireland, 3.62B, 23.54, -, 3.47, 3.45, 76.04, 44.20%, 90.32%, -14.10%, 42.60%, 2.10%, -5.00%, -8.90%, -9.40%, 2.70, 2.40, 0.28, 0.28, 83.50%, -9.00%, -9.10%, 4.09%, 18.07%, 23.01%, 35.99%, 13.63%, 2.56%
70, ALLO, Allogene Therapeutics Inc., Healthcare, Biotechnology, USA, 3.50B, -, -, 91.47, 3.18, -, -13.80%, -31.80%, 1.00%, 50.00%, -, -18.70%, -20.60%, -, 13.10, 13.10, 0.00, 0.00, -, -, -, -19.64%, -29.59%, -19.21%, -46.64%, 1.82%, 6.02%
72, ALNY, Alnylam Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 16.48B, -, -, 28.87, 17.95, -, 8.00%, 44.10%, 46.09%, -5.80%, 78.50%, -26.30%, -76.90%, -68.80%, 5.00, 4.80, 0.21, 0.21, 84.60%, -, -, 1.65%, -4.54%, 13.18%, 4.97%, 9.25%, 3.69%
74, ALRN, Aileron Therapeutics Inc., Healthcare, Biotechnology, USA, 112.90M, -, -, -, 1.66, -, 49.30%, -12.50%, 2.10%, 65.50%, -, -66.10%, -83.30%, -, 20.90, 20.90, 0.00, 0.01, -, -, -, 0.00%, -26.35%, 14.95%, -24.07%, 18.27%, 8.34%
76, ALVR, AlloVir Inc., Healthcare, Biotechnology, USA, 1.51B, -, -, -, 4.41, -, -227.00%, -6.70%, -, -268.30%, -, -29.60%, -37.10%, -, 21.90, 21.90, 0.00, 0.00, -, -, -, -3.14%, -38.93%, -32.20%, -, -39.02%, 7.89%
78, ALXO, ALX Oncology Holdings Inc., Healthcare, Biotechnology, USA, 2.27B, -, -, 4541.77, 5.41, -, -311.10%, -28.30%, -, -65.30%, -100.00%, -18.70%, -22.70%, -10.40%, 30.60, 30.60, 0.00, 0.00, 9.10%, -, -, -21.07%, -35.49%, -16.66%, -, -34.39%, 7.80%
80, AMEH, Apollo Medical Holdings Inc., Healthcare, Medical Care Facilities, USA, 1.91B, 27.25, -, 2.74, 4.23, 29.71, 160.80%, 0.00%, -, 178.90%, 6.70%, 5.70%, 16.80%, 4.30%, 2.90, 2.90, 0.65, 0.69, 23.30%, 14.00%, 6.70%, 17.80%, 37.76%, 91.86%, 84.65%, 90.91%, 4.47%
61, ALC, Alcon Inc., Healthcare, Medical Instruments & Supplies, Switzerland, 34.82B, 30.30, -, 5.10, 1.81, -, 85.60%, 19.20%, 6.90%, -, 1.40%, -, -, -, -, -, -, -, -, -, -, -7.81%, -1.08%, 10.29%, 9.66%, 5.61%, 1.53%
63, ALEC, Alector Inc., Healthcare, Biotechnology, USA, 1.45B, -, -, 80.35, 6.20, -, -43.30%, 8.90%, -, -22.90%, -43.10%, -39.80%, -69.70%, -73.00%, 5.80, 5.80, 0.00, 0.00, -, -, -, -7.39%, 2.12%, 33.94%, -45.57%, 17.65%, 6.87%
65, ALGS, Aligos Therapeutics Inc., Healthcare, Biotechnology, USA, 1.12B, -, -, -, 5.34, -, -109.30%, -5.90%, -, 47.80%, -, -, -, -, 8.70, 8.70, 0.00, 0.00, -, -, -, 2.88%, -4.52%, 55.32%, -, 0.83%, 9.57%
67, ALIM, Alimera Sciences Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 69.51M, -, -, 1.46, -, -, 52.30%, -273.70%, -, -163.50%, -22.80%, -16.00%, 23.50%, -2.50%, 2.70, 2.50, -, -, 86.20%, -6.60%, -16.40%, 2.54%, 26.35%, 121.52%, 108.79%, 148.82%, 5.09%
69, ALLK, Allakos Inc., Healthcare, Biotechnology, USA, 5.31B, -, -, -, 8.76, -, -64.20%, -15.10%, -10.50%, -82.80%, -, -31.30%, -34.00%, -, 27.50, 27.50, 0.00, 0.00, -, -, -, -6.56%, -14.24%, -2.21%, 56.06%, -27.54%, 4.65%
71, ALNA, Allena Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 63.50M, -, -, -, 2.53, -, 52.70%, -27.00%, -, 31.00%, -, -105.10%, -178.60%, -, 5.70, 5.70, 0.42, 0.00, -, -, -, -8.40%, -37.36%, -21.01%, -35.12%, -14.84%, 7.86%
73, ALPN, Alpine Immune Sciences Inc., Healthcare, Biotechnology, USA, 244.22M, -, -, 21.42, 4.78, 10.62, 41.20%, 21.00%, -, -49.80%, 190.90%, -24.90%, -66.40%, -39.80%, 2.30, 2.30, 0.12, 0.19, -, -, -, -16.98%, -17.75%, 17.66%, 188.11%, -15.40%, 8.65%
75, ALT, Altimmune Inc., Healthcare, Biotechnology, USA, 494.87M, -, -, 72.77, 2.00, -, -19.70%, 11.50%, -, -48.50%, -63.60%, -28.40%, -31.90%, -21.90%, 25.00, 25.00, 0.00, 0.00, -, -, -, -11.04%, -22.91%, 25.37%, 36.31%, 12.15%, 7.29%
77, ALXN, Alexion Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 39.24B, 12.42, 6.83, 6.27, 3.13, 13.19, -74.60%, 5.35%, 8.49%, 14.10%, 13.30%, 3.80%, 6.00%, 4.30%, 4.50, 4.00, 0.19, 0.20, 90.90%, 9.20%, 10.90%, 6.63%, 16.17%, 43.62%, 47.25%, 13.00%, 0.97%
79, AMED, Amedisys Inc., Healthcare, Medical Care Facilities, USA, 8.50B, 34.15, 3.20, 4.01, 10.75, 25.63, 43.60%, 8.58%, 13.29%, 57.00%, 9.20%, 12.60%, 26.20%, 18.90%, 0.80, 0.80, 0.29, 0.31, 43.50%, 11.50%, 9.50%, -9.57%, 1.26%, 9.86%, 34.53%, -11.92%, 3.03%
82, AMN, AMN Healthcare Services Inc., Healthcare, Medical Care Facilities, USA, 4.21B, 21.23, 4.80, 1.57, 4.72, 20.13, -38.10%, -17.93%, 6.89%, 439.70%, 47.00%, 5.30%, 15.50%, 7.60%, 1.40, 1.40, 1.00, 1.00, 32.80%, 8.10%, 4.80%, 10.28%, 16.27%, 33.50%, 99.95%, 29.96%, 3.23%
84, AMPH, Amphastar Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 905.51M, 13.62, 15.14, 2.46, 2.22, 20.08, -97.10%, 39.46%, 25.00%, 24.40%, 21.60%, 0.40%, 0.60%, 1.70%, 2.40, 1.60, 0.08, 0.11, 41.10%, 3.70%, 0.70%, 7.68%, 8.24%, 5.88%, 1.50%, -5.92%, 2.95%
86, AMRX, Amneal Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 1.68B, 6.32, -, 0.85, 2.60, 3.51, 95.40%, 9.95%, -12.10%, 29.50%, -1.10%, -0.40%, -5.60%, 2.70%, 2.40, 1.70, 8.75, 8.85, 33.70%, 4.00%, -0.90%, -0.18%, 9.27%, 42.21%, 16.22%, 23.85%, 4.19%
88, AMTI, Applied Molecular Transport Inc., Healthcare, Biotechnology, USA, 1.89B, -, -, -, 14.89, -, -236.20%, -4.70%, 38.70%, -23.00%, -, -48.00%, -51.30%, -, 12.60, 12.60, 0.00, 0.00, -, -, -, -12.63%, -15.32%, 52.77%, -, 55.80%, 9.58%
90, AMYT, Amryt Pharma plc, Healthcare, Drug Manufacturers - Specialty & Generic, Ireland, 420.85M, 6.87, -, 2.30, -, -, 107.00%, 1215.40%, -, -, 5.50%, -, -, -, -, -, -, -, -, -, -, -11.05%, -18.57%, -13.28%, -, -17.02%, 5.15%
92, ANGN, Angion Biomedica Corp., Healthcare, Biotechnology, USA, 469.53M, -, -, 163.03, 3.92, -, -33.20%, 16.40%, -, 36.60%, -50.00%, -, -, 143.90%, 7.90, 7.90, 0.00, 0.01, -, -, -, 9.12%, -22.49%, -, -, -9.28%, 6.07%
94, ANIK, Anika Therapeutics Inc., Healthcare, Biotechnology, USA, 644.70M, 51.26, -, 4.98, 2.42, 77.68, -189.10%, 1922.22%, 10.00%, -51.30%, -3.10%, -6.80%, -9.60%, -8.70%, 3.70, 2.80, 0.00, 0.00, 53.20%, -26.40%, -20.80%, 15.01%, 20.45%, 21.96%, 39.13%, 3.07%, 3.42%
96, ANIX, Anixa Biosciences Inc., Healthcare, Diagnostics & Research, USA, 125.09M, -, -, 250.19, 7.35, -, 23.40%, -19.50%, -, 29.90%, -, -97.90%, -106.30%, -, 9.50, 9.50, 0.00, 0.00, -, -, -, -16.77%, -22.76%, 74.12%, 74.12%, 29.32%, 8.27%
98, ANPC, AnPac Bio-Medical Science Co. Ltd., Healthcare, Biotechnology, China, 58.58M, -, -, 18.31, 108.00, -, 17.90%, 60.00%, -, -150.50%, 358.30%, -140.30%, -, -822.30%, 0.50, 0.50, 0.00, 2.60, 62.80%, -, -, -21.02%, -37.57%, -39.50%, -43.90%, -18.49%, 9.17%
100, ANVS, Annovis Bio Inc., Healthcare, Biotechnology, USA, 354.49M, -, -, -, 71.59, -, -498.10%, -, -, -381.60%, -, -97.60%, -107.70%, -, 3.70, 3.70, 0.00, 0.00, -, -, -, 99.91%, 68.28%, 680.28%, 915.79%, 498.14%, 22.75%
81, AMGN, Amgen Inc., Healthcare, Drug Manufacturers - General, USA, 135.20B, 13.39, 3.10, 5.37, 14.71, 22.50, -4.40%, 8.90%, 6.35%, -7.80%, -4.20%, 11.10%, 70.20%, 19.50%, 1.70, 1.30, 3.34, 3.50, 75.60%, 35.40%, 28.20%, 1.38%, 4.80%, 8.00%, 3.59%, 3.49%, 1.90%
83, AMPE, Ampio Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 358.11M, -, -, -, 20.11, -, 11.90%, 0.00%, -, 42.40%, -, -79.90%, -112.00%, -, 10.70, 10.70, 0.00, 0.00, -, -, -, -4.23%, 5.23%, 108.65%, 237.37%, 13.84%, 7.02%
85, AMRN, Amarin Corporation plc, Healthcare, Biotechnology, Ireland, 1.82B, 141.87, 58.35, 3.03, 2.82, -, 28.70%, 123.10%, 38.90%, 92.80%, -8.30%, 0.10%, 0.20%, -3.30%, 2.90, 2.10, 0.00, 0.00, 79.20%, 0.50%, 0.20%, -13.36%, -26.66%, -1.30%, -33.82%, -7.16%, 4.70%
87, AMS, American Shared Hospital Services, Healthcare, Medical Care Facilities, USA, 15.31M, -, -, 0.87, 0.83, 1.96, -, -, -, 120.80%, -4.30%, -14.20%, -30.80%, -23.60%, 1.60, 1.60, 0.61, 0.66, 25.60%, -52.20%, -39.10%, 4.92%, -1.54%, 31.96%, 39.13%, 15.32%, 25.64%
89, AMWL, American Well Corporation, Healthcare, Health Information Services, USA, 3.01B, -, -, 12.09, 2.54, -, -140.50%, 22.40%, -, -45.30%, 7.30%, -20.30%, -28.60%, -18.60%, 10.80, 10.70, 0.00, 0.00, 38.40%, -96.50%, -96.00%, -22.86%, -50.24%, -49.62%, -, -50.85%, 7.84%
91, ANAB, AnaptysBio Inc., Healthcare, Biotechnology, USA, 665.26M, -, -, 9.34, 1.71, -, 79.70%, -25.80%, -, -119.10%, -25.30%, -7.50%, -7.80%, -6.00%, 26.70, 26.70, 0.00, 0.00, -, -45.00%, -41.90%, -2.09%, -14.90%, -3.28%, 25.10%, 11.02%, 5.02%
93, ANGO, AngioDynamics Inc., Healthcare, Medical Instruments & Supplies, USA, 892.43M, 316.71, -, 3.27, 1.95, 91.06, -44.40%, 55.32%, 15.00%, 38.50%, 2.00%, -28.80%, -37.20%, -33.50%, 2.90, 1.90, 0.07, 0.00, 53.10%, -62.50%, -62.10%, -4.54%, 8.75%, 60.78%, 126.44%, 50.82%, 3.36%
95, ANIP, ANI Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 431.44M, 8.30, -, 2.02, 2.02, -, -478.40%, 23.02%, 2.20%, 101.20%, 9.40%, -, -, -3.30%, 2.20, 1.50, 0.83, 0.90, 60.00%, -, -, 3.00%, 14.31%, 17.40%, 10.59%, 18.29%, 6.22%
97, ANNX, Annexon Inc., Healthcare, Biotechnology, USA, 865.71M, -, -, -, 2.51, -, 26.20%, 1.10%, 38.60%, -911.30%, -, -28.00%, -36.70%, -, 30.90, 30.90, 0.00, 0.00, -, -, -, 5.34%, -29.39%, -14.25%, -, -15.62%, 8.51%
99, ANTM, Anthem Inc., Healthcare, Healthcare Plans, USA, 97.41B, 14.06, 1.61, 0.78, 2.88, 11.24, -2.60%, 12.34%, 13.22%, 13.00%, 9.10%, 5.30%, 13.90%, 10.10%, -, -, 0.67, 0.69, -, 5.70%, 3.80%, 3.97%, 27.85%, 28.85%, 35.40%, 24.02%, 1.67%
102, APLS, Apellis Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 4.58B, -, -, 18.27, 86.58, -, 6.30%, 17.50%, 35.40%, -1.20%, -, -42.20%, -242.20%, -38.00%, 9.20, 9.20, 7.47, 7.59, 90.00%, -, -, 16.67%, 18.04%, 18.58%, 67.05%, -1.61%, 6.14%
104, APM, Aptorum Group Limited, Healthcare, Biotechnology, United Kingdom, 97.50M, -, -, 108.33, 2.17, -, 131.10%, -1.60%, -, 171.10%, 50.00%, 21.70%, 24.50%, -46.00%, 8.70, 8.70, 0.05, 0.06, -11.40%, -, -, 2.56%, -9.68%, 20.17%, -9.04%, 13.36%, 9.34%
106, APR, Apria Inc., Healthcare, Medical Instruments & Supplies, USA, 1.10B, 18.95, -, 0.99, -, -, 195.30%, 16.87%, -, -21.40%, -2.10%, -, -, 14.00%, 1.10, 1.10, -, -, -, -, -, -2.47%, 48.97%, -, -, 30.35%, 6.29%
108, APTO, Aptose Biosciences Inc., Healthcare, Biotechnology, Canada, 463.22M, -, -, -, 4.31, -, -28.80%, 37.20%, -, -20.70%, -, -51.90%, -54.90%, -, 21.30, 21.30, 0.00, 0.00, -, -, -, -5.86%, 31.19%, -13.54%, -28.18%, 21.00%, 4.98%
110, APVO, Aptevo Therapeutics Inc., Healthcare, Biotechnology, USA, 110.23M, -, -, 16.45, 10.97, -, 38.20%, 18.80%, -, 43.20%, -, -62.60%, -294.10%, -, 2.10, -, 0.44, 1.41, -, -, -, -4.46%, -19.63%, -40.38%, 358.25%, -28.73%, 9.00%
112, AQST, Aquestive Therapeutics Inc., Healthcare, Biotechnology, USA, 134.30M, -, -, 2.79, -, -, 36.60%, 26.00%, -, 16.20%, 26.10%, -90.30%, 136.30%, 369.80%, 2.20, 2.10, -, -, 75.00%, -77.90%, -, -12.29%, -29.87%, -44.96%, -23.82%, -30.65%, 6.83%
114, ARAY, Accuray Incorporated, Healthcare, Medical Devices, USA, 395.41M, 63.58, -, 1.04, 5.07, 8.09, 122.50%, 139.29%, -, -114.50%, 3.10%, 1.00%, 6.40%, 9.30%, 1.90, 1.20, 2.09, 2.33, 40.90%, 6.10%, 1.20%, -9.55%, -21.98%, -2.29%, 102.86%, 2.16%, 4.30%
116, ARDS, Aridis Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 64.79M, -, -, 64.79, -, -, 30.60%, 80.40%, -, -5.60%, -, -150.70%, 274.00%, 280.00%, 0.60, 0.60, -, -, -, -, -, -7.29%, -8.83%, -17.55%, -16.77%, -4.78%, 5.92%
118, ARGX, argenx SE, Healthcare, Biotechnology, Netherlands, 14.31B, -, -, 262.47, 9.73, -, -1.50%, -7.90%, -12.80%, -, -44.20%, -, -, -, -, -, -, -, -, -, -, -4.23%, -18.07%, 5.09%, 27.22%, -5.13%, 3.19%
120, ARNA, Arena Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 3.76B, -, -, 11781.40, 3.36, -, -196.10%, 0.80%, -, 0.70%, -98.80%, -33.90%, -36.90%, -36.70%, 23.60, 23.60, 0.04, 0.04, -, -, -, -10.91%, -23.69%, -6.70%, 2.24%, -20.46%, 3.45%
101, APEN, Apollo Endosurgery Inc., Healthcare, Medical Devices, USA, 190.58M, -, -, 4.22, 72.00, -, 22.00%, 2.60%, -, 64.00%, 29.90%, -23.20%, -730.70%, -24.90%, 4.40, 3.60, 20.89, 21.30, 53.40%, -28.50%, -37.50%, 28.57%, 18.03%, 158.06%, 300.00%, 111.76%, 6.07%
103, APLT, Applied Therapeutics Inc., Healthcare, Biotechnology, USA, 510.17M, -, -, -, 3.43, -, -20.60%, -5.20%, -, -68.80%, -, -78.90%, -94.00%, -, 7.80, 7.80, 0.00, 0.00, -, -, -, 4.74%, -7.77%, -14.42%, -57.75%, -12.63%, 7.73%
105, APOP, Cellect Biotechnology Ltd., Healthcare, Biotechnology, Israel, 12.24M, -, -, -, 4.53, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 21.79%, -10.57%, 66.49%, 6.46%, 44.91%, 12.30%
107, APRE, Aprea Therapeutics Inc., Healthcare, Biotechnology, USA, 87.90M, -, -, -, 1.29, -, -89.90%, 8.40%, -, -2.20%, -, -55.00%, -64.00%, -, 7.10, 7.10, 0.00, 0.00, -, -, -, -11.16%, -30.02%, -82.42%, -84.29%, -14.23%, 4.81%
109, APTX, Aptinyx Inc., Healthcare, Biotechnology, USA, 176.61M, -, -, 103.89, 1.12, -, 40.10%, 7.50%, -, 35.80%, 25.00%, -36.80%, -38.00%, -34.80%, 39.30, 39.30, 0.00, 0.00, -, -, -, -9.61%, -31.72%, -25.73%, -32.09%, -26.59%, 5.96%
111, APYX, Apyx Medical Corporation, Healthcare, Medical Devices, USA, 339.13M, -, -, 10.80, 5.59, -, 21.40%, 17.90%, 15.00%, -150.30%, 72.00%, -19.90%, -23.30%, -25.30%, 6.50, 6.00, 0.00, 0.01, 65.00%, -55.10%, -47.40%, -3.45%, -9.10%, 28.31%, 120.50%, 35.97%, 4.49%
113, ARAV, Aravive Inc., Healthcare, Biotechnology, USA, 103.42M, -, -, 17.53, 1.35, -, -23.00%, -7.70%, -, 38.40%, -, -38.60%, -49.20%, -, 9.00, 9.00, 0.00, 0.00, -, -, -, -8.56%, -25.11%, -11.40%, -59.95%, -9.04%, 6.45%
115, ARCT, Arcturus Therapeutics Holdings Inc., Healthcare, Biotechnology, USA, 767.90M, 6.15, -, 85.32, 2.17, -, -65.00%, 176.60%, -, -218.90%, -19.20%, -33.20%, -43.00%, -, 8.80, 8.80, 0.16, 0.17, -, -, -, -21.60%, -46.52%, -51.81%, -24.96%, -32.64%, 7.29%
117, ARDX, Ardelyx Inc., Healthcare, Biotechnology, USA, 713.71M, -, -, 55.33, 5.30, -, 28.50%, 48.60%, 30.00%, -35.50%, 450.00%, -50.80%, -78.60%, -51.30%, 4.90, 4.90, 0.26, 0.39, 91.20%, -, -, -15.18%, 4.08%, 18.38%, -2.46%, 10.51%, 5.08%
119, ARMP, Armata Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 101.32M, -, -, 53.33, 2.41, -, 45.70%, -6.90%, -, 44.70%, -, -48.20%, -84.40%, -, 4.80, 4.80, 0.00, 0.02, -, -, -, -4.76%, -28.06%, 27.23%, 7.53%, 34.01%, 3.96%
122, ARQT, Arcutis Biotherapeutics Inc., Healthcare, Biotechnology, USA, 1.32B, -, -, -, 2.76, -, -231.80%, -15.10%, 9.80%, 34.00%, -, -47.90%, -52.10%, -, 30.40, 30.40, 0.00, 0.00, -, -, -, -13.75%, -24.65%, 2.85%, -21.46%, -6.33%, 6.59%
124, ARVN, Arvinas Inc., Healthcare, Biotechnology, USA, 3.38B, -, -, 159.96, 5.75, -, -41.40%, -19.70%, -, -49.40%, -11.30%, -28.70%, -33.40%, -, 16.50, 16.50, 0.00, 0.00, -, -, -, 4.18%, -5.90%, 210.46%, 118.64%, -14.35%, 5.51%
126, ASLN, ASLAN Pharmaceuticals Limited, Healthcare, Biotechnology, Singapore, 208.61M, -, -, -, -, -, -5.20%, -4.90%, -, 59.70%, -, -190.20%, -, -283.40%, 3.20, 3.20, -, -, -, -, -, -7.76%, -43.43%, 58.82%, 68.75%, 62.30%, 7.56%
128, ASND, Ascendis Pharma A/S, Healthcare, Biotechnology, Denmark, 7.32B, -, -, 861.14, 7.38, -, -76.60%, 15.80%, 24.00%, 11.50%, -68.20%, -47.10%, -54.50%, -35.50%, 9.40, 9.40, 0.11, 0.12, -, -, -, -5.34%, -14.02%, -17.13%, -7.64%, -19.43%, 4.81%
130, ASXC, Asensus Surgical Inc., Healthcare, Medical Devices, USA, 562.00M, -, -, 119.57, 2.34, -, 90.20%, 0.00%, -, 85.60%, 250.00%, -52.70%, -62.00%, -91.40%, 19.20, 18.00, 0.00, 0.01, -40.40%, -, -, 9.35%, -37.10%, 450.59%, 452.80%, 274.40%, 13.56%
132, ATHA, Athira Pharma Inc., Healthcare, Biotechnology, USA, 718.04M, -, -, -, 1.96, -, -915.40%, -22.00%, -, -50.90%, -, -, -, -, 69.30, 69.30, 0.00, 0.00, -, -, -, 3.75%, -6.82%, -12.93%, -, -41.78%, 6.16%
134, ATHX, Athersys Inc., Healthcare, Biotechnology, USA, 370.91M, -, -, 264.93, 8.79, -, -43.00%, 77.50%, -, -32.20%, 342.50%, -124.70%, -200.90%, -, 2.40, 2.40, 0.00, 0.00, -, -, -, -0.60%, -23.04%, -5.65%, -42.61%, -4.57%, 5.44%
136, ATNM, Actinium Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 152.10M, -, -, 253.50, 2.12, -, 58.40%, -2.00%, -, 70.60%, -, -35.30%, -38.30%, -, 17.70, 17.70, 0.00, 0.00, -, -, -, 4.35%, 1.24%, -25.07%, 27.88%, 4.62%, 4.74%
138, ATOS, Atossa Therapeutics Inc., Healthcare, Biotechnology, USA, 389.05M, -, -, -, 2.15, -, 2.70%, -10.50%, -, 88.20%, -, -44.60%, -50.20%, -, 102.30, 102.30, 0.00, 0.00, -, -, -, 38.79%, 12.98%, 105.10%, 35.29%, 238.95%, 11.85%
140, ATRC, AtriCure Inc., Healthcare, Medical Instruments & Supplies, USA, 3.36B, -, -, 15.80, 8.52, -, -22.10%, 27.20%, 20.00%, 10.70%, 11.50%, -6.90%, -11.90%, -9.30%, 5.10, 4.50, 0.15, 0.15, 72.90%, -21.00%, -22.90%, -1.67%, 12.70%, 71.28%, 56.31%, 34.24%, 3.51%
121, ARPO, Aerpio Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 79.10M, -, -, 5.27, 2.05, -, 82.30%, -50.00%, -, 2.70%, -, -10.70%, -11.30%, -14.70%, 19.30, 19.30, 0.00, 0.00, -, -, -32.30%, 45.30%, -3.41%, 8.97%, 51.79%, 73.47%, 14.03%
123, ARTL, Artelo Biosciences Inc., Healthcare, Biotechnology, USA, 28.50M, -, -, -, 1.63, -, -25.60%, 20.90%, -, 72.50%, -, -68.40%, -72.80%, -, 19.40, 19.40, 0.00, 0.00, -, -, -, -6.77%, -41.78%, 119.51%, -3.12%, 69.86%, 7.50%
125, ARWR, Arrowhead Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 7.57B, -, -, 85.01, 16.92, 45.85, -221.80%, 53.10%, 7.33%, -32.30%, 39.60%, -18.80%, -23.60%, -20.20%, 3.50, 3.50, 0.00, 0.00, -, -, -, -4.17%, -13.34%, 27.32%, 125.19%, -5.38%, 4.95%
127, ASMB, Assembly Biosciences Inc., Healthcare, Biotechnology, USA, 158.60M, -, -, 2.11, 0.64, -, 52.80%, -4.10%, 17.00%, 9.80%, -78.20%, -21.60%, -24.50%, -, 15.30, 15.30, 0.00, 0.00, -, -, -83.60%, -7.46%, -21.39%, -30.35%, -79.63%, -34.38%, 4.18%
129, ASRT, Assertio Holdings Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 77.79M, 5.32, -, 0.69, 0.65, -, 91.30%, -15.00%, 25.00%, -94.90%, 28.20%, -19.80%, -80.60%, -6.40%, 1.10, 1.10, 0.68, 0.80, 80.00%, -73.40%, -57.80%, -17.26%, -54.41%, 4.31%, -54.14%, 26.54%, 9.39%
131, ATEC, Alphatec Holdings Inc., Healthcare, Medical Devices, USA, 1.42B, -, -, 8.92, 5.27, -, -8.20%, 38.20%, 12.00%, 20.70%, 46.50%, -33.10%, -81.80%, -38.70%, 4.00, 3.20, 0.16, 0.18, 71.30%, -42.60%, -51.10%, -10.60%, -12.33%, 32.42%, 225.84%, -0.14%, 4.37%
133, ATHE, Alterity Therapeutics Limited, Healthcare, Biotechnology, Australia, 48.40M, -, -, 1719.21, 1.11, -, 25.00%, -, -, 34.60%, 1.50%, -80.20%, -94.60%, -, 12.30, 12.30, 0.00, 0.00, -, -, -, -10.07%, -20.71%, -13.55%, 123.77%, 0.00%, 7.19%
135, ATNF, 180 Life Sciences Corp., Healthcare, Biotechnology, USA, 190.70M, -, -, -, 9.38, -, -130.90%, -, -, -, -, -76.60%, -156.80%, -, 0.10, 0.10, 0.00, 0.55, -, -, -, -17.65%, 81.70%, 207.19%, -18.67%, 212.82%, 9.60%
137, ATNX, Athenex Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 449.82M, -, -, 3.25, 2.78, -, -2.80%, 14.70%, -, -12.50%, -12.60%, -42.10%, -86.40%, -42.00%, 5.10, 4.50, 0.93, 0.94, 33.40%, -, -, 15.52%, -14.10%, -65.77%, -56.85%, -57.59%, 9.33%
139, ATRA, Atara Biotherapeutics Inc., Healthcare, Biotechnology, USA, 1.15B, -, -, 319.49, 3.11, -, 26.90%, 5.00%, -, 28.70%, -, -63.80%, -78.00%, -, 5.50, 5.50, 0.00, 0.00, -, -, -, -6.68%, -20.72%, -41.02%, 17.91%, -30.92%, 5.70%
142, ATRS, Antares Pharma Inc., Healthcare, Medical Instruments & Supplies, USA, 687.01M, 15.82, -, 4.33, 5.29, 91.60, 83.30%, 130.28%, -, 252.30%, 27.20%, 34.20%, 67.80%, 37.40%, 1.90, 1.60, 0.12, 0.33, 59.30%, 12.80%, 39.30%, 2.85%, -11.78%, 31.02%, 38.33%, -0.50%, 3.67%
144, AUPH, Aurinia Pharmaceuticals Inc., Healthcare, Biotechnology, Canada, 1.86B, -, -, 37.12, 4.51, -, -53.00%, 45.50%, -, -, 172417.20%, -, -, -, -, -, -, -, -, -, -, 20.20%, 0.28%, 3.86%, -8.51%, 4.99%, 7.00%
146, AVAH, Aveanna Healthcare Holdings Inc., Healthcare, Medical Care Facilities, USA, 2.15B, -, -, 1.38, 6.01, -, 25.40%, -, -, -, 17.50%, -, -, -0.60%, 1.40, 1.40, 4.25, 4.29, -, -, -, 0.61%, -, -, -, 0.61%, 5.43%
148, AVDL, Avadel Pharmaceuticals plc, Healthcare, Drug Manufacturers - Specialty & Generic, Ireland, 459.09M, -, -, 45.45, 3.29, -, 95.70%, 86.80%, 15.00%, 5.40%, -100.00%, -1.70%, -3.40%, 3.00%, 26.60, -, 1.04, 0.00, 67.40%, -, -55.00%, -2.04%, -7.13%, 5.20%, -4.83%, 15.12%, 6.58%
150, AVGR, Avinger Inc., Healthcare, Medical Devices, USA, 98.20M, -, -, 10.79, 4.77, -, 85.40%, -, -, 85.70%, 13.00%, -62.80%, -159.50%, -, 5.10, 4.60, 0.55, 0.65, 33.20%, -, -, -16.00%, -37.50%, 265.09%, 182.26%, 138.58%, 8.67%
152, AVNS, Avanos Medical Inc., Healthcare, Medical Devices, USA, 1.93B, 25.06, -, 2.69, 1.54, -, -13.50%, 33.33%, 6.30%, -305.40%, 0.20%, -2.20%, -3.00%, -2.60%, 2.90, 1.80, 0.14, 0.14, 50.70%, -8.30%, -5.40%, -8.74%, -15.28%, -6.74%, 37.99%, -12.60%, 3.46%
154, AVXL, Anavex Life Sciences Corp., Healthcare, Biotechnology, USA, 867.76M, -, -, -, 11.22, -, 16.00%, -15.10%, -, 4.10%, -, -55.80%, -65.40%, -, 10.80, 10.80, 0.00, 0.00, -, -, -, 1.63%, -3.79%, 139.42%, 202.92%, 130.56%, 6.59%
156, AXDX, Accelerate Diagnostics Inc., Healthcare, Diagnostics & Research, USA, 439.54M, -, -, 38.90, -, -, 9.70%, 17.80%, 30.00%, -6.60%, 8.70%, -80.10%, 150.40%, -76.10%, 11.10, 9.80, -, -, 37.90%, -, -, 2.43%, -25.30%, -6.87%, -9.10%, 0.13%, 5.45%
158, AXLA, Axcella Health Inc., Healthcare, Biotechnology, USA, 124.09M, -, -, -, 1.95, -, 49.90%, -36.60%, 0.00%, 37.70%, -, -50.50%, -71.20%, -, 9.00, 9.00, 0.34, 0.41, -, -, -, -26.67%, -43.94%, -43.54%, -46.83%, -38.54%, 7.11%
160, AXSM, Axsome Therapeutics Inc., Healthcare, Biotechnology, USA, 2.27B, -, -, -, 23.62, -, -37.70%, 40.10%, -, 10.80%, -, -53.30%, -79.80%, -, 7.60, 7.60, 0.50, 0.00, -, -, -, -1.73%, -12.27%, -17.31%, -21.14%, -25.48%, 4.80%
141, ATRI, Atrion Corporation, Healthcare, Medical Instruments & Supplies, USA, 1.12B, -, -, 7.85, 4.63, -, -11.60%, -, -, -11.90%, -10.10%, 11.70%, 12.90%, 12.20%, 11.10, 6.50, 0.00, 0.00, 43.80%, 23.00%, 21.60%, -3.99%, -2.79%, 5.15%, -3.27%, -3.31%, 2.20%
143, ATXI, Avenue Therapeutics Inc., Healthcare, Biotechnology, USA, 84.92M, 10.12, -, -, 55.11, -, 81.10%, 281.50%, -, 20.00%, -, -132.00%, -175.70%, -, 4.10, 4.10, 0.00, 0.00, -, -, -, -5.34%, -4.25%, 48.95%, -56.76%, -16.64%, 8.23%
145, AUTL, Autolus Therapeutics plc, Healthcare, Biotechnology, United Kingdom, 448.52M, -, -, 280.32, 1.65, -, 4.20%, 4.50%, -, 10.50%, 33.30%, -44.50%, -56.50%, -68.60%, 5.90, 5.90, 0.00, 0.00, -, -, -, 16.32%, -3.35%, -37.33%, -47.04%, -25.84%, 10.01%
147, AVCO, Avalon GloboCare Corp., Healthcare, Medical Care Facilities, USA, 98.80M, -, -, 70.57, 19.00, -, 33.70%, -, -, 33.40%, 0.00%, -108.10%, -249.90%, -161.70%, 0.70, -, 0.72, 0.80, 30.70%, -, -, 10.68%, -9.52%, -10.24%, -28.30%, 1.79%, 8.09%
149, AVEO, AVEO Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 245.28M, -, -, 34.07, 2.77, -, -372.30%, 91.60%, -, -54.80%, 137.50%, -57.50%, -100.70%, -79.20%, 6.40, 6.40, 0.45, 0.45, 98.10%, -, -, 4.43%, -14.22%, 35.94%, -10.54%, 26.52%, 6.34%
151, AVIR, Atea Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.70B, 1.65, -, 14.84, 2.88, -, 23.60%, 2407.07%, -, 797.90%, -, 4.90%, 9.60%, -2.00%, 3.30, 3.30, 0.00, 0.00, -, -, 20.70%, -22.59%, -72.32%, -39.59%, -, -51.12%, 9.26%
153, AVRO, AVROBIO Inc., Healthcare, Biotechnology, USA, 373.80M, -, -, -, 1.61, -, -24.30%, -0.70%, -, 16.20%, -, -48.00%, -51.60%, -, 19.00, 19.00, 0.00, 0.00, -, -, -, -22.43%, -21.48%, -35.79%, -55.54%, -35.51%, 8.13%
155, AWH, "Aspira Womens Health Inc.", Healthcare, Diagnostics & Research, USA, 608.97M, -, -, 124.28, 11.65, -, -1.00%, -15.40%, -, -43.00%, 25.00%, -69.20%, -96.00%, -124.90%, 10.00, 10.00, 0.07, 0.09, 28.80%, -, -, -3.95%, -26.16%, 28.51%, 70.95%, -16.69%, 6.99%
157, AXGN, AxoGen Inc., Healthcare, Medical Devices, USA, 835.14M, -, -, 7.01, 6.90, -, 19.90%, 53.50%, -, 20.70%, 27.60%, -11.70%, -18.40%, -14.90%, 6.10, 5.50, 0.27, 0.27, 79.50%, -17.60%, -18.70%, 7.52%, -10.18%, 42.26%, 109.28%, 13.41%, 5.47%
159, AXNX, Axonics Inc., Healthcare, Medical Devices, USA, 2.62B, -, -, 21.92, 6.93, -, 46.90%, 48.60%, -, -30.70%, 30.80%, -16.90%, -20.80%, -17.40%, 9.50, 6.50, 0.23, 0.23, 59.40%, -50.70%, -52.50%, -7.49%, 7.89%, 32.20%, 57.32%, 15.56%, 4.99%
162, AYTU, Aytu Biopharma Inc., Healthcare, Biotechnology, USA, 128.42M, -, -, 2.25, 0.64, -, 91.30%, 55.60%, -, 6.90%, 64.60%, -23.20%, -38.40%, -, 1.20, 1.00, 0.12, 0.16, 50.80%, -70.30%, -74.40%, -24.29%, -35.04%, -43.56%, -65.91%, -15.05%, 5.90%
164, AZRX, AzurRx BioPharma Inc., Healthcare, Biotechnology, USA, 65.80M, -, -, -, 1.85, -, -116.80%, 27.60%, -, -392.90%, -, -487.80%, -, -, 3.70, 3.70, 0.00, 0.02, -, -, -, -10.89%, -43.33%, 8.82%, 5.85%, -12.37%, 7.82%
166, BAX, Baxter International Inc., Healthcare, Medical Instruments & Supplies, USA, 41.14B, 20.44, 3.46, 3.48, 4.91, 52.88, 37.10%, 14.34%, 11.47%, -9.40%, 5.10%, 5.40%, 12.60%, 8.60%, 2.50, 1.80, 0.67, 0.72, 39.20%, 12.20%, 9.00%, -3.78%, 5.36%, 8.93%, -8.77%, 2.34%, 1.41%
168, BBIO, BridgeBio Pharma Inc., Healthcare, Biotechnology, USA, 8.66B, -, -, 995.04, -, -, -53.40%, -2.80%, -, -50.90%, -99.10%, -59.60%, -, -88.40%, 10.00, 10.00, -, -, -, -, -, 7.11%, -17.67%, 22.14%, 101.84%, -16.75%, 5.08%
170, BCDA, BioCardia Inc., Healthcare, Biotechnology, USA, 68.51M, -, -, 342.54, 3.65, -, 43.10%, -5.80%, -, 73.40%, -78.60%, -77.20%, -108.90%, -78.20%, 4.80, -, 0.00, 0.00, -, -, -, 15.54%, 4.87%, 72.58%, -0.73%, 18.21%, 6.22%
172, BCLI, Brainstorm Cell Therapeutics Inc., Healthcare, Biotechnology, USA, 130.71M, -, -, -, 3.54, -, -0.40%, 33.80%, -, 34.80%, -, -80.00%, -113.00%, -, 5.00, 5.00, 0.00, 0.00, -, -, -, 1.99%, -13.73%, -28.26%, -51.95%, -20.88%, 5.62%
174, BCTX, BriaCell Therapeutics Corp., Healthcare, Biotechnology, Canada, 21.90M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -5.63%, -15.06%, -27.33%, -69.58%, -21.58%, 7.14%
176, BDSI, BioDelivery Sciences International Inc., Healthcare, Biotechnology, USA, 345.90M, 6.92, 0.57, 2.17, 3.27, -, 233.10%, 105.65%, 25.00%, 7.00%, 7.00%, 11.20%, 26.10%, 17.50%, 3.40, 3.10, 0.72, 0.72, 84.30%, 21.60%, 16.30%, 0.57%, -18.10%, -5.11%, -26.15%, -15.95%, 4.35%
178, BDTX, Black Diamond Therapeutics Inc., Healthcare, Biotechnology, USA, 493.57M, -, -, -, 1.69, -, -89.20%, -11.30%, -, -63.70%, -, -25.50%, -27.10%, -, 15.90, 15.90, 0.00, 0.00, -, -, -, -51.92%, -53.03%, -60.75%, -66.40%, -59.06%, 8.69%
180, BEAM, Beam Therapeutics Inc., Healthcare, Biotechnology, USA, 5.00B, -, -, 208319.98, 11.14, -, -108.70%, 36.00%, -, -224.10%, 0.00%, -84.90%, -133.10%, -, 5.00, 5.00, 0.01, 0.02, -, -, -, 0.17%, -18.15%, 75.05%, 206.18%, -4.18%, 9.55%
161, AYLA, Ayala Pharmaceuticals Inc., Healthcare, Biotechnology, Israel, 125.83M, -, -, 34.01, 2.32, -, -74.10%, -5.40%, -, -14.00%, 0.00%, -60.60%, -68.90%, -78.70%, 10.20, 10.20, 0.00, 0.00, 0.00%, -, -, -8.27%, -43.55%, -3.44%, -36.74%, -13.27%, 2.37%
163, AZN, AstraZeneca PLC, Healthcare, Drug Manufacturers - General, United Kingdom, 150.12B, 17.82, 2.03, 5.44, 10.32, 76.75, 137.20%, 25.15%, 18.50%, 99.20%, 15.20%, 6.20%, 29.20%, 12.20%, 0.90, 0.70, 1.24, 1.40, 79.00%, 21.20%, 14.40%, 10.51%, 18.05%, 7.93%, 3.97%, 13.56%, 1.17%
165, AZYO, Aziyo Biologics Inc., Healthcare, Medical Devices, USA, 126.76M, -, -, 2.77, 7.80, -, -112.20%, 33.70%, -, 93.00%, 30.30%, -, -, -31.00%, 2.10, 1.70, 0.95, 1.68, 47.40%, -, -, 21.84%, -19.08%, -2.79%, -, -7.92%, 8.55%
167, BBI, Brickell Biotech Inc., Healthcare, Biotechnology, USA, 55.42M, -, -, 69.27, 1.70, -, 81.00%, 24.00%, -, 67.30%, -96.00%, -81.70%, -108.80%, -76.30%, 4.10, 4.10, 0.01, 0.01, -, -, -, -22.36%, -39.16%, 24.46%, -29.72%, 4.45%, 6.55%
169, BCAB, BioAtla Inc., Healthcare, Biotechnology, USA, 1.41B, -, -, 3286.45, 7.40, -, -24.80%, -39.20%, -, 30.80%, -100.00%, -, -, -15.70%, 7.40, 7.40, 0.00, 0.00, -, -, -, -15.93%, -17.69%, -, -, 26.58%, 7.24%
171, BCEL, Atreca Inc., Healthcare, Biotechnology, USA, 263.47M, -, -, -, 1.50, -, -12.10%, 1.40%, -, 4.00%, -, -37.70%, -41.70%, -, 12.00, 12.00, 0.00, 0.00, -, -, -, -25.02%, -50.84%, -38.64%, -51.16%, -44.15%, 7.07%
173, BCRX, BioCryst Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 2.62B, -, -, 81.91, -, -, -16.00%, 34.80%, 19.90%, -48.60%, 297.90%, -83.00%, -, -69.30%, 2.70, 2.70, -, -, 76.60%, -, -, 30.12%, 31.64%, 231.30%, 250.83%, 111.68%, 7.52%
175, BCYC, Bicycle Therapeutics plc, Healthcare, Biotechnology, United Kingdom, 717.14M, -, -, 64.61, 4.59, -, 3.90%, -20.70%, -, -16.40%, 63.60%, -33.20%, -53.50%, -46.60%, 10.40, 10.40, 0.21, 0.21, -, -, -, -1.01%, 14.92%, 48.99%, 65.08%, 64.35%, 5.90%
177, BDSX, Biodesix Inc., Healthcare, Diagnostics & Research, USA, 377.72M, -, -, 8.29, 10.55, -, -0.90%, 36.40%, -, 77.60%, 17.50%, -, -, -33.30%, 5.00, 5.00, 0.83, 0.91, -, -, -, -9.01%, -24.11%, -19.59%, -, -28.32%, 9.22%
179, BDX, Becton Dickinson and Company, Healthcare, Medical Instruments & Supplies, USA, 70.07B, 18.46, 3.63, 3.72, 2.84, 22.84, -27.70%, 2.11%, 11.85%, 79.00%, 15.40%, 3.00%, 6.70%, 3.30%, 1.90, 1.30, 0.71, 0.71, 47.20%, 12.00%, 8.70%, -3.79%, -1.69%, 6.34%, -2.04%, -3.33%, 1.91%
182, BFRA, Biofrontera AG, Healthcare, Biotechnology, Germany, 199.65M, -, -, 6.58, 22.86, -, -72.70%, 2.10%, -, -, -22.00%, -, -, -, -, -, -, -, -, -, -, 30.37%, 8.31%, -1.49%, 13.86%, -2.71%, 7.71%
184, BHC, Bausch Health Companies Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 11.47B, 6.76, -, 1.43, -, 11.50, 68.90%, 14.03%, 6.05%, -297.50%, 0.70%, -3.30%, -291.10%, 4.10%, 1.10, 0.90, -, -, 71.40%, 2.10%, -12.70%, -1.65%, 1.29%, 67.76%, 74.03%, 54.62%, 3.28%
186, BIIB, Biogen Inc., Healthcare, Drug Manufacturers - General, USA, 40.25B, 13.27, -, 3.19, 3.80, 11.71, -21.10%, 10.12%, -12.33%, -66.70%, -23.80%, 12.20%, 27.70%, 19.60%, 2.10, 1.80, 0.68, 0.00, 85.50%, 29.40%, 23.90%, 0.81%, -2.11%, 10.64%, -10.99%, 9.24%, 2.39%
188, BIO, Bio-Rad Laboratories Inc., Healthcare, Medical Devices, USA, 17.81B, 47.61, 0.25, 6.59, 1.69, 33.65, 116.60%, 1.31%, 17.80%, 42.50%, 27.20%, 33.40%, 44.70%, -6.90%, 3.60, 2.60, 0.00, 0.00, 56.30%, 16.40%, -, -5.99%, 0.85%, 15.13%, 22.60%, 3.33%, 2.25%
190, BIOL, BIOLASE Inc., Healthcare, Medical Devices, USA, 105.80M, -, -, 4.05, 2.90, -, 27.30%, 31.20%, 20.00%, 71.00%, 68.80%, -, -, -71.50%, 5.10, 4.10, 0.49, 0.00, 29.00%, -, -, -4.57%, -28.22%, 153.05%, 81.30%, 73.99%, 8.17%
192, BKD, Brookdale Senior Living Inc., Healthcare, Medical Care Facilities, USA, 1.27B, -, -, 0.39, 1.79, -, 130.90%, 41.90%, 10.00%, -129.40%, -26.10%, -5.60%, -48.40%, -1.70%, 1.00, 1.00, 6.07, 6.42, 19.00%, -5.60%, -12.10%, 1.35%, 18.25%, 53.88%, 84.15%, 52.14%, 3.83%
194, BLFS, BioLife Solutions Inc., Healthcare, Medical Instruments & Supplies, USA, 1.34B, 174.40, -, 25.44, 5.30, 194.65, 214.70%, 246.20%, 10.00%, -103.20%, 37.70%, -10.60%, -11.70%, -1.10%, 7.10, 6.40, 0.01, 0.01, 55.20%, -13.30%, -39.30%, -3.70%, -18.12%, 0.94%, 102.49%, -16.50%, 6.56%
196, BLPH, Bellerophon Therapeutics Inc., Healthcare, Biotechnology, USA, 40.70M, -, -, -, 1.19, -, -7.70%, 14.20%, -, 46.60%, -, -47.60%, -59.10%, -, 5.00, 5.00, 0.00, 0.00, -, -, -, -4.61%, -36.79%, -36.31%, -70.80%, -37.93%, 4.92%
198, BLU, BELLUS Health Inc., Healthcare, Biotechnology, Canada, 309.00M, -, -, 20600.00, 2.35, -, 1.90%, -, -, -10.50%, -42.90%, -27.60%, -29.00%, -, 18.10, 18.10, 0.00, 0.00, -, -, -, -1.96%, -0.74%, 35.59%, -61.87%, 30.72%, 5.47%
200, BMEA, Biomea Fusion Inc., Healthcare, Biotechnology, USA, 497.97M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 2.00%, -, -, -, -6.94%, 6.90%
181, BFLY, Butterfly Network Inc., Healthcare, Medical Devices, USA, 2.18B, -, -, 176.17, 2.85, -, -, -, -, -, 45.80%, -28.10%, -35.50%, -, 11.60, 10.90, 0.00, 0.00, 51.60%, -, -, -18.12%, -39.15%, -32.35%, -, -40.63%, 7.55%
183, BGNE, BeiGene Ltd., Healthcare, Biotechnology, China, 31.79B, -, -, 36.85, 8.19, -, -13.80%, 14.10%, 37.00%, 114.60%, 75.90%, -22.30%, -31.80%, -37.50%, 4.60, 4.60, 0.05, 0.15, 89.70%, -, -, 0.62%, 12.25%, 35.72%, 116.57%, 38.75%, 4.53%
185, BHVN, Biohaven Pharmaceutical Holding Company Ltd., Healthcare, Biotechnology, USA, 5.37B, -, -, 50.53, -, -, -19.70%, 36.70%, -, -39.30%, -, -118.60%, 375.80%, -198.10%, 2.30, 2.10, -, -, 71.70%, -, -, 14.26%, 0.72%, -2.92%, 39.27%, 1.51%, 4.94%
187, BIMI, BOQI International Medical Inc., Healthcare, Pharmaceutical Retailers, China, 31.50M, -, -, 2.46, 0.95, -, -32.50%, -, -, -26.40%, -, -, -, -19.60%, 1.60, 1.60, 0.04, 0.30, 91.40%, -, -, -16.11%, -31.32%, -40.19%, -49.19%, -25.15%, 7.68%
189, BIOC, Biocept Inc., Healthcare, Diagnostics & Research, USA, 61.70M, -, -, 1.41, 2.26, -, 87.70%, -53.70%, 40.00%, 118.00%, 937.80%, -16.80%, -28.10%, -59.00%, 3.00, 2.70, 0.07, 0.11, 37.40%, -15.10%, -15.70%, -7.76%, -30.03%, 0.67%, 3.91%, 1.80%, 4.61%
191, BIVI, BioVie Inc., Healthcare, Biotechnology, USA, 203.64M, -, -, -, 16.77, -, -598.00%, 28.30%, -, -205.10%, -, -660.30%, -, -, 8.00, 8.00, 0.01, 0.01, -, -, -, -15.18%, -43.85%, 62.91%, 205.56%, -20.61%, 12.03%
193, BLCM, Bellicum Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 24.41M, -, -, 48.81, -, -, 94.40%, 41.70%, -, -132.30%, -90.30%, -71.30%, 130.40%, 2063.20%, 1.20, 1.20, -, -, -, -, -, -15.82%, -32.43%, -4.18%, -60.94%, -15.58%, 7.94%
195, BLI, Berkeley Lights Inc., Healthcare, Biotechnology, USA, 3.00B, -, -, 43.32, 11.73, -, -92.60%, 10.90%, -, -58.10%, 34.80%, -19.40%, -34.20%, -15.30%, 6.70, 6.40, 0.01, 0.08, 68.00%, -68.50%, -71.60%, -13.66%, -30.18%, -44.22%, -, -51.35%, 6.46%
197, BLRX, BioLineRx Ltd., Healthcare, Biotechnology, Israel, 123.07M, -, -, -, 3.03, -, 55.60%, 32.50%, -, -, -, -, -, -, -, -, -, -, -, -, -, -6.23%, -9.49%, 27.11%, 47.42%, 13.49%, 11.63%
199, BLUE, bluebird bio Inc., Healthcare, Biotechnology, USA, 2.14B, -, -, 8.85, 1.74, -, 30.50%, 15.30%, -, 15.70%, -41.60%, -33.30%, -43.20%, -46.00%, 5.30, 5.20, 0.00, 0.00, 97.20%, -, -, 2.94%, 3.46%, -28.01%, -51.09%, -28.08%, 4.75%
202, BMRN, BioMarin Pharmaceutical Inc., Healthcare, Biotechnology, USA, 14.14B, 84.39, -, 7.66, 3.38, 123.14, 117.90%, 280.40%, 32.16%, -78.30%, -3.20%, 13.80%, 20.40%, 0.20%, 5.30, 3.70, 0.26, 0.00, 71.10%, -6.30%, 43.10%, -3.59%, -2.36%, -1.09%, -27.45%, -11.85%, 2.39%
204, BNGO, Bionano Genomics Inc., Healthcare, Diagnostics & Research, USA, 1.73B, -, -, 165.18, 4.50, -, 80.20%, -16.70%, -, 87.20%, 190.90%, -31.60%, -38.80%, -75.10%, 51.60, 51.20, 0.04, 0.00, 33.60%, -, -, -6.66%, -37.30%, 1161.76%, 1274.16%, 100.32%, 9.35%
206, BNTC, Benitec Biopharma Inc., Healthcare, Biotechnology, USA, 35.51M, -, -, 739.86, 2.05, -, -, -, -, -, -98.70%, -, -, -, 5.10, 5.10, 0.00, 0.00, -, -, -, 10.82%, 61.30%, 66.43%, -35.48%, 57.00%, 8.66%
208, BOLT, Bolt Biotherapeutics Inc., Healthcare, Biotechnology, USA, 668.53M, -, -, 2894.08, 1.24, -, -89.30%, -4.50%, -, -319.40%, -100.00%, -, -, 46.80%, 22.60, 22.60, 0.00, 0.00, -, -, -, -27.64%, -41.63%, -, -, -45.54%, 9.06%
210, BPTH, Bio-Path Holdings Inc., Healthcare, Biotechnology, USA, 39.50M, -, -, -, 1.04, -, 12.60%, 7.90%, -, 52.50%, -, -48.80%, -52.90%, -, 21.50, 21.50, 0.00, 0.00, -, -, -, -6.56%, -11.76%, 63.79%, 3.07%, 62.86%, 6.21%
212, BRKR, Bruker Corporation, Healthcare, Medical Devices, USA, 10.52B, 32.01, 5.43, 4.97, 10.90, 37.67, -18.90%, 16.61%, 9.65%, 447.70%, 30.80%, 6.90%, 21.60%, 10.20%, 2.10, 1.30, 0.74, 0.85, 48.40%, 15.20%, 9.60%, -0.84%, 11.09%, 37.50%, 60.44%, 28.28%, 2.79%
214, BSX, Boston Scientific Corporation, Healthcare, Medical Devices, USA, 59.62B, 23.00, 18.11, 5.89, 3.84, 39.22, -119.10%, 16.79%, 16.90%, -, 8.20%, 0.70%, 1.30%, -0.30%, 1.80, 1.40, 0.58, 0.58, 64.40%, 1.40%, 2.00%, -3.51%, 9.38%, 26.83%, 12.00%, 18.36%, 1.61%
216, BTX, Brooklyn ImmunoTherapeutics Inc., Healthcare, Biotechnology, USA, 602.21M, -, -, 103.83, 24.83, -, -110.90%, -, -, 122.50%, -76.90%, -66.60%, -248.90%, -217.30%, 0.70, 0.70, 0.56, 2.22, 49.90%, -, -76.40%, -57.92%, 100.00%, 265.48%, 542.86%, 221.43%, 28.72%
218, BVXV, BiondVax Pharmaceuticals Ltd., Healthcare, Biotechnology, Israel, 45.30M, -, -, -, -, -, 97.00%, -, -, 67.90%, -, -, 15.60%, -, 0.20, 0.20, -, -, -, -, -, -5.61%, -30.50%, -6.19%, -84.77%, 7.83%, 6.96%
220, BXRX, Baudax Bio Inc., Healthcare, Biotechnology, USA, 64.50M, -, -, 92.14, -, -, -12.90%, 36.30%, -, 93.30%, -, -75.10%, 175.10%, 1335.50%, 3.10, 2.90, -, -, -, -, -, -21.48%, -36.85%, -19.38%, -78.75%, -10.59%, 8.53%
201, BMRA, Biomerica Inc., Healthcare, Diagnostics & Research, USA, 45.00M, 18.53, -, 5.06, 4.10, -, 11.40%, 140.00%, -, -76.10%, 200.00%, -35.80%, -45.10%, -17.00%, 8.00, 5.90, 0.00, 0.00, 14.00%, -62.80%, -61.60%, -22.34%, -41.97%, -43.85%, -43.59%, -26.71%, 8.05%
203, BMY, Bristol-Myers Squibb Company, Healthcare, Drug Manufacturers - General, USA, 146.72B, 8.21, -, 3.43, 3.91, 16.17, -298.80%, 7.63%, 7.80%, 360.00%, 2.70%, -5.10%, -14.20%, -12.10%, 1.60, 1.50, 1.18, 1.23, 76.70%, -18.10%, -14.50%, 4.50%, 6.64%, 4.58%, 10.05%, 5.95%, 1.45%
205, BNR, Burning Rock Biotech Limited, Healthcare, Diagnostics & Research, China, 3.02B, -, -, 41.12, 7.71, -, -109.40%, 15.70%, 5.16%, -112.60%, 58.40%, -20.40%, -22.60%, -16.70%, 8.80, 8.40, 0.00, 0.02, 73.80%, -, -, -9.92%, -26.94%, -3.32%, -, 17.19%, 9.25%
207, BNTX, BioNTech SE, Healthcare, Biotechnology, Germany, 47.75B, 6.69, -, 15.65, 16.14, -, 107.10%, -14.70%, -, -, 1134.30%, 53.50%, 88.30%, 4.90%, 2.70, 2.60, 0.09, 0.23, 88.60%, 65.50%, 47.80%, 13.55%, 85.10%, 94.36%, 311.87%, 150.25%, 8.31%
209, BPMC, Blueprint Medicines Corporation, Healthcare, Biotechnology, USA, 5.45B, -, -, 6.73, 3.79, 14.77, 176.90%, 14.50%, -, 18.40%, 248.40%, 22.70%, 27.30%, 20.90%, 8.30, 8.20, 0.00, 0.00, 99.90%, 39.80%, 40.20%, -7.61%, -8.77%, -13.26%, 40.24%, -18.55%, 3.95%
211, BPTS, Biophytis SA, Healthcare, Biotechnology, France, 127.28M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -19.18%, -, -, -, -31.82%, 2.43%
213, BSGM, BioSig Technologies Inc., Healthcare, Medical Devices, USA, 118.41M, -, -, 1184.10, 5.75, -, -13.70%, 51.70%, -, 43.30%, -, -151.80%, -185.70%, -, 6.00, 5.80, 0.00, 0.00, 16.10%, -, -, -1.63%, -19.56%, -20.44%, -61.41%, -7.18%, 9.21%
215, BTAI, BioXcel Therapeutics Inc., Healthcare, Biotechnology, USA, 830.04M, -, -, -, 4.34, -, -87.20%, 23.00%, -, -36.80%, -, -51.30%, -56.10%, -, 16.00, 16.00, 0.00, 0.00, -, -, -, -4.26%, -40.71%, -26.02%, -29.06%, -28.51%, 6.06%
217, BVS, Bioventus Inc., Healthcare, Diagnostics & Research, USA, 1.02B, 14.36, -, 3.13, 5.21, -, 279.20%, -16.91%, -, 127.90%, -16.20%, -, -, 14.90%, 1.80, 1.50, 1.19, 1.30, -, -, -, 23.47%, 36.87%, -, -, -7.44%, 4.89%
219, BWAY, BrainsWay Ltd., Healthcare, Diagnostics & Research, Israel, 183.25M, -, -, 8.31, 6.32, -, 45.80%, 46.20%, -, -, 12.30%, -, -, -, -, -, -, -, -, -, -, 29.84%, 24.61%, 75.43%, 42.82%, 47.75%, 5.56%
222, CABA, Cabaletta Bio Inc., Healthcare, Biotechnology, USA, 280.21M, -, -, -, 2.61, -, -55.50%, -16.30%, -, -23.70%, -, -30.20%, -31.30%, -, 26.60, 26.60, 0.00, 0.00, -, -, -, -0.53%, -1.13%, -19.52%, 32.63%, -9.13%, 7.60%
224, CALA, Calithera Biosciences Inc., Healthcare, Biotechnology, USA, 166.60M, -, -, -, 1.75, -, 31.00%, 7.40%, -, 25.50%, -, -62.70%, -74.50%, -, 7.70, 7.70, 0.00, 0.00, -, -, -, 3.64%, -21.38%, -52.80%, -60.82%, -53.56%, 6.04%
226, CANF, Can-Fite BioPharma Ltd., Healthcare, Biotechnology, Israel, 37.13M, -, -, 48.67, 5.54, -, 61.80%, 50.00%, -, -, -21.90%, -, -, -, -, -, -, -, -, -, -, -1.37%, 6.93%, 18.68%, 0.47%, 21.35%, 4.89%
228, CARA, Cara Therapeutics Inc., Healthcare, Biotechnology, USA, 683.71M, -, -, 5.30, 2.94, -, 107.00%, 52.90%, -, 24.60%, -76.50%, 6.70%, 7.50%, 2.40%, 11.40, 11.40, 0.00, 0.00, -, 9.20%, 10.90%, -3.41%, -28.13%, -9.70%, -14.37%, -10.18%, 4.74%
230, CATB, Catabasis Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 49.41M, -, -, -, -, -, 13.40%, 87.80%, -, -, -, -257.20%, -, -, 33.50, 33.50, -, -, -, -, -, -9.73%, -32.45%, 36.00%, -67.15%, -4.67%, 7.83%
232, CBIO, Catalyst Biosciences Inc., Healthcare, Biotechnology, USA, 135.10M, -, -, 22.52, 1.16, -, 36.20%, 13.90%, -, -184.60%, -90.90%, -66.40%, -77.90%, -, 8.20, 8.20, 0.00, 0.00, -1.90%, -, -, -17.88%, -31.46%, -26.38%, -40.78%, -32.33%, 4.23%
234, CCCC, C4 Therapeutics Inc., Healthcare, Biotechnology, USA, 1.61B, -, -, 47.68, 6.04, -, -50.40%, 4.20%, -, 52.50%, -65.40%, -, -, -20.60%, 8.60, 8.60, 0.04, 0.04, -, -, -, 7.91%, -12.83%, 7.76%, -, 11.53%, 7.63%
236, CCXI, ChemoCentryx Inc., Healthcare, Biotechnology, USA, 726.13M, -, -, 10.49, 1.96, -, 13.60%, 8.20%, -, -20.60%, 73.30%, -12.10%, -16.10%, -13.50%, 7.10, 7.10, 0.04, 0.07, -, -90.00%, -91.50%, -77.93%, -85.04%, -81.86%, -83.19%, -83.61%, 16.65%
238, CDMO, Avid Bioservices Inc., Healthcare, Biotechnology, USA, 1.27B, 116.28, -, 15.67, 14.68, 263.69, -54.60%, 96.77%, 15.00%, 120.20%, 60.30%, 7.50%, 16.60%, -23.60%, 1.90, 1.70, 0.00, 0.00, 24.60%, 17.20%, 11.50%, -2.16%, -2.25%, 142.37%, 264.38%, 84.40%, 4.25%
240, CDTX, Cidara Therapeutics Inc., Healthcare, Biotechnology, USA, 98.50M, -, -, 8.28, 50.50, -, -27.60%, -50.90%, -, 14.80%, -4.00%, -120.60%, -363.40%, -405.90%, 1.30, 1.30, 0.00, 3.11, -, -, -, -11.79%, -11.79%, -12.17%, -44.20%, 1.00%, 5.33%
221, BYSI, BeyondSpring Inc., Healthcare, Biotechnology, USA, 414.49M, -, -, 2072.44, 3.99, -, -31.60%, 20.40%, -, 0.10%, -, -103.10%, -150.40%, -71.00%, 8.20, 8.20, 0.02, 0.02, -, -, -, -2.35%, -21.79%, -4.78%, -39.00%, -15.00%, 5.56%
223, CAH, Cardinal Health Inc., Healthcare, Medical Distribution, USA, 16.27B, 9.10, 2.10, 0.10, 9.15, 17.40, -378.60%, 2.75%, 6.83%, -66.00%, 0.30%, 2.70%, 66.00%, -47.10%, 1.20, 0.60, 3.75, 3.76, 4.40%, 0.40%, 0.70%, -7.57%, 6.29%, 4.28%, 2.52%, 4.69%, 2.35%
225, CALT, Calliditas Therapeutics AB publ, Healthcare, Drug Manufacturers - Specialty & Generic, Sweden, 739.14M, -, -, -, -, -, 17.10%, 76.40%, -, -, -99.10%, -, -, -, -, -, -, -, -, -, -, -0.13%, 1.61%, -9.42%, -, -11.96%, 2.05%
227, CAPR, Capricor Therapeutics Inc., Healthcare, Biotechnology, USA, 84.90M, -, -, 424.48, 2.31, -, 57.40%, -4.20%, -, 23.50%, -74.00%, -44.20%, -52.80%, -43.10%, 11.40, 11.40, 0.09, 0.10, -, -, -, -16.52%, -36.94%, -5.96%, -18.32%, 10.50%, 7.52%
229, CASI, CASI Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 222.30M, -, -, 12.70, 2.00, -, 8.90%, 0.00%, -, -30.10%, 67.60%, -42.80%, -63.90%, -62.20%, 8.90, 8.60, 0.00, 0.02, 50.50%, -, -, -11.60%, -37.01%, -37.98%, -39.39%, -45.76%, 6.81%
231, CBAY, CymaBay Therapeutics Inc., Healthcare, Biotechnology, USA, 290.52M, -, -, -, 2.29, -, 51.70%, 2.70%, -, -34.00%, -, -34.90%, -37.40%, -, 16.90, 16.90, 0.00, 0.00, -, -, -, -8.44%, -17.22%, -41.74%, 14.17%, -26.31%, 6.74%
233, CBLI, Cleveland BioLabs Inc., Healthcare, Biotechnology, USA, 79.97M, -, -, 799.74, 8.31, -, 17.40%, -, -, 27.00%, -100.00%, -38.60%, -403.70%, 86.20%, 28.40, 28.40, 0.00, 0.00, -, -, -, -1.82%, -8.16%, 73.63%, 163.41%, 56.52%, 7.70%
235, CCM, Concord Medical Services Holdings Limited, Healthcare, Medical Care Facilities, China, 143.29M, -, -, 5.03, -, -, -30.60%, -, 20.00%, -0.40%, -21.00%, -6.30%, -850.00%, -26.60%, 1.20, 1.20, -, -, -12.30%, -, -, -5.44%, -10.08%, 62.54%, 121.48%, 20.44%, 7.71%
237, CDAK, Codiak BioSciences Inc., Healthcare, Biotechnology, USA, 448.55M, -, -, 153.88, 6.69, -, -31.50%, -0.70%, -, 36.60%, 993.30%, -, -, -229.60%, 8.70, 8.70, 0.37, 0.37, -, -, -, 17.81%, 23.00%, 151.33%, -, -29.97%, 8.39%
239, CDNA, CareDx Inc, Healthcare, Diagnostics & Research, USA, 4.24B, 125.63, -, 19.15, 8.73, -, 22.70%, 138.81%, 20.00%, 90.10%, 75.50%, -3.40%, -4.20%, -6.00%, 9.60, 9.30, 0.00, 0.00, 67.30%, -5.80%, -6.10%, 2.70%, -7.95%, 43.37%, 150.31%, 10.97%, 6.73%
242, CDXS, Codexis Inc., Healthcare, Biotechnology, USA, 1.31B, -, -, 18.15, 8.04, -, -91.60%, -5.00%, 15.00%, -8.60%, 22.40%, -14.30%, -19.60%, -14.30%, 7.70, 7.70, 0.00, 0.00, 78.70%, -34.90%, -35.10%, -13.32%, -12.69%, 14.78%, 65.06%, -6.09%, 6.15%
244, CEMI, Chembio Diagnostics Inc., Healthcare, Diagnostics & Research, USA, 64.79M, -, -, 1.89, 2.77, -, -65.80%, 23.80%, 25.00%, 23.20%, 26.10%, -37.00%, -80.90%, -49.00%, 3.40, 1.90, 0.79, 0.80, 32.90%, -65.90%, -72.90%, -22.00%, -41.58%, -40.26%, -66.87%, -32.84%, 5.80%
246, CERE, Cerevel Therapeutics Holdings Inc., Healthcare, Biotechnology, USA, 1.71B, -, -, -, 4.91, -, 20.40%, -6.90%, -, -, -, -69.00%, -78.70%, -, 10.20, 10.20, 0.00, 0.00, -, -, -, -10.69%, -17.33%, -6.15%, -, -20.87%, 7.25%
248, CERS, Cerus Corporation, Healthcare, Biotechnology, USA, 979.09M, -, -, 8.21, 10.53, -, 28.30%, 14.30%, -, 1.20%, 20.30%, -27.90%, -57.90%, -38.60%, 3.30, 2.90, 0.59, 0.70, 63.10%, -49.80%, -51.10%, -3.18%, -11.20%, -3.82%, -6.91%, -16.33%, 4.57%
250, CFMS, Conformis Inc., Healthcare, Medical Devices, USA, 158.73M, -, -, 2.40, 1.32, -, 23.70%, -29.40%, -14.58%, 37.00%, -16.40%, -29.00%, -84.00%, -69.10%, 4.30, 3.90, 0.29, 0.29, 49.40%, -39.60%, -40.00%, -6.00%, -16.64%, 38.06%, -10.63%, 33.88%, 7.77%
252, CGC, Canopy Growth Corporation, Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 9.97B, -, -, 19.71, 2.46, -, -, -, -, -, 23.20%, -, -, -, -, -, -, -, -, -, -, -4.75%, -24.88%, -2.90%, 50.20%, 5.88%, 5.02%
254, CGEN, Compugen Ltd., Healthcare, Biotechnology, Israel, 661.02M, -, -, 330.51, 5.82, -, 13.10%, -31.40%, -, -16.70%, -, -23.30%, -26.70%, -26.30%, 10.60, 10.60, 0.00, 0.00, 97.00%, -, -, -12.03%, -22.97%, -37.71%, -50.10%, -36.58%, 7.03%
256, CHEK, Check-Cap Ltd., Healthcare, Diagnostics & Research, Israel, 110.61M, -, -, -, 3.40, -, 73.70%, 0.00%, -, 84.80%, -, -57.50%, -66.80%, -, 10.20, 10.20, 0.00, 0.00, -, -, -, -2.44%, 11.11%, 306.09%, 204.18%, 247.83%, 8.27%
258, CHNG, Change Healthcare Inc., Healthcare, Health Information Services, USA, 7.13B, 12.42, -, 2.31, 2.32, 20.97, -18.70%, 15.98%, 5.30%, 87.90%, 1.40%, -1.10%, -3.50%, 1.60%, 1.10, 1.10, 1.46, 1.46, 56.80%, 2.90%, -3.60%, 1.91%, 1.74%, 36.20%, 87.82%, 25.68%, 0.95%
260, CI, Cigna Corporation, Healthcare, Healthcare Plans, USA, 89.05B, 11.25, 0.88, 0.55, 1.87, 10.94, 70.90%, 12.55%, 12.60%, 4.60%, 7.00%, 5.40%, 17.40%, 11.90%, -, -, 0.66, 0.66, -, 7.60%, 5.20%, 3.44%, 20.42%, 25.04%, 31.18%, 24.34%, 1.85%
241, CDXC, ChromaDex Corporation, Healthcare, Biotechnology, USA, 567.89M, -, -, 9.53, 12.21, -, 42.10%, 84.40%, -, -16.50%, 2.80%, -45.80%, -84.50%, -, 3.20, 2.60, 0.00, 0.00, 60.70%, -35.80%, -35.90%, -5.03%, -37.85%, 70.78%, 72.56%, 72.92%, 5.86%
243, CELC, Celcuity Inc., Healthcare, Diagnostics & Research, USA, 338.90M, -, -, -, 8.52, -, -28.20%, -95.10%, 29.00%, -15.10%, -, -49.50%, -52.40%, -, 30.50, 30.50, 0.00, 0.00, -, -, -, -2.10%, 84.16%, 189.73%, 159.48%, 195.74%, 8.22%
245, CERC, Cerecor Inc., Healthcare, Biotechnology, USA, 250.09M, -, -, 56.84, 7.14, -, -154.40%, 50.80%, -, 16.00%, -82.10%, -124.10%, -199.00%, -284.80%, 1.70, -, 0.00, 0.00, 93.00%, -, -, -5.04%, -29.22%, 9.09%, -18.27%, 0.00%, 9.26%
247, CERN, Cerner Corporation, Healthcare, Health Information Services, USA, 23.59B, 21.63, 2.57, 4.30, 5.53, -, 53.10%, 12.02%, 11.63%, 18.70%, -1.70%, -, -, 12.10%, 2.10, 2.10, 0.37, 0.43, 83.40%, -, -, 3.86%, 11.55%, 5.57%, 7.34%, -0.29%, 1.83%
249, CERT, Certara Inc., Healthcare, Biotechnology, USA, 4.04B, 72.28, -, 15.97, 4.68, 100.17, -534.10%, 62.50%, 46.92%, -12.40%, 16.20%, -4.30%, -7.50%, -2.10%, 5.50, 5.50, 0.36, 0.36, 58.60%, -10.60%, -19.50%, -21.01%, -26.86%, -, -, -21.98%, 6.03%
251, CFRX, ContraFect Corporation, Healthcare, Biotechnology, USA, 158.09M, -, -, -, 1.89, -, 19.90%, 13.20%, 12.70%, 63.70%, -, -37.40%, -96.20%, -, 11.50, 11.50, 0.00, 0.00, -, -, -, -6.70%, -24.77%, -31.18%, -21.86%, -20.00%, 6.50%
253, CGEM, Cullinan Oncology Inc., Healthcare, Biotechnology, USA, 1.31B, -, -, 69.12, 2.67, -, -150.80%, -53.30%, -, 98.50%, -, -, -, -, 45.20, 45.20, 0.00, 0.00, -, -, -, -9.30%, -38.56%, -, -, -0.60%, 9.29%
255, CHE, Chemed Corporation, Healthcare, Medical Care Facilities, USA, 7.89B, 25.84, 3.32, 3.77, 8.47, 18.41, 46.40%, 7.01%, 7.35%, 18.50%, 2.20%, 23.70%, 38.90%, 34.70%, 1.20, 1.20, 0.00, 0.00, 34.60%, 18.70%, 15.70%, 2.72%, 10.21%, 4.11%, 2.68%, -7.75%, 1.78%
257, CHMA, Chiasma Inc., Healthcare, Biotechnology, USA, 247.79M, -, -, 82.60, 4.23, -, -34.80%, 44.10%, 46.30%, -33.30%, -, -57.60%, -113.60%, -77.10%, 7.90, 7.10, 0.00, 0.00, 95.80%, -, -, 40.53%, 7.09%, -0.47%, -32.32%, -2.76%, 5.53%
259, CHRS, Coherus BioSciences Inc., Healthcare, Biotechnology, USA, 997.66M, -, -, 2.25, 7.52, 7.31, 32.30%, 92.40%, 4.20%, -596.80%, -28.60%, -9.90%, -34.80%, 22.30%, 2.40, 2.20, 2.34, 3.18, 91.30%, -11.70%, -17.20%, -10.48%, -17.85%, -27.09%, -29.40%, -24.28%, 3.99%
262, CKPT, Checkpoint Therapeutics Inc., Healthcare, Biotechnology, USA, 202.69M, -, -, 1013.44, 3.48, -, 40.90%, -21.30%, -, -43.50%, -90.00%, -62.10%, -74.80%, -65.50%, 8.50, 8.50, 0.00, 0.00, -, -, -, -9.46%, -19.28%, 10.74%, 26.42%, 1.13%, 8.88%
264, CLDX, Celldex Therapeutics Inc., Healthcare, Biotechnology, USA, 1.12B, -, -, 207.24, 5.70, -, 42.50%, 1.90%, -, 42.40%, -74.10%, -26.20%, -29.20%, -29.70%, 10.70, 10.70, 0.00, 0.00, -, -, -, -10.62%, -0.85%, 28.51%, 946.82%, 59.53%, 6.19%
266, CLLS, Cellectis S.A., Healthcare, Biotechnology, France, 683.37M, -, -, 11.68, 2.56, -, 20.70%, -26.50%, -, -158.60%, -46.10%, -23.70%, -39.10%, -22.10%, 5.80, 5.70, 0.39, 0.41, -, -, -, -17.18%, -30.94%, -30.11%, -15.16%, -42.09%, 6.47%
268, CLOV, Clover Health Investments Corp., Healthcare, Healthcare Plans, USA, 3.20B, -, -, 15.95, 4.90, -, -, -, 32.00%, -, 18.00%, -6.50%, -7.40%, -, 4.70, 4.70, 0.04, 0.08, -, -, -27.50%, -24.88%, -26.33%, -25.75%, -, -54.44%, 8.63%
270, CLRB, Cellectar Biosciences Inc., Healthcare, Biotechnology, USA, 83.80M, -, -, -, 2.08, -, 58.50%, 2.00%, -, 68.70%, -, -44.20%, -65.60%, -, 10.80, 10.80, 0.00, 0.00, -, -, -, 5.81%, -14.14%, 35.54%, 8.39%, -21.15%, 7.27%
272, CLSN, Celsion Corporation, Healthcare, Biotechnology, USA, 102.11M, -, -, 204.21, 1.42, -, 12.90%, 3.30%, -, 56.20%, 0.00%, -45.50%, -76.00%, -80.60%, 8.40, 8.40, 0.06, 0.09, -, -, -, -1.67%, -45.12%, 122.64%, -60.67%, 65.96%, 6.35%
274, CLVS, Clovis Oncology Inc., Healthcare, Biotechnology, USA, 545.78M, -, -, 3.41, -, -, 41.10%, 47.10%, 79.10%, 54.10%, -10.60%, -56.60%, 209.90%, -75.30%, 1.50, 1.30, -, -, 74.60%, -, -, -14.78%, -17.66%, 15.54%, -25.87%, 6.87%, 6.77%
276, CMMB, Chemomab Therapeutics Ltd., Healthcare, Biotechnology, Israel, 182.13M, -, -, -, 0.16, -, 60.30%, -20.80%, -, 88.60%, -, -46.60%, -54.10%, -, 12.90, 12.90, 0.00, 0.00, -, -, -, -44.04%, -70.50%, -29.54%, 0.57%, -36.05%, 12.62%
278, CMPS, COMPASS Pathways plc, Healthcare, Medical Care Facilities, United Kingdom, 1.39B, -, -, -, 6.74, -, -186.40%, -17.80%, -, 40.70%, -, -, -, -, 25.50, 25.50, 0.00, 0.00, -, -, -, -10.93%, -30.41%, -15.01%, -, -27.16%, 5.62%
280, CNC, Centene Corporation, Healthcare, Healthcare Plans, USA, 42.96B, 12.70, 1.70, 0.37, 1.63, 8.75, -0.60%, 10.86%, 10.32%, 1419.60%, 15.20%, 3.60%, 9.60%, 5.00%, -, -, 0.63, 0.64, -, 3.40%, 2.10%, 21.47%, 23.93%, 18.35%, 11.09%, 22.61%, 2.64%
261, CJJD, China Jo-Jo Drugstores Inc., Healthcare, Pharmaceutical Retailers, China, 41.11M, -, -, 0.32, 1.46, -, -453.40%, -, 30.00%, -, 6.30%, -10.70%, -40.70%, -12.80%, 1.10, 0.90, 0.09, 1.18, 22.40%, -9.00%, -8.60%, -0.86%, -13.79%, -9.87%, -61.42%, -1.84%, 4.95%
263, CLBS, Caladrius Biosciences Inc., Healthcare, Biotechnology, USA, 94.00M, -, -, -, 0.58, -, 71.90%, 43.90%, -, 49.00%, -, -21.20%, -22.80%, -, 25.70, 25.70, 0.00, 0.00, -, -, -, -6.17%, -20.83%, 4.83%, -20.00%, 6.29%, 5.04%
265, CLGN, CollPlant Biotechnologies Ltd., Healthcare, Biotechnology, Israel, 160.76M, 12.14, -, 26.35, 26.84, -, 62.40%, 40.10%, -, 53.60%, 50.00%, -48.70%, -94.70%, -124.40%, 1.70, 1.30, 0.00, 0.00, 51.10%, -91.80%, -94.10%, 16.76%, 23.65%, 115.23%, 66.75%, 59.47%, 4.84%
267, CLNN, Clene Inc., Healthcare, Biotechnology, USA, 631.45M, -, -, 2104.82, -, -, -415.20%, 35.90%, -, -188.60%, 100.00%, -, -, -783.70%, 13.10, 13.00, -, -, 30.40%, -, -, 21.79%, -16.05%, 5.75%, 9.16%, 26.53%, 12.49%
269, CLPT, ClearPoint Neuro Inc., Healthcare, Medical Devices, USA, 377.61M, -, -, 27.56, 7.91, -, -1.60%, 48.10%, 30.00%, -1.10%, 29.00%, -19.50%, -60.70%, -26.20%, 22.60, 21.50, 0.56, 0.00, 69.40%, -52.70%, -52.90%, -13.11%, -21.55%, 82.38%, 352.58%, 15.92%, 7.53%
271, CLSD, Clearside Biomedical Inc., Healthcare, Biotechnology, USA, 148.00M, -, -, 38.95, 8.55, -, 51.40%, -46.40%, -, -98.10%, -99.20%, -110.10%, -220.10%, -183.00%, 2.60, 2.60, 0.00, 0.00, -, -, -, -13.93%, -25.65%, 30.87%, 37.90%, -6.39%, 8.87%
273, CLVR, Clever Leaves Holdings Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 273.95M, -, -, 22.64, 1.19, -, -, -, -, -, 19.30%, -33.20%, -36.60%, -20.90%, 9.40, 8.40, 0.30, 0.30, 61.20%, -, -, 15.49%, -11.51%, -, -, 37.42%, 7.10%
275, CMD, Cantel Medical Corp., Healthcare, Medical Instruments & Supplies, USA, 3.44B, 26.18, 5.18, 3.24, 4.29, 22.23, -95.00%, 3.36%, 19.00%, -, 32.50%, -, -, 2.50%, 2.60, 1.80, 1.05, 1.09, 46.90%, -, -, -8.22%, 7.30%, 38.81%, 93.27%, 3.13%, 1.49%
277, CMPI, Checkmate Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 144.53M, -, -, -, 1.30, -, -21.70%, 5.20%, 45.10%, -46.20%, -, -39.50%, -74.40%, -, 12.90, 12.90, 0.00, 0.00, -, -, -, 5.96%, -50.18%, -42.47%, -, -53.67%, 7.40%
279, CMRX, Chimerix Inc., Healthcare, Biotechnology, USA, 684.48M, -, -, 122.23, 4.68, -, 65.50%, 84.40%, -, -619.70%, 16.70%, -119.00%, -136.20%, -60.60%, 6.70, 6.70, 0.00, 0.10, -, -, -, -13.01%, -21.41%, 111.92%, 150.64%, 61.90%, 5.69%
282, CNMD, CONMED Corporation, Healthcare, Medical Devices, USA, 3.97B, 37.01, 29.78, 4.51, 5.58, 85.61, -66.70%, 18.06%, 13.80%, 49.90%, -4.60%, 0.00%, 0.00%, 3.70%, 2.20, 1.20, 1.04, 1.06, 53.90%, 5.60%, 0.00%, -3.11%, 12.35%, 31.84%, 87.56%, 22.94%, 2.44%
284, CNST, Constellation Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 958.21M, -, -, -, 2.51, -, -37.30%, -10.60%, -, -37.50%, -, -29.90%, -33.10%, -, 15.40, 15.40, 0.00, 0.00, -, -, -, -6.91%, -26.08%, -22.16%, -44.24%, -31.22%, 5.52%
286, CNTG, Centogene N.V., Healthcare, Diagnostics & Research, Germany, 231.61M, -, -, 1.48, 2.21, -, 2.60%, -31.70%, -, 173.60%, 362.50%, -17.50%, -39.10%, -22.30%, 1.70, 1.50, 0.27, 0.37, 36.40%, -15.30%, -16.70%, -12.25%, -23.30%, -16.01%, -44.32%, -9.00%, 5.31%
288, COCP, Cocrystal Pharma Inc., Healthcare, Biotechnology, USA, 111.10M, -, -, 69.44, 1.55, -, 88.40%, -5.60%, -, 19.60%, -, -20.60%, -21.70%, -18.30%, 23.10, 23.10, 0.00, 0.00, -, -, -, -7.38%, -28.48%, -33.92%, 17.10%, -16.91%, 13.26%
290, COGT, Cogent Biosciences Inc., Healthcare, Biotechnology, USA, 332.20M, -, -, 415.25, 2.28, -, -287.10%, 3.50%, -, 58.40%, -, -112.10%, -292.30%, -66.40%, 28.20, 28.20, 0.00, 0.00, -, -, -, 0.81%, 5.22%, -9.22%, 285.78%, -22.89%, 5.09%
292, COO, The Cooper Companies Inc., Healthcare, Medical Instruments & Supplies, USA, 19.42B, 27.14, 0.87, 7.88, 3.23, 94.35, -47.90%, 11.21%, 10.00%, 2221.70%, 5.30%, 31.10%, 52.30%, 5.10%, 1.30, 0.80, 0.24, 0.30, 63.20%, 13.60%, 91.20%, -3.47%, 0.67%, 19.59%, 24.12%, 8.29%, 1.78%
294, CPHI, China Pharma Holdings Inc., Healthcare, Drug Manufacturers - Specialty & Generic, China, 25.90M, -, -, 2.25, 3.69, -, 86.20%, -, 10.00%, -10.90%, 33.30%, -13.90%, -37.80%, -19.50%, 0.40, 0.10, 0.12, 0.71, 17.70%, -23.00%, -25.90%, -28.88%, -40.24%, 21.27%, 31.34%, 32.35%, 9.05%
296, CPRX, Catalyst Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 576.78M, 12.92, -, 4.80, 3.22, -, 134.70%, 15.68%, -, -26.60%, 3.80%, 41.50%, 46.90%, 43.90%, 11.20, 10.90, 0.00, 0.00, 85.40%, 33.60%, 60.10%, 16.42%, 38.25%, 58.45%, 28.31%, 65.57%, 5.02%
298, CRBP, Corbus Pharmaceuticals Holdings Inc., Healthcare, Biotechnology, USA, 255.11M, -, -, 91.11, 2.75, -, -27.40%, 6.70%, -, 67.70%, -66.70%, -89.50%, -182.20%, -191.90%, 5.50, 5.50, 0.20, 0.20, -, -, -, 14.81%, -9.58%, 80.83%, -70.91%, 73.60%, 9.49%
300, CRIS, Curis Inc., Healthcare, Biotechnology, USA, 1.28B, -, -, 123.97, 10.83, -, 36.60%, -6.70%, -, 61.50%, -18.50%, -24.80%, -62.20%, -18.90%, 23.20, 23.20, 0.00, 0.01, 95.00%, -, -, 32.84%, 38.06%, 951.09%, 1624.14%, 75.82%, 10.39%
281, CNCE, Concert Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 128.12M, -, -, 16.22, 1.20, -, 27.20%, 0.30%, -, 4.90%, -28.60%, -49.30%, -59.50%, -55.30%, 14.90, 14.90, 0.00, 0.00, -, -, -, -3.37%, -41.65%, -63.50%, -62.15%, -68.20%, 5.54%
283, CNSP, CNS Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 46.69M, -, -, -, 4.02, -, -100.30%, -22.40%, -, -22.50%, -, -123.50%, -141.50%, -, 6.70, 6.70, 0.00, 0.03, -, -, -, -9.76%, -33.93%, -22.11%, -30.45%, 3.93%, 5.54%
285, CNTB, Connect Biopharma Holdings Limited, Healthcare, Biotechnology, China, 855.66M, -, -, -, -, -, -, 10.90%, -, -, -, -, -, -, -, -, -, -, -, -, -, -4.25%, -, -, -, -19.52%, 7.31%
287, CO, Global Cord Blood Corporation, Healthcare, Diagnostics & Research, Hong Kong, 755.97M, -, 0.33, 4.17, 1.11, 9.47, 61.50%, -, 30.00%, -19.30%, -13.10%, 6.40%, 11.70%, 11.80%, 10.30, 10.20, 0.00, 0.00, 84.70%, 47.20%, 41.30%, 25.77%, 41.20%, 59.69%, 138.28%, 64.42%, 4.88%
289, CODX, Co-Diagnostics Inc., Healthcare, Diagnostics & Research, USA, 227.01M, 13.61, -, 2.44, 3.03, 5.54, 510.30%, -29.40%, -, 664.00%, 24903.40%, 83.70%, 88.90%, 62.40%, 18.40, 16.90, 0.00, 0.00, 79.20%, 57.00%, 55.30%, -9.12%, -41.90%, -33.53%, -55.17%, -13.23%, 6.25%
291, COLL, Collegium Pharmaceutical Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 840.69M, 10.67, 38.51, 2.62, 4.92, 7.24, 212.10%, 43.31%, 0.55%, -, 14.60%, 6.50%, 24.50%, 12.50%, 1.30, 1.20, 1.40, 1.68, 61.20%, 22.60%, 13.10%, 7.37%, 4.19%, 23.98%, 8.34%, 19.27%, 4.13%
293, CORT, Corcept Therapeutics Incorporated, Healthcare, Biotechnology, USA, 2.53B, 20.71, -, 7.43, 4.94, 17.70, 11.10%, 26.42%, -, -26.40%, -14.80%, 18.40%, 20.10%, 19.60%, 10.10, 10.00, 0.00, 0.00, 98.50%, 32.40%, 29.20%, -7.93%, -15.16%, -5.39%, 42.67%, -17.43%, 3.40%
295, CPIX, Cumberland Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 44.49M, 29.50, -, 1.12, 0.94, 7.18, 27.80%, 25.00%, 30.00%, 82.20%, 26.50%, -2.20%, -4.40%, -10.40%, 2.20, 1.70, 0.32, 0.00, 77.00%, -12.10%, -5.30%, 8.06%, -12.98%, 1.37%, -10.88%, 0.00%, 4.39%
297, CPSI, Computer Programs and Systems Inc., Healthcare, Health Information Services, USA, 474.54M, 11.46, 1.94, 1.81, 2.24, -, -31.20%, 14.74%, 17.00%, 0.60%, -2.60%, -, -, 5.90%, 1.80, 1.80, 0.33, 0.35, 51.40%, -, -, 9.32%, 4.18%, 10.93%, 46.34%, 20.60%, 3.70%
299, CRDF, Cardiff Oncology Inc., Healthcare, Biotechnology, USA, 312.82M, -, -, 782.04, 2.50, -, 61.30%, -57.80%, -, 66.20%, 0.00%, -28.40%, -30.50%, -14.90%, 28.70, 28.70, 0.00, 0.00, -, -, -, -11.67%, -21.79%, -60.58%, 240.08%, -53.31%, 7.40%
302, CRMD, CorMedix Inc., Healthcare, Biotechnology, USA, 278.93M, -, -, 929.78, 3.27, -, 57.20%, -17.60%, -, 6.80%, 0.00%, -47.90%, -53.40%, -49.90%, 27.20, 27.20, 0.00, 0.00, 14.10%, -, -, -15.64%, -19.84%, -20.98%, 63.57%, -2.69%, 7.12%
304, CRON, Cronos Group Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 3.35B, -, -, 71.68, 1.90, -, -, -, -, -, 133.30%, -, -, -, -, -, -, -, -, -, -, 8.82%, -18.31%, 13.05%, 37.98%, 29.83%, 5.11%
306, CRTX, Cortexyme Inc., Healthcare, Biotechnology, USA, 1.31B, -, -, -, 7.82, -, -35.60%, -25.30%, 18.30%, -28.50%, -, -42.00%, -45.80%, -, 8.40, 8.40, 0.00, 0.00, -, -, -, 6.60%, 13.56%, -14.89%, -10.24%, 48.92%, 8.49%
308, CRY, CryoLife Inc., Healthcare, Medical Devices, USA, 1.14B, 430.00, -, 4.43, 3.75, 2855.07, -172.00%, 138.90%, 2.00%, 54.40%, 7.10%, -1.70%, -4.20%, 0.50%, 4.10, 2.80, 1.06, 1.07, 66.50%, 2.00%, -5.10%, 22.65%, 11.19%, 36.61%, 26.75%, 22.02%, 5.05%
310, CSII, Cardiovascular Systems Inc., Healthcare, Medical Devices, USA, 1.57B, -, -, 6.82, 5.64, -, 51.90%, 68.40%, 33.80%, -82.40%, 3.40%, -6.80%, -8.60%, -9.30%, 5.70, 5.00, 0.08, 0.08, 78.00%, -9.50%, -10.10%, -3.66%, -6.47%, 11.05%, 1.21%, -10.44%, 4.04%
312, CSTL, Castle Biosciences Inc., Healthcare, Diagnostics & Research, USA, 1.49B, -, -, 21.87, 3.57, 991.24, -411.20%, 48.40%, -, -664.60%, 31.00%, -4.70%, -5.20%, -1.90%, 24.30, 24.10, 0.00, 0.00, 84.80%, -19.60%, -22.20%, -11.96%, -26.95%, 37.45%, 55.95%, -10.75%, 7.14%
314, CTIC, CTI BioPharma Corp., Healthcare, Biotechnology, USA, 223.90M, -, -, -, 6.83, -, -6.80%, 45.20%, -, -15.90%, -, -95.70%, -135.10%, -, 2.50, 2.50, 0.00, 0.12, -, -, -, -2.05%, -27.58%, -36.10%, 134.31%, -25.78%, 5.59%
316, CTMX, CytomX Therapeutics Inc., Healthcare, Biotechnology, USA, 532.42M, -, -, 7.98, 2.98, 23.25, 68.40%, -26.50%, -0.90%, -195.60%, -67.70%, -15.40%, -80.10%, -69.70%, 4.10, 4.10, 0.00, 0.00, -, -92.00%, -90.90%, -24.55%, -15.27%, -2.59%, -19.19%, 9.31%, 5.53%
318, CTXR, Citius Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 314.30M, 7.35, -, -, 1.75, -, 42.00%, 203.30%, -, 66.70%, -, -33.40%, -39.60%, -, 35.20, 35.20, 0.00, 0.00, -, -, -, 8.06%, 9.62%, 141.04%, 162.67%, 123.53%, 8.47%
320, CUTR, Cutera Inc., Healthcare, Medical Devices, USA, 682.40M, 49.84, -, 4.13, 16.40, -, -63.30%, 69.23%, 25.00%, 97.70%, 54.30%, -7.50%, -23.30%, -36.00%, 3.50, 3.00, 3.24, 3.41, 54.00%, -5.80%, -7.20%, 34.06%, 9.28%, 55.13%, 189.01%, 59.19%, 5.51%
301, CRL, Charles River Laboratories International Inc., Healthcare, Diagnostics & Research, USA, 16.69B, 29.86, 2.78, 5.49, 7.73, 34.83, 41.90%, 13.70%, 16.50%, 18.60%, 16.60%, 6.90%, 18.90%, 8.60%, 1.80, 1.50, 1.01, 1.01, 37.10%, 15.20%, 12.30%, 1.23%, 16.71%, 49.32%, 88.13%, 35.27%, 2.91%
303, CRNX, Crinetics Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 669.18M, -, -, 9425.09, 3.87, -, -16.20%, -14.70%, -, 2.10%, -100.00%, -41.50%, -44.80%, -, 15.40, 15.40, 0.00, 0.00, -, -, -, -1.18%, 11.85%, 34.28%, 7.41%, 24.38%, 4.98%
305, CRSP, CRISPR Therapeutics AG, Healthcare, Biotechnology, Switzerland, 8.97B, -, -, 8155.49, 4.91, -, -550.50%, -667.10%, -, -31.70%, 150.00%, -24.80%, -27.40%, -21.30%, 22.10, 22.10, 0.00, 0.00, -, -, -, -10.39%, -9.27%, 7.44%, 83.00%, -22.81%, 5.76%
307, CRVS, Corvus Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 106.09M, -, -, -, 1.00, -, 87.20%, 18.30%, -, 23.70%, -, -5.90%, -7.10%, -, 4.90, 4.90, 0.00, 0.00, -, -, -, -2.84%, -18.93%, -29.74%, -20.58%, -23.03%, 6.62%
309, CSBR, Champions Oncology Inc., Healthcare, Biotechnology, USA, 132.02M, 57.03, -, 3.37, 15.95, -, 142.90%, 175.00%, 15.00%, 71.30%, 20.00%, -5.20%, -19.20%, -35.80%, 1.20, 1.20, 0.00, 0.00, 47.10%, -3.20%, -3.10%, -16.36%, -20.25%, -17.53%, -2.28%, -12.79%, 5.45%
311, CSLT, Castlight Health Inc., Healthcare, Health Information Services, USA, 281.10M, 79.13, -, 1.97, 2.30, 20.22, -49.00%, -, 30.00%, 94.90%, -10.00%, -5.30%, -7.20%, -, 2.50, 2.50, 0.00, 0.01, 64.70%, -6.40%, -6.20%, 4.00%, -2.15%, 52.94%, 131.05%, 40.00%, 8.52%
313, CSU, Capital Senior Living Corporation, Healthcare, Medical Care Facilities, USA, 102.70M, -, -, 0.30, -, -, -706.20%, -256.60%, 10.30%, 180.80%, -41.90%, -27.10%, 101.70%, -7.20%, 0.10, 0.10, -, -, -, 6.80%, -61.70%, 17.64%, 59.97%, 245.78%, 371.52%, 278.28%, 7.20%
315, CTLT, Catalent Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 17.90B, 30.63, 2.08, 4.76, 4.81, -, 20.60%, 17.11%, 17.00%, 94.30%, 38.50%, 6.10%, 15.10%, 5.70%, 2.40, 1.90, 0.85, 0.87, 33.20%, 19.40%, 13.20%, -7.98%, -9.94%, 10.76%, 34.86%, 0.73%, 2.59%
317, CTSO, Cytosorbents Corporation, Healthcare, Medical Devices, USA, 351.27M, 168.54, -, 8.19, 4.52, -, 66.20%, 120.80%, -, 5.10%, 21.80%, -10.30%, -13.10%, -11.70%, 8.20, 7.80, 0.00, 0.00, 73.40%, -25.00%, -19.90%, -11.10%, -15.90%, -1.22%, -20.76%, 1.51%, 3.83%
319, CUE, Cue Biopharma Inc., Healthcare, Biotechnology, USA, 448.27M, -, -, 117.97, 6.26, -, 6.20%, -6.30%, -, 14.80%, 77.80%, -44.90%, -56.20%, -57.30%, 4.70, 4.70, 0.00, 0.00, -, -, -, 19.40%, 7.42%, 12.91%, -48.19%, 14.63%, 8.17%
322, CVET, Covetrus Inc., Healthcare, Health Information Services, USA, 3.69B, 25.59, 85.76, 0.84, 2.48, 369.33, 98.20%, 17.32%, 11.55%, 60.10%, 3.50%, 0.00%, -0.10%, 0.50%, 2.10, 1.30, 0.69, 0.70, 18.40%, 0.50%, 0.00%, -2.85%, -18.72%, 4.32%, 81.54%, -3.48%, 5.64%
324, CVS, CVS Health Corporation, Healthcare, Healthcare Plans, USA, 113.78B, 10.49, 3.84, 0.42, 1.60, 11.05, 7.60%, 7.54%, 4.00%, 9.90%, 3.50%, 3.20%, 10.70%, 7.40%, 0.90, 0.60, 0.84, 0.87, 39.30%, 4.60%, 2.70%, 13.19%, 24.77%, 27.81%, 31.83%, 26.56%, 2.11%
326, CYAD, Celyad Oncology SA, Healthcare, Biotechnology, Belgium, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -15.34%, -26.69%, -42.68%, -51.28%, -29.23%, 6.53%
328, CYCN, Cyclerion Therapeutics Inc., Healthcare, Biotechnology, USA, 109.61M, -, -, 84.31, 2.28, -, 43.00%, 23.70%, -, 46.20%, -90.00%, -59.80%, -113.80%, -129.00%, 3.30, 3.30, 0.00, 0.07, -, -, -, 41.48%, -16.92%, 0.31%, -18.59%, 5.88%, 10.59%
330, CYTH, Cyclo Therapeutics Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 50.92M, -, -, 56.58, 1.64, -, 19.70%, -96.90%, -, 41.00%, -50.00%, -156.40%, -566.80%, -, 3.80, 3.80, 0.00, 0.01, 91.90%, -, -, 1.60%, -3.94%, 27.38%, -54.00%, 90.34%, 9.69%
332, DARE, Dare Bioscience Inc., Healthcare, Biotechnology, USA, 66.10M, -, -, -, 18.29, -, 5.70%, -3.10%, -, 7.90%, -, -355.40%, -, -, 1.60, 1.60, 0.00, 0.00, -, -, -, -15.23%, -35.68%, -3.76%, 21.96%, -4.48%, 6.72%
334, DBVT, DBV Technologies S.A., Healthcare, Biotechnology, France, 642.28M, -, -, 56.96, 3.12, -, -39.40%, 20.50%, 21.22%, -, 32.60%, -, -, -, -, -, -, -, -, -, -, -7.73%, 7.14%, 146.84%, 20.62%, 123.28%, 3.89%
336, DCTH, Delcath Systems Inc., Healthcare, Medical Devices, USA, 66.87M, -, -, 39.34, 3.47, -, 97.60%, 13.20%, 15.00%, 99.00%, 33.30%, -88.90%, -174.10%, -, 3.00, 2.90, 0.00, 0.10, 61.30%, -, -, -9.32%, -46.53%, -36.57%, 37.00%, -40.29%, 6.18%
338, DGX, Quest Diagnostics Incorporated, Healthcare, Diagnostics & Research, USA, 17.32B, 16.45, 3.06, 1.68, 2.60, 9.80, 70.70%, -27.88%, 3.26%, 372.70%, 49.30%, 13.00%, 27.90%, 13.80%, 1.80, 1.60, 0.59, 0.59, 40.10%, 23.80%, 17.40%, 0.16%, 12.95%, 5.90%, 11.32%, 10.49%, 2.03%
340, DMAC, DiaMedica Therapeutics Inc., Healthcare, Biotechnology, USA, 133.90M, -, -, -, 6.02, -, 11.80%, -63.70%, 30.00%, -4.30%, -, -56.00%, -59.80%, -, 20.50, 20.50, 0.00, 0.00, -, -, -, -22.00%, -20.41%, 32.80%, 60.39%, -26.92%, 7.12%
321, CVAC, CureVac N.V., Healthcare, Biotechnology, Germany, 20.70B, 13.59, -, 423.60, 22.89, -, -28.20%, 467.61%, -, -170.60%, 87.50%, -, -, -14.20%, 5.60, 5.60, 0.07, 0.08, -, -, -, -3.07%, 15.91%, 36.30%, -, 37.51%, 6.22%
323, CVM, CEL-SCI Corporation, Healthcare, Biotechnology, USA, 964.94M, 20.49, -, 4824.69, 29.47, -, -16.00%, 264.10%, -, -12.10%, -, -77.00%, -142.20%, -89.50%, 3.40, 3.20, 0.41, 0.00, -, -, -, -14.54%, 14.11%, 72.22%, 61.37%, 84.48%, 9.43%
325, CWBR, CohBar Inc., Healthcare, Biotechnology, USA, 80.30M, -, -, -, 4.81, -, -9.40%, -18.50%, -, 32.90%, -, -81.80%, -105.40%, -, 7.40, 7.40, 0.03, 0.04, -, -, -, -6.02%, -21.88%, -1.57%, -50.59%, -6.72%, 8.27%
327, CYCC, Cyclacel Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 65.68M, -, -, -, 1.06, -, 65.30%, -91.50%, -, 66.10%, -, -, -, -, 18.20, 18.20, 0.00, 0.00, -, -, -, 0.84%, -4.02%, 92.23%, 42.83%, -8.19%, 5.83%
329, CYH, Community Health Systems Inc., Healthcare, Medical Care Facilities, USA, 1.93B, 18.04, 0.29, 0.16, -, 1.09, 173.90%, 156.82%, 13.62%, -423.40%, -0.40%, 2.70%, -23.00%, 15.40%, 1.50, 1.40, -, -, 83.40%, 13.50%, 3.60%, 37.48%, 61.98%, 67.10%, 353.02%, 92.06%, 6.43%
331, CYTK, Cytokinetics Incorporated, Healthcare, Biotechnology, USA, 1.60B, -, -, 27.32, 22.98, -, 6.70%, -17.90%, 15.00%, 0.50%, 71.10%, -29.70%, -213.60%, -37.70%, 12.10, 12.10, 1.94, 2.03, -, -, -, -17.28%, 11.04%, 31.59%, 5.41%, 5.05%, 5.12%
333, DBTX, Decibel Therapeutics Inc., Healthcare, Biotechnology, USA, 206.39M, -, -, -, 0.60, -, 113.20%, 51.10%, -, 41.00%, -, -, -, -, 12.60, 12.60, 0.00, 0.00, -, -, -, -5.49%, -50.69%, -, -, -50.36%, 10.81%
335, DCPH, Deciphera Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.97B, -, -, 29.32, 3.87, -, -6.50%, 27.50%, 21.00%, 21.90%, 40474.20%, -39.50%, -45.60%, -49.90%, 8.60, 8.50, 0.00, 0.00, 99.30%, -, -, -27.88%, -23.27%, -45.40%, -42.39%, -40.88%, 5.59%
337, DFFN, Diffusion Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 69.40M, -, -, -, 1.10, -, 83.00%, 0.00%, -, 24.90%, -, -48.00%, -52.00%, -, 22.40, 22.40, 0.00, 0.00, -, -, -, -10.46%, -36.76%, -9.49%, -46.00%, -11.70%, 8.28%
339, DHR, Danaher Corporation, Healthcare, Diagnostics & Research, USA, 182.05B, 28.22, 2.51, 7.34, 4.92, 31.91, 49.80%, 2.37%, 16.08%, 181.10%, 57.90%, 6.20%, 13.00%, 6.60%, 2.10, 1.70, 0.55, 0.55, 57.60%, 24.10%, 18.50%, -0.17%, 13.50%, 17.92%, 53.74%, 15.31%, 1.63%
342, DNLI, Denali Therapeutics Inc., Healthcare, Biotechnology, USA, 8.00B, -, -, 23.52, 6.96, 19.25, 130.50%, -16.50%, -, -4.50%, 119.40%, 4.80%, 6.40%, 5.40%, 26.20, 26.20, 0.00, 0.00, -, 15.10%, 17.00%, 3.70%, -1.65%, 4.90%, 128.49%, -24.08%, 5.67%
344, DRNA, Dicerna Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 2.42B, -, -, 13.62, 19.64, -, 13.70%, -126.00%, -, -27.40%, 40.00%, -17.10%, -82.90%, -82.20%, 3.30, 3.30, 0.00, 0.00, -, -65.80%, -67.60%, 4.92%, 12.88%, 39.50%, 51.14%, 47.98%, 5.85%
346, DSGN, Design Therapeutics Inc., Healthcare, Biotechnology, USA, 1.46B, -, -, 6447.67, -, -, -, -36.60%, -, -, -, -, -, -, -, -, -, -, -, -, -, 5.65%, -, -, -, -36.85%, 9.57%
348, DVA, DaVita Inc., Healthcare, Medical Care Facilities, USA, 12.82B, 12.51, 1.05, 1.11, 10.49, 11.56, 39.30%, 12.35%, 17.09%, 15.20%, -0.70%, 4.30%, 48.50%, 13.60%, 1.70, 1.60, 7.07, 7.21, 31.00%, 13.80%, 6.70%, 4.89%, 16.74%, 9.55%, 48.31%, 2.27%, 2.11%
350, DXCM, DexCom Inc., Healthcare, Diagnostics & Research, USA, 35.00B, 111.20, 3.02, 17.27, 18.69, 148.30, 362.20%, 47.19%, 23.60%, 91.70%, 24.70%, 12.80%, 31.20%, 15.80%, 5.70, 5.20, 0.92, 0.00, 68.40%, 15.10%, 25.40%, -12.40%, -6.88%, 18.19%, -2.36%, -0.09%, 3.78%
352, DYN, Dyne Therapeutics Inc., Healthcare, Biotechnology, USA, 964.67M, -, -, -, 1.98, -, -286.80%, -23.70%, -, -48.00%, -, -, -, -, 36.20, 36.20, 0.00, 0.00, -, -, -, -0.47%, 7.91%, -2.55%, -, -9.00%, 5.70%
354, EAR, Eargo Inc., Healthcare, Medical Devices, USA, 1.30B, -, -, 18.78, 7.01, -, -51.60%, 30.90%, 59.20%, -, 73.20%, -, -, -17.50%, 9.30, 9.20, 0.08, 0.00, -, -, -, -41.12%, -40.01%, -25.96%, -, -24.10%, 8.94%
356, EBS, Emergent BioSolutions Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 3.10B, 11.86, 0.92, 1.82, 2.12, 9.98, 445.20%, -37.22%, 9.20%, 632.00%, 78.20%, 14.30%, 28.60%, 14.30%, 3.20, 2.10, 0.55, 0.56, 69.00%, 31.70%, 22.70%, -3.96%, -40.66%, -24.57%, -27.36%, -32.31%, 3.59%
358, EDAP, EDAP TMS S.A., Healthcare, Medical Devices, France, 198.52M, 29.61, 160.71, 3.67, 6.03, -, -214.50%, 59.44%, 3.00%, 156.80%, 35.50%, -, 1.40%, -0.70%, 2.30, 1.80, 0.04, 0.09, 44.40%, 4.50%, 0.80%, -6.51%, -23.38%, 61.10%, 150.00%, 30.56%, 7.43%
360, EDSA, Edesa Biotech Inc., Healthcare, Biotechnology, Canada, 82.20M, -, -, 822.00, 3.78, -, -34.10%, -74.80%, -, -13.90%, -, -64.30%, -88.70%, -97.00%, 4.60, -, 0.00, 0.00, 96.60%, -, -, 12.97%, 10.19%, 18.30%, 104.23%, 47.53%, 8.51%
341, DMTK, DermTech Inc., Healthcare, Diagnostics & Research, USA, 1.22B, -, -, 176.25, 4.33, -, 26.10%, -10.40%, -, -5.40%, 56.30%, -38.00%, -40.20%, -55.30%, 36.90, 36.80, 0.00, 0.00, 1.00%, -, -, -2.73%, -41.11%, 223.48%, 230.00%, 26.14%, 9.37%
343, DRIO, DarioHealth Corp., Healthcare, Diagnostics & Research, USA, 258.86M, -, -, 27.25, 2.03, -, 39.80%, 20.50%, -, 69.40%, 111.80%, -68.70%, -79.80%, -106.00%, 7.50, 7.10, 0.00, 0.00, 29.60%, -, -, -22.12%, -40.12%, 26.03%, 154.27%, 13.86%, 8.63%
345, DRRX, DURECT Corporation, Healthcare, Drug Manufacturers - Specialty & Generic, USA, 382.01M, -, -, 12.44, 4.34, -, 40.10%, -160.00%, 15.00%, 10.20%, 37.50%, -, -, -20.70%, 9.00, 8.80, 0.22, 0.26, 95.60%, -, -, -12.70%, -26.01%, -11.29%, -29.49%, -20.29%, 4.62%
347, DTIL, Precision BioSciences Inc., Healthcare, Biotechnology, USA, 636.33M, -, -, 18.94, 10.12, 424.22, 5.30%, -15.70%, -, 36.90%, 132.90%, -52.70%, -159.70%, -, 3.40, 3.40, 0.00, 0.00, -, -, -, 10.03%, -18.18%, -8.51%, 50.21%, 26.26%, 7.64%
349, DVAX, Dynavax Technologies Corporation, Healthcare, Biotechnology, USA, 952.18M, 15.33, -, 8.00, 9.21, -, 65.50%, -1.47%, -, 105.30%, 664.20%, -16.20%, -86.40%, -28.70%, 3.90, 3.30, 1.80, 1.80, 71.50%, -17.20%, -51.90%, -21.61%, -7.87%, 92.94%, 33.99%, 84.27%, 6.21%
351, DYAI, Dyadic International Inc., Healthcare, Biotechnology, USA, 105.48M, -, -, 62.05, 4.05, -, -10.30%, 26.20%, -, -48.40%, 66.70%, -33.60%, -35.80%, -35.40%, 10.80, 10.80, 0.00, 0.00, 12.00%, -, -, -16.04%, -30.19%, -33.74%, -38.10%, -29.93%, 8.26%
353, DYNT, Dynatronics Corporation, Healthcare, Medical Devices, USA, 19.40M, -, -, 0.44, 1.22, 24.25, -102.10%, 41.20%, -, 96.90%, -16.10%, -10.60%, -33.90%, -16.00%, 1.80, 1.20, 0.19, 0.42, 27.40%, -8.60%, -9.20%, -5.08%, -18.84%, 57.99%, 68.47%, 38.27%, 5.17%
355, EARS, Auris Medical Holding Ltd., Healthcare, Biotechnology, Bermuda, 44.91M, -, -, 257.41, 1.43, -, 40.20%, -, -, 69.10%, -, -66.00%, -90.50%, -, 3.80, 3.80, 0.00, 0.03, -, -, -, 1.99%, 10.80%, 212.17%, 259.36%, 37.02%, 9.51%
357, ECOR, electroCore Inc., Healthcare, Medical Instruments & Supplies, USA, 83.50M, -, -, 20.87, 3.05, -, 60.80%, 17.80%, -, 57.70%, 71.40%, -63.90%, -85.30%, -95.80%, 5.20, 5.00, 0.03, 0.05, 54.50%, -, -, -3.45%, -36.36%, 12.75%, 80.74%, 7.69%, 7.30%
359, EDIT, Editas Medicine Inc., Healthcare, Biotechnology, USA, 2.35B, -, -, 25.68, 3.51, -, 26.00%, -3.70%, -, -24.40%, 14.00%, -20.70%, -28.40%, -34.30%, 9.90, 9.90, 0.00, 0.00, -, -, -, -9.15%, -27.60%, 15.28%, 25.42%, -51.58%, 6.92%
362, EHC, Encompass Health Corporation, Healthcare, Medical Care Facilities, USA, 8.47B, 19.56, 2.48, 1.80, 5.13, 27.26, -21.20%, 6.90%, 11.39%, 22.40%, 4.10%, 4.60%, 19.50%, 11.10%, 1.20, 1.20, 1.91, 1.99, 95.60%, 14.30%, 6.50%, -0.17%, 7.32%, 4.10%, 17.12%, 3.75%, 1.84%
364, EKSO, Ekso Bionics Holdings Inc., Healthcare, Medical Instruments & Supplies, USA, 73.10M, -, -, 7.86, 1.49, -, 12.70%, -6.90%, -, 21.80%, 26.70%, -55.20%, -126.10%, -177.20%, 9.10, 8.80, 0.06, 0.08, 60.80%, -, -, 10.94%, -19.32%, -0.87%, 48.30%, -7.34%, 7.09%
366, ELDN, Eledon Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 127.00M, -, -, -, 0.77, -, 35.60%, 40.80%, -, 93.30%, -, -15.60%, -22.80%, -, 26.20, 26.20, 0.00, 0.00, -, -, -, -4.42%, -37.98%, -61.00%, -58.36%, -38.18%, 8.20%
368, ELOX, Eloxx Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 128.40M, -, -, -, 22.29, -, 35.50%, 1.60%, -, 37.80%, -, -98.00%, -242.60%, -, 1.60, 1.60, 1.75, 3.75, -, -, -, -27.44%, -63.72%, -47.83%, -53.98%, -60.80%, 9.25%
370, ENLV, Enlivex Therapeutics Ltd., Healthcare, Biotechnology, Israel, 168.75M, -, -, -, 3.79, -, 19.00%, -, -, -, -, -, -, -, 19.10, 19.10, 0.00, 0.00, -, -, -, -22.56%, -37.07%, 12.08%, 80.54%, 11.15%, 6.55%
372, ENSG, The Ensign Group Inc., Healthcare, Medical Care Facilities, USA, 4.52B, 21.31, 1.74, 1.85, 5.15, 13.17, 86.60%, 8.53%, 15.00%, 18.10%, 6.40%, 7.10%, 22.50%, 18.90%, 1.20, 1.20, 0.13, 0.13, 23.00%, 9.40%, 7.30%, -4.01%, -0.02%, 14.85%, 90.30%, 14.10%, 3.70%
374, ENTX, Entera Bio Ltd., Healthcare, Biotechnology, Israel, 77.00M, -, -, 192.51, 9.23, -, 39.00%, -7.70%, -, 54.20%, 100.00%, -87.40%, -134.70%, -157.10%, 2.80, 2.80, 0.03, 0.06, 42.70%, -, -, -5.00%, 103.14%, 207.79%, 68.23%, 199.07%, 6.93%
376, ENZ, Enzo Biochem Inc., Healthcare, Diagnostics & Research, USA, 151.91M, -, -, 1.57, 2.39, -, -, -, -, 129.60%, 62.40%, -9.30%, -17.50%, -43.20%, 2.30, 2.00, 0.07, 0.19, 41.40%, -12.30%, -11.00%, -3.75%, 4.41%, 56.35%, 8.07%, 22.22%, 5.06%
378, EPIX, ESSA Pharma Inc., Healthcare, Biotechnology, Canada, 1.32B, -, -, -, 5.62, -, 30.90%, -, -, 20.90%, -, -, -, -, 65.80, 65.80, 0.00, 0.00, -, -, -, 2.56%, 17.33%, 387.21%, 505.75%, 165.05%, 5.98%
380, EQ, Equillium Inc., Healthcare, Biotechnology, USA, 196.93M, -, -, -, 1.95, -, 0.60%, -16.40%, -, 26.30%, -, -37.70%, -45.70%, -, 14.40, 14.40, 0.08, 0.11, -, -, -, 0.46%, -12.18%, 33.60%, 90.14%, 22.62%, 6.89%
361, EGRX, Eagle Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 531.30M, 9.94, 13.78, 2.90, 2.71, 9.47, -14.00%, 26.97%, 2.70%, 84.70%, -10.40%, 5.70%, 7.90%, 10.20%, 3.90, 3.70, 0.12, 0.16, 73.50%, 13.70%, 7.90%, -3.20%, -12.69%, -14.80%, -22.71%, -14.92%, 3.83%
363, EIGR, Eiger BioPharmaceuticals Inc., Healthcare, Biotechnology, USA, 272.03M, -, -, 75.57, 2.11, -, 25.00%, -101.10%, -, 237.40%, -, -14.60%, -22.10%, -, 9.70, 9.60, 0.25, 0.00, 98.50%, -, -, -8.71%, -24.93%, -10.17%, -34.88%, -36.05%, 5.10%
365, ELAN, Elanco Animal Health Incorporated, Healthcare, Drug Manufacturers - Specialty & Generic, USA, 16.97B, 27.07, -, 4.40, 2.19, -, -792.00%, 29.28%, 7.45%, -3.10%, 88.80%, -3.70%, -7.30%, -4.10%, 1.60, 0.90, 0.69, 0.77, 50.70%, -17.40%, -14.80%, 11.98%, 6.92%, 13.22%, 68.05%, 17.31%, 2.37%
367, ELMD, Electromed Inc., Healthcare, Medical Devices, USA, 83.32M, 23.48, 1.80, 2.51, 2.57, 24.50, 105.50%, 40.00%, 15.00%, -65.90%, 1.10%, 9.30%, 10.40%, 13.40%, 7.60, 7.10, 0.00, 0.00, 78.30%, 11.50%, 9.90%, -0.10%, -12.43%, 0.72%, -31.62%, 0.51%, 5.06%
369, ENDP, Endo International plc, Healthcare, Drug Manufacturers - Specialty & Generic, Ireland, 1.37B, 2.82, -, 0.49, -, 2.68, 131.60%, -5.36%, -3.60%, -70.80%, -12.50%, 1.00%, -13.90%, 8.40%, 1.80, 1.50, -, -, 51.50%, 19.10%, 3.40%, -0.34%, -21.84%, 10.75%, 52.07%, -18.25%, 5.51%
371, ENOB, Enochian Biosciences Inc., Healthcare, Biotechnology, USA, 188.81M, -, -, -, 1.17, -, 48.60%, -, -, -163.20%, -, -7.70%, -8.20%, -, 3.50, 3.50, 0.04, 0.04, -, -, -, 18.66%, 11.81%, 36.58%, 14.65%, 37.97%, 7.03%
373, ENTA, Enanta Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 999.96M, -, -, 10.62, 2.25, -, -182.00%, -28.40%, -, -262.60%, -27.20%, -15.20%, -16.20%, -9.40%, 16.10, 16.10, 0.00, 0.00, -, -89.90%, -78.60%, -5.24%, -2.15%, 13.32%, -5.50%, 15.58%, 4.29%
375, ENVB, Enveric Biosciences Inc., Healthcare, Biotechnology, USA, 48.79M, -, -, -, 1.91, -, 89.50%, -, -, 91.60%, -, -, -, -, 37.40, 37.40, 0.00, 0.00, -, -, -, -10.08%, -38.23%, -60.46%, -57.77%, -47.65%, 9.99%
377, EOLS, Evolus Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 586.12M, -, -, 10.05, 17.17, -, -51.50%, 58.20%, 16.50%, 126.60%, 16.20%, -70.50%, -, -251.10%, 0.90, 0.90, 0.00, 0.83, 67.40%, -, -, 18.51%, -13.51%, 187.77%, 136.76%, 222.02%, 6.64%
379, EPZM, Epizyme Inc., Healthcare, Biotechnology, USA, 852.46M, -, -, 38.75, 9.68, -, -19.10%, 19.20%, 38.00%, -35.00%, 442.90%, -59.40%, -143.20%, -59.60%, 8.70, 8.30, 2.65, 2.65, 66.80%, -, -, 1.98%, -15.85%, -30.55%, -53.11%, -24.22%, 5.36%
382, ESPR, Esperion Therapeutics Inc., Healthcare, Biotechnology, USA, 569.43M, -, -, 2.44, -, -, -45.70%, 50.60%, 16.90%, -23.00%, 344.40%, -51.50%, 230.50%, -145.70%, 2.80, 2.60, -, -, 98.20%, -55.60%, -66.90%, -27.10%, -30.19%, -26.20%, -53.01%, -23.42%, 6.30%
384, ETNB, 89bio Inc., Healthcare, Biotechnology, USA, 383.67M, -, -, -, 1.99, -, 26.10%, -27.20%, 16.00%, 3.40%, -, -30.30%, -31.80%, -, 23.40, 23.40, 0.00, 0.00, -, -, -, -29.95%, -23.48%, -30.10%, -26.63%, -22.45%, 8.02%
386, ETTX, Entasis Therapeutics Holdings Inc., Healthcare, Biotechnology, USA, 85.11M, -, -, -, 1.99, -, 37.00%, -5.70%, -, 74.90%, -, -76.30%, -88.30%, -, 6.40, 6.40, 0.00, 0.00, -, -, -, 11.79%, -13.50%, 33.90%, -14.44%, -4.05%, 8.72%
388, EVFM, Evofem Biosciences Inc., Healthcare, Biotechnology, USA, 83.00M, -, -, 51.87, -, -, -6.50%, 40.70%, -, -41.90%, -, -150.20%, -702.10%, -131.30%, 1.10, 0.90, -, -, 37.20%, -, -, -41.10%, -77.60%, -61.95%, -84.25%, -64.32%, 7.89%
390, EVH, Evolent Health Inc., Healthcare, Health Information Services, USA, 1.71B, 1214.38, -, 1.73, 2.67, -, -8.50%, 108.70%, 30.00%, 85.70%, -2.80%, -19.90%, -42.20%, -35.50%, 1.20, 1.20, 0.33, 0.37, 31.00%, -26.50%, -26.80%, -10.30%, -0.56%, 33.36%, 118.81%, 21.21%, 5.40%
392, EVOK, Evoke Pharma Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 40.10M, -, -, 400.98, 4.92, -, -61.50%, 8.80%, 40.00%, -14.20%, -, -127.70%, -, -, 3.10, 3.00, 0.64, 0.64, -33.50%, -, -, -27.65%, -59.54%, -59.27%, -50.20%, -52.33%, 8.81%
394, EWTX, Edgewise Therapeutics Inc., Healthcare, Biotechnology, USA, 1.41B, -, -, -, 0.15, -, -76.40%, -, -, -, -, -, -, -, 64.00, 64.00, 0.00, 0.00, -, -, -, 1.37%, -, -, -, -3.77%, 9.23%
396, EXEL, Exelixis Inc., Healthcare, Biotechnology, USA, 7.04B, 23.84, -, 6.83, 3.68, 46.47, -65.50%, 171.84%, -, -96.80%, 19.10%, 3.10%, 3.50%, 4.80%, 6.70, 6.60, 0.00, 0.00, 96.10%, 5.10%, 6.30%, -8.67%, 1.12%, 20.40%, -8.74%, 12.36%, 3.62%
398, EYEN, Eyenovia Inc., Healthcare, Biotechnology, USA, 122.61M, -, -, 30.65, 9.96, -, 36.30%, 14.50%, -, 32.90%, -, -78.70%, -144.60%, -125.20%, 1.70, 1.70, 0.02, 0.09, 60.00%, -, -, -10.49%, -19.80%, 38.55%, 65.40%, -21.12%, 7.51%
400, EYPT, EyePoint Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 283.99M, -, -, 8.28, 2.10, -, 35.00%, 14.50%, -, 56.50%, -2.70%, -41.80%, -121.90%, -, 11.90, 11.40, 0.33, 0.33, 81.80%, -, -, -8.81%, -19.76%, 106.95%, 14.30%, 49.39%, 6.85%
381, ERYP, ERYTECH Pharma S.A., Healthcare, Biotechnology, France, 126.95M, -, -, 34.14, 4.44, -, -13.70%, 35.90%, -, -, -40.90%, -, -, -, -, -, -, -, -, -, -, -19.55%, -31.87%, -23.73%, 10.60%, -36.37%, 4.94%
383, ESTA, Establishment Labs Holdings Inc., Healthcare, Medical Devices, Costa Rica, 1.88B, -, -, 20.81, 26.25, -, 12.00%, 29.20%, -, 63.10%, 23.70%, -17.60%, -35.30%, -22.40%, 5.20, 4.30, 0.69, 0.69, 63.10%, -24.60%, -30.20%, 8.41%, 14.36%, 201.13%, 305.49%, 112.01%, 6.57%
385, ETON, Eton Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 208.13M, 20.17, -, 17.64, 8.02, -, -29.10%, 37.25%, -, 138.60%, -82.40%, -66.20%, -121.00%, -, 9.50, 9.00, 0.30, 0.33, 85.00%, -, -, -18.85%, -13.37%, -5.87%, 53.48%, -13.16%, 6.12%
387, EVAX, Evaxion Biotech A/S, Healthcare, Biotechnology, Denmark, 123.27M, -, -, -, 4.32, -, -34.10%, -35.70%, -, 43.20%, -, -, -, -, 5.40, 5.40, 0.04, 0.04, -, -, -, -8.17%, -4.80%, -, -, -31.85%, 10.49%
389, EVGN, Evogene Ltd., Healthcare, Biotechnology, Israel, 138.19M, -, -, 138.19, 2.58, -, -18.00%, -2.80%, -, -0.80%, 300.00%, -35.50%, -53.50%, -51.20%, 5.40, 5.40, 0.04, 0.05, 44.80%, -, -, -23.18%, -43.69%, 20.00%, 237.86%, -25.96%, 8.48%
391, EVLO, Evelo Biosciences Inc., Healthcare, Biotechnology, USA, 720.52M, -, -, -, 7.85, -, 11.10%, 1.80%, -, 23.10%, -, -85.50%, -166.10%, -, 7.20, 7.20, 0.33, 0.34, -, -, -, 9.64%, 11.28%, 158.57%, 207.09%, 11.00%, 8.14%
393, EW, Edwards Lifesciences Corporation, Healthcare, Medical Devices, USA, 58.65B, 38.04, 4.69, 13.11, 12.84, 81.80, -21.00%, 14.12%, 15.31%, 9.50%, 7.80%, 12.30%, 19.70%, 15.60%, 3.80, 2.90, 0.13, 0.13, 75.20%, 20.60%, 19.00%, -0.37%, 11.81%, 13.88%, 28.03%, 5.12%, 1.88%
395, EXAS, Exact Sciences Corporation, Healthcare, Diagnostics & Research, USA, 19.07B, -, -, 12.79, 6.13, -, -777.40%, 7.20%, -, -601.40%, 57.70%, -7.30%, -13.10%, -17.30%, 3.80, 3.70, 0.48, 0.57, 76.20%, -29.60%, -22.40%, -16.91%, -21.17%, -4.61%, 28.70%, -16.57%, 5.92%
397, EYEG, EyeGate Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 29.81M, -, -, 2471.85, 2.41, -, 20.70%, 5.70%, -, 14.00%, -, -62.30%, -104.30%, -, 4.90, 4.90, 0.02, 0.00, -, -, -, 7.07%, -22.30%, 27.62%, -13.92%, -10.95%, 5.81%
399, EYES, Second Sight Medical Products Inc., Healthcare, Medical Devices, USA, 143.52M, -, -, -, 6.72, -, 68.30%, -, -, 78.70%, -, -86.40%, -154.00%, -, 4.00, -, 0.00, 0.10, -, -, -, -16.48%, 219.79%, 448.62%, 525.85%, 219.79%, 12.41%
402, FBIO, Fortress Biotech Inc., Healthcare, Biotechnology, USA, 369.79M, 8.57, -, 8.35, 3.08, -, 11.50%, 192.20%, 25.50%, 44.00%, -10.10%, -13.40%, -47.30%, -57.40%, 5.90, 5.90, 0.64, 0.70, 66.80%, -, -97.10%, -7.14%, 3.87%, 54.41%, 38.97%, 27.13%, 6.93%
404, FDMT, 4D Molecular Therapeutics Inc., Healthcare, Biotechnology, USA, 722.70M, -, -, 53.09, 2.93, -, 6.00%, -6.90%, 35.30%, 80.60%, 300.00%, -, -, -22.10%, 19.00, 19.00, 0.00, 0.00, -, -, -, -30.76%, -38.36%, -, -, -35.92%, 7.33%
406, FGEN, FibroGen Inc., Healthcare, Biotechnology, USA, 1.96B, -, -, 10.29, 5.25, 21.28, -137.10%, -65.80%, -, 11.90%, 57.40%, -22.60%, -44.50%, -40.20%, 3.70, 3.60, 0.11, 0.14, 94.10%, -95.20%, -96.00%, -5.60%, -57.95%, -46.90%, -36.45%, -42.71%, 5.27%
408, FIXX, Homology Medicines Inc., Healthcare, Biotechnology, USA, 384.72M, -, -, 12.25, 1.66, -, -13.60%, -31.20%, -9.40%, 97.30%, 74.10%, -38.30%, -49.60%, -66.50%, 10.80, 10.80, 0.00, 0.00, -, -, -, -3.35%, -41.03%, -30.83%, -53.37%, -41.19%, 5.19%
410, FLGC, Flora Growth Corp., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 160.52M, -, -, 1605.19, -, -, -401.80%, -, -, -645.80%, -, -, -, -84.50%, 6.40, 6.20, 0.02, 0.04, 67.00%, -, -, -, -, -, -, -16.08%, -
412, FLXN, Flexion Therapeutics Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 409.46M, -, -, 4.55, -, -, 35.80%, 58.20%, 20.00%, 40.00%, 22.40%, -41.50%, -, -45.20%, 3.50, 3.30, -, -, 74.40%, -92.80%, -, 3.33%, -26.64%, -22.79%, -26.77%, -27.47%, 5.51%
414, FMTX, Forma Therapeutics Holdings Inc., Healthcare, Biotechnology, USA, 1.39B, -, -, -, 2.15, -, -120.20%, -7.70%, -, -435.60%, -, -, -, -, 20.10, 20.10, 0.00, 0.00, -, -, -, 4.78%, -27.07%, -30.98%, -, -19.57%, 6.41%
416, FOLD, Amicus Therapeutics Inc., Healthcare, Biotechnology, USA, 2.39B, -, -, 8.98, 9.75, -, 27.90%, 41.90%, -1.00%, 28.20%, 9.80%, -30.70%, -83.20%, -38.00%, 5.00, 4.90, 1.55, 1.55, 88.40%, -85.90%, -95.10%, -7.12%, -21.46%, -59.31%, -25.77%, -59.90%, 3.73%
418, FORA, Forian Inc., Healthcare, Health Information Services, USA, 330.31M, -, -, 606.21, 8.98, -, -216.10%, -, -, -477.20%, -65.20%, -, -, -44.10%, 2.00, -, 0.00, 0.00, -, -, -, -15.15%, -35.26%, 91.73%, 60.81%, 1.73%, 5.58%
420, FRLN, Freeline Therapeutics Holdings plc, Healthcare, Biotechnology, United Kingdom, 394.33M, -, -, -, -, -, 39.10%, 2.80%, -, -, -, -, -, -, -, -, -, -, -, -, -, -6.46%, -27.87%, -31.25%, -, -39.76%, 10.56%
401, FATE, Fate Therapeutics Inc., Healthcare, Biotechnology, USA, 7.17B, -, -, 178.82, 9.05, -, -46.20%, -19.10%, -10.10%, -9.30%, 344.00%, -25.10%, -35.70%, -33.30%, 8.50, 8.50, 0.00, 0.00, -, -, -, -10.80%, -20.71%, 34.08%, 136.20%, -15.76%, 7.16%
403, FBRX, Forte Biosciences Inc., Healthcare, Biotechnology, USA, 497.56M, -, -, -, 8.61, -, 84.30%, -51.60%, -, 62.60%, -, -116.30%, -124.00%, -, 23.60, 23.60, 0.00, 0.00, -, -, -, -3.29%, 19.62%, -6.96%, 95.81%, -2.39%, 7.54%
405, FENC, Fennec Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 179.68M, -, -, 898.40, 7.68, -, -19.00%, -151.10%, -, 5.30%, -, -57.40%, -62.70%, -61.50%, 9.60, 9.60, 0.00, 0.00, -, -, -, 13.38%, -1.34%, -6.47%, -0.41%, -1.07%, 5.13%
407, FHTX, Foghorn Therapeutics Inc., Healthcare, Biotechnology, USA, 371.85M, -, -, 531.21, 3.06, -, -32.50%, 0.00%, -, 76.90%, -, -, -, -41.40%, 10.10, 10.10, 0.16, 0.16, -, -, -, -1.98%, -36.10%, -43.88%, -, -48.64%, 5.44%
409, FLDM, Fluidigm Corporation, Healthcare, Diagnostics & Research, USA, 436.97M, -, -, 3.05, 3.52, -, 24.10%, 38.00%, -8.06%, -11.10%, 18.80%, -18.10%, -40.90%, -25.80%, 1.80, 1.40, 0.44, 0.44, 59.90%, -38.60%, -39.00%, 15.31%, 22.11%, 0.87%, 33.03%, -3.33%, 8.44%
411, FLGT, Fulgent Genetics Inc., Healthcare, Diagnostics & Research, USA, 2.23B, 21.16, -, 2.88, 2.66, 6.83, 38.10%, -72.15%, -, -, 3417.10%, 81.60%, 101.40%, 36.50%, 3.40, 3.40, 0.00, 0.02, 79.30%, 71.70%, 53.90%, -6.94%, -33.50%, 102.88%, 325.20%, 42.17%, 5.81%
413, FMS, Fresenius Medical Care AG & Co. KGaA, Healthcare, Medical Care Facilities, Germany, 23.48B, 11.75, 5.28, 1.31, 2.09, -, 3.20%, 18.40%, 3.18%, -48.30%, -3.90%, -, -, -, -, -, -, -, -, -, -, 1.08%, 14.38%, -4.28%, -5.02%, -3.56%, 0.86%
415, FNCH, Finch Therapeutics Group Inc., Healthcare, Biotechnology, USA, 730.23M, -, -, 94.60, 2.88, -, -89.60%, -40.40%, -, -, -, -, -, 42.00%, 17.20, 17.20, 0.01, 0.01, -, -, -, 3.92%, -, -, -, -31.57%, 8.81%
417, FONR, FONAR Corporation, Healthcare, Medical Devices, USA, 123.26M, -, -, 1.43, 0.86, 7.85, -46.80%, -, -, 202.30%, 6.50%, 5.20%, 7.20%, 8.70%, 6.10, 5.90, 0.01, 0.02, 50.30%, 16.10%, 11.00%, 4.50%, -9.86%, -7.27%, -24.27%, 4.26%, 3.14%
419, FREQ, Frequency Therapeutics Inc., Healthcare, Biotechnology, USA, 309.31M, -, -, 8.99, 1.70, -, -29.30%, -27.80%, -, -275.20%, -35.60%, -17.80%, -23.00%, -13.30%, 10.60, 10.60, 0.08, 0.08, -, -, -, -20.77%, -81.56%, -66.03%, -52.32%, -74.90%, 8.95%
422, FULC, Fulcrum Therapeutics Inc., Healthcare, Biotechnology, USA, 294.06M, -, -, 22.80, 2.20, -, 29.50%, -3.40%, 6.40%, 33.60%, 500.00%, -48.40%, -61.70%, -75.20%, 6.50, 6.50, 0.00, 0.00, -, -, -, -20.48%, -31.68%, -21.11%, -55.15%, -23.74%, 5.79%
424, FVE, Five Star Senior Living Inc., Healthcare, Medical Care Facilities, USA, 194.78M, 21.46, 1.03, 0.17, 0.89, 3.10, 94.00%, 27.27%, 14.25%, 119.10%, -9.50%, 2.90%, 6.20%, 6.90%, 1.50, 1.50, 0.05, 0.05, 15.40%, 1.00%, 1.10%, 16.25%, -3.99%, 1.18%, 61.99%, -12.90%, 6.21%
426, GALT, Galectin Therapeutics Inc., Healthcare, Biotechnology, USA, 237.01M, -, -, -, 14.18, -, -7.10%, -1.50%, -, -78.00%, -, -82.60%, -103.50%, -, 4.90, 4.90, 0.00, 0.00, -, -, -, -6.37%, 71.12%, 52.11%, 31.02%, 77.23%, 10.38%
428, GBIO, Generation Bio Co., Healthcare, Biotechnology, USA, 1.97B, -, -, -, 4.13, -, -63.70%, 1.00%, -, -50.30%, -, -24.40%, -26.80%, -, 42.20, 42.20, 0.00, 0.00, -, -, -, -9.03%, -14.78%, -13.79%, -, 20.85%, 6.38%
430, GBT, Global Blood Therapeutics Inc., Healthcare, Biotechnology, USA, 2.41B, -, -, 16.24, 6.57, -, 11.80%, 35.40%, 37.00%, -0.40%, 176.60%, -35.80%, -57.60%, -43.00%, 9.50, 8.70, 0.41, 0.41, 98.40%, -, -, -8.04%, -13.60%, -12.36%, -45.04%, -11.27%, 4.31%
432, GEG, Great Elm Group Inc., Healthcare, Medical Distribution, USA, 70.20M, 6.60, -, 1.09, 1.23, -, -88.70%, 29.03%, 20.00%, 76.50%, -6.80%, -1.70%, -5.70%, 0.40%, 2.30, 2.30, 1.95, 2.04, 56.30%, -1.60%, -5.10%, -1.12%, -23.48%, -2.94%, 32.00%, -8.33%, 6.42%
434, GERN, Geron Corporation, Healthcare, Biotechnology, USA, 452.41M, -, -, 1508.02, 2.23, -, 22.70%, -2.90%, 5.00%, -5.30%, 0.00%, -32.00%, -38.90%, -32.70%, 7.50, 7.50, 0.12, 0.12, -, -, -, -8.61%, -25.81%, -23.76%, -14.29%, -13.21%, 5.77%
436, GHSI, Guardion Health Sciences Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 37.90M, -, -, 19.95, 0.77, -, 66.40%, -, -, 30.20%, 0.00%, -44.10%, -47.20%, -100.60%, 44.80, 44.50, 0.00, 0.00, 51.10%, -, -, -12.29%, -41.20%, 5.09%, -50.54%, -36.95%, 7.68%
438, GKOS, Glaukos Corporation, Healthcare, Medical Instruments & Supplies, USA, 3.45B, -, -, 14.52, 5.70, -, -821.50%, 29.90%, 8.00%, 70.80%, 23.00%, -8.20%, -12.80%, -12.20%, 1.40, 1.40, 0.10, 0.58, 68.10%, -34.80%, -34.80%, -22.58%, -24.47%, 11.32%, 88.76%, -2.23%, 3.88%
440, GLPG, Galapagos NV, Healthcare, Biotechnology, Belgium, 4.99B, -, -, 9.41, 1.87, -, 20.50%, -10.50%, 0.71%, -, -, -, -, -, -, -, -, -, -, -, -, -3.31%, -10.03%, -36.96%, -62.45%, -23.08%, 2.24%
421, FSTX, F-star Therapeutics Inc., Healthcare, Biotechnology, United Kingdom, 145.38M, -, -, 10.24, 1.94, -, -65.50%, 5.50%, -, 45.20%, 462.10%, -62.30%, -91.50%, -52.10%, 1.00, 1.00, 0.00, 0.00, -, -, -, -21.85%, -16.12%, 33.33%, 12.73%, -24.62%, 9.58%
423, FUSN, Fusion Pharmaceuticals Inc., Healthcare, Biotechnology, Canada, 342.60M, -, -, -, 1.23, -, -831.10%, -21.70%, -, -50.60%, -, -27.60%, -28.70%, -, 30.70, 30.70, 0.00, 0.00, -, -, -, -3.07%, -29.89%, -34.32%, -, -30.13%, 6.52%
425, FWP, Forward Pharma A/S, Healthcare, Biotechnology, Denmark, 53.10M, -, -, -, 0.64, -, 78.40%, -, 21.00%, 83.00%, -, -8.20%, -8.30%, -, 74.50, 74.50, 0.00, 0.00, -, -, -, -3.14%, -3.01%, 4.48%, 22.75%, 3.89%, 5.91%
427, GANX, Gain Therapeutics Inc., Healthcare, Biotechnology, USA, 126.23M, -, -, -, 1.16, -, -63.10%, -37.90%, -, -, -, -, -, -, 20.40, 20.40, 0.02, 0.02, -, -, -, -13.55%, -, -, -, -5.45%, 7.66%
429, GBS, GBS Inc., Healthcare, Medical Devices, USA, 39.10M, -, -, 96.32, 2.23, -, -43.80%, -, -, 69.70%, -, -, -, -, 10.60, 10.60, 0.00, 0.00, -, -, -, -25.12%, -61.95%, -, -, -59.32%, 9.41%
431, GDRX, GoodRx Holdings Inc., Healthcare, Health Information Services, USA, 14.74B, 68.85, -, 25.51, 20.17, 135.68, -720.20%, 54.00%, 33.23%, -94.60%, 20.20%, -25.40%, -107.30%, -19.30%, 17.80, 17.80, 0.88, 0.89, 94.10%, -56.20%, -55.30%, -8.33%, -19.55%, -3.79%, -, -8.01%, 6.52%
433, GENE, Genetic Technologies Limited, Healthcare, Diagnostics & Research, Australia, 55.81M, -, -, 2170.56, 3.43, -, -157.90%, -, -, -, 2704.80%, -, -, -, 14.60, 14.50, 0.01, 0.02, -, -, -, -2.14%, -6.80%, 28.84%, 71.25%, 14.17%, 6.50%
435, GH, Guardant Health Inc., Healthcare, Diagnostics & Research, USA, 12.57B, -, -, 42.19, 14.79, -, -211.70%, 18.50%, 12.60%, -269.70%, 16.60%, -18.80%, -30.90%, -12.10%, 21.30, 21.00, 1.34, 0.00, 66.20%, -, -, -22.76%, -18.42%, 10.19%, 37.32%, -3.69%, 5.12%
437, GILD, Gilead Sciences Inc., Healthcare, Drug Manufacturers - General, USA, 82.65B, 9.94, 107.87, 3.23, 4.38, 15.88, -97.70%, -5.89%, 2.98%, 12.20%, 15.80%, 0.50%, 1.70%, 5.00%, 1.40, 1.20, 1.47, 1.59, 80.60%, 17.80%, 1.20%, 3.56%, 5.84%, 11.11%, -15.06%, 13.47%, 2.08%
439, GLMD, Galmed Pharmaceuticals Ltd., Healthcare, Biotechnology, Israel, 65.99M, -, -, -, 1.15, -, -39.50%, 4.80%, 20.00%, -32.90%, -, -53.20%, -60.00%, -, 8.40, 8.40, 0.00, 0.00, -, -, -, -22.85%, -35.00%, -31.03%, -45.26%, -16.40%, 9.18%
442, GLTO, Galecto Inc., Healthcare, Biotechnology, Denmark, 123.51M, -, -, -, 0.88, -, 19.40%, -, 47.60%, -128.90%, -, -, -, -, 21.10, 21.10, 0.00, 0.00, -, -, -, -9.85%, -51.64%, -66.60%, -, -57.55%, 4.93%
444, GMAB, Genmab A/S, Healthcare, Biotechnology, Denmark, 26.55B, 5.22, -, 2.63, -, -, 476.40%, 22.70%, 27.00%, -60.50%, -31.00%, -, -, -, -, -, -, -, -, -, -, 8.96%, 15.66%, 13.12%, 33.31%, -0.10%, 1.97%
446, GMED, Globus Medical Inc., Healthcare, Medical Devices, USA, 7.20B, 32.75, 4.17, 8.72, 4.60, 43.62, -33.40%, 16.28%, 14.50%, 74.20%, 19.30%, 7.60%, 8.40%, 5.80%, 6.60, 4.70, 0.00, 0.00, 72.90%, 16.60%, 14.70%, -0.62%, 14.96%, 20.50%, 31.86%, 10.49%, 2.11%
448, GNCA, Genocea Biosciences Inc., Healthcare, Biotechnology, USA, 127.39M, -, -, 90.99, 78.67, -, 47.90%, 1.40%, -, 60.30%, -, -52.10%, -447.60%, -191.80%, 6.00, 6.00, 4.22, 6.56, -, -, -, -11.28%, -23.13%, 17.41%, -14.49%, -2.48%, 7.16%
450, GNLN, Greenlane Holdings Inc., Healthcare, Pharmaceutical Retailers, USA, 65.18M, -, -, 0.47, 3.15, -, -294.60%, 52.50%, -, -487.30%, 0.30%, -11.70%, -76.90%, -209.20%, 2.30, 1.30, 0.51, 0.58, 16.40%, -28.30%, -10.30%, -15.65%, -31.69%, 23.17%, 12.79%, -2.02%, 7.33%
452, GOSS, Gossamer Bio Inc., Healthcare, Biotechnology, USA, 673.28M, -, -, -, 2.31, -, -7.80%, 1.30%, 5.20%, 11.00%, -, -44.30%, -71.30%, -, 15.80, 15.80, 0.64, 0.64, -, -, -, -2.64%, -14.79%, -5.26%, -30.29%, -12.41%, 4.97%
454, GRAY, Graybug Vision Inc., Healthcare, Biotechnology, USA, 81.11M, -, -, -, 0.99, -, 28.30%, 14.60%, -, 76.30%, -, -, -, -, 14.10, 14.10, 0.00, 0.00, -, -, -, -18.11%, -79.36%, -84.31%, -, -86.29%, 8.77%
456, GRFS, Grifols S.A., Healthcare, Drug Manufacturers - General, Spain, 11.92B, 11.21, 2.80, 2.23, 4.69, -, 1.50%, 18.20%, 11.50%, -34.10%, -3.80%, -, -, -, -, -, -, -, -, -, -, -1.52%, 6.13%, -3.95%, -7.61%, -5.15%, 3.12%
458, GRTX, Galera Therapeutics Inc., Healthcare, Biotechnology, USA, 212.62M, -, -, -, -, -, -25.30%, 9.40%, 19.90%, -0.90%, -, -81.20%, -492.90%, -, 4.10, 4.10, -, -, -, -, -, 5.54%, -23.21%, -22.65%, -18.07%, -16.23%, 8.19%
460, GTBP, GT Biopharma Inc., Healthcare, Biotechnology, USA, 348.25M, -, -, -, 11.57, -, 43.50%, 48.10%, -, -341.00%, -, -637.90%, 362.60%, -, 7.60, 7.60, 0.00, 0.00, -, -, -, 42.24%, 234.11%, 489.26%, 401.29%, 139.18%, 9.90%
441, GLSI, Greenwich LifeSciences Inc., Healthcare, Biotechnology, USA, 437.91M, -, -, -, 15.98, -, 48.80%, -11.20%, -, -128.20%, -, -13.50%, -14.60%, -, 45.20, 45.20, 0.00, 0.00, -, -, -, -2.86%, 10.10%, 599.62%, -, 1.67%, 6.86%
443, GLYC, GlycoMimetics Inc., Healthcare, Biotechnology, USA, 126.81M, -, -, 57.64, 1.03, -, 16.60%, -7.90%, -, -60.10%, -87.80%, -39.10%, -42.90%, -40.20%, 12.30, 12.30, 0.00, 0.00, -, -, -, 2.00%, -28.97%, -29.36%, -9.89%, -32.18%, 8.06%
445, GMDA, Gamida Cell Ltd., Healthcare, Biotechnology, Israel, 366.43M, -, -, -, 4.64, -, -63.00%, 7.40%, -, 3.00%, -, -55.90%, -100.90%, -, 9.00, 9.00, 0.82, 0.82, -, -, -, -13.00%, -33.98%, -1.67%, 15.28%, -22.65%, 5.81%
447, GMTX, Gemini Therapeutics Inc., Healthcare, Biotechnology, USA, 503.69M, -, -, -, 2.30, -, 73.70%, -8.50%, -, -, -, -, -, -, 13.70, 13.70, 0.02, 0.05, -, -, -, 3.19%, -21.15%, 22.39%, -, 11.82%, 9.18%
449, GNFT, Genfit SA, Healthcare, Biotechnology, France, 183.00M, -, -, 23.59, -, -, -, -, -, -, -92.80%, -, -, -, -, -, -, -, -, -, -, -9.71%, -21.26%, -18.53%, -23.37%, -16.67%, 3.43%
451, GNPX, Genprex Inc., Healthcare, Biotechnology, USA, 177.09M, 37.40, -, -, 3.37, -, 24.00%, 104.90%, -, 28.40%, -, -57.80%, -58.60%, -, 82.10, 77.00, 0.00, 0.00, -, -, -, -4.35%, -30.48%, 22.62%, 31.69%, -9.88%, 7.03%
453, GOVX, GeoVax Labs Inc., Healthcare, Biotechnology, USA, 33.50M, -, -, 27.91, 1.40, -, 99.70%, 5.50%, -, 88.50%, -85.70%, -35.50%, -40.70%, -29.00%, 46.40, 46.40, 0.00, 0.01, -, -, -, 1.69%, 3.24%, 105.30%, -30.51%, 60.36%, 7.85%
455, GRCL, Gracell Biotechnologies Inc., Healthcare, Biotechnology, China, 1.07B, -, -, -, -, -, -36.70%, 36.20%, -, -, -, -, -, -, 8.70, 8.70, -, -, -, -, -, 21.26%, -39.69%, -, -, -39.90%, 11.62%
457, GRTS, Gritstone bio Inc., Healthcare, Biotechnology, USA, 436.36M, -, -, 10.27, 2.27, -, 1.00%, -59.50%, -, 122.60%, 52.60%, -38.70%, -53.30%, -63.60%, 9.30, 9.30, 0.00, 0.00, -, -, -, -0.22%, -34.66%, 171.39%, 42.41%, 133.50%, 7.60%
459, GSK, GlaxoSmithKline plc, Healthcare, Drug Manufacturers - General, United Kingdom, 95.19B, 12.65, 2.90, 2.07, 4.58, 25.82, 23.20%, 12.89%, 4.50%, -31.80%, -18.40%, 6.50%, 36.70%, 17.30%, 0.90, 0.60, 1.55, 1.76, 67.60%, 23.00%, 16.20%, 3.39%, 14.94%, 4.14%, -7.51%, 5.35%, 0.92%
462, GTHX, G1 Therapeutics Inc., Healthcare, Biotechnology, USA, 935.26M, -, -, 15.72, 3.60, -, 19.80%, 2.80%, -, 21.10%, -, -36.10%, -46.00%, -49.60%, 11.60, 11.50, 0.12, 0.12, 99.60%, -, -, -0.91%, -5.85%, 59.12%, 27.99%, 20.73%, 5.85%
464, HAE, Haemonetics Corporation, Healthcare, Medical Instruments & Supplies, USA, 2.85B, 18.23, 3.64, 3.27, 3.99, 23.80, 42.10%, 11.40%, 10.00%, 7.20%, -7.20%, 7.80%, 16.40%, 9.60%, 3.40, 1.90, 0.41, 0.43, 45.70%, 15.80%, 12.20%, -15.79%, -56.37%, -49.95%, -48.52%, -52.45%, 3.62%
466, HAPP, Happiness Biotech Group Limited, Healthcare, Drug Manufacturers - Specialty & Generic, China, 45.29M, -, -, 0.81, 0.50, 5.81, -34.60%, -, -, -63.90%, -30.30%, 9.40%, 10.10%, 15.20%, 12.80, 12.50, 0.00, 0.03, 43.50%, 16.70%, 13.40%, -1.14%, -13.86%, -9.84%, -32.14%, -5.43%, 3.58%
468, HBIO, Harvard Bioscience Inc., Healthcare, Medical Instruments & Supplies, USA, 273.28M, 17.63, -, 2.60, 3.61, 42.70, -63.10%, 29.32%, 10.00%, 85.70%, 13.40%, -2.60%, -5.20%, -1.70%, 2.40, 1.30, 0.54, 0.57, 57.40%, 1.30%, -3.80%, -2.78%, 58.37%, 85.19%, 165.15%, 63.17%, 4.87%
470, HCAT, Health Catalyst Inc., Healthcare, Health Information Services, USA, 2.42B, -, -, 12.10, 8.76, -, 77.40%, 49.10%, -, -37.20%, 23.70%, -23.00%, -46.70%, -23.20%, 1.30, 1.30, 0.00, 0.64, 49.20%, -55.50%, -63.10%, -7.46%, 10.61%, 50.94%, 97.83%, 23.34%, 4.26%
472, HCSG, Healthcare Services Group Inc., Healthcare, Medical Care Facilities, USA, 2.24B, 23.75, 2.42, 1.30, 4.56, 15.74, 52.40%, 5.69%, 9.00%, 21.40%, -9.20%, 13.50%, 21.90%, 18.00%, 3.90, 3.70, 0.00, 0.00, 16.10%, 6.80%, 6.00%, 0.20%, 0.28%, 24.85%, 25.38%, 6.73%, 2.59%
474, HEXO, HEXO Corp., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 878.73M, -, -, 7.87, 1.62, -, -, -, -, -, 93.30%, -, -, -, -, -, -, -, -, -, -, 10.80%, -1.78%, 127.22%, 183.62%, 95.11%, 6.12%
476, HJLI, Hancock Jaffe Laboratories Inc., Healthcare, Medical Devices, USA, 49.11M, -, -, -, 0.79, -, 37.60%, 7.10%, -, 69.30%, -, -68.40%, -82.20%, -, 23.60, 23.60, 0.00, 0.01, -, -, -, -5.74%, -17.92%, -34.33%, -27.48%, -31.68%, 6.18%
478, HOLX, Hologic Inc., Healthcare, Medical Instruments & Supplies, USA, 16.22B, 14.98, 3.68, 3.05, 4.30, 8.96, 671.70%, -44.76%, 2.35%, 553.00%, 103.40%, 25.80%, 63.50%, 21.10%, 2.60, 2.10, 0.71, 0.73, 68.90%, 46.70%, 35.90%, -4.79%, -15.51%, -7.58%, 18.98%, -13.41%, 1.99%
480, HOTH, Hoth Therapeutics Inc., Healthcare, Biotechnology, USA, 34.50M, -, -, -, 1.28, -, 30.70%, 23.40%, -, -35.30%, -, -97.30%, -104.70%, -, 27.00, 27.00, 0.00, 0.00, -, -, -, -2.68%, -37.23%, -13.17%, -49.83%, -38.82%, 6.75%
461, GTH, Genetron Holdings Limited, Healthcare, Diagnostics & Research, China, 1.83B, -, -, 26.52, 7.75, -, -88.10%, 36.10%, -, 66.80%, 19.90%, -147.90%, -173.30%, -14.80%, 7.40, 7.20, 0.03, 0.06, 62.00%, -70.60%, -, -2.58%, -21.10%, 59.53%, -, 51.21%, 6.96%
463, GTS, Triple-S Management Corporation, Healthcare, Healthcare Plans, USA, 595.81M, -, 0.51, 0.15, 0.60, 2.28, -27.40%, -, 10.00%, 189.00%, 23.30%, 3.80%, 11.90%, 7.20%, -, -, 0.05, 0.09, -, 4.40%, 3.00%, 6.71%, 0.92%, 12.44%, 27.14%, 18.50%, 2.90%
465, HALO, Halozyme Therapeutics Inc., Healthcare, Biotechnology, USA, 5.94B, 16.49, 0.85, 17.94, 84.51, 51.29, 282.30%, 81.69%, 43.00%, 522.10%, 250.40%, 25.10%, 154.10%, 26.30%, 8.80, 8.20, 11.61, 12.92, 83.20%, 53.50%, 49.20%, -19.29%, -10.89%, 0.66%, 70.62%, -3.04%, 3.41%
467, HARP, Harpoon Therapeutics Inc., Healthcare, Biotechnology, USA, 659.63M, -, -, 28.43, 6.36, -, 22.00%, 31.70%, -, -286.60%, 172.70%, -48.70%, -137.20%, -95.40%, 2.40, 2.40, 0.00, 0.00, -, -, -, -7.58%, 0.34%, 41.33%, -5.24%, 24.14%, 6.69%
469, HCA, HCA Healthcare Inc., Healthcare, Medical Care Facilities, USA, 72.00B, 14.10, 1.23, 1.37, 294.23, 10.23, 8.50%, 8.20%, 13.09%, 145.50%, 8.70%, 9.50%, -947.10%, 18.80%, 1.40, 1.20, 124.85, 125.80, 83.90%, 15.30%, 8.70%, 6.36%, 22.42%, 39.82%, 100.93%, 30.60%, 1.99%
471, HCM, HUTCHMED China Limited, Healthcare, Drug Manufacturers - General, Hong Kong, 4.43B, -, -, 19.43, 8.91, -, -, -, -, -, 13.60%, -, -, -, -, -, -, -, -, -, -, 3.73%, -1.03%, -4.22%, 36.41%, -7.09%, 5.43%
473, HEPA, Hepion Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 126.50M, -, -, -, 0.77, -, 65.60%, -13.30%, -, 88.00%, -, -40.90%, -48.70%, -, 41.10, 41.10, 0.00, 0.00, -, -, -, -4.49%, -14.57%, 7.59%, -8.11%, -22.37%, 5.89%
475, HGEN, Humanigen Inc., Healthcare, Biotechnology, USA, 1.34B, 4.72, -, 1679.60, 63.22, -, -426.20%, 4.18%, 12.50%, -, -, -202.30%, -356.10%, -193.80%, 1.90, 1.90, 1.44, 0.00, -, -, -, 9.06%, 9.41%, 125.78%, 172.46%, 15.60%, 9.40%
477, HNGR, Hanger Inc., Healthcare, Medical Care Facilities, USA, 986.19M, 20.91, 1.97, 0.98, 20.02, 7.39, 36.80%, 8.81%, 10.00%, 79.30%, 1.60%, 5.40%, 132.00%, 12.90%, 1.50, 1.10, 10.05, 10.27, 68.80%, 8.30%, 5.00%, 5.43%, 17.14%, 11.58%, 40.69%, 17.46%, 3.21%
479, HOOK, HOOKIPA Pharma Inc., Healthcare, Biotechnology, USA, 497.86M, -, -, 23.48, 3.55, -, 29.70%, -15.00%, 4.80%, -35.70%, 43.20%, -32.90%, -40.90%, -33.10%, 7.60, 7.60, 0.03, 0.04, -, -, -, 32.88%, 39.67%, 50.36%, 52.98%, 50.50%, 8.06%
482, HQY, HealthEquity Inc., Healthcare, Health Information Services, USA, 6.82B, 49.01, 56.96, 9.30, 4.63, 40.48, -79.90%, 20.37%, 12.80%, -, -6.50%, 0.30%, 0.70%, 1.60%, 2.20, 2.20, 0.67, 0.72, 56.60%, 4.50%, 1.20%, 7.36%, -0.30%, 16.20%, 34.13%, 19.24%, 3.12%
484, HRMY, Harmony Biosciences Holdings Inc., Healthcare, Biotechnology, USA, 1.82B, 11.21, -, 9.13, 16.82, -, 61.70%, 206.45%, -, 116.40%, 201.50%, -2.40%, 16.10%, -1.90%, 5.30, 5.20, 1.81, 1.81, 82.60%, 20.60%, -3.70%, 10.17%, -11.79%, -35.51%, -, -11.59%, 6.12%
486, HRTX, Heron Therapeutics Inc., Healthcare, Biotechnology, USA, 1.37B, -, -, 16.49, 6.17, -, 0.00%, 51.90%, 47.50%, -0.90%, -21.30%, -61.40%, -88.30%, -93.70%, 2.70, 2.30, 0.00, 0.04, 58.20%, -, -, -24.69%, -26.64%, -25.26%, -27.17%, -37.30%, 7.29%
488, HSIC, Henry Schein Inc., Healthcare, Medical Distribution, USA, 10.75B, 17.50, 1.50, 1.01, 3.22, 20.20, -40.20%, 6.34%, 16.53%, 26.90%, 20.40%, 5.70%, 13.70%, 10.90%, 1.70, 0.90, 0.15, 0.20, 27.90%, 5.60%, 4.10%, 4.06%, 17.80%, 18.57%, 25.23%, 13.73%, 2.64%
490, HSTM, HealthStream Inc., Healthcare, Health Information Services, USA, 838.81M, 174.53, 7.47, 3.40, 2.45, 18.23, 0.60%, 476.92%, 12.00%, -66.80%, 3.10%, 1.90%, 2.80%, 3.60%, 1.00, 1.00, 0.00, 0.00, 63.40%, 4.80%, 3.80%, 5.95%, 12.70%, 35.30%, 14.93%, 19.87%, 2.95%
492, HTBX, Heat Biologics Inc., Healthcare, Biotechnology, USA, 162.61M, -, -, 62.54, 1.17, -, 61.30%, 4.90%, -, 59.50%, -44.40%, -23.90%, -25.80%, -22.40%, 44.00, 44.00, 0.00, 0.00, -, -, -, -5.57%, -19.29%, -14.16%, -7.42%, 23.32%, 5.92%
494, HUGE, FSD Pharma Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 63.71M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 0.00%, -14.49%, 19.59%, -40.40%, 13.46%, 6.50%
496, HZNP, Horizon Therapeutics Public Limited Company, Healthcare, Drug Manufacturers - General, Ireland, 20.70B, 17.92, 5.68, 9.46, 5.33, 37.95, -37.60%, 41.31%, 14.00%, -670.40%, -3.80%, 4.60%, 8.00%, 8.90%, 2.40, 2.10, 0.66, 0.67, 75.50%, 14.40%, 12.80%, -3.21%, -0.27%, 33.03%, 80.68%, 25.30%, 3.48%
498, IBIO, iBio Inc., Healthcare, Biotechnology, USA, 326.80M, -, -, 108.93, 2.96, -, 35.40%, -, -, 39.60%, 700.00%, -21.70%, -31.10%, -15.60%, 17.70, 17.60, 0.30, 0.31, 83.60%, -, -, 2.84%, -19.89%, -0.68%, -9.38%, 38.10%, 10.68%
500, ICAD, iCAD Inc., Healthcare, Health Information Services, USA, 418.65M, -, -, 13.17, 7.38, -, -7.90%, 95.50%, 15.00%, 88.30%, 30.30%, -13.10%, -21.90%, -26.00%, 4.40, 4.20, 0.13, 0.13, 72.80%, -22.10%, -23.40%, -8.76%, -13.33%, 76.12%, 40.12%, 24.62%, 4.74%
481, HOWL, Werewolf Therapeutics Inc., Healthcare, Biotechnology, USA, 409.79M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -7.58%, -
483, HRC, Hill-Rom Holdings Inc., Healthcare, Medical Instruments & Supplies, USA, 7.40B, 17.43, 3.43, 2.49, 4.01, 17.16, 48.50%, 5.40%, 7.70%, 86.70%, 5.40%, 6.10%, 16.20%, 8.50%, 1.60, 1.20, 0.89, 0.94, 52.20%, 13.40%, 9.50%, -3.49%, 3.76%, 16.56%, 9.45%, 13.59%, 1.95%
485, HROW, Harrow Health Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 246.74M, 32.28, 1.69, 4.70, 8.52, 137.08, 169.20%, 216.67%, 15.00%, 101.60%, 30.50%, 17.50%, 40.50%, 0.70%, 4.00, 3.60, 0.39, 0.49, 72.20%, 11.10%, 18.60%, 15.00%, 16.31%, 53.08%, 70.06%, 34.11%, 8.19%
487, HSDT, Helius Medical Technologies Inc., Healthcare, Medical Devices, USA, 31.26M, -, -, 62.52, 4.95, -, 70.50%, -, -, 73.60%, 0.00%, -227.70%, -362.60%, -413.70%, 1.90, 1.80, 0.00, 0.00, 44.00%, -, -, -22.51%, -3.92%, -2.20%, -22.73%, 1.36%, 5.33%
489, HSKA, Heska Corporation, Healthcare, Diagnostics & Research, USA, 2.08B, 203.02, -, 9.17, 4.42, 443.10, -745.80%, 700.00%, 25.00%, 127.20%, 97.10%, -1.70%, -2.30%, -2.50%, 8.50, 7.50, 0.20, 0.20, 41.10%, -1.20%, -3.20%, 9.15%, -1.61%, 56.83%, 125.35%, 36.05%, 4.05%
491, HSTO, Histogen Inc., Healthcare, Biotechnology, USA, 35.80M, -, -, 23.87, 1.38, -, -133.80%, 26.80%, 38.00%, 57.00%, -60.00%, -112.20%, -179.90%, -224.50%, 11.60, 11.60, 0.01, 0.02, 38.50%, -, -, -12.38%, -16.09%, -35.71%, -77.08%, 30.62%, 5.91%
493, HTGM, HTG Molecular Diagnostics Inc., Healthcare, Diagnostics & Research, USA, 23.99M, -, -, 3.08, 1.33, -, 40.60%, 18.30%, -, 36.70%, -36.40%, -54.80%, -122.40%, -64.50%, 4.20, 4.00, 0.68, 0.98, 51.50%, -, -, -19.83%, -38.21%, -20.68%, -53.20%, -22.34%, 7.52%
495, HUM, Humana Inc., Healthcare, Healthcare Plans, USA, 56.68B, 17.75, 1.18, 0.72, 3.98, 19.33, 26.00%, 13.54%, 13.17%, 79.50%, 9.20%, 10.00%, 25.60%, 17.80%, -, -, 0.43, 0.54, -, 6.50%, 4.70%, -2.22%, 13.71%, 9.14%, 6.59%, 6.69%, 1.78%
497, IART, Integra LifeSciences Holdings Corporation, Healthcare, Medical Devices, USA, 5.83B, 20.52, 2.00, 4.23, 3.81, 26.13, 170.70%, 15.04%, 17.23%, 398.20%, 1.60%, 4.80%, 11.70%, 5.50%, 2.50, 1.70, 0.97, 1.07, 63.90%, 10.20%, 12.30%, -8.02%, -0.55%, 26.93%, 32.51%, 6.36%, 2.44%
499, IBRX, ImmunityBio Inc., Healthcare, Biotechnology, USA, 6.52B, -, -, 32613.16, -, -, -27.80%, 25.00%, -1.70%, -108.90%, -50.00%, -76.10%, -, -60.70%, 1.20, 1.20, -, -, -, -, -, -2.12%, -47.30%, 132.76%, 160.39%, 31.66%, 7.47%
502, ICLR, ICON Public Limited Company, Healthcare, Diagnostics & Research, Ireland, 11.82B, 23.87, 2.79, 4.02, 6.11, -, -9.40%, 9.12%, 12.63%, 7.10%, 20.00%, 10.50%, 19.10%, 15.60%, -, -, 0.18, 0.00, 28.60%, 13.60%, 11.50%, 3.53%, 29.34%, 18.86%, 32.83%, 14.76%, 2.51%
504, ICUI, ICU Medical Inc., Healthcare, Medical Instruments & Supplies, USA, 4.40B, 26.41, 3.00, 3.49, 2.89, 28.56, -14.20%, 13.63%, 16.00%, 39.70%, -3.20%, 5.30%, 6.40%, 5.80%, 5.20, 3.50, 0.00, 0.00, 35.90%, 7.80%, 7.40%, -0.13%, 0.28%, 12.51%, 4.23%, -3.00%, 2.84%
506, IDXX, IDEXX Laboratories Inc., Healthcare, Diagnostics & Research, USA, 47.25B, 61.34, 4.29, 16.53, 67.90, 70.89, 37.30%, 12.28%, 16.74%, 82.20%, 24.20%, 31.20%, 131.70%, 39.90%, 1.80, 1.40, 1.11, 1.29, 58.90%, 27.90%, 23.60%, 0.99%, 3.71%, 25.00%, 80.69%, 11.65%, 2.47%
508, IFRX, InflaRx N.V., Healthcare, Biotechnology, Germany, 137.71M, -, -, -, 0.61, -, 38.70%, 1.00%, -, 42.60%, -, -28.90%, -32.10%, -, 17.70, 17.70, 0.00, 0.00, -, -, -, -18.45%, -29.23%, -22.78%, -65.42%, -39.36%, 6.91%
510, IIN, IntriCon Corporation, Healthcare, Medical Instruments & Supplies, USA, 210.13M, 28.74, -, 1.86, 2.18, 21.22, -20.30%, 7.17%, -, 133.10%, 47.90%, 0.10%, 0.20%, -3.40%, 3.40, 2.50, 0.00, 0.00, 26.40%, -0.10%, 0.10%, -5.58%, -9.85%, 25.59%, 57.92%, 23.37%, 5.25%
512, IKT, Inhibikase Therapeutics Inc., Healthcare, Biotechnology, USA, 53.82M, -, -, 29.90, 6.69, -, 43.30%, -, -, -348.40%, 366.70%, -69.30%, -251.10%, -27.90%, 3.30, 3.30, 0.03, 0.15, -, -, -, 1.90%, -20.27%, -, -, -22.46%, 7.80%
514, IMAB, I-Mab, Healthcare, Biotechnology, China, 5.41B, -, 12.67, 22.38, 5.86, -, 126.50%, -357.90%, 25.90%, 391.80%, -, -, -, 9.80%, 9.30, 9.30, 0.00, 0.00, -, -, -, 35.12%, 26.73%, 119.11%, 225.19%, 71.94%, 6.92%
516, IMCC, IM Cannabis Corp., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 221.63M, -, -, 9.50, -, -, -, -, -, -, 554.30%, -, -, -, -, -, -, -, -, -, -, -28.69%, -53.19%, -18.83%, -, -43.59%, 9.55%
518, IMGN, ImmunoGen Inc., Healthcare, Biotechnology, USA, 1.23B, -, -, 9.13, 13.15, -, 64.10%, -3.80%, -, 1.70%, 18.00%, -16.20%, -169.70%, -24.40%, 2.40, 2.40, 0.00, 0.02, -, -20.40%, -36.60%, -22.94%, -30.95%, 16.60%, 32.05%, -4.19%, 5.43%
520, IMNM, Immunome Inc., Healthcare, Biotechnology, USA, 271.54M, -, -, -, 5.88, -, -48.70%, -12.00%, -, 67.40%, -, -, -, -, 9.00, 9.00, 0.00, 0.01, -, -, -, -22.60%, -47.63%, 100.96%, -, 116.12%, 8.19%
501, ICCC, ImmuCell Corporation, Healthcare, Biotechnology, USA, 74.84M, -, -, 5.16, 2.53, -, 25.40%, -, -, -260.60%, -16.30%, -3.30%, -4.80%, -1.40%, 5.60, 4.60, 0.30, 0.33, 42.80%, -13.70%, -9.20%, -4.31%, -14.52%, 67.29%, 116.63%, 64.20%, 5.99%
503, ICPT, Intercept Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 566.42M, -, -, 1.76, -, -, 23.40%, -4.40%, -8.89%, 57.30%, 12.40%, -38.20%, 154.40%, -58.70%, 3.30, 3.30, -, -, 98.40%, -55.10%, -69.10%, -18.64%, -23.29%, -55.52%, -76.99%, -32.67%, 7.12%
505, IDRA, Idera Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 57.00M, -, -, -, 1.14, -, -12.50%, 18.60%, -, 510.50%, -, -14.60%, 23.20%, -, 9.40, 9.40, 0.00, 0.00, -, -, -, -0.85%, -76.22%, -70.82%, -32.37%, -68.12%, 6.05%
507, IDYA, IDEAYA Biosciences Inc., Healthcare, Biotechnology, USA, 678.45M, -, -, 25.32, 2.75, -, 58.50%, -50.90%, -, 52.20%, -, -11.30%, -15.80%, -17.80%, 8.50, 8.50, 0.00, 0.00, -, -, -, -1.99%, 2.91%, 50.82%, 105.82%, 43.93%, 6.57%
509, IGMS, IGM Biosciences Inc., Healthcare, Biotechnology, USA, 2.34B, -, -, -, 7.00, -, -87.00%, -23.50%, -, -64.30%, -, -31.00%, -33.70%, -, 23.00, 23.00, 0.00, 0.00, -, -, -, 3.98%, -19.24%, 15.74%, 15.24%, -15.45%, 8.10%
511, IKNA, Ikena Oncology Inc., Healthcare, Biotechnology, USA, 683.64M, -, -, 72.41, 2.83, -, -163.20%, 45.10%, -, 19.90%, -67.90%, -, -, 44.00%, 9.40, 9.40, 0.00, 0.00, -, -, -, -21.19%, -, -, -, -43.75%, 9.44%
513, ILMN, Illumina Inc., Healthcare, Diagnostics & Research, USA, 59.71B, 56.36, 4.73, 17.19, 12.03, 67.09, -34.10%, 19.63%, 20.10%, -14.50%, 27.20%, 8.10%, 13.30%, 6.50%, 4.40, 4.20, 0.34, 0.44, 67.60%, 16.80%, 18.10%, 1.43%, -9.15%, 33.44%, 11.73%, 9.63%, 2.51%
515, IMAC, IMAC Holdings Inc., Healthcare, Medical Care Facilities, USA, 47.59M, -, -, 3.78, 0.98, -, 46.00%, 23.80%, -, 18.00%, -6.10%, -22.20%, -38.00%, -33.00%, 2.80, 2.80, 0.01, 0.11, 87.40%, -38.60%, -41.80%, 17.61%, -14.22%, 70.00%, 21.43%, 22.22%, 8.45%
517, IMCR, Immunocore Holdings plc, Healthcare, Biotechnology, United Kingdom, 1.77B, -, -, 43.91, -, -, 28.70%, 1.50%, -, 28.30%, 32.10%, -, -, -61.20%, 2.80, 2.80, 1.12, 1.15, -, -, -, 2.50%, -16.41%, -, -, -5.09%, 6.47%
519, IMMP, Immutep Limited, Healthcare, Biotechnology, Australia, 326.96M, -, -, 51.46, 5.36, -, -, -, -, -, -76.90%, -, -, -, -, -, -, -, -, -, -, 45.66%, 83.27%, 169.52%, 293.75%, 60.51%, 7.44%
522, IMRA, IMARA Inc., Healthcare, Biotechnology, USA, 133.70M, -, -, -, 1.69, -, -149.70%, 1.40%, -, 86.50%, -, -46.20%, -49.20%, -, 14.60, 14.60, 0.00, 0.00, -, -, -, -0.27%, -47.55%, -74.03%, -78.29%, -67.03%, 5.98%
524, IMTX, Immatics N.V., Healthcare, Biotechnology, Germany, 705.81M, -, -, 14.99, 6.17, -, -400.20%, -15.80%, 29.87%, 95.20%, 5.70%, -, -, -63.10%, 3.30, 3.30, 0.05, 0.07, -, -, -, -10.38%, 0.18%, 9.45%, -16.19%, 4.08%, 4.36%
526, IMV, IMV Inc., Healthcare, Biotechnology, Canada, 164.54M, -, -, 54845.91, 4.14, -, -, -, -, -, -100.00%, -, -, -, -, -, -, -, -, -, -, -12.90%, -31.16%, -29.57%, -17.63%, -21.10%, 5.73%
528, INBX, Inhibrx Inc., Healthcare, Biotechnology, USA, 834.55M, -, -, 64.75, 13.14, -, -109.00%, -2.50%, -, 64.50%, -93.20%, -, -, -64.40%, 4.10, 4.10, 0.49, 0.49, -, -, -, 7.79%, -26.76%, -19.45%, -, -35.82%, 12.06%
530, INFI, Infinity Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 288.11M, -, -, 160.06, 4.83, -, 18.10%, -3.40%, -, 19.10%, 25.00%, -66.70%, -, 167.40%, 11.60, 11.60, 0.00, 0.00, 39.70%, -, -, -1.19%, 2.78%, 83.98%, 270.00%, 57.08%, 7.21%
532, INGN, Inogen Inc., Healthcare, Medical Devices, USA, 1.40B, -, -, 4.57, 3.85, 41.09, -128.20%, 39.50%, 11.10%, 54.50%, -1.80%, -1.10%, -1.40%, -2.10%, 5.60, 5.10, 0.00, 0.00, 45.50%, -2.20%, -1.60%, -6.62%, 16.32%, 71.22%, 62.66%, 38.34%, 3.72%
534, INMB, INmune Bio Inc., Healthcare, Biotechnology, USA, 193.50M, -, -, 12972.73, 3.05, -, -35.00%, -47.20%, -, -65.10%, -, -33.80%, -35.30%, -, 22.40, 22.40, 0.00, 0.00, -, -, -, 15.40%, -20.09%, 60.09%, 137.89%, -21.25%, 9.79%
536, INNV, InnovAge Holding Corp., Healthcare, Medical Care Facilities, USA, 2.85B, 95.96, -, 4.60, 7.93, -, 34.20%, 164.70%, -, -241.80%, 7.90%, -, -, 12.90%, 2.70, 2.70, 0.24, 0.25, 27.70%, -2.80%, -6.20%, -16.05%, -, -, -, -11.57%, 5.33%
538, INOV, Inovalon Holdings Inc., Healthcare, Health Information Services, USA, 4.84B, 33.43, 6.91, 7.01, 6.45, 33.85, 188.30%, 24.90%, 21.00%, 641.80%, 14.90%, 1.70%, 4.70%, 4.80%, 2.20, 2.20, 1.23, 1.25, 75.20%, 12.40%, 4.70%, 5.31%, 22.40%, 69.61%, 66.63%, 72.59%, 2.59%
540, INSP, Inspire Medical Systems Inc., Healthcare, Medical Devices, USA, 5.25B, -, -, 39.06, 23.64, -, -57.10%, 29.90%, 0.11%, 11.10%, 89.70%, -20.80%, -25.00%, -22.10%, 13.40, 12.80, 0.11, 0.11, 84.90%, -41.30%, -42.50%, -19.27%, -22.05%, 6.77%, 138.29%, 3.30%, 5.64%
521, IMPL, Impel NeuroPharma Inc., Healthcare, Biotechnology, USA, 216.86M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -25.73%, -, -, -, -25.53%, 4.35%
523, IMRN, Immuron Limited, Healthcare, Biotechnology, Australia, 29.81M, -, -, 30.34, 1.06, -, -, -, -, -, -98.70%, -, -, -, -, -, -, -, -, -, -, -5.17%, -21.07%, -29.54%, 153.33%, -16.48%, 5.10%
525, IMUX, Immunic Inc., Healthcare, Biotechnology, USA, 300.60M, -, -, -, 2.08, -, 37.90%, 0.00%, 15.50%, -106.60%, -, -48.20%, -52.10%, -, 7.40, 7.40, 0.00, 0.00, -, -, -, -12.39%, -14.06%, -22.27%, 12.68%, -11.64%, 7.19%
527, IMVT, Immunovant Inc., Healthcare, Biotechnology, USA, 1.48B, -, -, -, 3.58, -, 16.20%, -14.00%, -, -17.90%, -, -31.00%, -32.90%, -, 26.00, 26.00, 0.00, 0.00, -, -, -, -6.99%, 2.09%, -68.99%, -40.92%, -67.18%, 5.25%
529, INCY, Incyte Corporation, Healthcare, Biotechnology, USA, 18.18B, 18.79, 1.85, 6.73, 6.75, 31.97, -166.00%, 47.36%, 20.89%, 107.30%, 6.40%, 13.90%, 19.00%, -12.40%, 3.90, 3.90, 0.01, 0.01, 95.90%, 18.50%, 17.70%, -1.31%, 5.21%, 3.23%, -17.79%, -3.68%, 2.49%
531, INFU, InfuSystem Holdings Inc., Healthcare, Medical Instruments & Supplies, USA, 387.76M, 33.45, 1.10, 3.87, 8.77, 15.09, -56.20%, 58.00%, 20.00%, 243.50%, 13.40%, 20.90%, 52.90%, 23.40%, 1.90, 1.70, 0.74, 0.76, 60.50%, 9.60%, 18.40%, -18.68%, 2.10%, 18.06%, 59.35%, -1.49%, 4.82%
533, INM, InMed Pharmaceuticals Inc., Healthcare, Biotechnology, Canada, 23.75M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -20.91%, -33.11%, -8.81%, -62.37%, -10.33%, 8.84%
535, INMD, InMode Ltd., Healthcare, Medical Devices, Israel, 3.27B, 28.88, 2.75, 14.14, 11.34, 33.56, 10.90%, 7.96%, 13.80%, 306.10%, 62.10%, 33.30%, 38.70%, 28.20%, 9.10, 8.60, 0.00, 0.00, 85.00%, 40.50%, 41.20%, -2.66%, 18.06%, 95.82%, 191.23%, 79.78%, 5.12%
537, INO, Inovio Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.59B, -, -, 243.88, 2.63, -, 11.30%, 72.50%, -, -2.90%, -69.20%, -36.30%, -48.50%, -24.90%, 14.20, 14.20, 0.02, 0.02, -, -, -, 9.58%, -34.91%, -27.33%, -48.81%, -14.69%, 6.11%
539, INSM, Insmed Incorporated, Healthcare, Biotechnology, USA, 2.74B, -, -, 16.32, 12.55, -, -0.20%, 24.90%, -, -20.30%, 8.90%, -39.70%, -103.00%, -41.10%, 6.20, 5.50, 1.87, 1.87, 75.40%, -, -, -29.51%, -34.80%, -36.24%, 1.28%, -26.10%, 5.59%
542, INVO, INVO Bioscience Inc., Healthcare, Medical Devices, USA, 44.90M, -, -, 29.93, 7.68, -, -240.60%, 95.50%, -, 15.50%, 133.30%, -148.90%, -974.20%, -86.20%, 5.20, 5.00, 0.00, 0.05, 91.70%, -, -, 3.79%, 31.53%, 38.17%, 25.00%, 45.51%, 4.73%
544, IONS, Ionis Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 5.19B, -, -, 7.34, 7.71, -, -257.00%, 3.40%, -, -124.60%, -16.30%, -18.20%, -46.00%, -29.30%, 6.70, 6.70, 1.28, 1.38, 98.30%, -28.70%, -69.70%, -14.01%, -31.08%, -25.86%, -33.73%, -34.12%, 4.69%
546, IPA, ImmunoPrecise Antibodies Ltd., Healthcare, Biotechnology, Canada, 149.20M, -, -, 8.68, -, -, -, -, -, -, 11.90%, -, -, -, -, -, -, -, -, -, -, -24.37%, -40.89%, 0.00%, 53.33%, -47.69%, 8.45%
548, IQV, IQVIA Holdings Inc., Healthcare, Diagnostics & Research, USA, 45.51B, 24.36, 5.80, 3.79, 7.66, 37.46, 49.50%, 13.42%, 19.77%, 649.80%, 13.90%, 0.70%, 3.10%, 3.50%, 1.10, 1.10, 2.08, 2.11, 33.70%, 5.00%, 1.50%, 2.00%, 23.55%, 41.38%, 60.62%, 34.04%, 1.84%
550, IRMD, IRadimed Corporation, Healthcare, Medical Devices, USA, 344.84M, 35.65, 176.57, 10.68, 5.43, 66.32, -94.20%, 47.17%, 17.50%, -22.60%, 5.70%, 1.40%, 1.60%, 0.70%, 14.10, 13.10, 0.00, 0.00, 74.90%, 0.70%, 3.10%, 3.92%, 15.44%, 15.54%, 19.61%, 21.97%, 4.12%
552, IRWD, Ironwood Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 1.90B, 9.81, -, 4.77, 17.01, -, 74.90%, 11.01%, -, 1093.60%, 11.10%, 27.30%, 402.50%, 28.50%, 22.80, -, 3.96, 0.00, 99.80%, 43.90%, 35.80%, 2.75%, 20.65%, -0.52%, 18.91%, 1.58%, 3.22%
554, ISR, Isoray Inc., Healthcare, Medical Instruments & Supplies, USA, 110.50M, -, -, 11.51, 1.43, -, 33.50%, -33.30%, -, 25.00%, -10.30%, -13.60%, -15.40%, -61.00%, 35.50, 35.10, 0.00, 0.00, 50.40%, -36.00%, -36.60%, -13.53%, -47.37%, 120.45%, 11.27%, 77.78%, 5.91%
556, ITCI, Intra-Cellular Therapies Inc., Healthcare, Biotechnology, USA, 3.21B, -, -, 85.35, 5.21, -, -20.50%, 41.20%, -, 10.50%, 20447.20%, -35.70%, -39.40%, -35.20%, 16.30, 16.20, 0.00, 0.00, 91.30%, -, -, 14.33%, 12.70%, 54.01%, 88.75%, 23.93%, 4.70%
558, ITMR, Itamar Medical Ltd., Healthcare, Medical Devices, Israel, 335.61M, -, -, 8.18, 6.76, -, -15.20%, 54.90%, -, -, 30.80%, -, -, -, -, -, -, -, -, -, -, -14.35%, -13.22%, -1.06%, 34.47%, 3.12%, 4.63%
560, ITRM, Iterum Therapeutics plc, Healthcare, Biotechnology, Ireland, 220.30M, -, -, -, 5.58, -, 69.50%, -12.50%, -, 24.80%, -, -261.90%, 435.90%, -, 2.40, 2.40, 1.11, 1.32, -, -, -, 21.85%, -18.08%, 82.00%, -65.56%, 46.61%, 8.61%
541, INVA, Innoviva Inc., Healthcare, Biotechnology, USA, 1.38B, 8.20, 0.31, 4.01, 2.15, -, 45.50%, -1.20%, 19.34%, 43.00%, 8.60%, 26.00%, 47.80%, 28.20%, 98.00, 98.00, 0.61, 0.61, -, 94.40%, 73.70%, 15.25%, 17.98%, 27.37%, -3.72%, 8.56%, 3.59%
543, INZY, Inozyme Pharma Inc., Healthcare, Biotechnology, USA, 401.80M, -, -, -, 2.58, -, -426.60%, -11.80%, -11.60%, -23.80%, -, -41.50%, -56.20%, -, 21.70, 21.70, 0.00, 0.00, -, -, -, -10.75%, -18.61%, -37.34%, -, -20.74%, 6.65%
545, IOVA, Iovance Biotherapeutics Inc., Healthcare, Biotechnology, USA, 2.86B, -, -, -, 4.23, -, -18.10%, -7.70%, -, 6.90%, -, -34.00%, -38.30%, -, 11.00, 11.00, 0.00, 0.00, -, -, -, -40.75%, -52.95%, -51.05%, -42.13%, -59.98%, 9.54%
547, IPHA, Innate Pharma S.A., Healthcare, Biotechnology, France, 308.80M, -, -, 4.38, -, -, -, -, -, -, 26.40%, -, -, -, -, -, -, -, -, -, -, -8.54%, -8.00%, -22.11%, -38.81%, -4.40%, 2.07%
549, IRIX, IRIDEX Corporation, Healthcare, Medical Devices, USA, 121.91M, -, -, 3.10, 4.39, 12.31, 28.90%, 58.20%, 30.00%, -17.00%, 33.30%, -19.80%, -33.80%, -33.40%, 3.50, 2.90, 0.01, 0.10, 42.20%, -17.20%, -17.00%, -9.86%, 25.96%, 362.35%, 351.72%, 213.15%, 6.03%
551, IRTC, iRhythm Technologies Inc., Healthcare, Medical Instruments & Supplies, USA, 2.20B, -, -, 7.99, 7.11, -, 26.90%, 20.60%, -, -182.00%, 17.00%, -14.20%, -22.70%, -11.70%, 5.70, 5.50, 0.06, 0.10, 71.90%, -22.50%, -22.70%, -1.89%, -50.65%, -66.22%, -39.30%, -68.19%, 5.89%
553, ISEE, IVERIC bio Inc., Healthcare, Biotechnology, USA, 635.38M, -, -, -, 3.95, -, 18.20%, 20.70%, -, -1.80%, -, -43.30%, -47.50%, -, 9.30, 9.30, 0.00, 0.00, -, -, -, 2.76%, 8.94%, 12.22%, 76.31%, 2.32%, 4.58%
555, ISRG, Intuitive Surgical Inc., Healthcare, Medical Instruments & Supplies, USA, 98.80B, 53.17, 8.03, 21.71, 9.80, 75.15, -23.60%, 17.84%, 10.81%, 34.30%, 17.50%, 10.80%, 12.40%, 9.30%, 6.70, 6.10, 0.00, 0.00, 66.50%, 26.00%, 25.80%, -2.44%, 10.93%, 15.94%, 45.20%, 2.94%, 2.08%
557, ITGR, Integer Holdings Corporation, Healthcare, Medical Devices, USA, 2.98B, 19.05, 4.43, 2.88, 2.33, 20.43, -15.50%, 24.18%, 10.00%, -31.00%, -11.50%, 2.80%, 5.50%, 5.60%, 2.50, 1.60, 0.51, 0.54, 26.40%, 10.70%, 6.50%, -4.93%, -2.11%, 24.92%, 14.26%, 11.43%, 2.49%
559, ITOS, iTeos Therapeutics Inc., Healthcare, Biotechnology, USA, 733.07M, -, -, -, 2.31, -, -55.40%, -32.90%, -, -96.20%, -, -17.20%, -21.80%, -, 27.50, 27.50, 0.00, 0.00, -, -, -, -14.09%, -51.64%, -29.87%, -, -39.27%, 6.10%
562, IVC, Invacare Corporation, Healthcare, Medical Devices, USA, 275.12M, 70.80, -, 0.32, 0.98, -, 48.00%, 126.20%, 10.00%, -, -10.20%, -, -, -4.40%, 1.60, 1.00, 1.00, 1.03, 28.80%, -, -, -9.09%, -15.70%, -8.68%, 29.87%, -10.61%, 4.81%
564, JAZZ, Jazz Pharmaceuticals plc, Healthcare, Biotechnology, Ireland, 10.00B, 9.51, 0.67, 4.10, 2.65, 11.12, -53.60%, 24.43%, 29.00%, 174.00%, 13.60%, 8.10%, 14.80%, 5.90%, 4.20, 4.10, 0.49, 0.55, 93.40%, 29.70%, 21.30%, 7.47%, 5.53%, 25.59%, 49.29%, 7.92%, 2.51%
566, JNJ, Johnson & Johnson, Healthcare, Drug Manufacturers - General, USA, 444.54B, 16.24, 4.01, 5.28, 6.76, 43.51, -4.20%, 9.46%, 7.45%, 12.70%, 7.90%, 8.90%, 23.60%, 14.60%, 1.30, 1.00, 0.46, 0.51, 66.40%, 20.70%, 17.90%, 3.08%, 6.23%, 17.80%, 13.78%, 7.54%, 1.17%
568, JYNT, The Joint Corp., Healthcare, Medical Care Facilities, USA, 992.28M, 140.47, 3.58, 15.85, 43.34, 107.86, 293.00%, 43.75%, 20.00%, 176.90%, 28.70%, 25.00%, 96.20%, 51.50%, 1.30, 1.30, 0.00, 0.09, 89.20%, 10.60%, 23.40%, 24.90%, 71.65%, 172.96%, 370.42%, 170.68%, 5.88%
570, KALV, KalVista Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 652.32M, -, -, 171.66, 8.28, -, -18.80%, -17.80%, -, -7.40%, -, -47.60%, -53.80%, -48.20%, 9.60, 9.60, 0.00, 0.00, -, -, -, 7.02%, -19.23%, 45.08%, 140.00%, 42.18%, 5.29%
572, KDNY, Chinook Therapeutics Inc., Healthcare, Biotechnology, USA, 758.50M, -, -, 917.18, 2.31, -, -20.60%, 7.60%, 9.00%, -88.30%, -97.10%, -, -, -24.50%, 9.00, 9.00, 0.00, 0.00, -, -, -, -3.17%, -4.24%, 20.53%, 0.92%, 4.04%, 7.35%
574, KIDS, OrthoPediatrics Corp., Healthcare, Medical Devices, USA, 1.08B, -, -, 14.18, 4.88, -, -110.30%, 53.60%, -, -79.50%, 31.10%, -12.10%, -16.40%, -11.00%, 4.20, 2.60, 0.00, 0.00, 77.60%, -37.00%, -50.40%, -1.28%, 1.24%, 22.27%, 22.46%, 36.95%, 5.36%
576, KLDO, Kaleido Biosciences Inc., Healthcare, Biotechnology, USA, 296.39M, -, -, 227.99, 3.97, -, 27.40%, 7.30%, -, 9.90%, -, -104.90%, -189.70%, -190.10%, 7.40, 7.40, 0.23, 0.30, -, -, -, -10.81%, -26.81%, -1.64%, -0.55%, -21.10%, 8.59%
578, KMPH, KemPharm Inc., Healthcare, Biotechnology, USA, 286.52M, 204.80, -, 12.30, 2.33, -, 75.80%, 117.90%, -, -30.20%, 476.20%, -174.90%, 204.00%, -242.40%, 20.70, 20.70, 0.00, 0.01, -, -50.50%, -, 4.92%, 4.49%, -41.66%, 241.15%, -8.57%, 5.40%
580, KNTE, Kinnate Biopharma Inc., Healthcare, Biotechnology, USA, 1.04B, -, -, -, 2.70, -, -201.70%, -40.30%, -, -144.10%, -, -, -, -, 32.20, 32.20, 0.00, 0.00, -, -, -, -11.16%, -31.55%, -, -, -40.98%, 8.51%
561, IVA, Inventiva S.A., Healthcare, Biotechnology, France, 527.69M, -, -, 100.26, -, -, -, -, -, -, -55.00%, -, -, -, -, -, -, -, -, -, -, 2.71%, -13.27%, 4.96%, -, -5.79%, 2.77%
563, JAGX, Jaguar Health Inc., Healthcare, Biotechnology, USA, 230.70M, -, -, 23.54, 6.40, -, 88.90%, -11.10%, 40.00%, 82.80%, 33.30%, -91.10%, -325.90%, -85.40%, 3.50, 3.30, 0.76, 0.80, 67.30%, -, -, 5.26%, -25.58%, 665.18%, 231.19%, 96.32%, 10.05%
565, JNCE, Jounce Therapeutics Inc., Healthcare, Biotechnology, USA, 404.51M, -, -, 6.33, 1.29, -, -174.70%, -5.70%, -, 25.70%, -, -20.80%, -24.30%, -21.40%, 20.70, 20.70, 0.00, 0.00, -, -69.80%, -68.80%, -16.84%, -39.62%, 17.34%, 45.64%, 12.14%, 6.61%
567, JUPW, Jupiter Wellness Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 49.08M, -, -, 49.08, 11.12, -, -626.00%, -, -, -219.30%, -58.50%, -208.70%, -415.70%, -108.30%, 5.50, 5.10, 0.00, 0.02, 45.00%, -, -, -2.41%, -22.20%, 5.95%, -, -12.57%, 7.39%
569, KALA, Kala Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 351.71M, -, -, 40.90, 3.17, -, 27.80%, 46.20%, 40.90%, 8.40%, 200.00%, -48.90%, -101.40%, -55.90%, 9.00, 8.50, 0.66, 0.66, 58.20%, -, -, -28.03%, -23.23%, -22.60%, -54.10%, -16.67%, 8.47%
571, KDMN, Kadmon Holdings Inc., Healthcare, Biotechnology, USA, 672.38M, -, -, 320.18, 48.00, -, -39.30%, 26.50%, -, 10.70%, -91.00%, -48.90%, -145.50%, -132.10%, 11.00, 11.00, 16.52, 16.71, 29.80%, -, -, -5.88%, -22.42%, -5.42%, -13.51%, -7.47%, 5.46%
573, KERN, Akerna Corp., Healthcare, Health Information Services, USA, 98.20M, -, -, 6.64, 2.07, -, 19.40%, -, -, 32.20%, 29.00%, -36.30%, -68.80%, -29.90%, 1.50, 1.50, 0.02, 0.21, 57.20%, -, -, 3.79%, -26.14%, 26.96%, -52.80%, 35.19%, 9.45%
575, KIN, Kindred Biosciences Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 216.92M, -, -, 4.93, 2.37, -, 65.10%, 49.20%, 40.00%, 59.20%, 300.00%, -8.20%, -11.20%, -22.90%, 12.10, 12.10, 0.20, 0.24, 97.00%, -15.20%, -20.00%, 0.84%, 6.39%, 20.75%, 12.59%, 12.06%, 5.37%
577, KMDA, Kamada Ltd., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 262.66M, 45.15, 2.57, 2.10, 1.47, -, -55.30%, -23.50%, 6.00%, -48.50%, -25.20%, -, -, -, -, -, -, -, -, -, -, -3.45%, -5.32%, -11.33%, -25.22%, -9.41%, 2.23%
579, KNSA, Kiniksa Pharmaceuticals Ltd., Healthcare, Biotechnology, Bermuda, 925.20M, -, -, -, 3.43, -, 12.90%, 20.80%, -, -51.80%, -, -56.00%, -61.90%, -, 7.80, 7.70, 0.00, 0.00, -, -, -, -19.25%, -37.73%, -22.99%, -34.69%, -22.86%, 5.45%
582, KPTI, Karyopharm Therapeutics Inc., Healthcare, Biotechnology, USA, 700.64M, -, -, 6.19, -, -, 15.40%, 40.10%, -, 1.60%, 28.70%, -61.50%, -357.70%, -71.30%, 4.10, 4.10, -, -, 97.50%, -, -, -2.93%, -32.51%, -37.08%, -49.81%, -40.05%, 5.73%
584, KRON, Kronos Bio Inc., Healthcare, Biotechnology, USA, 1.43B, -, -, -, 2.97, -, -343.60%, 0.70%, -, 60.70%, -, -, -, -, 35.90, 35.90, 0.00, 0.00, -, -, -, -4.09%, -17.28%, -27.87%, -, -18.28%, 6.50%
586, KRTX, Karuna Therapeutics Inc., Healthcare, Biotechnology, USA, 3.37B, -, -, -, 8.87, -, -53.40%, -8.40%, -14.80%, -198.80%, -, -14.10%, -14.40%, -, 50.30, 50.30, 0.00, 0.00, -, -, -, 1.19%, -10.38%, 14.11%, 19.13%, 10.07%, 5.79%
588, KTRA, Kintara Therapeutics Inc., Healthcare, Biotechnology, USA, 56.80M, -, -, -, -, -, 72.30%, 57.70%, -, -32.30%, -, -236.00%, -, -, 6.50, 6.50, -, -, -, -, -, 17.52%, -22.22%, 18.38%, 64.29%, 25.78%, 9.41%
590, KYMR, Kymera Therapeutics Inc., Healthcare, Biotechnology, USA, 2.06B, -, -, 41.68, 7.81, -, -28.50%, -35.80%, -14.90%, 69.40%, 544.80%, -, -, -16.20%, 3.10, 3.10, 0.00, 0.00, -, -, -, 5.23%, -0.76%, 1.89%, -, -22.44%, 8.67%
592, KZR, Kezar Life Sciences Inc., Healthcare, Biotechnology, USA, 281.82M, -, -, -, 2.08, -, 48.40%, -21.00%, -, 16.50%, -, -28.20%, -30.30%, -, 19.30, 19.30, 0.00, 0.00, -, -, -, -0.17%, -7.14%, 1.42%, 19.92%, 9.58%, 7.05%
594, LBPH, Longboard Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 145.62M, -, -, -, 0.47, -, -, -, -, -, -, -, -, -, 30.60, 30.60, 0.00, 0.00, -, -, -, -13.05%, -, -, -, -50.39%, 10.83%
596, LCI, Lannett Company Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 204.68M, 23.89, -, 0.40, 1.37, 2.33, 88.00%, 260.00%, 15.00%, 57.80%, -22.20%, -19.40%, -91.30%, 3.30%, 3.80, 2.60, 4.92, 4.92, 18.10%, -42.70%, -38.20%, -6.32%, -28.93%, -31.53%, -43.79%, -34.05%, 5.73%
598, LEGN, Legend Biotech Corporation, Healthcare, Biotechnology, USA, 5.21B, -, -, 66.97, 25.40, -, -122.00%, 6.80%, -, -77.70%, 19.10%, -48.30%, -111.30%, -107.50%, 3.30, 3.20, 0.01, 0.02, -, -, -, 30.75%, 48.96%, 35.34%, -, 39.81%, 6.06%
600, LGND, Ligand Pharmaceuticals Incorporated, Healthcare, Biotechnology, USA, 1.96B, 24.59, 2.64, 9.39, 2.59, 40.42, -100.60%, -22.18%, 19.23%, 171.90%, 66.30%, 3.10%, 5.50%, 2.90%, 4.60, 4.20, 0.47, 0.48, 83.70%, 10.50%, 18.80%, -19.26%, -24.80%, 34.65%, 15.88%, 18.35%, 4.12%
581, KOD, Kodiak Sciences Inc., Healthcare, Biotechnology, USA, 4.32B, -, -, -, 5.25, -, -132.50%, -33.30%, 12.40%, -79.80%, -, -21.10%, -28.00%, -, 26.60, 26.60, 0.00, 0.00, -, -, -, -31.86%, -37.96%, -36.75%, 29.42%, -43.08%, 6.91%
583, KRMD, Repro Med Systems Inc., Healthcare, Medical Instruments & Supplies, USA, 190.91M, -, -, 8.19, 4.97, -, -300.10%, 75.00%, -, -357.60%, -14.30%, -6.70%, -7.70%, -3.50%, 8.60, 6.80, 0.00, 0.00, 61.80%, -17.30%, -12.60%, 18.28%, 8.38%, -5.53%, -57.81%, -29.07%, 7.09%
585, KROS, Keros Therapeutics Inc., Healthcare, Biotechnology, USA, 1.23B, -, -, -, 5.10, -, -356.80%, -35.20%, -, -2.00%, -, -23.80%, -24.80%, -, 28.60, 28.60, 0.00, 0.00, -, -, -, -22.18%, -11.57%, -27.76%, 89.84%, -22.65%, 8.61%
587, KRYS, Krystal Biotech Inc., Healthcare, Biotechnology, USA, 1.46B, -, -, -, 3.22, -, -42.60%, 0.60%, -, -141.80%, -, -12.30%, -12.80%, -, 44.40, 44.40, 0.00, 0.00, -, -, -, -18.57%, -23.66%, 41.03%, 26.90%, 8.73%, 6.16%
589, KURA, Kura Oncology Inc., Healthcare, Biotechnology, USA, 1.53B, -, -, -, 2.51, -, -12.20%, -11.80%, 19.93%, -9.60%, -, -20.60%, -22.20%, -, 24.30, 24.30, 0.01, 0.01, -, -, -, -19.06%, -25.83%, -37.45%, 30.19%, -31.87%, 5.19%
591, KZIA, Kazia Therapeutics Limited, Healthcare, Biotechnology, Australia, 118.49M, -, -, 325.99, 4.17, -, 4.40%, -, -, 48.00%, -99.80%, -49.60%, -71.70%, -, 7.60, 7.60, 0.00, 0.00, -, -, -, -12.75%, -8.47%, -0.52%, 245.82%, 10.07%, 4.57%
593, LABP, Landos Biopharma Inc., Healthcare, Biotechnology, USA, 420.42M, -, -, -, 2.83, -, -118.50%, -58.60%, -, -320.40%, -, -, -, -, 12.40, 12.40, 0.00, 0.00, -, -, -, -4.10%, -32.47%, -, -, -8.50%, 7.20%
595, LBPS, 4D pharma plc, Healthcare, Biotechnology, United Kingdom, 245.14M, -, -, 355.27, -, -, -, -, -, -, 16.90%, -, -, -, -, -, -, -, -, -, -, -15.16%, -, -, -, -25.24%, 5.02%
597, LCTX, Lineage Cell Therapeutics Inc., Healthcare, Biotechnology, USA, 387.49M, -, -, 227.94, 3.20, -, -71.00%, -33.30%, -, 84.10%, -20.00%, -12.10%, -13.50%, -26.10%, 9.80, 9.80, 0.00, 0.00, 76.30%, -, -, -10.90%, -1.66%, 79.55%, 168.80%, 34.66%, 7.41%
599, LFMD, LifeMD Inc., Healthcare, Pharmaceutical Retailers, USA, 317.49M, -, -, 6.20, -, -, 73.00%, 60.00%, -, -111.80%, 323.30%, -, -, 3923.80%, 1.20, 1.00, -, -, 79.70%, -, -, 32.51%, -39.56%, 61.00%, 788.28%, 97.24%, 14.35%
602, LH, Laboratory Corporation of America Holdings, Healthcare, Diagnostics & Research, USA, 26.91B, 17.19, -, 1.76, 2.70, 9.90, 90.00%, -29.06%, -11.00%, 339.40%, 47.40%, 13.70%, 30.20%, 12.10%, 1.70, 1.50, 0.50, 0.55, 38.00%, 24.50%, 17.30%, 2.80%, 13.66%, 39.71%, 56.56%, 34.85%, 1.89%
604, LHDX, Lucira Health Inc., Healthcare, Diagnostics & Research, USA, 193.60M, -, -, 40.46, 0.82, -, -341.10%, 11.70%, -, -98.60%, -, -, -, 84.90%, 12.50, 11.50, 0.00, 0.00, -, -, -, -24.12%, -74.52%, -, -, -80.22%, 12.78%
606, LIVN, LivaNova PLC, Healthcare, Medical Devices, United Kingdom, 4.08B, 37.38, -, 4.34, 3.82, 354.65, -119.70%, 33.19%, 29.30%, -177.00%, 2.10%, -16.80%, -33.90%, -15.20%, 2.30, 1.90, 0.61, 0.62, 65.40%, -29.30%, -43.90%, -2.86%, 8.86%, 55.95%, 56.18%, 26.17%, 2.54%
608, LJPC, La Jolla Pharmaceutical Company, Healthcare, Biotechnology, USA, 123.50M, 20.48, -, 2.06, -, -, 66.40%, -44.00%, 13.20%, 233.70%, 348.70%, -18.80%, 19.50%, 39.00%, 4.60, 4.20, -, -, 77.60%, -13.10%, -27.40%, -0.69%, -15.85%, -8.90%, -8.90%, 10.82%, 8.02%
610, LMAT, LeMaitre Vascular Inc., Healthcare, Medical Instruments & Supplies, USA, 1.06B, 36.63, -, 7.84, 5.93, 37.05, 17.40%, 10.69%, -1.80%, 83.10%, 17.30%, 9.40%, 14.40%, 10.80%, 4.10, 2.30, 0.16, 0.18, 65.30%, 24.00%, 17.80%, -4.92%, -0.56%, 24.09%, 90.44%, 26.44%, 3.42%
612, LMNX, Luminex Corporation, Healthcare, Medical Instruments & Supplies, USA, 1.74B, 34.00, 4.93, 3.99, 3.47, -, 238.20%, 23.02%, 15.00%, 1288.70%, 22.50%, -, -, 4.00%, 8.40, 6.10, 0.52, 0.52, 60.30%, -, -, 0.60%, 16.78%, 59.08%, 18.39%, 59.56%, 0.63%
614, LNTH, Lantheus Holdings Inc., Healthcare, Diagnostics & Research, USA, 1.54B, 27.09, -, 4.51, 3.08, 341.66, -131.50%, 133.68%, 37.32%, 59.90%, 2.00%, -0.90%, -1.50%, -0.80%, 2.60, 2.10, 0.32, 0.34, 44.40%, 1.50%, -2.30%, 3.10%, 27.43%, 86.54%, 76.62%, 79.76%, 4.50%
616, LPCN, Lipocine Inc., Healthcare, Biotechnology, USA, 109.50M, 4.57, -, -, 2.35, -, 25.10%, 340.00%, -, 70.50%, -, -59.80%, -87.00%, -, 8.50, 8.50, 0.03, 0.11, -, -, -, -14.69%, -21.29%, -25.15%, 33.54%, -10.29%, 6.49%
618, LQDA, Liquidia Corporation, Healthcare, Biotechnology, USA, 161.61M, -, -, 42.53, 2.08, -, 31.50%, -1.50%, -, 59.40%, -, -68.90%, -104.10%, -71.60%, 7.00, 7.00, 0.17, 0.18, 75.60%, -, -, 3.79%, 2.73%, 2.38%, -67.42%, 2.03%, 7.01%
620, LTRN, Lantern Pharma Inc., Healthcare, Biotechnology, USA, 170.55M, -, -, -, 1.86, -, -135.90%, -31.20%, -, -207.60%, -, -20.90%, -21.60%, -, 124.10, 124.10, 0.00, 0.00, -, -, -, -4.36%, -20.04%, -2.01%, -, -21.45%, 7.07%
601, LGVN, Longeveron Inc., Healthcare, Biotechnology, USA, 125.80M, -, -, 29.27, 4.37, -, -25.70%, -, -, -33.80%, -89.50%, -, -, -151.10%, 9.10, 9.10, 0.00, 0.00, -, -, -, 8.20%, -16.46%, -, -, -10.93%, 6.33%
603, LHCG, LHC Group Inc., Healthcare, Medical Care Facilities, USA, 6.34B, 28.86, 3.41, 3.06, 3.94, 11.72, 11.50%, 7.50%, 14.84%, 82.40%, 2.30%, 5.10%, 8.20%, 8.90%, 1.00, 1.00, 0.00, 0.00, 40.30%, 9.40%, 6.00%, -6.71%, 6.41%, 0.01%, 21.13%, -7.72%, 3.11%
605, LIFE, aTyr Pharma Inc., Healthcare, Biotechnology, USA, 69.60M, -, -, 29.00, 1.29, -, 74.80%, 6.80%, 13.00%, -299.10%, 1325.70%, -54.90%, -67.20%, -, 11.70, 11.70, 0.00, 0.00, -, -, -, 10.19%, -2.78%, 26.46%, 21.39%, 17.01%, 6.64%
607, LIXT, Lixte Biotechnology Holdings Inc., Healthcare, Biotechnology, USA, 37.81M, -, -, -, 8.56, -, -32.60%, -, -, -294.50%, -, -112.60%, -, -, 32.50, 32.50, 0.00, 0.00, -, -, -, -5.19%, -38.84%, -26.74%, -33.70%, -13.57%, 10.66%
609, LLY, Eli Lilly and Company, Healthcare, Drug Manufacturers - General, USA, 191.04B, 23.19, 2.36, 7.50, 26.32, 53.15, 36.90%, 8.72%, 12.67%, -7.00%, 16.10%, 13.60%, 113.60%, 22.60%, 1.40, 1.10, 2.35, 2.35, 75.90%, 22.10%, 23.90%, 9.63%, -3.26%, 37.99%, 30.59%, 18.30%, 1.89%
611, LMNL, Liminal BioSciences Inc., Healthcare, Biotechnology, Canada, 126.72M, -, -, 63.36, 44.20, -, 65.80%, -7.80%, -, 42.30%, 0.00%, -99.80%, -382.40%, -118.10%, 2.40, 2.20, 17.23, 19.10, 44.30%, -, -, -10.53%, -11.60%, 11.34%, -57.25%, 5.24%, 9.40%
613, LNSR, LENSAR Inc., Healthcare, Medical Devices, USA, 90.41M, -, -, 3.29, -, -, 41.10%, 48.00%, -, -, 19.30%, -, -, -, -, -, -, -, -, -, -, 17.30%, -7.29%, -13.22%, -, 14.07%, 5.88%
615, LOGC, LogicBio Therapeutics Inc., Healthcare, Biotechnology, USA, 141.81M, -, -, 48.90, 2.57, -, 27.60%, -21.30%, -, 21.10%, -50.00%, -54.90%, -80.50%, -44.40%, 8.60, 8.60, 0.13, 0.18, -, -, -, -23.60%, -51.77%, -30.74%, -36.30%, -42.73%, 6.92%
617, LPTX, Leap Therapeutics Inc., Healthcare, Biotechnology, USA, 96.70M, -, -, 64.47, 2.53, -, 57.00%, -9.60%, -2.49%, 72.00%, 0.00%, -51.50%, -59.50%, -61.10%, 5.90, 5.90, 0.00, 0.00, -, -, -, -4.71%, -33.33%, 8.00%, -31.65%, -28.00%, 5.74%
619, LRMR, Larimar Therapeutics Inc., Healthcare, Biotechnology, USA, 132.21M, -, -, -, 1.69, -, 75.50%, -10.40%, -, 3.10%, -, -, -, -, 10.30, 10.30, 0.00, 0.00, -, -, -, -40.64%, -52.10%, -60.26%, -32.44%, -61.19%, 14.06%
622, LUNG, Pulmonx Corporation, Healthcare, Medical Devices, USA, 1.58B, -, -, 47.20, 7.01, -, -418.60%, 15.50%, 46.70%, -61.30%, 7.00%, -22.60%, -493.30%, -13.40%, 17.10, 16.20, 0.08, 0.08, 66.40%, -, -, -8.80%, -28.67%, -18.71%, -, -37.82%, 6.07%
624, LXRX, Lexicon Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 655.51M, -, -, 40.97, 4.14, -, -147.40%, -34.30%, -, 76.60%, -97.70%, -5.80%, -13.40%, -27.90%, 3.70, -, 0.00, 0.08, 91.50%, -, -80.60%, -12.90%, -42.24%, 166.06%, 129.84%, 28.36%, 5.96%
626, MACK, Merrimack Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 85.31M, -, -, -, 5.42, -, 85.80%, -, 5.60%, -379.20%, -, -22.10%, -24.10%, -, 23.80, 23.80, 0.00, 0.00, -, -, -, -11.72%, -10.86%, 69.31%, 88.79%, -7.11%, 5.66%
628, MASS, 908 Devices Inc., Healthcare, Medical Devices, USA, 1.10B, -, -, 40.93, 8.63, -, -12.50%, 21.30%, -, -, -33.70%, -, -, -3.80%, 17.60, 16.90, 0.11, 0.11, -, -, -, -20.64%, -26.69%, -, -, -26.02%, 7.20%
630, MBOT, Microbot Medical Inc., Healthcare, Medical Instruments & Supplies, USA, 54.84M, -, -, -, 2.45, -, 24.10%, -, -, -9.00%, -, -34.50%, -36.90%, -, 18.20, 18.20, 0.00, 0.00, -, -, -, 3.78%, -9.54%, 5.64%, 1.72%, 11.47%, 5.60%
632, MCK, McKesson Corporation, Healthcare, Medical Distribution, USA, 30.74B, 9.29, -, 0.13, -, 8.06, -667.60%, 7.81%, 10.06%, -26.00%, 1.00%, -7.40%, -167.50%, -61.00%, 1.00, 0.60, -, -, 5.10%, -2.10%, -1.90%, 1.11%, 10.73%, 7.18%, 21.25%, 10.62%, 2.48%
634, MD, MEDNAX Inc., Healthcare, Medical Care Facilities, USA, 2.80B, 19.72, 144.97, 1.61, 3.53, -, -122.70%, 23.16%, 1.29%, 128.00%, 1.30%, -, -, 3.30%, 2.00, 2.00, 1.30, 1.30, -, -, -, 18.84%, 30.53%, 57.07%, 105.92%, 30.32%, 3.96%
636, MDGS, Medigus Ltd., Healthcare, Medical Devices, Israel, 40.29M, -, -, 199.46, 0.05, -, -, -, -, -, -49.30%, -, -, -, -, -, -, -, -, -, -, -14.78%, -32.42%, -44.37%, -19.16%, -9.42%, 6.32%
638, MDRX, Allscripts Healthcare Solutions Inc., Healthcare, Health Information Services, USA, 2.46B, 20.98, -, 1.69, 1.45, -, 42.50%, 14.03%, 8.00%, 130.70%, -3.40%, 24.10%, 50.40%, -6.30%, 1.30, 1.30, 0.10, 0.00, 38.40%, -7.60%, 50.20%, 10.41%, 11.69%, 22.64%, 175.16%, 20.43%, 3.02%
640, MDVL, MedAvail Holdings Inc, Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 421.79M, -, -, 23.83, 7.98, -, 19.30%, 12.40%, -, 72.80%, 112.10%, -103.90%, -120.00%, -40.20%, 8.00, 7.60, 0.00, 0.04, 30.20%, -, -, -3.17%, -16.24%, -13.07%, 20.90%, -14.68%, 6.40%
621, LUMO, Lumos Pharma Inc., Healthcare, Biotechnology, USA, 85.83M, -, -, 858.31, 0.80, -, 91.00%, -13.50%, 15.20%, -630.70%, -, -10.50%, -12.70%, -10.60%, 24.00, 24.00, 0.00, 0.00, -, -, -, -14.52%, -29.99%, -33.71%, -24.66%, -70.65%, 5.70%
623, LVTX, Lava Therapeutics B.V., Healthcare, Biotechnology, Netherlands, 280.00M, -, -, 87.89, 2.08, -, -56.60%, -44.20%, -, -, -, -, -, -134.90%, 29.60, 29.60, 0.03, 0.00, -, -, -, -5.42%, -, -, -, -20.63%, 7.03%
625, LYRA, Lyra Therapeutics Inc., Healthcare, Biotechnology, USA, 96.28M, -, -, -, 1.38, -, -96.90%, 5.10%, -6.20%, -73.10%, -, -30.80%, -33.20%, -, 16.20, 16.20, 0.00, 0.00, -, -, -, -29.47%, -54.00%, -44.60%, -54.76%, -37.02%, 7.51%
627, MASI, Masimo Corporation, Healthcare, Medical Instruments & Supplies, USA, 11.92B, 49.86, 4.59, 10.16, 8.96, 64.97, 20.50%, 14.54%, 11.90%, -17.60%, 10.90%, 13.80%, 16.70%, 16.50%, 5.00, 3.90, 0.00, 0.00, 64.30%, 21.50%, 19.50%, -7.63%, -15.81%, -12.15%, -10.24%, -19.67%, 2.63%
629, MBIO, Mustang Bio Inc., Healthcare, Biotechnology, USA, 292.49M, -, -, -, 2.02, -, 11.30%, 6.10%, -, 34.20%, -, -58.10%, -66.60%, -, 19.90, 19.90, 0.00, 0.00, -, -, -, 3.08%, -7.97%, -1.47%, -10.19%, -11.49%, 5.43%
631, MBRX, Moleculin Biotech Inc., Healthcare, Biotechnology, USA, 103.79M, -, -, -, 0.91, -, 9.40%, -9.00%, -, -40.30%, -, -44.00%, -60.40%, -, 19.20, 19.20, 0.00, 0.00, -, -, -, 1.93%, -14.75%, -20.74%, -43.43%, -22.64%, 4.33%
633, MCRB, Seres Therapeutics Inc., Healthcare, Biotechnology, USA, 1.97B, -, -, 64.18, 13.45, -, 10.00%, 20.40%, -, -38.00%, -30.50%, -37.90%, -95.00%, -44.10%, 5.30, 5.30, 0.15, 0.18, -, -, -, -0.33%, 2.38%, -28.17%, 284.52%, -13.84%, 8.46%
635, MDGL, Madrigal Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.86B, -, -, -, 6.83, -, -140.10%, 7.30%, 0.00%, -41.60%, -, -66.00%, -77.20%, -, 6.30, 6.30, 0.00, 0.00, -, -, -, -18.38%, -4.46%, 0.32%, -3.21%, 1.02%, 4.94%
637, MDNA, Medicenna Therapeutics Corp., Healthcare, Biotechnology, Canada, 205.79M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 8.36%, -3.23%, 0.78%, -23.73%, -16.88%, 7.44%
639, MDT, Medtronic plc, Healthcare, Medical Devices, Ireland, 168.71B, 20.03, 4.35, 5.60, 3.36, 96.57, 2.30%, 11.25%, 10.94%, -33.90%, 0.80%, 3.70%, 7.00%, 6.70%, 2.10, 1.70, 0.52, 0.60, 65.70%, 10.80%, 11.70%, -3.73%, 7.41%, 11.72%, 28.41%, 8.07%, 1.41%
642, MDXG, MiMedx Group Inc., Healthcare, Medical Devices, USA, 1.15B, -, -, 4.65, -, -, -221.80%, 74.10%, 15.00%, -100.80%, -2.80%, -46.70%, -, -87.00%, 2.70, 2.50, -, -, 84.20%, -19.00%, -35.80%, 5.01%, 0.19%, 63.46%, 197.77%, 17.73%, 5.56%
644, MEDS, Trxade Group Inc., Healthcare, Pharmaceutical Retailers, USA, 30.70M, 9.60, -, 1.71, 3.58, -, -586.10%, 258.30%, -, -431.40%, 40.90%, -31.30%, -35.60%, -28.20%, 7.40, 7.00, 0.00, 0.02, 30.30%, -18.40%, -18.70%, -13.81%, -44.39%, -26.87%, -32.46%, -31.57%, 6.13%
646, MESO, Mesoblast Limited, Healthcare, Biotechnology, Australia, 971.43M, -, -, 59.23, 1.75, -, 18.90%, -4.50%, 48.80%, 4.70%, 0.00%, -14.00%, -18.70%, -9.80%, 1.00, 1.00, 0.11, 0.19, -, -, -, 7.06%, -19.48%, -34.44%, -38.16%, -8.95%, 4.15%
648, MGNX, MacroGenics Inc., Healthcare, Biotechnology, USA, 1.89B, -, -, 17.53, 5.25, -, 21.60%, -17.90%, -, 1.80%, 23.40%, -36.00%, -46.00%, -44.30%, 7.10, 6.90, 0.00, 0.00, 100.00%, -, -, -9.65%, 29.02%, 40.94%, 67.31%, 40.81%, 5.50%
650, MGTX, MeiraGTx Holdings plc, Healthcare, Biotechnology, USA, 616.41M, -, -, 38.77, 2.75, -, 6.90%, 4.00%, 2.40%, -25.40%, 9.50%, -20.50%, -32.50%, -, 4.30, 4.30, 0.00, 0.00, -, -, -, -8.07%, -9.87%, 0.44%, -7.08%, -8.92%, 5.61%
652, MIST, Milestone Pharmaceuticals Inc., Healthcare, Biotechnology, Canada, 174.00M, -, -, -, 1.89, -, 51.30%, -20.10%, -, 54.40%, -, -37.60%, -39.70%, -, 23.60, 23.60, 0.00, 0.00, -, -, -, 3.42%, -19.44%, -9.02%, 91.46%, -9.70%, 6.10%
654, MLND, Millendo Therapeutics Inc., Healthcare, Biotechnology, USA, 21.71M, -, -, -, 0.91, -, 40.60%, 63.00%, -, 32.20%, -, -72.40%, -92.80%, -, 6.40, 6.40, 0.00, 0.01, -, -, -, 4.39%, -44.91%, -31.21%, -55.26%, -44.39%, 9.20%
656, MMSI, Merit Medical Systems Inc., Healthcare, Medical Instruments & Supplies, USA, 3.41B, 26.87, 73.90, 3.51, 3.44, 25.53, -283.20%, 16.19%, 11.50%, 436.90%, 2.20%, 0.30%, 0.40%, 0.10%, 2.10, 1.10, 0.32, 0.33, 42.20%, 1.20%, 0.40%, -4.69%, 8.49%, 9.87%, 34.12%, 8.70%, 2.85%
658, MNMD, Mind Medicine MindMed Inc., Healthcare, Biotechnology, USA, 1.11B, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -21.30%, -6.59%, 113.33%, 755.88%, 11.48%, 11.60%
660, MNPR, Monopar Therapeutics Inc., Healthcare, Biotechnology, USA, 72.52M, -, -, -, 2.76, -, -41.90%, -50.00%, -, -50.90%, -, -38.50%, -40.30%, -, 32.00, 32.00, 0.00, 0.00, -, -, -, -3.87%, -20.25%, 16.53%, -25.84%, -6.70%, 6.56%
641, MDWD, MediWound Ltd., Healthcare, Biotechnology, Israel, 95.40M, -, -, 4.11, 18.89, -, -548.40%, -56.70%, -, -15.70%, 31.80%, -29.30%, -124.30%, -92.10%, 2.40, 2.30, 0.33, 0.73, 37.70%, -37.20%, -41.40%, -26.25%, -37.96%, -8.36%, 65.85%, -8.11%, 8.40%
643, MEDP, Medpace Holdings Inc., Healthcare, Diagnostics & Research, USA, 5.97B, 32.98, 2.90, 6.25, 6.96, -, 44.20%, 15.71%, 13.61%, 50.60%, 12.60%, -, -, 17.90%, 1.20, 1.20, 0.00, 0.00, 30.60%, -, -, -1.32%, 0.26%, 37.27%, 79.98%, 20.01%, 2.78%
645, MEIP, MEI Pharma Inc., Healthcare, Biotechnology, USA, 320.89M, -, -, 7.85, 7.20, 6.74, -113.70%, 10.30%, -0.10%, -581.20%, 100.00%, -31.10%, -90.80%, -31.40%, 5.30, 5.30, 0.00, 0.00, 95.40%, -, -, -18.87%, -24.80%, -0.69%, -21.20%, 9.09%, 7.21%
647, MGLN, Magellan Health Inc., Healthcare, Healthcare Plans, USA, 2.46B, 22.37, -, 0.53, 1.28, -, -69.10%, 18.59%, -1.30%, 52.50%, 3.50%, 11.80%, 22.70%, 1.20%, 3.10, 3.00, 0.28, 0.28, 3.40%, 0.40%, 8.50%, -0.11%, 1.03%, 16.93%, 25.60%, 13.70%, 0.44%
649, MGTA, Magenta Therapeutics Inc., Healthcare, Biotechnology, USA, 585.76M, -, -, -, 4.64, -, 17.70%, -2.80%, -, 29.20%, -, -43.10%, -47.80%, -, 14.70, 14.70, 0.00, 0.00, -, -, -, 3.87%, 11.66%, 79.51%, 39.71%, 57.53%, 8.93%
651, MIRM, Mirum Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 489.09M, -, -, -, 3.72, -, -79.10%, 39.10%, -, -95.20%, -, -69.70%, -94.20%, -, 6.20, 6.20, 0.00, 0.00, -, -, -, -12.67%, -10.50%, -23.92%, -1.84%, -5.27%, 5.63%
653, MITO, Stealth BioTherapeutics Corp, Healthcare, Biotechnology, Cayman Islands, 77.30M, -, -, -, -, -, 40.50%, -16.70%, -, 66.90%, -, -156.50%, -, -, 2.10, 2.10, -, -, -, -, -, 11.38%, -21.26%, 3.79%, -30.10%, -8.36%, 11.15%
655, MLSS, Milestone Scientific Inc., Healthcare, Medical Instruments & Supplies, USA, 144.89M, -, -, 21.95, 7.17, -, 29.30%, 10.00%, -, 54.60%, 61.10%, -32.30%, -39.30%, -45.30%, 7.10, 6.20, 0.00, 0.02, 63.70%, -, -, -16.80%, -45.12%, 17.51%, 13.04%, -1.89%, 8.29%
657, MNKD, MannKind Corporation, Healthcare, Biotechnology, USA, 1.10B, -, -, 16.61, -, -, 3.10%, 43.80%, 35.60%, -19.30%, 7.40%, -38.80%, 33.80%, 82.50%, 3.90, 3.90, -, -, 62.70%, -71.30%, -91.70%, -8.30%, 10.22%, 49.83%, 192.72%, 41.21%, 6.32%
659, MNOV, MediciNova Inc., Healthcare, Biotechnology, USA, 200.91M, -, -, 50.23, 2.18, -, -4.00%, -59.40%, 20.00%, 93.60%, -, -14.00%, -14.70%, -, 44.50, 44.50, 0.00, 0.00, -, -, -, -10.59%, -25.70%, -28.72%, -20.97%, -19.77%, 4.88%
662, MOH, Molina Healthcare Inc., Healthcare, Healthcare Plans, USA, 14.62B, 15.36, 1.45, 0.68, 6.70, 6.51, -2.60%, 22.82%, 14.16%, 33.30%, 43.40%, 8.20%, 34.20%, 17.40%, 1.60, 1.60, 1.09, 0.00, 17.80%, 5.30%, 3.40%, -0.95%, 13.10%, 23.93%, 35.27%, 18.19%, 2.31%
664, MORF, Morphic Holding Inc., Healthcare, Biotechnology, USA, 1.81B, -, -, 42.37, 4.49, -, -2.20%, -11.80%, -, -14.40%, -41.10%, -17.40%, -26.10%, -32.10%, 13.40, 13.40, 0.00, 0.00, -, -, -, -9.55%, -41.83%, 51.55%, 137.54%, 47.12%, 5.98%
666, MOVE, Movano Inc., Healthcare, Medical Devices, USA, 167.08M, -, -, -, 0.85, -, -51.50%, -, -, -200.00%, -, -, -, -, 29.40, 29.40, 0.00, 0.01, -, -, -, -8.91%, -, -, -, -24.09%, 3.74%
668, MREO, Mereo BioPharma Group plc, Healthcare, Biotechnology, United Kingdom, 347.50M, -, -, -, 2.26, -, -, -, -, -, -, -, -, -, 3.00, 3.00, 1.06, 1.65, -, -, -, -9.42%, -17.63%, 37.97%, 157.48%, -8.66%, 7.80%
670, MRKR, Marker Therapeutics Inc., Healthcare, Biotechnology, USA, 249.01M, -, -, 498.02, 2.27, -, -29.80%, 5.60%, -, -10.50%, -, -53.70%, -75.20%, -105.80%, 16.30, 16.30, 0.00, 0.00, -, -, -, 8.58%, 13.67%, 76.36%, 28.19%, 100.69%, 9.41%
672, MRNS, Marinus Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 625.70M, -, -, 178.77, 5.55, -, 29.50%, -8.90%, 20.00%, 41.70%, -, -61.10%, -73.20%, -51.20%, 8.10, 8.10, 0.00, 0.00, -, -, -, 13.27%, 4.21%, 14.81%, 65.55%, 37.87%, 5.58%
674, MRTX, Mirati Therapeutics Inc., Healthcare, Biotechnology, USA, 7.87B, -, -, 600.61, 6.38, -, -39.80%, -0.30%, -, -32.20%, 224.70%, -39.30%, -43.10%, -27.10%, 16.90, 16.90, 0.00, 0.00, -, -, -, -3.87%, -22.37%, -29.85%, 59.44%, -28.00%, 4.95%
676, MRVI, Maravai LifeSciences Holdings Inc., Healthcare, Biotechnology, USA, 9.69B, 32.84, -, 34.10, 32.09, -, -51.30%, -0.26%, -4.00%, -, 38.20%, -, -, 16.10%, 2.60, 2.30, 5.18, 5.24, -, -, -, -1.47%, 2.93%, 39.24%, -, 33.83%, 5.39%
678, MTBC, CareCloud Inc., Healthcare, Health Information Services, USA, 122.79M, -, -, 1.09, 1.14, 102.32, -198.10%, 57.90%, -, 13.50%, 36.10%, -16.80%, -23.40%, -8.20%, 1.70, 1.60, 0.00, 0.00, 38.70%, -6.30%, -20.00%, 3.44%, -15.39%, -20.06%, 28.40%, -7.28%, 4.75%
680, MTD, Mettler-Toledo International Inc., Healthcare, Diagnostics & Research, USA, 30.18B, 37.46, 3.08, 9.31, 150.05, 41.93, 10.90%, 7.94%, 15.50%, 56.80%, 23.90%, 23.20%, 189.90%, 37.30%, 1.30, 0.90, 7.71, 7.96, 58.60%, 25.20%, 20.20%, -2.04%, 14.65%, 15.62%, 63.64%, 14.15%, 2.09%
661, MODV, ModivCare Inc., Healthcare, Medical Care Facilities, USA, 2.06B, 23.80, 5.84, 1.41, 4.98, -, 436.60%, 3.17%, 10.00%, 15.00%, 23.50%, -, -, 11.00%, 1.10, 1.10, 1.16, 0.00, 24.00%, -, -, 3.32%, 16.26%, 8.65%, 82.89%, 6.20%, 4.10%
663, MOR, MorphoSys AG, Healthcare, Biotechnology, Germany, 2.89B, -, -, 8.83, 4.66, -, -319.80%, 54.50%, -, -, 225.40%, -, -, -, -, -, -, -, -, -, -, -5.03%, -12.93%, -17.77%, -31.79%, -22.09%, 2.17%
665, MOTS, Motus GI Holdings Inc., Healthcare, Diagnostics & Research, USA, 48.70M, -, -, 487.05, 2.22, -, 34.70%, 29.80%, -, -13.10%, -63.60%, -89.60%, -172.40%, -, 2.90, 2.80, 0.00, 0.41, -, -, -, -6.42%, -32.45%, 24.33%, -17.07%, 7.59%, 7.83%
667, MPLN, MultiPlan Corporation, Healthcare, Healthcare Plans, USA, 5.70B, 41.78, -, 4.78, 2.33, -, 550.00%, 57.81%, -, -, 1.20%, -10.10%, -27.10%, -2.90%, 1.00, 1.00, 2.05, 2.05, 96.70%, -, -40.10%, 9.33%, 20.74%, 12.53%, -17.66%, 5.63%, 6.52%
669, MRK, Merck & Co. Inc., Healthcare, Drug Manufacturers - General, USA, 192.23B, 10.44, 2.97, 4.00, 7.13, 980.79, -28.00%, 12.14%, 9.22%, -1.00%, 0.20%, 7.70%, 25.80%, 10.80%, 1.00, 0.80, 0.89, 1.16, 67.70%, 14.60%, 14.60%, 3.00%, 4.85%, -5.21%, -5.98%, -7.22%, 1.62%
671, MRNA, Moderna Inc., Healthcare, Biotechnology, USA, 72.09B, 9.92, 8.78, 26.39, 19.27, 14.40, -26.10%, -26.30%, 16.80%, 907.10%, 3960.80%, 8.50%, 19.80%, -28.40%, 1.40, 1.30, 0.04, 0.05, 92.60%, 23.20%, 21.90%, 5.32%, 17.54%, 69.45%, 200.83%, 77.09%, 6.14%
673, MRSN, Mersana Therapeutics Inc., Healthcare, Biotechnology, USA, 1.00B, -, -, 1251.21, 4.99, -, -120.80%, -5.50%, -, -42.60%, -73.80%, -37.70%, -44.40%, -37.80%, 6.60, 6.60, 0.03, 0.00, -, -, -, -13.63%, -27.60%, -42.47%, -36.75%, -46.19%, 5.15%
675, MRUS, Merus N.V., Healthcare, Biotechnology, Netherlands, 807.30M, -, -, 25.23, 3.24, -, -28.40%, -21.60%, -, 50.80%, 33.30%, -29.70%, -60.50%, -74.70%, 7.30, 7.30, 0.00, 0.00, -, -, -, -2.49%, -11.25%, 30.72%, 54.95%, 20.65%, 8.75%
677, MSON, Misonix Inc., Healthcare, Medical Devices, USA, 348.49M, -, -, 5.16, 2.33, -, -50.00%, 14.60%, 30.00%, 78.00%, -7.10%, -11.90%, -16.50%, -7.80%, 4.40, 3.40, 0.29, 0.31, 70.50%, -31.40%, -35.80%, 1.27%, 5.32%, 35.05%, 37.76%, 53.52%, 4.44%
679, MTCR, Metacrine Inc., Healthcare, Biotechnology, USA, 109.88M, -, -, -, 1.40, -, -28.70%, 15.80%, -, 49.10%, -, -, -, -, 17.30, 17.30, 0.12, 0.00, -, -, -, 1.98%, -55.51%, -49.82%, -, -47.58%, 8.09%
682, MTNB, Matinas BioPharma Holdings Inc., Healthcare, Biotechnology, USA, 159.30M, -, -, 796.49, 2.57, -, 6.30%, 60.00%, -, 7.70%, -, -30.10%, -34.90%, -, 17.30, 17.30, 0.00, 0.00, -, -, -, -18.00%, -40.77%, -14.60%, -14.44%, -43.38%, 6.55%
684, MYGN, Myriad Genetics Inc., Healthcare, Diagnostics & Research, USA, 2.23B, 146.17, -, 3.95, 2.49, -, 63.40%, 225.00%, -8.20%, 66.40%, 5.50%, -7.70%, -12.00%, -6.10%, 2.20, 2.00, 0.18, 0.18, 68.50%, -30.80%, -19.00%, -5.23%, -7.16%, 57.33%, 97.18%, 44.88%, 5.65%
686, MYO, Myomo Inc., Healthcare, Medical Devices, USA, 53.47M, -, -, 6.01, 3.44, -, 82.30%, 34.70%, -0.47%, 77.30%, 130.00%, -67.20%, -84.70%, -96.70%, 4.90, 4.70, 0.00, 0.00, 67.40%, -, -, 1.14%, -15.30%, 43.26%, 182.71%, 57.95%, 8.53%
688, NAOV, NanoVibronix Inc., Healthcare, Medical Devices, USA, 20.29M, -, -, 33.82, 4.62, -, 69.50%, -, -, 4.70%, 0.00%, -151.70%, -361.30%, -195.50%, 9.50, 9.30, 0.00, 0.00, 39.20%, -, -, -17.66%, -27.05%, 32.00%, -58.42%, 8.83%, 6.76%
690, NAVB, Navidea Biopharmaceuticals Inc., Healthcare, Biotechnology, USA, 48.81M, -, -, 54.23, 11.33, -, 37.30%, -33.30%, -, 20.10%, -50.00%, -151.00%, -, -535.60%, 2.10, 2.10, 0.00, 0.05, 100.00%, -, -, 3.03%, -30.33%, -27.35%, -35.11%, -20.93%, 7.37%
692, NBRV, Nabriva Therapeutics plc, Healthcare, Biotechnology, Ireland, 49.60M, -, -, 7.29, 0.66, -, 51.50%, 33.70%, -, 78.50%, 212.50%, -92.70%, -142.70%, -169.20%, 4.30, 3.80, 0.09, 0.14, 87.90%, -, -, -17.37%, -28.12%, -67.22%, -87.89%, -42.98%, 9.04%
694, NBTX, Nanobiotix S.A., Healthcare, Biotechnology, France, 589.38M, -, -, 234.63, -, -, -, 3.60%, -, -, 52.20%, -, -, -, -, -, -, -, -, -, -, 9.39%, 1.48%, -, -, 3.76%, 2.59%
696, NCNA, NuCana plc, Healthcare, Biotechnology, United Kingdom, 160.10M, -, -, -, 1.21, -, -22.70%, -19.20%, -, -57.50%, -, -37.20%, -40.70%, -, 10.50, 10.50, 0.00, 0.01, -, -, -, -30.93%, -43.12%, -31.39%, -51.20%, -31.85%, 8.26%
698, NEO, NeoGenomics Inc., Healthcare, Diagnostics & Research, USA, 4.80B, -, -, 10.57, 5.65, -, -51.70%, 77.80%, 20.00%, -184.90%, 9.00%, -1.00%, -1.50%, 0.30%, 13.90, 13.60, 0.63, 0.63, 39.90%, -5.60%, -2.40%, -16.68%, -22.83%, -10.24%, 53.73%, -23.79%, 5.19%
700, NEPH, Nephros Inc., Healthcare, Medical Instruments & Supplies, USA, 87.41M, -, -, 9.93, 6.94, -, -15.80%, 62.10%, -, 55.20%, 8.00%, -24.60%, -39.50%, -31.40%, 10.40, 7.10, 0.02, 0.04, 57.10%, -43.90%, -48.00%, 10.90%, 6.84%, 41.36%, 12.18%, 1.98%, 4.42%
681, MTEM, Molecular Templates Inc., Healthcare, Biotechnology, USA, 504.93M, -, -, 28.21, 4.34, -, -19.90%, -11.60%, 3.90%, -5.60%, -22.00%, -62.40%, -142.40%, -137.60%, 2.70, 2.70, 0.14, 0.00, -, -, -, -4.49%, -22.13%, 1.13%, -42.40%, -4.79%, 5.92%
683, MTP, Midatech Pharma plc, Healthcare, Biotechnology, United Kingdom, 24.21M, -, -, 62.08, 3.29, -, -, -, -, -, -62.80%, -, -, -, -, -, -, -, -, -, -, -3.05%, -20.08%, 4.37%, 52.80%, 2.14%, 7.05%
685, MYMD, MyMD Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 165.58M, -, -, -, 1.12, -, 68.80%, -, -, 94.70%, -, -, -, -, 14.40, -, 0.00, 0.00, -, -, -, 3.31%, -35.55%, 19.40%, -35.74%, 9.80%, 8.37%
687, MYOV, Myovant Sciences Ltd., Healthcare, Biotechnology, United Kingdom, 2.19B, -, -, 36.96, -, 5.94, 15.80%, 44.00%, -, -22.70%, -, -57.90%, 106.40%, -, 2.50, 2.50, -, -, 96.70%, -, -, 13.41%, -1.76%, 7.23%, 91.27%, -15.17%, 6.17%
689, NARI, Inari Medical Inc., Healthcare, Medical Devices, USA, 4.41B, 198.52, 10.18, 25.94, 20.08, 832.42, 29.60%, 23.38%, 39.00%, 50.20%, 112.60%, 7.80%, 8.70%, 8.90%, 10.70, 10.10, 0.00, 0.00, 91.20%, 12.10%, 10.10%, -23.43%, -22.47%, 26.66%, 97.61%, -0.39%, 6.22%
691, NBIX, Neurocrine Biosciences Inc., Healthcare, Biotechnology, USA, 9.19B, 24.07, 0.75, 8.79, 7.52, 34.86, 977.20%, 85.87%, 31.50%, -15.20%, -0.20%, 24.40%, 40.50%, 30.80%, 5.70, 5.60, 0.27, 0.00, 99.00%, 11.20%, 38.50%, 0.93%, -12.07%, 1.16%, -22.88%, 0.39%, 3.27%
693, NBSE, NeuBase Therapeutics Inc., Healthcare, Biotechnology, USA, 173.71M, -, -, -, 5.02, -, 72.00%, -18.30%, 4.00%, 7.10%, -, -55.30%, -61.10%, -, 7.10, 7.10, 0.00, 0.00, -, -, -, -17.81%, -47.94%, -32.77%, -33.72%, -26.04%, 7.42%
695, NBY, NovaBay Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 29.49M, -, -, 3.01, 2.72, -, 35.10%, 21.40%, -, 35.70%, -5.30%, -73.60%, -115.00%, -52.30%, 4.30, 4.00, 0.00, 0.00, 61.00%, -64.60%, -, -13.04%, -35.76%, 11.28%, -16.38%, 1.38%, 6.26%
697, NDRA, ENDRA Life Sciences Inc., Healthcare, Diagnostics & Research, USA, 87.90M, -, -, -, 4.51, -, 73.00%, 25.90%, -, 78.10%, -, -124.70%, -152.60%, -, 24.00, 23.00, 0.00, 0.00, -, -, -, -14.17%, -19.70%, 153.80%, 130.43%, 182.67%, 7.03%
699, NEOG, Neogen Corporation, Healthcare, Diagnostics & Research, USA, 4.98B, 136.76, 8.01, 11.06, 6.11, 86.41, -2.00%, 14.80%, 10.00%, 8.30%, 16.80%, 7.40%, 8.00%, 7.50%, 12.10, 9.90, 0.00, 0.00, 46.50%, 16.40%, 13.70%, -4.21%, 9.83%, 25.01%, 29.61%, 16.41%, 2.32%
702, NERV, Minerva Neurosciences Inc., Healthcare, Biotechnology, USA, 126.50M, -, -, 3.07, 2.78, -, 102.60%, -22.10%, -, 33.60%, -, 7.00%, 9.90%, 3.50%, 24.30, 24.30, 0.00, 0.00, -, -, 12.80%, 21.40%, -6.05%, -24.94%, -20.49%, 26.07%, 8.12%
704, NFH, New Frontier Health Corporation, Healthcare, Medical Care Facilities, China, 1.61B, 131.98, -, 4.56, 1.22, 38.79, 8.50%, 228.60%, -, 78.00%, -73.30%, -2.90%, -5.00%, -1.00%, 1.00, 1.00, 0.26, 0.26, 81.40%, -3.30%, -17.40%, 1.07%, 0.53%, 28.98%, 38.25%, 31.98%, 1.33%
706, NH, NantHealth Inc., Healthcare, Health Information Services, USA, 286.89M, -, -, 4.03, -, -, -34.30%, 25.00%, -, -71.30%, -11.00%, -46.70%, 90.60%, -20.20%, 0.20, -, -, -, 59.10%, -41.80%, -, 0.00%, -35.24%, 13.48%, -1.14%, -19.20%, 5.57%
708, NKTR, Nektar Therapeutics, Healthcare, Biotechnology, USA, 3.27B, -, -, 25.99, 3.30, -, 1.20%, 25.60%, -7.30%, 13.40%, -53.40%, -28.10%, -38.10%, -39.50%, 8.90, 8.80, 0.00, 0.00, 83.00%, -, -, -10.05%, -23.50%, 9.65%, -16.73%, 6.29%, 4.02%
710, NLSP, NLS Pharmaceutics AG, Healthcare, Biotechnology, Switzerland, 40.99M, -, -, -, -, -, 47.50%, -, -, 44.40%, -, -291.90%, 42.90%, -, 0.00, 0.00, -, -, -, -, -, -5.74%, 15.38%, -, -, 19.38%, 6.03%
712, NMRD, Nemaura Medical Inc., Healthcare, Medical Devices, USA, 314.12M, -, -, -, 30.24, -, 18.80%, -, -, -195.00%, -, -47.70%, -98.60%, -, 3.80, 3.60, 0.17, 0.51, -, -, -, 187.74%, 88.50%, 219.48%, 86.44%, 261.01%, 25.03%
714, NMTR, 9 Meters Biopharma Inc., Healthcare, Biotechnology, USA, 319.21M, -, -, -, 8.00, -, 28.30%, 26.70%, -, 70.60%, -, -234.60%, -347.50%, -, 6.70, 6.70, 0.00, 0.00, -, -, -, 5.79%, -26.44%, 17.43%, 126.55%, 49.01%, 7.25%
716, NNVC, NanoViricides Inc., Healthcare, Biotechnology, USA, 42.00M, -, -, -, 1.23, -, -2.00%, -, -, 84.50%, -, -29.60%, -31.00%, -, 26.70, 26.70, 0.00, 0.01, -, -, -, -14.32%, -14.93%, -0.55%, -52.26%, 25.09%, 7.40%
718, NOVN, Novan Inc., Healthcare, Biotechnology, USA, 121.99M, -, -, 27.11, 130.08, -, 74.60%, 20.00%, -, 64.20%, -33.30%, -68.50%, -, -755.40%, 4.80, 4.80, 0.11, 1.00, -, -, -, -41.32%, -51.82%, 64.32%, 93.67%, -4.00%, 11.54%
720, NRBO, NeuroBo Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 64.69M, -, -, -, 4.62, -, 55.10%, 1.40%, -, 49.10%, -, -209.90%, -268.00%, -, 14.70, 14.70, 0.00, 0.00, -, -, -, -20.79%, -34.87%, -47.78%, -78.67%, -46.29%, 8.36%
701, NEPT, Neptune Wellness Solutions Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 210.18M, -, -, 3.98, 1.38, -, -, 66.70%, -, -, -63.80%, -, -, -, -, -, -, -, -, -, -, -5.93%, -20.13%, -26.59%, -57.38%, -18.59%, 6.47%
703, NEXI, NexImmune Inc., Healthcare, Biotechnology, USA, 433.47M, -, -, -, -, -, -35.30%, -9.80%, -, -, -, -, -, -, 0.30, 0.30, -, -, -, -, -, -4.82%, -23.73%, -, -, -26.65%, 5.33%
705, NGM, NGM Biopharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.18B, -, -, 14.00, 2.86, -, -75.90%, -16.30%, -, -27.70%, -11.50%, -30.60%, -35.30%, -, 10.60, 10.60, 0.00, 0.00, -, -, -, -46.56%, -44.53%, -33.89%, -23.67%, -50.29%, 6.69%
707, NHC, National HealthCare Corporation, Healthcare, Medical Care Facilities, USA, 1.13B, -, -, 1.10, 1.39, 7.22, -38.70%, -, -, 178.70%, -2.00%, 6.70%, 11.40%, 4.70%, 1.70, 1.70, 0.01, 0.02, 42.40%, 4.60%, 8.80%, 3.16%, 3.43%, 14.39%, 9.15%, 10.24%, 2.83%
709, NKTX, Nkarta Inc., Healthcare, Biotechnology, USA, 826.44M, -, -, -, 2.60, -, -684.80%, -18.30%, -, -106.80%, -, -38.50%, -46.50%, -, 32.30, 32.30, 0.00, 0.00, -, -, -, -24.85%, -50.46%, -31.12%, -, -60.39%, 8.95%
711, NLTX, Neoleukin Therapeutics Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 423.47M, -, -, -, 3.08, -, 75.00%, -7.40%, 31.10%, -54.80%, -, -20.40%, -22.60%, -, 21.60, 21.60, 0.00, 0.00, -, -, -, -22.79%, -18.79%, -21.27%, -17.65%, -28.87%, 6.21%
713, NMTC, NeuroOne Medical Technologies Corporation Common Stock, Healthcare, Medical Devices, USA, -, -, -, -, -, -, -46.80%, -, -, -120.10%, -, -165.40%, -461.60%, -223.20%, 15.10, -, 0.00, 0.00, 92.80%, -, -, -, -, -, -, -, -
715, NNOX, Nano-X Imaging Ltd., Healthcare, Medical Devices, Israel, 1.24B, -, -, -, 5.20, -, -141.80%, 18.30%, -, -62.40%, -, -25.50%, -26.70%, -, 12.10, 12.10, 0.00, 0.00, -, -, -, -26.73%, -44.22%, -45.73%, -, -45.25%, 10.09%
717, NOTV, Inotiv Inc., Healthcare, Diagnostics & Research, USA, 384.89M, 33.62, -, 5.64, 39.49, 1924.47, -467.40%, 511.10%, -, -19.60%, 17.50%, -6.00%, -48.10%, -8.10%, 0.50, 0.50, 2.54, 4.37, 31.90%, -3.30%, -5.50%, 6.37%, 36.18%, 283.36%, 368.55%, 102.28%, 9.64%
719, NPCE, NeuroPace Inc., Healthcare, Medical Devices, USA, 509.05M, -, -, 12.37, -, -, 19.80%, -, -, 0.00%, -, -, -, 13.80%, -, -, -, -, -, -, -, -7.73%, -, -, -, -8.13%, 9.67%
722, NRIX, Nurix Therapeutics Inc., Healthcare, Biotechnology, USA, 1.14B, -, -, 57.18, 4.00, -, -44.70%, -13.50%, -, 42.50%, 72.40%, -15.50%, -27.30%, -15.30%, 6.50, 6.50, 0.00, 0.00, -, -, -, -19.69%, -23.03%, -26.19%, -, -15.15%, 8.03%
724, NSTG, NanoString Technologies Inc., Healthcare, Biotechnology, USA, 2.45B, -, -, 20.04, 10.49, -, -139.40%, 3.30%, -, 40.60%, 18.80%, -22.70%, -52.10%, -19.90%, 14.10, 13.40, 0.95, 0.95, 53.40%, -70.60%, -81.10%, -30.65%, -25.38%, 19.38%, 81.76%, -17.03%, 7.17%
726, NTLA, Intellia Therapeutics Inc., Healthcare, Biotechnology, USA, 4.89B, -, -, 94.93, 9.22, -, -13.80%, -7.80%, 30.00%, -9.20%, -50.40%, -25.40%, -33.90%, -, 9.90, 9.90, 0.00, 0.00, -, -, -, -6.42%, 17.04%, 108.98%, 327.98%, 37.76%, 8.65%
728, NTUS, Natus Medical Incorporated, Healthcare, Medical Devices, USA, 906.38M, 17.75, -, 2.15, 2.20, 25.18, -6.40%, 26.89%, 22.00%, 166.70%, 5.00%, -1.80%, -2.60%, -3.20%, 1.90, 1.40, 0.00, 0.09, 53.80%, -3.00%, -2.50%, 2.45%, 3.76%, 24.94%, 25.23%, 33.73%, 3.70%
730, NUVA, NuVasive Inc., Healthcare, Medical Devices, USA, 3.54B, 24.94, -, 3.33, 4.19, 32.27, -158.90%, 24.09%, 20.41%, -248.20%, 4.30%, -2.00%, -5.60%, 2.10%, 3.50, 2.10, 1.05, 1.05, 69.70%, 2.10%, -4.70%, -4.91%, 10.86%, 43.40%, 12.54%, 21.07%, 2.64%
732, NUWE, Nuwellis Inc., Healthcare, Medical Devices, USA, 27.09M, -, -, 3.52, 0.56, -, 96.20%, -, -, 89.20%, 18.70%, -73.80%, -87.20%, -103.90%, 10.20, 9.20, 0.00, 0.00, 54.20%, -, -, -21.48%, -47.11%, -43.14%, -64.27%, -42.32%, 7.27%
734, NVCN, Neovasc Inc., Healthcare, Medical Devices, Canada, 60.96M, -, -, 31.14, 13.38, -, 79.70%, 50.00%, -, -, -9.20%, -, -, -, -, -, -, -, -, -, -, -6.05%, -36.81%, 10.71%, -68.40%, -4.37%, 7.02%
736, NVIV, InVivo Therapeutics Holdings Corp., Healthcare, Biotechnology, USA, 24.98M, -, -, -, 0.77, -, 96.30%, -, -, 97.00%, -, -48.80%, -56.80%, -, 17.30, 17.30, 0.00, 0.00, -, -, -, -14.88%, -44.88%, 15.15%, -55.76%, -16.98%, 8.73%
738, NVOS, Novo Integrated Sciences Inc., Healthcare, Medical Care Facilities, USA, 61.01M, -, -, 8.59, 1.80, -, -, -, -, -157.80%, -12.50%, -18.20%, -21.70%, -14.80%, 1.00, 1.00, 0.00, 0.05, 40.20%, -86.20%, -90.40%, -17.78%, -54.79%, -26.00%, -22.11%, -47.14%, 10.75%
740, NVS, Novartis AG, Healthcare, Drug Manufacturers - General, Switzerland, 218.57B, 13.02, 3.15, 4.38, 3.94, 47.52, 14.20%, 7.73%, 8.06%, -4.20%, -0.10%, 6.30%, 14.80%, 8.80%, 0.70, 0.50, 0.54, 0.75, 70.60%, 19.70%, 15.90%, 2.73%, 1.06%, -0.90%, 1.09%, -6.41%, 0.80%
721, NRC, National Research Corporation, Healthcare, Diagnostics & Research, USA, 1.25B, -, 2.72, 9.28, 16.61, 31.61, 15.00%, -, 13.00%, -21.20%, 4.70%, 26.50%, 57.90%, 40.00%, 1.70, 1.70, 0.35, 0.40, 64.00%, 32.30%, 25.70%, -5.17%, -11.26%, -10.51%, -15.67%, 11.88%, 3.80%
723, NSPR, InspireMD Inc., Healthcare, Medical Devices, Israel, 42.80M, -, -, 17.12, 0.05, -, 90.30%, -6.20%, -, -23.80%, 0.00%, -47.30%, -58.60%, -85.10%, 16.10, 15.70, 0.00, 0.00, -4.30%, -, -, -12.44%, -58.81%, 1.30%, -57.55%, 4.63%, 9.14%
725, NTEC, Intec Pharma Ltd, Healthcare, Biotechnology, Israel, 16.97M, -, -, -, 1.12, -, 173.30%, -181.90%, -, -, -, -, -, -, -, -, -, -, -, -, -, -8.50%, -18.04%, 24.01%, -34.32%, 9.28%, 10.51%
727, NTRA, Natera Inc., Healthcare, Diagnostics & Research, USA, 8.14B, -, -, 18.12, 21.89, -, -58.00%, 12.60%, -, -63.00%, 62.00%, -29.30%, -60.80%, -30.10%, 4.70, 4.60, 0.75, 0.89, 49.80%, -55.70%, -57.50%, -13.90%, -23.77%, 11.34%, 114.69%, -5.41%, 5.44%
729, NURO, NeuroMetrix Inc., Healthcare, Medical Instruments & Supplies, USA, 11.30M, -, -, 1.53, 2.10, -, 82.20%, -, 15.00%, 96.50%, 0.00%, -18.30%, -28.00%, -40.30%, 3.30, 2.90, 0.00, 0.00, 71.70%, -19.80%, -20.30%, -4.26%, -16.57%, 45.45%, 40.38%, -7.59%, 5.92%
731, NUVB, Nuvation Bio Inc., Healthcare, Biotechnology, USA, 2.98B, -, -, -, 7.29, -, -100.00%, -43.50%, -, -, -, -, -, -, 83.20, 83.20, 0.00, 0.00, -, -, -, 22.69%, 34.53%, 41.35%, -, 21.54%, 6.40%
733, NVAX, Novavax Inc., Healthcare, Biotechnology, USA, 11.17B, 4.60, -, 12.15, 10.37, 19.41, -32.00%, 490.10%, 0.00%, -423.70%, 3072.20%, -40.60%, -125.70%, -38.00%, 1.90, 1.90, 0.33, 0.44, -, -65.50%, -66.90%, -37.85%, -38.57%, 43.88%, 220.63%, 32.38%, 10.42%
735, NVCR, NovoCure Limited, Healthcare, Medical Instruments & Supplies, USA, 20.82B, 649.68, -, 39.50, 56.20, 209.90, 205.50%, 1062.96%, -, 45.10%, 32.30%, 1.50%, 3.30%, 2.30%, 9.20, 8.90, 1.50, 1.50, 79.40%, 6.40%, 2.20%, -0.64%, 33.83%, 74.84%, 202.54%, 17.89%, 4.79%
737, NVO, Novo Nordisk A/S, Healthcare, Drug Manufacturers - General, Denmark, 139.85B, 23.22, 18.86, 6.72, 19.01, 32.10, 10.00%, 8.22%, 1.39%, 7.90%, -0.20%, 30.50%, 71.00%, 58.50%, 0.80, 0.60, 0.05, 0.17, 83.20%, 41.60%, 33.80%, 6.28%, 8.33%, 19.29%, 19.65%, 12.96%, 1.05%
739, NVRO, Nevro Corp., Healthcare, Medical Devices, USA, 5.31B, -, -, 14.61, 14.26, -, 26.70%, 41.20%, 25.00%, -9.20%, 1.30%, -11.30%, -23.30%, -9.20%, 3.00, 2.70, 0.39, 0.86, 69.70%, -17.20%, -24.20%, -13.27%, -11.22%, -10.81%, 19.98%, -12.94%, 3.28%
742, NVTA, Invitae Corporation, Healthcare, Diagnostics & Research, USA, 6.09B, -, -, 19.10, 2.35, -, -68.00%, 11.80%, 8.00%, 42.90%, 61.40%, -26.70%, -46.90%, -22.80%, 5.30, 5.10, 0.19, 0.19, 26.80%, -, -, -17.77%, -34.17%, -38.57%, 71.11%, -31.16%, 6.57%
744, NXTC, NextCure Inc., Healthcare, Biotechnology, USA, 219.80M, -, -, 9.82, 0.78, -, 38.10%, -9.80%, -, -280.60%, -100.00%, -20.20%, -20.90%, -13.90%, 33.30, 33.30, 0.01, 0.01, -, -, -, -13.64%, -31.62%, -23.11%, -74.85%, -27.98%, 4.97%
746, OBLN, Obalon Therapeutics Inc., Healthcare, Medical Devices, USA, 32.39M, -, -, 40.48, 2.92, -, 68.30%, -, -, 35.20%, -92.20%, -83.60%, -161.40%, -234.40%, 1.90, -, 0.00, 0.04, 42.70%, -, -, 19.08%, -13.81%, 267.36%, 221.68%, 108.00%, 23.67%
748, OCDX, Ortho Clinical Diagnostics Holdings plc, Healthcare, Diagnostics & Research, USA, 4.84B, 26.41, -, 2.74, 11.23, -, -35.10%, 16.29%, 38.56%, -, 7.00%, -, -, 3.30%, 1.60, 1.10, 5.95, 6.32, -, -, -, 6.26%, 16.83%, -, -, 27.64%, 4.29%
750, OCUL, Ocular Therapeutix Inc., Healthcare, Biotechnology, USA, 1.11B, -, -, 50.43, 13.24, -, -34.30%, 48.70%, -, 42.40%, 180.80%, -73.80%, -326.00%, -50.00%, 8.30, 8.30, 0.48, 0.58, 90.30%, -, -, -24.01%, -25.18%, -11.86%, 106.82%, -29.66%, 6.35%
752, OCX, OncoCyte Corporation, Healthcare, Biotechnology, USA, 397.09M, -, -, 172.65, 3.40, -, -4.60%, -5.90%, -, 62.10%, -, -34.10%, -48.70%, -75.50%, 6.50, 6.50, 0.01, 0.04, -17.30%, -, -, -11.07%, -9.43%, 155.49%, 60.14%, 84.94%, 7.67%
754, OFIX, Orthofix Medical Inc., Healthcare, Medical Devices, USA, 797.72M, 52.18, -, 1.96, 2.21, 13.14, 108.60%, 34.02%, 9.40%, -178.80%, -3.20%, 4.40%, 6.70%, -0.90%, 2.60, 1.80, 0.06, 0.06, 74.40%, -1.50%, 5.80%, -8.66%, -12.79%, 6.71%, 19.42%, -5.30%, 3.21%
756, OGI, OrganiGram Holdings Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 957.33M, -, -, 13.22, 2.82, -, -, -, -, -, -36.90%, -, -, -, -, -, -, -, -, -, -, 17.58%, 1.90%, 163.11%, 84.48%, 141.35%, 7.54%
758, OLMA, Olema Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.14B, -, -, -, 3.37, -, -455.80%, -59.80%, -, -355.50%, -, -, -, -, 62.60, 62.60, 0.00, 0.00, -, -, -, -6.64%, -30.84%, -43.52%, -, -41.85%, 9.04%
760, OMCL, Omnicell Inc., Healthcare, Health Information Services, USA, 6.01B, 34.62, 11.93, 6.58, 5.91, 31.11, -48.50%, 11.22%, 15.00%, 17.50%, 9.60%, 2.10%, 3.70%, 2.70%, 3.10, 2.80, 0.47, 0.47, 46.90%, 4.70%, 3.80%, -3.38%, 7.42%, 30.16%, 107.74%, 15.81%, 3.43%
741, NVST, Envista Holdings Corporation, Healthcare, Medical Instruments & Supplies, USA, 7.07B, 20.71, -, 2.89, 1.87, 22.08, -87.30%, 9.34%, -3.36%, 477.30%, 29.60%, 1.80%, 3.40%, 1.80%, 1.00, 0.80, 0.24, 0.35, 54.50%, 6.80%, 5.00%, -0.59%, 10.56%, 49.86%, 106.43%, 29.38%, 2.43%
743, NXGN, NextGen Healthcare Inc., Healthcare, Health Information Services, USA, 1.09B, 16.13, 17.62, 1.96, 2.55, 11.50, 24.50%, 8.99%, 6.51%, 86.50%, 5.70%, 1.40%, 2.30%, 3.00%, 1.10, -, 0.00, 0.00, 50.50%, 2.30%, 1.70%, -12.52%, -14.83%, -8.01%, 59.11%, -9.98%, 3.42%
745, NYMX, Nymox Pharmaceutical Corporation, Healthcare, Biotechnology, Bahamas, 131.40M, -, -, 26280.80, -, -, 16.80%, -, -, 14.30%, -100.00%, -367.30%, -941.30%, -, 0.90, 0.90, -, -, -, -, -, -27.27%, -41.98%, -26.21%, -56.07%, -38.71%, 8.40%
747, OBSV, ObsEva SA, Healthcare, Biotechnology, Switzerland, 164.60M, -, -, 9682.38, 4.06, -, 33.10%, 3.80%, -, 39.00%, 20.00%, -98.10%, -312.90%, -, 4.30, 4.30, 0.53, 0.54, -, -, -, -5.19%, -24.16%, 49.74%, -21.93%, 40.38%, 5.96%
749, OCGN, Ocugen Inc., Healthcare, Biotechnology, USA, 1.73B, 2.22, -, 40511.95, 34.92, -, 79.00%, 151.12%, -, 49.30%, -, -119.50%, -154.50%, -, 12.00, 12.00, 0.04, 0.05, -, -, -, -27.01%, -12.87%, 2889.73%, 2716.13%, 377.05%, 14.69%
751, OCUP, Ocuphire Pharma Inc., Healthcare, Biotechnology, USA, 54.71M, -, -, -, 5.04, -, 39.40%, 15.10%, -, -511.60%, -, -, -, -, 5.20, 5.20, 0.00, 0.00, -, -, -, -11.15%, -56.89%, -27.01%, -54.78%, -30.05%, 8.00%
753, ODT, Odonate Therapeutics Inc., Healthcare, Biotechnology, USA, 128.99M, -, -, -, 1.23, -, 5.00%, 93.00%, -, 8.40%, -, -80.90%, -101.40%, -, 4.10, 4.10, 0.00, 0.00, -, -, -, 2.37%, -82.12%, -75.65%, -89.41%, -81.98%, 6.99%
755, OGEN, Oragenics Inc., Healthcare, Biotechnology, USA, 78.08M, -, -, -, 2.15, -, -27.00%, 0.00%, -, 54.90%, -, -135.60%, -224.50%, -, 42.30, 42.30, 0.00, 0.00, -, -, -, -14.95%, -32.67%, 74.27%, 21.58%, 52.96%, 8.26%
757, OLK, Olink Holding AB publ, Healthcare, Diagnostics & Research, Sweden, 4.20B, -, -, 77.76, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -1.45%, -, -, -, -1.86%, 9.71%
759, OM, Outset Medical Inc., Healthcare, Medical Devices, USA, 2.24B, -, -, 34.05, 6.73, -, -16.10%, 8.10%, -, -949.70%, 218.10%, -32.30%, -68.80%, -33.20%, 9.20, 8.50, 0.10, 0.00, -14.00%, -, -, -17.02%, -5.46%, -20.07%, -, -15.08%, 6.31%
762, OMI, Owens & Minor Inc., Healthcare, Medical Distribution, USA, 3.39B, 13.67, 0.87, 0.39, 4.03, 13.00, 471.90%, -17.69%, 21.02%, 521.10%, 9.60%, 3.40%, 18.90%, 10.70%, 1.70, 0.70, 1.25, 0.00, 16.80%, 3.40%, 1.30%, 22.13%, 30.96%, 77.91%, 463.81%, 65.29%, 6.29%
764, ONCS, OncoSec Medical Incorporated, Healthcare, Biotechnology, USA, 147.21M, -, -, -, 2.39, -, 40.50%, 23.40%, -, 71.00%, -, -98.90%, -171.20%, -, 5.80, 5.80, 0.01, 0.02, -, -, -, -17.32%, -29.77%, -18.33%, 79.82%, -37.83%, 7.37%
766, ONCY, Oncolytics Biotech Inc., Healthcare, Biotechnology, Canada, 160.49M, -, -, -, 4.07, -, 62.70%, -, -, -, -, -76.00%, -102.60%, -, 22.20, 22.20, 0.01, 0.01, -, -, -, -0.33%, -9.23%, 18.68%, 25.00%, 28.15%, 5.27%
768, ONTX, Onconova Therapeutics Inc., Healthcare, Biotechnology, USA, 111.32M, -, -, 556.61, 2.63, -, 90.30%, -71.40%, -, 32.30%, 0.00%, -81.10%, -139.30%, -403.20%, 6.60, 6.60, 0.00, 0.00, -, -, -, -38.65%, -65.43%, 67.67%, 6.80%, -4.25%, 14.62%
770, OPCH, Option Care Health Inc., Healthcare, Medical Care Facilities, USA, 3.42B, 26.54, 38.21, 1.11, 3.24, 33.27, 90.80%, 72.32%, 10.00%, 85.90%, 7.60%, 0.30%, 0.90%, 5.60%, 1.60, 1.20, 1.10, 1.11, 22.30%, 5.00%, 0.30%, -5.42%, -7.23%, 16.00%, 20.66%, 17.26%, 3.98%
772, OPK, OPKO Health Inc., Healthcare, Diagnostics & Research, USA, 2.60B, 57.88, 1.68, 1.47, 1.44, 36.32, 109.00%, -45.00%, 12.00%, 152.50%, 157.80%, 5.00%, 7.30%, 2.10%, 1.50, 1.10, 0.14, 0.15, 36.80%, 7.70%, 6.80%, -7.06%, -18.72%, -3.29%, 67.54%, -3.29%, 4.60%
774, OPRX, OptimizeRx Corporation, Healthcare, Health Information Services, USA, 864.51M, 54.70, -, 18.39, 6.49, -, 36.60%, 78.88%, 50.00%, 73.80%, 47.40%, -0.90%, -1.00%, -4.30%, 18.50, 18.50, 0.00, 0.00, 55.10%, -1.20%, -1.40%, -2.19%, -17.51%, 96.09%, 332.39%, 57.64%, 7.15%
776, OPTN, OptiNose Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 171.02M, -, -, 3.17, -, -, 21.30%, 57.50%, -, 21.80%, 69.00%, -57.00%, -, -66.10%, 3.40, 3.10, -, -, 85.40%, -, -, -14.25%, -20.45%, -25.12%, -26.16%, -22.95%, 5.86%
778, ORGS, Orgenesis Inc., Healthcare, Biotechnology, USA, 113.60M, -, -, 7.47, 2.15, -, -215.50%, 11.80%, -, 97.70%, 394.70%, -76.60%, -105.90%, -147.10%, 2.90, 2.90, 0.13, 0.21, 98.40%, -, -, 2.55%, -31.49%, -0.62%, -33.56%, 7.33%, 10.17%
780, ORMP, Oramed Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 353.09M, -, -, 130.77, 6.30, -, 31.80%, -22.50%, -, 17.60%, 0.00%, -32.00%, -42.70%, -35.70%, 9.70, 9.70, 0.00, 0.00, -, -, -, 5.98%, 27.43%, 256.66%, 266.88%, 171.70%, 6.22%
761, OMER, Omeros Corporation, Healthcare, Biotechnology, USA, 923.10M, -, -, 12.95, -, -, -41.50%, 25.90%, -, -6.00%, -10.20%, -90.00%, 97.50%, -95.50%, 3.10, 3.00, -, -, 98.70%, -, -, -15.19%, -21.74%, 29.72%, 2.08%, 6.34%, 4.53%
763, ONCR, Oncorus Inc., Healthcare, Biotechnology, USA, 432.06M, -, -, -, 2.34, -, -62.40%, -18.60%, -, 67.20%, -, -, -, -, 25.90, 25.90, 0.00, 0.00, -, -, -, 0.94%, 8.52%, -31.66%, -, -46.80%, 6.99%
765, ONCT, Oncternal Therapeutics Inc., Healthcare, Biotechnology, USA, 276.48M, -, -, 78.99, 2.57, -, 74.40%, -42.40%, 0.00%, 60.70%, 16.70%, -26.80%, -29.90%, -15.50%, 19.80, 19.80, 0.00, 0.00, -, -, -, -11.92%, -18.60%, 124.02%, 85.95%, 16.12%, 8.51%
767, ONEM, 1Life Healthcare Inc., Healthcare, Health Information Services, USA, 4.84B, -, -, 11.56, 10.48, -, -74.60%, 49.40%, -, -4.10%, 51.80%, -8.90%, -18.10%, -9.00%, 5.50, 5.50, 0.64, 0.00, 39.40%, -17.80%, -22.50%, -14.88%, -24.18%, 13.88%, 14.55%, -15.23%, 5.89%
769, ONVO, Organovo Holdings Inc., Healthcare, Diagnostics & Research, USA, 55.37M, -, -, -, 3.10, -, 37.40%, -, -, 29.10%, -, -70.40%, -73.60%, -80.70%, 24.20, -, 0.00, 0.00, -, -, -, 6.21%, -29.43%, 9.68%, -25.57%, -23.58%, 9.11%
771, OPGN, OpGen Inc., Healthcare, Diagnostics & Research, USA, 82.30M, -, -, 18.70, 1.40, -, 78.40%, 58.20%, -, 5.70%, 33.30%, -68.80%, -144.10%, -52.80%, 6.50, 6.30, 0.42, 0.43, 7.50%, -, -, -7.20%, 0.00%, 9.50%, 12.89%, 7.35%, 6.64%
773, OPNT, Opiant Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 55.28M, -, -, 1.74, 1.59, -, -120.20%, -217.60%, -, -66.50%, 48.80%, -6.00%, -8.70%, -3.30%, 9.10, 9.10, 0.55, 0.55, 80.30%, -9.10%, -9.50%, 2.60%, -3.58%, 53.15%, 13.86%, 57.53%, 4.86%
775, OPT, Opthea Limited, Healthcare, Biotechnology, Australia, 386.20M, -, -, 1691.99, -, -, -, -, -, -, 28.80%, -, -, -, -, -, -, -, -, -, -, -0.54%, -19.24%, -28.85%, -, -18.41%, 5.14%
777, ORGO, Organogenesis Holdings Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 2.30B, 42.45, 1.12, 6.06, 14.50, 3280.47, 136.40%, 30.43%, 44.46%, 147.70%, 66.30%, 16.40%, 43.70%, 12.60%, 2.50, 2.10, 0.40, 0.53, 75.20%, 14.80%, 11.70%, -16.33%, 8.65%, 248.24%, 331.72%, 136.79%, 8.67%
779, ORIC, ORIC Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 904.86M, -, -, -, 3.03, -, -244.10%, -26.80%, -, -51.70%, -, -33.30%, -34.40%, -, 36.50, 36.50, 0.00, 0.00, -, -, -, -7.41%, -35.94%, -19.31%, -21.26%, -32.50%, 7.09%
782, ORTX, Orchard Therapeutics plc, Healthcare, Biotechnology, United Kingdom, 638.90M, -, -, 245.73, 2.04, -, 12.80%, 13.80%, -, 40.20%, -100.00%, -42.60%, -60.20%, -76.80%, 6.80, 6.70, 0.06, 0.08, 67.00%, -, -, -14.54%, -29.32%, 9.19%, -44.95%, 21.06%, 6.76%
784, OSH, Oak Street Health Inc., Healthcare, Medical Care Facilities, USA, 14.68B, -, -, 15.01, 31.45, -, -57.20%, 24.20%, -, -68.60%, 43.30%, -27.00%, -673.90%, -44.10%, 2.20, 2.20, 0.00, 0.00, 8.30%, -14.00%, -18.40%, -2.23%, 16.20%, 28.19%, -, -1.26%, 5.50%
786, OSUR, OraSure Technologies Inc., Healthcare, Medical Instruments & Supplies, USA, 700.18M, 22.94, -, 3.52, 1.71, -, -182.50%, 23.60%, 20.00%, 143.80%, 85.40%, -0.90%, -1.00%, -4.10%, 6.50, 5.60, 0.00, 0.00, 62.40%, 6.70%, -1.90%, 5.26%, -13.11%, -14.50%, -33.91%, -9.21%, 4.31%
788, OTLK, Outlook Therapeutics Inc., Healthcare, Biotechnology, USA, 461.79M, -, -, -, 19.14, -, 66.00%, 15.20%, -, 76.10%, -, -150.50%, -675.90%, -, 1.80, 1.80, 0.01, 0.55, -, -, -, 15.02%, 24.65%, 121.49%, 162.75%, 106.15%, 7.36%
790, OVID, Ovid Therapeutics Inc., Healthcare, Biotechnology, USA, 286.81M, -, -, 1.30, 1.24, 2.25, 10.10%, -138.50%, -, 822.10%, -, 102.10%, 128.20%, -186.80%, 14.50, 14.50, 0.00, 0.00, -, 52.20%, 52.00%, 7.24%, 36.96%, -30.72%, -22.43%, 79.65%, 5.92%
792, PACB, Pacific Biosciences of California Inc., Healthcare, Diagnostics & Research, USA, 5.37B, -, -, 58.18, 18.78, -, 130.50%, 26.40%, -1.00%, -, 85.90%, -10.90%, -30.10%, 8.20%, 35.40, 35.00, 3.19, 0.00, 41.20%, -64.30%, -64.20%, -19.21%, -23.20%, 86.04%, 668.47%, 4.28%, 7.70%
794, PALI, Palisade Bio Inc., Healthcare, Biotechnology, USA, 26.78M, -, -, -, 1.42, -, 69.10%, -, -, 85.80%, -, -81.00%, -91.80%, -, 8.60, 8.60, 0.00, 0.00, -, -, -, -51.15%, -56.21%, 4.61%, -30.98%, -27.84%, 14.29%
796, PAVM, PAVmed Inc., Healthcare, Medical Devices, USA, 434.39M, -, -, -, 8.28, -, -31.50%, 15.00%, -, 61.60%, -, -130.40%, -656.70%, -, 15.20, 15.20, 0.00, 0.01, -, -, -, 12.77%, 28.64%, 170.41%, 166.33%, 150.00%, 8.17%
798, PBLA, Panbela Therapeutics Inc., Healthcare, Biotechnology, USA, 43.09M, -, -, -, 5.45, -, 43.30%, 0.00%, -, 14.80%, -, -62.40%, -76.90%, -, 6.70, 6.70, 0.00, 0.00, -, -, -, -9.87%, -8.50%, 28.44%, -20.00%, 17.98%, 5.01%
800, PCRX, Pacira BioSciences Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 2.70B, 15.29, 0.54, 6.09, 4.09, 69.70, 32.10%, 35.98%, 33.85%, 18.30%, 12.60%, 12.70%, 26.30%, 15.10%, 3.10, 2.80, 0.49, 0.72, 73.10%, 9.20%, 33.30%, -5.50%, -16.39%, -4.25%, 38.04%, 1.39%, 3.81%
781, ORPH, Orphazyme A/S, Healthcare, Biotechnology, Denmark, 195.73M, -, -, -, -, -, -, 39.80%, -, -, -, -, -, -, -, -, -, -, -, -, -, -40.80%, -54.73%, -40.49%, -, -47.81%, 5.13%
783, OSCR, Oscar Health Inc., Healthcare, Healthcare Plans, USA, 5.09B, -, -, 13.02, 2.92, -, -55.80%, -, 19.10%, -, -, -, -, 35.00%, -, -, 0.00, 0.00, -, -, -, 12.33%, -, -, -, -27.47%, 6.42%
785, OSMT, Osmotica Pharmaceuticals plc, Healthcare, Biotechnology, USA, 184.41M, -, -, 1.20, 2.14, 32.93, 74.60%, 19.50%, -, -189.80%, -50.80%, -21.30%, -74.80%, -21.00%, 3.30, 3.00, 2.58, 2.58, 56.00%, -50.80%, -56.20%, -2.02%, -23.62%, -50.43%, -51.26%, -29.37%, 5.25%
787, OTIC, Otonomy Inc., Healthcare, Biotechnology, USA, 134.21M, -, -, 671.04, 2.18, -, 24.70%, 28.90%, 20.40%, 38.90%, -50.00%, -48.00%, -83.00%, -53.40%, 7.20, 7.10, 0.24, 0.27, -, -, -, -1.27%, -19.10%, -45.81%, -8.98%, -63.99%, 6.98%
789, OTRK, Ontrak Inc., Healthcare, Medical Care Facilities, USA, 537.42M, -, -, 5.42, 9.43, -, 7.70%, 27.30%, 30.00%, 3.60%, 133.30%, -25.00%, -96.90%, -13.30%, 3.10, 3.10, 0.82, 0.82, 50.50%, -11.90%, -25.00%, -6.95%, -3.92%, -36.42%, 53.36%, -50.83%, 7.60%
791, OYST, Oyster Point Pharma Inc., Healthcare, Biotechnology, USA, 467.35M, -, -, -, 2.72, -, -36.60%, 6.80%, -, 5.70%, -, -35.20%, -37.20%, -, 13.30, 13.30, 0.00, 0.00, -, -, -, -14.05%, -11.51%, -13.60%, -37.03%, -4.78%, 6.20%
793, PAHC, Phibro Animal Health Corporation, Healthcare, Drug Manufacturers - Specialty & Generic, USA, 1.13B, 21.34, 3.67, 1.41, 5.29, -, -38.20%, 4.68%, 7.25%, -9.90%, 0.50%, 5.40%, 21.20%, 8.20%, 2.80, 1.60, 1.65, 1.76, 32.80%, 9.20%, 5.40%, 15.34%, 23.75%, 46.14%, 7.60%, 45.16%, 3.52%
795, PASG, Passage Bio Inc., Healthcare, Biotechnology, USA, 746.50M, -, -, -, 1.54, -, -150.90%, -6.10%, -, 24.10%, -, -34.90%, -36.90%, -, 23.20, 23.20, 0.00, 0.00, -, -, -, -31.88%, -32.12%, -29.14%, -39.85%, -48.18%, 7.99%
797, PBH, Prestige Consumer Healthcare Inc., Healthcare, Medical Distribution, USA, 2.51B, 13.04, 3.83, 2.66, 1.84, 11.76, 17.00%, 5.93%, 4.00%, -2.50%, -5.30%, 4.80%, 12.70%, 8.60%, 2.20, 1.30, 1.09, 1.10, 58.00%, 30.20%, 17.50%, 13.11%, 17.95%, 37.12%, 18.18%, 43.02%, 2.51%
799, PBYI, Puma Biotechnology Inc., Healthcare, Biotechnology, USA, 430.65M, -, -, 1.58, 25.73, -, 22.30%, -61.50%, -, 193.80%, 91.80%, -10.30%, -317.40%, -50.70%, 1.20, 1.10, 4.65, 6.05, 78.00%, -4.50%, -9.80%, 6.03%, 3.33%, -4.52%, 3.33%, 2.83%, 4.88%
802, PCVX, Vaxcyte Inc., Healthcare, Biotechnology, USA, 1.13B, -, -, -, 3.30, -, -190.60%, -2.40%, 11.80%, 26.10%, -, -20.90%, -23.50%, -, 5.90, 5.90, 0.00, 0.00, -, -, -, 12.31%, -18.43%, -37.92%, -, -20.70%, 7.18%
804, PDEX, Pro-Dex Inc., Healthcare, Medical Instruments & Supplies, USA, 124.42M, 21.10, -, 3.13, 6.39, -, 55.60%, 35.00%, -, 65.80%, 37.60%, 17.20%, 30.20%, 22.80%, 4.10, 2.80, 0.57, 0.63, 37.10%, 15.40%, 15.50%, 21.68%, 33.88%, -9.98%, 73.50%, 10.36%, 5.03%
806, PEN, Penumbra Inc., Healthcare, Medical Devices, USA, 9.07B, 149.71, -, 15.30, 13.86, -, -132.90%, 79.31%, 23.10%, 704.60%, 23.20%, -0.70%, -0.80%, -3.00%, 5.70, 3.50, 0.04, 0.04, 61.00%, -4.40%, -0.90%, -19.59%, -14.52%, 11.15%, 44.48%, 42.35%, 4.73%
808, PETS, PetMed Express Inc., Healthcare, Pharmaceutical Retailers, USA, 580.02M, 16.96, 1.72, 1.88, 4.11, 38.67, 18.00%, 6.04%, 11.04%, -3.50%, -3.50%, 18.10%, 22.30%, 20.50%, 3.60, 2.80, 0.00, 0.00, 29.10%, 12.20%, 9.90%, -2.00%, -15.69%, -3.95%, -19.94%, -9.86%, 4.18%
810, PGEN, Precigen Inc., Healthcare, Biotechnology, USA, 1.41B, -, -, 14.42, 7.33, -, 43.30%, -33.30%, 2.40%, 13.20%, -17.80%, -37.20%, -150.60%, -36.20%, 5.70, 5.30, 1.00, 1.00, 43.90%, -80.40%, -, -19.71%, -19.51%, -11.76%, 200.00%, -35.29%, 7.17%
812, PHAR, Pharming Group N.V., Healthcare, Biotechnology, Netherlands, 776.17M, -, -, 4.18, -, -, -, -, -, -38.70%, 11.60%, -, -, -, -, -, -, -, -, -, -, -7.50%, -12.08%, -, -, -20.04%, 1.73%
814, PHAT, Phathom Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.16B, -, -, -, 7.80, -, 62.40%, 6.60%, -, -19.90%, -, -56.10%, -81.80%, -, 5.90, 5.90, 0.22, 0.29, -, -, -, -11.20%, -23.40%, -17.14%, -16.39%, 6.41%, 7.11%
816, PHGE, BiomX Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 151.11M, -, -, -, 2.68, -, 64.40%, -, -, -36.20%, -, -44.80%, -52.00%, -, 7.20, 7.20, 0.00, 0.00, -, -, -, -12.23%, -22.69%, -4.29%, 2.20%, -5.49%, 5.16%
818, PHR, Phreesia Inc., Healthcare, Health Information Services, USA, 2.48B, -, -, 16.66, 8.36, -, 84.70%, 16.70%, -, -79.40%, 27.40%, -11.10%, -14.90%, -9.40%, 5.00, 5.00, 0.02, 0.04, 64.80%, -17.30%, -18.40%, -5.73%, -22.80%, 16.06%, 68.83%, -8.77%, 4.57%
820, PINC, Premier Inc., Healthcare, Health Information Services, USA, 4.23B, 13.43, 2.96, 2.67, 1.82, 34.42, 26.90%, 0.20%, 6.00%, -85.80%, 40.40%, 6.30%, 10.10%, 14.50%, 1.00, 0.80, 0.15, 0.28, 51.90%, 16.50%, 13.40%, -6.54%, -0.87%, -5.90%, -5.15%, -5.98%, 2.15%
801, PCSA, Processa Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 97.48M, -, -, -, 2.86, -, -263.00%, -14.00%, -, 9.20%, -, -103.70%, -122.10%, -, 22.40, 22.40, 0.00, 0.00, -, -, -, -26.79%, -53.20%, 9.04%, -63.39%, -6.75%, 8.46%
803, PDCO, Patterson Companies Inc., Healthcare, Medical Distribution, USA, 3.21B, 15.50, -, 0.57, 3.34, -, -821.80%, 2.64%, 11.64%, 105.70%, 6.50%, -17.50%, -54.80%, -40.20%, 1.40, 0.70, 0.52, 0.75, 21.20%, -7.80%, -8.50%, 0.00%, 0.49%, 18.16%, 65.26%, 9.82%, 3.24%
805, PDSB, PDS Biotechnology Corporation, Healthcare, Biotechnology, USA, 257.30M, -, -, -, 11.19, -, 38.30%, -16.20%, -, 64.60%, -, -49.20%, -55.90%, -, 9.30, 9.30, 0.00, 0.00, -, -, -, 113.66%, 183.72%, 522.45%, 831.30%, 470.09%, 14.69%
807, PETQ, PetIQ Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 1.18B, 19.73, -, 1.39, 4.37, -, -522.10%, 35.88%, 25.00%, 184.90%, 36.10%, -9.00%, -27.80%, -8.70%, 2.50, 1.50, 1.80, 1.82, 17.80%, 0.40%, -8.70%, -4.29%, 15.26%, 41.19%, 33.96%, 6.89%, 3.66%
809, PFE, Pfizer Inc., Healthcare, Drug Manufacturers - General, USA, 216.35B, 11.24, 1.85, 4.66, 3.15, 43.62, -33.10%, -9.22%, 12.57%, 95.10%, 44.60%, 6.60%, 17.00%, 7.60%, 1.50, 1.20, 0.52, 0.58, 91.00%, 22.00%, 23.90%, 0.34%, 14.96%, 6.02%, 7.01%, 5.22%, 1.76%
811, PGNY, Progyny Inc., Healthcare, Health Information Services, USA, 5.40B, 116.23, 1.83, 13.99, 30.35, 225.91, 549.80%, 35.71%, 60.95%, 316.10%, 50.70%, 24.80%, 38.50%, 27.60%, 2.30, 2.30, 0.00, 0.00, 21.30%, 4.20%, 14.90%, 9.51%, 46.75%, 84.50%, 156.57%, 51.07%, 4.97%
813, PHAS, PhaseBio Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 163.49M, -, -, 510.91, 12.52, -, -137.60%, 9.10%, -, -68.80%, -100.00%, -158.50%, -, 652.70%, 5.30, 5.30, 0.64, 1.29, -, -, -, 10.82%, -12.21%, -8.40%, -43.76%, 0.60%, 7.91%
815, PHG, Koninklijke Philips N.V., Healthcare, Diagnostics & Research, Netherlands, 50.58B, 21.81, 9.43, 2.16, 3.36, -, 2.50%, 21.14%, 4.10%, -308.60%, 3.60%, -, 10.10%, 7.10%, -, -, 0.47, 0.61, 43.90%, 7.50%, 6.20%, -0.86%, 2.58%, 11.29%, 26.76%, 4.26%, 1.02%
817, PHIO, Phio Pharmaceuticals Corp., Healthcare, Biotechnology, USA, 29.90M, -, -, -, 0.76, -, 90.10%, -, -, 75.90%, -, -44.70%, -50.80%, -, 15.20, 15.20, 0.00, 0.00, -, -, -, -5.13%, -27.92%, -0.89%, -27.21%, -17.47%, 8.22%
819, PHVS, Pharvaris B.V., Healthcare, Biotechnology, Netherlands, 671.17M, -, -, -, -, -, -223.70%, -17.40%, 25.60%, -, -, -, -, -, 19.00, 19.00, 0.00, 0.00, -, -, -, -17.54%, -47.74%, -, -, -29.31%, 8.68%
822, PKI, PerkinElmer Inc., Healthcare, Diagnostics & Research, USA, 16.24B, 23.74, 0.40, 3.66, 4.06, 13.50, 212.40%, -35.78%, 37.90%, 489.70%, 100.40%, 14.20%, 30.80%, 14.00%, 1.80, 1.40, 0.55, 0.64, 58.30%, 31.60%, 24.20%, 11.16%, 11.83%, 13.78%, 44.39%, 1.09%, 2.32%
824, PLSE, Pulse Biosciences Inc., Healthcare, Medical Instruments & Supplies, USA, 500.97M, -, -, -, 23.13, -, 5.30%, 30.10%, -, -25.50%, -, -98.50%, -191.40%, -, 7.30, 7.10, 2.01, 2.01, -, -, -, -10.91%, -38.74%, 22.31%, 98.46%, -24.39%, 9.43%
826, PLXP, PLx Pharma Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 335.97M, -, -, 11040.73, 5.43, -, 54.60%, 53.00%, 40.00%, -668.30%, -100.00%, -82.10%, -, -, 60.20, 60.10, 0.00, 0.00, -, -, -, 39.68%, 69.37%, 164.64%, 302.72%, 168.48%, 7.51%
828, PMVP, PMV Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.58B, -, 1.11, -, 4.42, -, -30.50%, -38.10%, 23.10%, 89.10%, -, -, -, -, 57.80, 57.80, 0.00, 0.00, -, -, -, 0.91%, -1.57%, -0.23%, -, -44.07%, 6.61%
830, POAI, Predictive Oncology Inc., Healthcare, Medical Instruments & Supplies, USA, 56.81M, -, -, 47.34, 1.22, -, 67.70%, 63.30%, -, 88.50%, 0.00%, -97.90%, -166.10%, -390.80%, 8.60, 8.60, 0.00, 0.00, 63.50%, -, -, 5.36%, -26.25%, 65.08%, -23.38%, 61.11%, 9.17%
832, PPBT, Purple Biotech Ltd., Healthcare, Biotechnology, Israel, 95.61M, -, -, 95.61, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 27.27%, 14.95%, 33.82%, 15.92%, 43.31%, 5.69%
834, PRAH, PRA Health Sciences Inc., Healthcare, Diagnostics & Research, USA, 11.08B, 25.08, 3.44, 3.32, 7.05, 22.39, -17.40%, 12.70%, 15.20%, 36.20%, 19.20%, 5.30%, 15.40%, 9.60%, 1.20, 1.20, 0.74, 0.82, 27.10%, 10.00%, 6.40%, 2.66%, 18.42%, 55.31%, 65.14%, 36.26%, 1.42%
836, PRFX, PainReform Ltd., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 30.19M, -, -, -, -, -, -, 26.50%, -, -, -, -, -, -, -, -, -, -, -, -, -, -12.28%, -53.27%, -34.35%, -, -32.89%, 13.43%
838, PRLD, Prelude Therapeutics Incorporated, Healthcare, Biotechnology, USA, 1.55B, -, -, -, 4.40, -, 29.30%, -48.30%, 30.10%, 92.70%, -, -, -, -, 29.40, 29.40, 0.00, 0.00, -, -, -, -14.09%, -48.65%, -23.35%, -, -51.42%, 9.15%
840, PROG, Progenity Inc., Healthcare, Biotechnology, USA, 160.30M, -, -, 1.95, -, -, -38.30%, 11.60%, -, -47.80%, 45.80%, -141.20%, 268.20%, -285.10%, 1.30, 1.10, -, -, -8.60%, -, -, -15.08%, -52.82%, -33.76%, -, -51.22%, 10.79%
821, PIRS, Pieris Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 241.21M, -, -, 7.61, 5.06, -, -22.20%, 27.80%, -, -13.80%, 17.30%, -33.30%, -94.70%, -110.00%, 2.90, 2.90, 0.00, 0.00, -, -, -, 55.66%, 24.64%, 19.03%, -4.44%, 37.60%, 14.23%
823, PLRX, Pliant Therapeutics Inc., Healthcare, Biotechnology, USA, 1.09B, -, -, 72.10, 4.06, -, -870.70%, -28.20%, -, -298.80%, -92.40%, -24.90%, -25.90%, -14.70%, 26.40, 26.40, 0.00, 0.00, -, -, -, -9.87%, -15.25%, 0.97%, -, 32.31%, 8.17%
825, PLX, Protalix BioTherapeutics Inc., Healthcare, Biotechnology, Israel, 137.96M, -, -, 2.19, -, -, -68.20%, 78.40%, 25.00%, 36.40%, 9.80%, -, -, -, -, -, -, -, -, -, -, -14.12%, -37.58%, -21.04%, -8.98%, -16.25%, 6.88%
827, PMD, Psychemedics Corporation, Healthcare, Diagnostics & Research, USA, 36.30M, -, -, 1.86, 2.86, -, -350.30%, -, 20.00%, 151.00%, -24.00%, -14.70%, -27.70%, -22.40%, 2.50, 2.50, 0.26, 0.31, 24.20%, -29.40%, -18.50%, -2.22%, -9.59%, 55.66%, 13.79%, 29.67%, 2.63%
829, PNTG, The Pennant Group Inc., Healthcare, Medical Care Facilities, USA, 930.43M, 31.94, -, 2.30, 9.68, 26.06, 505.30%, 21.93%, -, -69.20%, 15.10%, 2.80%, 14.90%, 15.80%, 0.80, 0.80, 0.25, 0.25, 23.90%, 4.00%, 3.40%, -18.27%, -34.57%, -28.57%, 34.44%, -40.97%, 5.72%
831, PODD, Insulet Corporation, Healthcare, Medical Devices, USA, 18.03B, 175.34, -, 18.81, 30.47, -, -44.60%, 110.97%, -, 100.00%, 27.40%, 0.50%, 1.50%, 2.90%, 6.40, 5.50, 1.80, 1.82, 65.00%, 6.30%, 0.90%, -10.58%, -0.22%, 8.36%, 43.01%, 5.49%, 5.03%
833, PPD, PPD Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 16.19B, 27.24, 9.18, 3.46, -, 68.97, 108.30%, 14.62%, 14.86%, 893.60%, 30.30%, 0.90%, -5.60%, 11.30%, 1.10, 1.10, -, -, 38.40%, 7.70%, 1.10%, -0.15%, 29.84%, 36.85%, 69.31%, 34.77%, 0.24%
835, PRAX, Praxis Precision Medicines Inc., Healthcare, Biotechnology, USA, 813.18M, -, -, -, 2.84, -, -52.90%, -4.70%, -, -145.20%, -, -48.50%, -107.80%, -, 20.30, 20.30, 0.00, 0.00, -, -, -, -39.20%, -52.81%, -47.28%, -, -64.39%, 10.26%
837, PRGO, Perrigo Company plc, Healthcare, Drug Manufacturers - Specialty & Generic, Ireland, 6.12B, 16.14, -, 1.29, 1.11, 21.02, -211.60%, 10.34%, 10.00%, -95.00%, -6.80%, -2.00%, -4.00%, 0.90%, 3.10, 2.30, 0.63, 0.64, 35.90%, 0.00%, -4.90%, 9.75%, 9.18%, -3.73%, -15.76%, 3.18%, 2.70%
839, PROF, Profound Medical Corp., Healthcare, Medical Devices, Canada, 359.53M, -, -, 49.22, -, -, -, -, -, -, 27.00%, -, -, -, -, -, -, -, -, -, -, -3.12%, -22.77%, -5.25%, 43.19%, -14.06%, 5.63%
842, PRPO, Precipio Inc., Healthcare, Diagnostics & Research, USA, 80.60M, -, -, 12.03, 4.09, -, 63.50%, 5.00%, 20.00%, 89.60%, 50.00%, -43.90%, -64.40%, -67.30%, 0.90, 0.80, 0.02, 0.03, 22.30%, -, -, 75.13%, 26.82%, 49.10%, 295.04%, 59.90%, 28.42%
844, PRTA, Prothena Corporation plc, Healthcare, Biotechnology, Ireland, 1.34B, -, -, 1493.83, 5.00, -, -43.00%, -156.10%, -8.40%, -54.50%, 100.00%, -34.40%, -57.60%, -61.10%, 15.00, 15.00, 0.00, 0.00, -, -, -, 8.64%, 35.74%, 160.91%, 173.64%, 142.88%, 7.15%
846, PRTK, Paratek Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 394.23M, -, -, 7.12, -, -, 44.40%, 59.30%, -, 40.70%, 107.60%, -45.80%, 95.70%, -52.50%, 6.20, 5.60, -, -, 82.10%, -, -, 4.18%, 14.80%, 34.98%, 85.14%, 31.31%, 4.62%
848, PRVB, Provention Bio Inc., Healthcare, Biotechnology, USA, 676.83M, -, -, -, 2.58, -, -76.90%, 18.90%, -, -97.50%, -, -70.70%, -79.70%, -, 7.90, 7.90, 0.00, 0.00, -, -, -, -1.42%, -40.17%, -46.10%, -43.25%, -55.08%, 10.09%
850, PSTI, Pluristem Therapeutics Inc., Healthcare, Biotechnology, Israel, 116.21M, -, -, -, 1.60, -, 94.40%, 5.40%, -, -14.30%, -, -67.90%, -81.10%, -, 5.00, 5.00, 0.00, 0.00, -, -, -, -14.81%, -40.74%, -60.47%, -54.17%, -47.95%, 6.71%
852, PSTX, Poseida Therapeutics Inc., Healthcare, Biotechnology, USA, 540.72M, -, -, -, 2.30, -, -157.60%, 2.40%, 2.70%, -32.80%, -, -41.70%, -96.10%, -, 9.90, 9.90, 0.12, 0.13, -, -, -, -12.07%, -25.16%, -26.27%, -, -22.97%, 7.10%
854, PTE, PolarityTE Inc., Healthcare, Biotechnology, USA, 87.10M, -, -, 6.27, 3.08, -, 70.20%, 13.20%, 15.00%, 42.10%, 422.20%, -93.90%, -172.00%, -143.10%, 4.40, 4.40, 0.06, 0.17, 56.30%, -, -, 7.55%, -14.29%, 75.87%, 16.76%, 67.65%, 9.17%
856, PTIX, Protagenic Therapeutics Inc., Healthcare, Biotechnology, USA, 35.39M, -, -, -, -, -, -44.50%, -, -, -136.00%, -, -, -, -, 0.30, 0.30, -, -, -, -, -, -5.51%, 92.24%, -85.58%, -71.16%, 112.38%, 20.27%
858, PTPI, Petros Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 31.00M, -, -, 2.63, 1.41, -, 36.70%, -, -, 109.20%, -73.70%, -, -, -64.20%, 0.60, 0.60, 0.00, 0.24, 67.00%, -, -, -8.18%, -11.14%, -, -, -31.14%, 12.56%
860, PYPD, PolyPid Ltd., Healthcare, Biotechnology, Israel, 173.00M, -, -, -, 2.42, -, -420.40%, -0.90%, -, -0.80%, -, -, -, -, 16.40, 16.40, 0.00, 0.00, -, -, -, 1.60%, -15.78%, -14.41%, -, -4.04%, 4.01%
841, PRPH, ProPhase Labs Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 84.29M, 1.58, -, 3.02, 1.33, -, 25.30%, 93.61%, -, 183.10%, 705.30%, -0.70%, -1.20%, -, 3.70, 2.80, 0.19, 0.19, 47.00%, -0.20%, -0.90%, -4.24%, -36.08%, -41.15%, 216.81%, -45.13%, 6.87%
843, PRQR, ProQR Therapeutics N.V., Healthcare, Biotechnology, Netherlands, 396.80M, -, -, 34.81, 5.24, -, 32.40%, -17.60%, -, 22.90%, -66.70%, -43.80%, -67.50%, -46.50%, 6.90, 6.90, 0.64, 0.69, -, -, -, -2.65%, 31.37%, 54.07%, 12.23%, 48.57%, 6.02%
845, PRTG, Portage Biotech Inc., Healthcare, Biotechnology, Canada, 336.64M, -, -, -, 3.22, -, 10.90%, -, -, -187.60%, -, -3.20%, -5.50%, -, 3.20, 3.20, 0.00, 0.00, -, -, -, -0.21%, -17.28%, 128.64%, 96.92%, 43.44%, 5.11%
847, PRVA, Privia Health Group Inc., Healthcare, Health Information Services, USA, 3.36B, -, -, 4.12, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -5.81%, -, -, -, -5.81%, 9.55%
849, PSNL, Personalis Inc., Healthcare, Biotechnology, USA, 977.42M, -, -, 12.16, 2.73, -, 13.80%, -16.00%, -, -0.70%, 8.90%, -17.20%, -21.20%, -21.70%, 9.70, 9.60, 0.00, 0.00, 29.20%, -56.00%, -55.40%, -8.13%, -30.82%, -14.29%, 89.95%, -38.57%, 7.78%
851, PSTV, Plus Therapeutics Inc., Healthcare, Biotechnology, USA, 49.60M, -, -, 248.02, 2.06, -, 32.90%, 11.40%, -, -17.40%, -, -70.50%, -213.90%, -103.10%, 1.90, -, 0.00, 0.68, -, -, -, -0.84%, -9.20%, 11.79%, 48.12%, 17.33%, 11.54%
853, PTCT, PTC Therapeutics Inc., Healthcare, Biotechnology, USA, 2.76B, -, -, 6.41, 9.42, -, -55.30%, 42.60%, -9.51%, -1.50%, 72.60%, -22.80%, -97.80%, -31.20%, 4.50, 4.40, 3.80, 3.92, 94.40%, -, -, -7.60%, -32.48%, -38.19%, -22.56%, -35.65%, 3.98%
855, PTGX, Protagonist Therapeutics Inc., Healthcare, Biotechnology, USA, 1.55B, -, -, 49.63, 5.99, -, 35.50%, -11.70%, -, 25.10%, 72.20%, -26.30%, -32.00%, -23.80%, 8.30, 8.30, 0.00, 0.00, -, -, -, 17.07%, 31.25%, 51.79%, 112.40%, 74.16%, 5.98%
857, PTN, Palatin Technologies Inc., Healthcare, Biotechnology, USA, 126.62M, -, -, -, 2.04, -, -158.00%, 36.40%, -, -5.80%, -, -30.50%, -37.50%, -29.40%, 7.90, 7.30, 0.00, 0.00, -, -, -, -13.38%, -31.69%, 24.21%, 8.40%, -18.69%, 6.43%
859, PULM, Pulmatrix Inc., Healthcare, Biotechnology, USA, 53.53M, -, -, 4.74, 0.76, -, 45.40%, -10.80%, -, 61.10%, -50.00%, -40.30%, -63.90%, -, 9.10, 9.10, 0.00, 0.00, -, -81.40%, -, -7.87%, -44.61%, -27.30%, -44.61%, -21.81%, 7.12%
862, QGEN, QIAGEN N.V., Healthcare, Diagnostics & Research, Netherlands, 11.34B, 21.72, 6.71, 5.49, 4.02, 27.57, 938.90%, -8.27%, 3.84%, 224.30%, 52.40%, 7.90%, 16.30%, 6.50%, 3.30, 2.70, 0.68, 0.68, 65.80%, 23.40%, 21.70%, 1.94%, -1.99%, 4.47%, 12.72%, -6.60%, 1.69%
864, QLI, Qilian International Holding Group Limited, Healthcare, Drug Manufacturers - Specialty & Generic, China, 171.22M, -, -, 3.42, -, 36.43, -5.00%, -, -, -2.00%, -0.80%, 12.50%, 22.50%, 11.80%, 2.00, 1.40, 0.00, 0.28, 15.10%, 9.50%, 10.10%, 3.98%, -15.16%, -, -, -53.00%, 5.00%
866, QTRX, Quanterix Corporation, Healthcare, Medical Devices, USA, 1.85B, -, -, 18.85, 3.76, -, 34.50%, 11.70%, -, 28.80%, 73.20%, -9.80%, -12.00%, -14.60%, 13.20, 12.80, 0.00, 0.02, 59.00%, -30.40%, -30.70%, -20.01%, -37.71%, 22.77%, 86.63%, 10.73%, 7.86%
868, RAD, Rite Aid Corporation, Healthcare, Pharmaceutical Retailers, USA, 1.00B, 80.13, -, 0.04, 1.60, -, 78.80%, -60.55%, -3.69%, 94.70%, 3.30%, -1.00%, -14.90%, 0.90%, 1.40, 0.70, 5.01, 5.02, 19.50%, 0.00%, -0.40%, 2.87%, -13.37%, 45.35%, 39.15%, 15.41%, 5.20%
870, RAPT, RAPT Therapeutics Inc., Healthcare, Biotechnology, USA, 482.11M, -, -, 90.96, 5.23, -, -16.00%, -4.50%, -, -17.70%, 33.30%, -45.60%, -52.50%, -52.00%, 9.20, 9.20, 0.00, 0.00, -, -, -, -13.88%, 3.04%, 0.94%, 5.58%, -2.28%, 7.42%
872, RCEL, AVITA Medical Inc., Healthcare, Medical Devices, USA, 445.72M, -, -, 24.88, 6.54, -, 34.80%, -5.20%, -, -, 56.60%, -, -, -58.90%, 8.30, 8.00, 0.00, 0.00, -, -, -, -12.96%, -15.96%, -18.24%, -43.91%, -2.80%, 4.08%
874, RCM, R1 RCM Inc., Healthcare, Health Information Services, USA, 6.36B, 38.58, -, 4.92, 19.45, 103.21, 448.00%, 173.10%, 25.00%, 907.70%, 6.90%, -45.00%, -438.00%, 20.90%, 1.30, 1.30, 1.80, 1.92, 20.00%, 10.80%, -40.70%, -15.01%, -18.14%, 14.55%, 118.19%, -3.62%, 4.35%
876, RDHL, RedHill Biopharma Ltd., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 333.21M, -, -, 5.17, 5.89, -, -46.80%, 68.80%, -, -, 1249.70%, -, -, -63.20%, -, -, 1.62, 1.65, 43.90%, -, -, 4.02%, -21.45%, -15.30%, 1.83%, -10.27%, 4.68%
878, RDUS, Radius Health Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 937.88M, 23.76, -, 3.80, -, -, 18.70%, 200.00%, 29.60%, 58.80%, 17.50%, -45.50%, 62.60%, -71.70%, 2.40, 2.30, -, -, 93.00%, -25.20%, -35.30%, -13.96%, 1.74%, 19.52%, 52.37%, 8.01%, 5.38%
880, REGN, Regeneron Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 52.77B, 12.70, 1.42, 5.74, 4.42, 26.01, 65.30%, -15.37%, 10.00%, 86.00%, 38.30%, 24.50%, 38.00%, 23.90%, 3.10, 2.60, 0.17, 0.23, 86.80%, 43.40%, 43.50%, 3.59%, 8.50%, -1.16%, -18.01%, 4.00%, 2.32%
861, QDEL, Quidel Corporation, Healthcare, Diagnostics & Research, USA, 5.17B, 11.20, 0.75, 2.78, 3.37, 5.08, 971.80%, -42.39%, 7.20%, 339.30%, 114.80%, 61.30%, 88.50%, 61.30%, 3.50, 3.00, 0.00, 0.00, 82.50%, 65.60%, 50.90%, 9.69%, -29.21%, -34.66%, -32.51%, -34.26%, 5.30%
863, QLGN, Qualigen Therapeutics Inc., Healthcare, Biotechnology, USA, 53.90M, -, -, 11.47, 3.29, -, 95.80%, 4.80%, -, 89.10%, -30.30%, -110.30%, -502.50%, -62.20%, 2.70, 2.60, 0.00, 0.00, 19.10%, -, -, -13.18%, -44.31%, -44.80%, -70.39%, -36.54%, 8.00%
865, QTNT, Quotient Limited, Healthcare, Diagnostics & Research, Switzerland, 428.81M, -, -, 10.11, 52.00, -, 25.30%, 6.70%, -, 20.90%, 11.40%, -40.20%, -, -47.90%, 3.30, 2.90, 20.43, 23.68, 53.80%, -, -, 5.85%, -10.54%, -39.18%, -46.60%, -20.15%, 7.08%
867, QURE, uniQure N.V., Healthcare, Biotechnology, Netherlands, 1.60B, -, -, 42.28, 6.90, -, 9.40%, -167.10%, -, -44.50%, 400.00%, -38.50%, -57.40%, -39.00%, 8.80, 8.80, 0.31, 0.31, -, -, -, 2.00%, -8.73%, -25.31%, -48.29%, -3.87%, 4.98%
869, RAIN, Rain Therapeutics Inc., Healthcare, Biotechnology, USA, 537.68M, -, -, -, -, -, -93.40%, -, -, -, -, -, -, -, 9.90, 9.90, -, -, -, -, -, 24.19%, -, -, -, 25.76%, 8.31%
871, RARE, Ultragenyx Pharmaceutical Inc., Healthcare, Biotechnology, USA, 6.99B, -, -, 20.91, 6.47, -, 56.90%, 11.80%, 17.20%, 1.10%, 173.80%, -13.70%, -22.80%, -28.70%, 8.40, 8.30, 0.00, 0.00, 95.60%, -94.60%, -61.00%, -10.40%, -28.61%, -15.12%, 48.57%, -26.53%, 5.26%
873, RCKT, Rocket Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 2.74B, -, -, -, 5.45, -, -60.00%, 0.80%, 10.80%, -45.20%, -, -33.50%, -41.60%, -, 11.70, 11.70, 0.11, 0.13, -, -, -, -8.11%, -23.75%, 36.57%, 125.94%, -22.50%, 5.72%
875, RCUS, Arcus Biosciences Inc., Healthcare, Biotechnology, USA, 1.77B, -, -, 20.74, 2.50, 25.39, -16.00%, -16.60%, -, -72.70%, 427.80%, -22.40%, -31.30%, -24.70%, 6.40, 6.40, 0.00, 0.00, -, -, -, -25.73%, -32.39%, 1.85%, -20.83%, -4.39%, 5.29%
877, RDNT, RadNet Inc., Healthcare, Diagnostics & Research, USA, 1.40B, 38.93, 8.61, 1.27, 7.46, 8.57, -199.30%, 23.64%, 15.00%, 155.30%, 12.00%, 0.60%, 6.70%, 4.70%, 0.60, 0.60, 3.27, 3.50, 21.20%, 6.00%, 1.00%, 14.19%, 36.37%, 37.51%, 55.34%, 35.26%, 4.42%
879, RDY, "Dr. Reddys Laboratories Limited", Healthcare, Drug Manufacturers - Specialty & Generic, India, 12.01B, 20.81, -, 4.67, 5.09, 46.85, 3.80%, 18.69%, -1.60%, 103.50%, 12.50%, 8.60%, 13.10%, 9.90%, 1.80, 1.20, 0.04, 0.12, 53.80%, 13.50%, 11.40%, 3.49%, 18.10%, 10.94%, 33.55%, 0.11%, 1.17%
882, REPL, Replimune Group Inc., Healthcare, Biotechnology, USA, 1.80B, -, -, -, 4.04, -, -13.80%, -16.60%, -, -2.30%, -, -18.50%, -20.80%, -, 33.30, 33.30, 0.05, 0.05, -, -, -, 7.15%, 10.02%, -22.09%, 107.51%, 2.15%, 6.26%
884, RFL, Rafael Holdings Inc., Healthcare, Biotechnology, USA, 827.72M, -, -, 183.94, 6.92, -, -86.90%, -, -, -536.30%, -16.70%, -12.40%, -14.50%, -8.00%, 0.60, 0.60, 0.00, 0.00, -, -, -, 24.88%, 43.21%, 150.36%, 199.02%, 121.70%, 7.52%
886, RGLS, Regulus Therapeutics Inc., Healthcare, Biotechnology, USA, 77.23M, -, -, 7.72, 2.60, -, 58.20%, -3.00%, 39.60%, 65.80%, 27677.80%, -47.00%, -91.00%, -46.10%, 3.70, 3.70, 0.00, 0.17, -, -, -, -32.90%, -26.94%, 62.22%, 31.51%, -26.94%, 9.40%
888, RHE, Regional Health Properties Inc., Healthcare, Medical Care Facilities, USA, 21.69M, -, -, 1.08, -, 6.20, -132.90%, -, -, 0.50%, 57.80%, -8.80%, 19.00%, -, 1.80, 1.80, -, -, 89.00%, 12.50%, -48.00%, 130.40%, 105.28%, 736.81%, 879.67%, 236.59%, 39.36%
890, RLAY, Relay Therapeutics Inc., Healthcare, Biotechnology, USA, 3.00B, -, -, 35.94, 3.96, -, -195.40%, -16.60%, -, -63.30%, -, -37.10%, -49.90%, -7.30%, 46.20, 46.20, 0.00, 0.00, -, -, -, -3.54%, -20.08%, -40.55%, -, -22.71%, 6.03%
892, RMD, ResMed Inc., Healthcare, Medical Instruments & Supplies, USA, 29.97B, 37.27, 3.23, 9.70, 11.06, 57.49, 50.20%, 5.08%, 20.40%, -148.20%, -0.10%, 10.00%, 17.00%, 18.60%, 1.70, 1.10, 0.27, 0.27, 58.20%, 28.60%, 14.80%, -0.99%, 5.23%, -0.09%, 28.00%, -3.16%, 2.11%
894, RMTI, Rockwell Medical Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 81.61M, -, -, 1.31, 2.42, -, 27.10%, 41.20%, 38.00%, 18.40%, -1.90%, -42.80%, -108.20%, -, 5.40, 5.10, 0.61, 0.61, 4.40%, -45.50%, -49.70%, -11.71%, -37.40%, -12.55%, -59.34%, -13.85%, 5.50%
896, RNLX, Renalytix AI plc, Healthcare, Diagnostics & Research, United Kingdom, 1.24B, -, -, 3102.36, 13.68, -, 72.30%, -, -, -305.60%, -, -, -, -, 21.20, 21.20, 0.00, 0.01, -, -, -, 10.68%, 27.60%, 134.09%, -, 106.00%, 7.37%
898, RPRX, Royalty Pharma plc, Healthcare, Biotechnology, USA, 24.39B, 13.41, 3.37, 11.11, 3.16, -, -66.60%, 12.23%, 8.00%, -88.00%, 14.40%, 3.50%, 12.30%, 14.70%, 9.40, 9.40, 1.19, 0.00, -, 65.30%, 25.70%, -9.44%, -16.47%, -2.07%, -, -19.84%, 3.03%
900, RUBY, Rubius Therapeutics Inc., Healthcare, Biotechnology, USA, 2.21B, -, -, -, 6.67, -, -0.20%, 2.30%, -, 14.90%, -, -47.40%, -78.70%, -, 11.00, 11.00, 0.22, 0.25, -, -, -, -2.48%, 147.27%, 273.55%, 278.76%, 221.87%, 7.70%
881, REPH, Recro Pharma Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 103.81M, -, -, 1.69, -, -, -661.30%, 68.90%, 15.00%, 30.90%, -22.90%, -26.00%, 199.10%, -8.70%, 5.20, 4.10, -, -, 18.40%, -14.10%, -43.20%, -13.91%, -42.46%, -3.78%, -49.34%, -19.65%, 8.30%
883, RETA, Reata Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 4.99B, -, -, 580.03, 13.41, -, 16.10%, 8.20%, -, 12.90%, -35.70%, -36.30%, -88.40%, -48.10%, 7.00, 7.00, 0.00, 0.20, -, -, -, 35.39%, 7.98%, -9.97%, -5.90%, 10.61%, 6.76%
885, RGEN, Repligen Corporation, Healthcare, Medical Instruments & Supplies, USA, 9.96B, 72.46, 4.02, 23.01, 6.43, 272.96, 155.50%, 11.70%, 31.50%, 180.20%, 87.60%, 4.70%, 6.00%, 4.00%, 3.00, 2.60, 0.00, 0.16, 57.40%, 21.80%, 18.40%, -14.32%, -17.64%, 0.65%, 39.43%, -4.71%, 4.53%
887, RGNX, REGENXBIO Inc., Healthcare, Biotechnology, USA, 1.50B, -, -, 9.62, 2.66, -, -15.60%, 2.20%, 2.00%, -11.10%, 7.40%, -18.80%, -27.80%, -32.90%, 5.90, 5.90, 0.00, 0.00, 76.20%, -80.60%, -77.90%, 1.73%, -17.03%, -1.07%, -6.35%, -22.24%, 4.49%
889, RIGL, Rigel Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 641.51M, -, -, 4.79, 8.09, -, 55.90%, -350.00%, -, 78.00%, 45.20%, -7.80%, -20.30%, -53.90%, 3.80, 3.60, 0.25, 0.25, 99.20%, -6.10%, -8.60%, 0.54%, -16.78%, 26.96%, 90.28%, 6.29%, 6.01%
891, RLMD, Relmada Therapeutics Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 608.44M, -, -, -, 6.29, -, -392.00%, 4.20%, -, -85.10%, -, -58.90%, -62.90%, -, 8.20, 8.20, 0.00, 0.00, -, -, -, -10.92%, 2.67%, -0.83%, -28.25%, 7.86%, 4.41%
893, RMED, Ra Medical Systems Inc., Healthcare, Medical Devices, USA, 16.70M, -, -, 4.07, 0.63, -, 80.40%, 56.60%, -, 82.30%, -21.40%, -99.60%, -151.70%, -154.10%, 3.30, 3.00, 0.09, 0.13, -27.00%, -, -, -22.99%, -53.90%, -52.06%, -74.81%, -56.26%, 16.31%
895, RNA, Avidity Biosciences Inc., Healthcare, Biotechnology, USA, 909.24M, -, -, 112.25, 3.11, -, -265.90%, -15.20%, -, -361.60%, 92.90%, -18.40%, -20.00%, -14.50%, 17.80, 17.80, 0.00, 0.00, -, -, -, -2.70%, -8.20%, -20.95%, -, -6.97%, 7.92%
897, RPHM, Reneo Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 234.57M, -, -, -, -, -, -, -, -, -, -, -, -, -, 23.80, 23.80, -, -, -, -, -, -27.07%, -, -, -, -27.65%, 9.38%
899, RPTX, Repare Therapeutics Inc., Healthcare, Biotechnology, Canada, 1.20B, -, -, 4007.68, 4.46, -, -242.90%, -15.70%, -, -61.20%, -, -17.20%, -21.30%, -18.50%, 26.40, 26.40, 0.00, 0.00, -, -, -, -1.64%, -3.87%, 6.35%, -, -5.77%, 5.17%
902, RVNC, Revance Therapeutics Inc., Healthcare, Biotechnology, USA, 2.12B, -, -, 74.21, 8.07, -, -32.60%, 34.20%, 11.60%, 6.50%, 12409.00%, -43.50%, -93.60%, -48.80%, 8.00, 7.90, 1.15, 1.15, 68.50%, -, -, 1.09%, 10.49%, 20.81%, 41.67%, 4.48%, 4.05%
904, RVPH, Reviva Pharmaceuticals Holdings Inc., Healthcare, Biotechnology, USA, 51.20M, -, -, -, 0.46, -, -15.90%, -38.70%, -, -278.70%, -, -1.40%, -1.50%, -, 0.10, 0.10, 0.05, 0.05, -, -, -, -14.97%, -43.63%, -53.79%, -52.15%, -42.82%, 11.12%
906, RXDX, Prometheus Biosciences Inc., Healthcare, Biotechnology, USA, 783.48M, -, -, 637.49, 3.01, -, -86.10%, 0.00%, -, -, -, -, -, -, 36.30, 36.30, 0.02, 0.02, -, -, -, -2.96%, -, -, -, -7.91%, 10.93%
908, RYTM, Rhythm Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.01B, -, -, -, 2.45, -, 21.40%, -66.50%, 16.10%, 216.30%, -, -21.00%, -23.10%, -, 24.50, 24.50, 0.00, 0.00, -, -, -, -8.79%, -26.94%, -18.83%, 1.13%, -34.04%, 5.51%
910, SAGE, Sage Therapeutics Inc., Healthcare, Biotechnology, USA, 4.20B, -, 0.15, 3.77, 2.03, -, 185.50%, 19.90%, 41.10%, 32.80%, -30.40%, 43.90%, 46.60%, 28.80%, 33.10, 33.10, 0.00, 0.00, 99.90%, 56.70%, 57.20%, -11.76%, -20.26%, -15.84%, 94.85%, -19.55%, 4.73%
912, SAVA, Cassava Sciences Inc., Healthcare, Biotechnology, USA, 2.22B, -, -, -, 7.24, -, 8.80%, -820.00%, -, -99.00%, -, -8.10%, -8.30%, -, 107.10, 107.10, 0.00, 0.00, -, -, -, 13.35%, 7.71%, 600.26%, 2419.63%, 690.62%, 9.10%
914, SBTX, Silverback Therapeutics Inc., Healthcare, Biotechnology, USA, 937.67M, -, -, -, 2.60, -, -37.50%, -26.60%, -, -157.40%, -, -, -, -, 32.60, 32.60, 0.00, 0.00, -, -, -, -19.12%, -47.09%, -, -, -40.59%, 9.64%
916, SCPS, Scopus BioPharma Inc., Healthcare, Biotechnology, USA, 124.68M, -, -, -, 26.22, -, -338.30%, -52.20%, -, -19.70%, -, -, -, -, 1.90, 1.90, 0.00, 0.61, -, -, -, -7.21%, -20.89%, -, -, -52.29%, 21.03%
918, SDC, SmileDirectClub Inc., Healthcare, Medical Devices, USA, 3.16B, -, -, 4.79, 14.40, -, -138.50%, 69.20%, 34.80%, 2.10%, 1.40%, -8.20%, -26.90%, -32.70%, 4.10, 3.90, 3.33, 3.38, 70.40%, -31.90%, -11.80%, -25.63%, -29.16%, -32.15%, 5.12%, -31.24%, 5.75%
920, SEEL, Seelos Therapeutics Inc., Healthcare, Biotechnology, USA, 333.01M, -, -, -, 8.56, -, 83.10%, 10.90%, -, -95.40%, -, -174.60%, -353.90%, -, 3.10, 3.10, 0.13, 0.22, -, -, -, -50.48%, -1.28%, 243.21%, 150.41%, 94.94%, 9.90%
901, RVMD, Revolution Medicines Inc., Healthcare, Biotechnology, USA, 2.22B, -, -, 53.26, 2.92, -, -91.70%, -9.70%, -, -43.30%, -12.20%, -20.70%, -24.40%, -23.20%, 15.90, 15.90, 0.00, 0.00, -, -, -, -14.42%, -34.96%, -28.48%, -2.64%, -24.45%, 6.12%
903, RVP, Retractable Technologies Inc., Healthcare, Medical Instruments & Supplies, USA, 300.61M, -, -, 2.49, 4.57, -, 968.20%, -, -, 518.30%, 347.30%, -, -, 41.70%, 2.50, 2.20, 0.03, 0.05, 50.90%, -, -, -8.55%, -44.47%, -25.19%, 67.10%, -15.36%, 7.02%
905, RWLK, ReWalk Robotics Ltd., Healthcare, Medical Devices, Israel, 86.21M, -, -, 17.59, 0.98, -, 69.50%, 11.10%, -, 77.10%, 62.50%, -32.20%, -40.80%, -55.30%, 17.90, 17.00, 0.00, 0.00, 51.00%, -, -, -3.61%, -35.07%, 35.51%, 47.24%, 41.67%, 7.95%
907, RXRX, Recursion Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 4.25B, -, -, 1073.56, -, -, -39.20%, -, -, -, -, -, -, 44.70%, 8.30, 8.30, -, -, -, -, -, -22.52%, -, -, -, -15.78%, 10.45%
909, RZLT, Rezolute Inc., Healthcare, Biotechnology, USA, 90.08M, -, -, -, 2.96, -, 80.80%, -18.80%, -, 48.50%, -, -79.60%, -93.60%, -, 9.00, 9.00, 0.00, 0.00, -, -, -, 58.19%, -6.43%, -48.35%, 178.74%, -13.84%, 15.51%
911, SANA, Sana Biotechnology Inc., Healthcare, Biotechnology, USA, 4.01B, -, -, -, 2.83, -, -118.20%, 6.80%, -, -217.70%, -, -, -, -, 27.50, 27.50, 0.00, 0.00, -, -, -, -10.65%, -36.95%, -, -, -40.26%, 8.24%
913, SBBP, Strongbridge Biopharma plc, Healthcare, Biotechnology, USA, 177.81M, -, -, 5.49, 3.04, -, 14.80%, 69.20%, 20.00%, 25.10%, 25.40%, -39.80%, -72.50%, -52.20%, 3.60, 3.60, 0.31, 0.00, 94.90%, -, -, -4.91%, -20.25%, -5.97%, -26.32%, 3.70%, 5.01%
915, SCPH, scPharmaceuticals Inc., Healthcare, Biotechnology, USA, 156.50M, -, -, -, 2.05, -, 26.10%, -17.90%, -, 25.90%, -, -28.60%, -37.30%, -, 10.30, 10.30, 0.19, 0.26, -, -, -, -12.79%, -25.33%, -38.81%, -32.05%, 6.99%, 4.23%
917, SCYX, SCYNEXIS Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 192.94M, -, -, 15.95, 9.58, -, 46.20%, 41.80%, -, 74.80%, -, -74.30%, -327.40%, -, 3.80, 3.80, 0.47, 0.47, -, -, -, 30.34%, 14.18%, 40.68%, 27.02%, 25.23%, 6.58%
919, SDGR, Schrodinger Inc., Healthcare, Health Information Services, USA, 5.02B, -, -, 44.03, 7.78, 534.04, -1.90%, -17.90%, -, 99.90%, 22.50%, -1.70%, -2.00%, -9.80%, 10.00, 10.00, 0.00, 0.00, 56.10%, -64.10%, -9.40%, -7.82%, -37.94%, 10.35%, 2.53%, -11.37%, 5.66%
922, SELB, Selecta Biosciences Inc., Healthcare, Biotechnology, USA, 492.42M, -, -, 17.84, -, 14.61, 44.00%, 24.60%, -, -7.20%, 79.60%, -49.40%, 509.20%, -842.40%, 1.90, 1.90, -, -, -, -, -, 37.78%, -1.59%, 32.72%, 18.26%, 43.23%, 8.25%
924, SENS, Senseonics Holdings Inc., Healthcare, Diagnostics & Research, USA, 886.11M, -, -, 113.60, -, -, -25.60%, 79.70%, 32.10%, -227.70%, -56.60%, -482.50%, 360.10%, 122.60%, 12.20, 11.80, -, -, 36.00%, -, -, -2.83%, -40.63%, 456.76%, 341.40%, 136.29%, 8.15%
926, SGEN, Seagen Inc., Healthcare, Biotechnology, USA, 27.42B, 1159.33, 1.10, 12.06, 8.22, 37.28, 451.20%, 105.50%, 39.20%, 31.40%, 41.60%, 20.20%, 24.10%, 17.10%, 8.00, 7.60, 0.00, 0.00, 88.90%, 25.80%, 29.10%, 11.58%, 1.84%, -6.10%, -1.18%, -11.30%, 3.85%
928, SGMO, Sangamo Therapeutics Inc., Healthcare, Biotechnology, USA, 1.56B, -, -, 11.87, 3.28, 15.40, -6.00%, -6.30%, -, 13.20%, 100.80%, -13.50%, -24.80%, -26.10%, 4.60, 4.60, 0.00, 0.00, -, -99.90%, -94.40%, -9.41%, -10.09%, 10.34%, -3.66%, -30.92%, 4.84%
930, SGTX, Sigilon Therapeutics Inc., Healthcare, Biotechnology, USA, 383.94M, -, -, 30.23, 2.30, -, -70.60%, -2.70%, -, -25.80%, -9.50%, -, -, 70.50%, 4.30, 4.30, 0.14, 0.00, -, -, -, -20.83%, -59.39%, -, -, -75.70%, 9.40%
932, SIBN, SI-BONE Inc., Healthcare, Medical Devices, USA, 1.02B, -, -, 13.19, 6.09, -, 3.30%, 25.80%, 40.20%, 20.10%, 21.40%, -22.90%, -31.90%, -, 15.20, 14.60, 0.24, 0.00, 88.10%, -51.80%, -56.10%, -14.24%, -6.30%, 37.57%, 72.50%, 0.90%, 4.78%
934, SIGA, SIGA Technologies Inc., Healthcare, Biotechnology, USA, 547.71M, 8.92, 8.62, 4.31, 4.41, 8.64, 893.70%, 5.33%, 1.00%, 90.30%, 84.60%, 46.80%, 56.10%, 48.00%, 17.70, 15.00, 0.00, 0.00, 88.30%, 68.00%, 50.70%, 0.14%, 8.13%, -0.28%, 17.70%, -3.03%, 3.16%
936, SINT, Sintx Technologies Inc., Healthcare, Medical Devices, USA, 37.50M, -, -, 74.99, 1.51, -, 79.00%, 18.90%, -, 92.10%, -50.00%, -38.20%, -46.20%, -32.50%, 8.00, 8.00, 0.02, 0.02, 24.00%, -, -, -5.84%, -29.27%, -22.46%, 110.18%, -7.64%, 8.37%
938, SLDB, Solid Biosciences Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 424.61M, -, -, 128.67, 1.34, -, 41.60%, -14.00%, -, 65.90%, -, -56.60%, -70.10%, -, 12.00, 12.00, 0.00, 0.00, -, -, -, -26.64%, -55.40%, 21.02%, 28.81%, -49.87%, 7.53%
940, SLNO, Soleno Therapeutics Inc., Healthcare, Diagnostics & Research, USA, 82.10M, -, -, -, 2.19, -, 56.30%, 2.40%, 15.00%, 14.30%, -, -40.70%, -59.20%, -, 4.50, 4.50, 0.00, 0.00, -, -, -, -16.26%, -61.13%, -46.91%, -69.35%, -46.63%, 5.33%
921, SEER, Seer Inc., Healthcare, Biotechnology, USA, 1.88B, -, -, 2870.07, 3.31, -, -207.50%, -4.50%, -, -124.60%, 0.00%, -, -, -7.80%, 72.50, 72.30, 0.00, 0.00, -, -, -, -40.53%, -43.02%, -, -, -47.31%, 9.45%
923, SEM, Select Medical Holdings Corporation, Healthcare, Medical Care Facilities, USA, 5.41B, 14.14, 0.92, 0.96, 4.56, -, 75.00%, 11.62%, 18.61%, 107.10%, 9.30%, -, -, 10.50%, 1.20, 1.20, 2.96, 2.97, 15.20%, -, -, 5.48%, 21.50%, 61.57%, 148.27%, 44.87%, 3.06%
925, SESN, Sesen Bio Inc., Healthcare, Biotechnology, USA, 547.59M, 77.91, -, 35.33, 55.83, -, 83.90%, 108.50%, -, -195.90%, -, -, -, 244.80%, 7.30, 7.30, 0.00, 0.00, -, -, -, 16.72%, 23.16%, 191.30%, 316.56%, 148.15%, 8.97%
927, SGFY, Signify Health Inc., Healthcare, Health Information Services, USA, 4.13B, 98.44, -, 6.27, 3.95, -, 49.10%, 267.14%, -, -, 36.70%, -, -, 5.10%, 5.20, 5.20, 0.37, 0.38, 48.70%, 3.50%, -4.40%, -13.50%, -30.15%, -, -, -19.84%, 6.57%
929, SGRY, Surgery Partners Inc., Healthcare, Medical Care Facilities, USA, 3.49B, 342.28, -, 1.81, 9.53, 15.72, -39.40%, 137.00%, 0.70%, 25.10%, 16.20%, -2.80%, -79.10%, 6.80%, 1.80, 1.70, 8.29, 8.47, 25.80%, 11.60%, -7.80%, 16.27%, 41.21%, 133.19%, 336.63%, 101.76%, 4.72%
931, SHC, Sotera Health Company, Healthcare, Diagnostics & Research, USA, 6.81B, 24.17, -, 8.32, 14.52, -, -116.20%, 18.13%, 34.33%, 138.10%, 9.60%, -, -, 7.10%, 2.40, 2.10, 4.04, 4.04, -, -, -, -6.08%, -12.68%, -9.94%, -, -12.17%, 4.34%
933, SIEN, Sientra Inc., Healthcare, Medical Devices, USA, 405.49M, -, -, 5.23, -, -, 31.90%, 58.50%, 20.00%, -75.60%, 37.30%, -63.50%, -, -108.60%, 2.30, 1.60, -, -, 53.00%, -68.70%, -, 0.43%, -12.12%, 26.55%, 79.38%, 78.92%, 6.49%
935, SILK, Silk Road Medical Inc, Healthcare, Medical Devices, USA, 1.68B, -, -, 21.47, 16.47, -, 37.10%, 31.70%, -, 1.80%, 16.90%, -26.70%, -42.30%, -28.20%, 10.10, 9.40, 0.48, 0.48, 72.50%, -57.40%, -61.40%, -21.34%, -12.15%, -13.28%, 26.94%, -22.86%, 5.00%
937, SIOX, Sio Gene Therapies Inc., Healthcare, Biotechnology, USA, 131.60M, -, -, -, 1.35, -, 63.50%, -8.30%, -, 67.60%, -, -53.30%, -65.60%, -, 10.80, 10.80, 0.00, 0.00, -, -, -, -15.56%, -21.11%, -1.30%, -28.53%, -17.99%, 7.03%
939, SLGL, Sol-Gel Technologies Ltd., Healthcare, Biotechnology, Israel, 239.45M, -, -, 27.21, 4.67, -, -3.00%, 62.50%, -, -, -80.00%, -, -, -, 10.80, 10.80, 0.00, 0.00, -, -, -, -8.10%, 9.66%, 22.83%, 33.81%, 5.52%, 6.56%
942, SLRX, Salarius Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 58.20M, -, -, 10.78, 0.80, -, 76.60%, -20.80%, -, 72.30%, 18.20%, -25.60%, -27.70%, -34.30%, 20.90, -, 0.00, 0.00, -, -, -, -3.76%, -35.03%, 86.86%, 29.31%, 40.66%, 9.44%
944, SMMT, Summit Therapeutics Inc., Healthcare, Biotechnology, USA, 769.18M, -, -, 1098.82, 8.15, -, -80.90%, 0.00%, -, 53.80%, -71.40%, -, -, -66.60%, 4.40, 4.40, 0.00, 0.00, -, -, -, 25.12%, 18.13%, 82.71%, 93.56%, 66.38%, 9.70%
946, SNDX, Syndax Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 896.09M, -, -, 597.39, 4.15, -, -1.50%, 6.10%, -, 3.50%, 0.00%, -36.00%, -45.10%, -26.20%, 11.40, 11.40, 0.07, 0.09, -, -, -, 15.17%, -23.93%, -20.58%, 13.40%, -17.40%, 6.57%
948, SNN, Smith & Nephew plc, Healthcare, Medical Devices, United Kingdom, 19.00B, 24.27, 9.28, 4.17, 3.61, -, -25.30%, -4.88%, 4.60%, 19.60%, -52.40%, -, -, 5.50%, -, -, -, -, 69.40%, -, -, 0.79%, 11.28%, 14.65%, 6.64%, 3.20%, 1.41%
950, SNSE, Sensei Biotherapeutics Inc., Healthcare, Biotechnology, USA, 378.74M, -, -, -, 1.37, -, 1.70%, -10.00%, -, 3.30%, -, -, -, -, 69.80, 69.80, 0.00, 0.00, -, -, -, -5.55%, -26.88%, -, -, -34.23%, 10.08%
952, SOLY, Soliton Inc., Healthcare, Medical Devices, USA, 477.91M, -, -, -, 17.54, -, 23.70%, 34.50%, 36.00%, -25.70%, -, -47.20%, -50.70%, -, 9.80, 9.60, 0.00, 0.00, -, -, -, 24.26%, 71.12%, 170.06%, 124.37%, 190.10%, 2.57%
954, SPNE, SeaSpine Holdings Corporation, Healthcare, Medical Devices, USA, 677.43M, -, -, 4.23, 3.57, -, 23.40%, 22.80%, -7.60%, 4.10%, 16.30%, -19.40%, -25.20%, -24.50%, 4.40, 2.90, 0.16, 0.16, 63.50%, -27.00%, -27.10%, -1.97%, -0.83%, 42.42%, 91.36%, 16.79%, 6.47%
956, SPRB, Spruce Biosciences Inc., Healthcare, Biotechnology, USA, 319.90M, -, -, -, 2.34, -, -125.70%, -8.70%, -, 27.80%, -, -, -, -, 22.10, 22.10, 0.03, 0.03, -, -, -, -19.07%, -34.28%, -45.65%, -, -41.88%, 6.53%
958, SQZ, SQZ Biotechnologies Company, Healthcare, Biotechnology, USA, 389.05M, -, -, 18.53, 2.10, -, -51.70%, -11.70%, 38.00%, 56.40%, -72.60%, -, -, -40.10%, 5.00, 5.00, 0.00, 0.00, -, -, -, 10.59%, -10.72%, -53.73%, -, -53.17%, 7.71%
960, SRGA, Surgalign Holdings Inc., Healthcare, Medical Devices, USA, 183.20M, -, -, 1.87, 4.17, -, 26.40%, 13.30%, 15.00%, 54.00%, -14.00%, -, -, -803.90%, 2.20, 1.80, 0.00, 0.00, 58.10%, -, -, 6.81%, -24.32%, -10.09%, -27.94%, -10.50%, 8.52%
941, SLP, Simulations Plus Inc., Healthcare, Health Information Services, USA, 1.05B, 82.47, 6.43, 23.02, 6.54, 123.75, 5.90%, 17.86%, 15.00%, 31.20%, 27.20%, 7.50%, 8.30%, 6.00%, 20.70, 20.70, 0.00, 0.00, 76.60%, 26.40%, 23.70%, -17.70%, -27.73%, -4.76%, 4.16%, -26.61%, 4.87%
943, SLS, SELLAS Life Sciences Group Inc., Healthcare, Biotechnology, USA, 161.70M, -, -, 21.28, 6.20, -, 80.70%, -0.80%, -, 75.60%, -, -50.20%, -87.80%, -60.60%, 5.30, 5.30, 0.00, 0.00, 98.70%, -, -, 49.31%, 41.71%, 236.90%, 248.69%, 105.85%, 7.94%
945, SNDL, Sundial Growers Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 1.57B, -, -, 33.37, 1.59, -, -63.70%, 100.00%, -, 75.50%, -29.30%, -, -, -70.90%, 9.90, 9.50, 0.00, 0.00, 12.50%, -, -, 7.99%, -28.15%, 246.43%, 13.98%, 104.86%, 9.38%
947, SNGX, Soligenix Inc., Healthcare, Biotechnology, USA, 40.10M, -, -, 25.06, 2.17, -, -33.30%, -2.10%, 1.00%, 80.20%, -88.90%, -64.80%, -144.60%, -126.80%, 7.30, 7.30, 0.57, 0.59, 29.60%, -, -, -31.54%, -37.42%, -50.49%, -46.60%, -20.31%, 6.45%
949, SNOA, Sonoma Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 15.89M, -, -, 0.75, 1.27, -, 84.40%, -, -, 62.20%, 11.40%, -9.60%, -15.40%, -73.80%, 4.20, 3.40, 0.11, 0.11, 40.50%, -15.90%, -7.90%, -0.78%, -8.61%, 10.72%, -21.24%, 5.23%, 5.39%
951, SNY, Sanofi, Healthcare, Drug Manufacturers - General, France, 133.51B, 12.18, 1.20, 2.96, 2.12, -, 324.80%, 16.27%, 7.50%, -6.80%, -4.60%, -, -, 14.20%, -, -, -, -, 67.60%, 23.30%, 17.70%, 1.37%, 16.38%, 6.43%, 8.80%, 9.96%, 1.01%
953, SONN, Sonnet BioTherapeutics Holdings Inc., Healthcare, Biotechnology, USA, 33.40M, -, -, -, 14.09, -, 89.10%, -14.40%, -, 92.40%, -, -, -, -, 1.40, -, 0.05, 0.05, -, -, -, -22.89%, -33.19%, -39.92%, -62.47%, -30.49%, 10.58%
955, SPPI, Spectrum Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 549.21M, -, -, -, 4.11, -, -12.50%, 47.70%, -, 32.50%, -, -77.20%, -112.30%, -, 3.60, 3.60, 0.00, 0.00, -, -, -, 11.29%, -4.43%, -24.34%, 17.35%, 1.17%, 5.55%
957, SPRO, Spero Therapeutics Inc., Healthcare, Biotechnology, USA, 437.90M, -, -, 29.39, 3.59, -, -5.00%, -30.30%, 36.90%, 45.80%, 329.40%, -54.00%, -65.10%, -59.90%, 7.30, 7.30, 0.00, 0.00, -, -, -, 5.92%, -22.91%, -8.92%, 22.67%, -25.22%, 6.45%
959, SRDX, Surmodics Inc., Healthcare, Diagnostics & Research, USA, 732.62M, 57.98, 10.24, 6.87, 5.13, 34.56, -85.20%, 270.45%, 10.00%, 444.00%, 53.50%, 4.30%, 5.50%, 1.00%, 5.90, 5.50, 0.00, 0.00, 84.80%, 8.20%, 6.90%, -4.86%, 0.00%, 36.27%, 43.46%, 21.90%, 3.36%
962, SRPT, Sarepta Therapeutics Inc., Healthcare, Biotechnology, USA, 6.13B, -, -, 10.69, 11.22, -, 26.80%, 44.50%, -, -819.80%, 29.20%, -24.70%, -87.10%, -32.20%, 6.20, 5.60, 2.04, 2.04, 87.20%, -, -, 5.94%, -13.08%, -44.26%, -50.32%, -55.63%, 5.12%
964, SRRK, Scholar Rock Holding Corporation, Healthcare, Biotechnology, USA, 921.64M, -, -, 61.04, 4.07, -, -51.90%, -25.20%, -, -31.60%, -6.00%, -36.30%, -60.10%, -30.40%, 4.60, 4.60, 0.10, 0.10, -, -, -, -23.25%, -52.69%, -39.89%, 46.03%, -44.63%, 7.05%
966, SSKN, STRATA Skin Sciences Inc., Healthcare, Medical Devices, USA, 47.10M, -, -, 2.12, 1.97, 21.41, -10.80%, 47.10%, 25.00%, -129.20%, -13.40%, -12.50%, -22.60%, -12.20%, 1.20, 1.00, 0.03, 0.41, 60.60%, -25.30%, -26.10%, -17.65%, -19.08%, -16.67%, 12.90%, -6.67%, 4.42%
968, STAA, STAAR Surgical Company, Healthcare, Medical Instruments & Supplies, USA, 6.72B, 217.96, 21.73, 37.54, 31.81, 244.37, -58.80%, 213.08%, 30.00%, -47.80%, 44.30%, 4.50%, 5.70%, 2.20%, 6.20, 5.70, 0.00, 0.01, 74.10%, 8.60%, 6.20%, 4.94%, 37.10%, 109.00%, 276.37%, 84.33%, 7.28%
970, STIM, Neuronetics Inc., Healthcare, Diagnostics & Research, USA, 360.96M, -, -, 7.20, 3.35, -, 7.80%, 31.50%, -, 53.60%, 7.00%, -23.30%, -49.30%, -38.70%, 12.70, 12.20, 0.34, 0.34, 78.10%, -37.80%, -45.40%, 24.61%, -17.96%, 59.46%, 641.53%, 22.14%, 9.64%
972, STRM, Streamline Health Solutions Inc., Healthcare, Health Information Services, USA, 80.81M, -, -, 7.15, 3.42, -, -168.10%, 17.60%, 15.00%, 36.20%, 11.10%, 1.10%, 1.60%, -23.70%, 1.00, 1.00, 0.05, 0.13, 49.90%, -52.80%, 2.60%, -11.76%, -7.14%, 27.06%, 109.65%, 25.00%, 4.87%
974, STRR, Star Equity Holdings Inc., Healthcare, Medical Devices, USA, 14.19M, 7.26, -, 0.17, 0.57, -, -20.40%, 218.80%, 16.00%, 84.40%, 16.70%, -, -, -17.50%, 1.30, 1.00, 0.11, 0.66, 17.00%, -, -, -5.15%, -18.82%, 0.73%, 33.98%, -23.12%, 5.33%
976, STSA, Satsuma Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 167.41M, -, -, -, 0.83, -, -68.60%, 6.00%, -, 29.70%, -, -44.10%, -47.80%, -, 25.50, 25.50, 0.00, 0.02, -, -, -, -1.69%, -19.82%, 14.98%, -80.08%, 13.23%, 6.62%
978, STXS, Stereotaxis Inc., Healthcare, Medical Instruments & Supplies, USA, 556.59M, -, -, 18.87, 17.43, -, -15.40%, 23.10%, -, 4.40%, -1.40%, -15.00%, -25.00%, -18.20%, 3.90, 3.60, 0.03, 0.06, 68.40%, -22.80%, -26.90%, 6.23%, 0.88%, 82.69%, 94.19%, 57.56%, 6.55%
980, SURF, Surface Oncology Inc., Healthcare, Biotechnology, USA, 373.89M, -, -, 4.19, 2.37, -, 179.10%, -31.20%, -, -151.20%, -95.90%, 11.60%, 17.00%, 34.80%, 12.00, 12.00, 0.08, 0.09, -, 24.90%, 23.80%, 25.56%, 0.22%, 16.65%, 76.91%, -2.16%, 7.16%
961, SRNE, Sorrento Therapeutics Inc., Healthcare, Biotechnology, USA, 2.22B, 4.38, -, 47.77, 9.17, -, 41.00%, 2.87%, 37.00%, 102.40%, 85.70%, -40.40%, -124.80%, -104.90%, 2.80, 2.70, 0.35, 0.44, 76.60%, -, -, -11.32%, -26.63%, 8.99%, 48.91%, 10.18%, 6.72%
963, SRRA, Sierra Oncology Inc., Healthcare, Biotechnology, USA, 218.83M, -, -, 729.42, 2.06, -, 74.60%, 20.70%, -, 45.70%, -, -60.30%, -65.40%, -66.40%, 12.30, 12.30, 0.00, 0.00, -, -, -, -0.38%, 20.33%, 22.05%, 27.71%, 11.62%, 4.68%
965, SRTS, Sensus Healthcare Inc., Healthcare, Medical Devices, USA, 59.40M, 56.25, -, 5.40, 2.90, -, -297.20%, 154.50%, -, 69.00%, 82.40%, -15.60%, -20.70%, -31.60%, 5.10, 4.20, 0.01, 0.01, 55.90%, -39.50%, -39.80%, -6.49%, -27.13%, 24.57%, 50.63%, -6.74%, 6.51%
967, SSY, SunLink Health Systems Inc., Healthcare, Medical Care Facilities, USA, 20.79M, -, -, 0.51, 1.24, 5.33, 69.80%, -, -, -935.90%, -22.80%, 5.40%, 10.20%, -4.40%, 2.20, 1.90, 0.13, 0.21, 61.30%, 5.10%, 3.70%, 27.68%, 44.44%, 132.52%, 236.63%, 125.20%, 22.98%
969, STE, STERIS plc, Healthcare, Medical Instruments & Supplies, Ireland, 16.29B, 22.85, 4.13, 5.24, 4.20, 51.48, -2.80%, 12.72%, 10.00%, -28.30%, 6.10%, 6.60%, 10.70%, 7.70%, 2.10, 1.60, 0.43, 0.00, 43.20%, 17.60%, 12.80%, -10.39%, 7.36%, 0.83%, 15.05%, 0.70%, 1.77%
971, STOK, Stoke Therapeutics Inc., Healthcare, Biotechnology, USA, 1.44B, -, -, -, 5.33, -, -46.10%, -14.40%, -, -36.60%, -, -23.50%, -24.30%, -, 45.10, 45.10, 0.00, 0.00, -, -, -, 17.72%, -35.13%, -17.36%, 43.38%, -35.96%, 5.65%
973, STRO, Sutro Biopharma Inc., Healthcare, Biotechnology, USA, 877.09M, -, -, 17.47, 2.78, -, 59.40%, -6.00%, -, 21.70%, 104.20%, -12.80%, -15.70%, -19.90%, 11.70, 11.70, 0.08, 0.00, -, -, -85.40%, -11.00%, -19.09%, 12.79%, 85.91%, -14.28%, 7.15%
975, STRRP, Star Equity Holdings Inc., Healthcare, Medical Devices, USA, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 15.13%, -3.72%, 21.89%, 9.10%, 10.39%, 2.20%
977, STTK, Shattuck Labs Inc., Healthcare, Biotechnology, USA, 1.14B, -, -, 114.53, 3.80, -, -274.80%, -21.30%, -, 55.10%, -76.80%, -, -, -11.90%, 18.50, 18.50, 0.00, 0.00, -, -, -, -26.43%, -35.40%, -23.40%, -, -48.22%, 9.95%
979, SUPN, Supernus Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 1.59B, 29.94, 8.55, 2.87, 2.09, 9.77, 12.60%, 25.73%, 1.69%, -73.80%, 37.80%, 7.40%, 15.50%, 11.70%, 2.40, 2.20, 0.51, 0.52, 88.60%, 28.40%, 20.00%, -4.54%, 14.85%, 39.94%, 23.76%, 18.64%, 3.21%
982, SWAV, ShockWave Medical Inc., Healthcare, Medical Devices, USA, 6.14B, 1249.31, -, 72.71, 30.65, -, 7.10%, 109.20%, -, -14.30%, 109.90%, -25.40%, -30.90%, -27.10%, 7.00, 6.00, 0.06, 0.08, 72.50%, -75.90%, -83.50%, 10.69%, 46.39%, 85.20%, 308.77%, 73.45%, 6.38%
984, SXTC, China SXT Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, China, 21.10M, -, -, 3.63, 1.08, -, -, -, -, -55.30%, 0.00%, -, -, -, -, -, -, -, -, -, -, -10.42%, -37.98%, 4.50%, -18.48%, -1.89%, 8.08%
986, SYBX, Synlogic Inc., Healthcare, Biotechnology, USA, 202.11M, -, -, 505.27, 1.43, -, 2.70%, 14.40%, -, 22.10%, -100.00%, -39.70%, -49.00%, -52.50%, 14.50, 14.50, 0.00, 0.00, -, -, -, 4.47%, -1.58%, 52.65%, 49.00%, 73.15%, 7.92%
988, SYN, Synthetic Biologics Inc., Healthcare, Biotechnology, USA, 68.07M, -, -, -, 0.60, -, 32.50%, 23.10%, -, 37.10%, -, -78.70%, -145.80%, -, 37.10, 37.10, 0.00, 0.00, -, -, -, -10.26%, -25.11%, 41.89%, 32.44%, 37.08%, 7.81%
990, SYRS, Syros Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 405.19M, -, -, 23.15, 2.64, -, 2.70%, -23.60%, -, 40.90%, 100.00%, -42.90%, -92.90%, -62.90%, 8.30, 8.30, 0.27, 0.27, -, -, -, 3.37%, -31.75%, -18.56%, -34.12%, -40.55%, 9.55%
992, TARA, Protara Therapeutics Inc., Healthcare, Biotechnology, USA, 105.51M, -, -, -, 0.57, -, 84.40%, -4.60%, -, 33.70%, -, -22.70%, -23.30%, -, 26.50, 26.50, 0.00, 0.00, -, -, -, -16.77%, -45.80%, -61.18%, -82.57%, -60.84%, 5.54%
994, TARS, Tarsus Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 677.40M, -, -, -, 3.70, -, -425.30%, -257.30%, -, 289.40%, -, -, -, -, 18.90, 18.90, 0.00, 0.00, -, -, -, 10.33%, -9.43%, 67.44%, -, -19.38%, 7.10%
996, TBPH, Theravance Biopharma Inc., Healthcare, Biotechnology, Cayman Islands, 1.14B, -, -, 17.14, -, -, -4.90%, 32.80%, 21.30%, 11.50%, -28.10%, -57.20%, 96.30%, -96.60%, 3.40, 3.40, -, -, -, -, -, -12.90%, -1.14%, 2.25%, -31.56%, -2.76%, 4.16%
998, TCMD, Tactile Systems Technology Inc., Healthcare, Medical Devices, USA, 1.05B, 61.52, -, 5.64, 8.40, -, -105.70%, 90.00%, 5.00%, -70.10%, -2.10%, -1.00%, -1.40%, -0.60%, 4.40, 3.60, 0.00, 0.00, 45.80%, -1.80%, -0.80%, -6.89%, 1.66%, 25.90%, 10.98%, 19.65%, 4.70%
1000, TCRR, TCR2 Therapeutics Inc., Healthcare, Biotechnology, USA, 732.68M, -, -, -, 2.03, -, 48.10%, -20.70%, 0.00%, 10.10%, -, -28.00%, -30.10%, -, 32.60, 32.60, 0.10, 0.11, -, -, -, -19.57%, -32.64%, -30.99%, 89.60%, -38.09%, 5.57%
981, SVRA, Savara Inc., Healthcare, Biotechnology, USA, 203.40M, -, -, 678.00, 0.79, -, 57.20%, 0.00%, -, 50.60%, -, -33.50%, -44.40%, -, 27.00, 27.00, 0.14, 0.00, -, -, -, -6.25%, -1.10%, 39.53%, -26.23%, 56.52%, 7.19%
983, SWTX, SpringWorks Therapeutics Inc., Healthcare, Biotechnology, USA, 4.02B, -, -, 114.79, 7.35, -, 10.50%, -14.90%, -, -73.70%, -, -14.00%, -14.50%, -8.30%, 25.70, 25.70, 0.00, 0.00, -, -, -, 11.27%, -6.22%, 21.70%, 114.18%, 12.44%, 5.76%
985, SY, So-Young International Inc., Healthcare, Health Information Services, China, 1.06B, 2.08, -, 4.61, 2.59, -, -96.50%, 87.69%, -, -23.90%, 96.90%, -0.10%, -0.10%, -2.00%, 4.80, 4.80, 0.00, 0.00, 85.00%, -4.80%, -0.20%, 4.70%, -38.17%, -28.83%, 5.95%, -11.79%, 9.33%
987, SYK, Stryker Corporation, Healthcare, Medical Devices, USA, 95.89B, 24.70, 5.31, 6.52, 7.11, 52.51, -23.30%, 12.51%, 13.02%, -39.10%, 10.20%, 4.30%, 10.80%, 6.90%, 2.30, 1.40, 0.97, 0.97, 62.80%, 14.00%, 9.60%, -3.10%, 3.85%, 9.22%, 30.42%, 4.17%, 1.71%
989, SYNH, Syneos Health Inc., Healthcare, Diagnostics & Research, USA, 9.11B, 17.70, 2.72, 2.04, 2.83, 16.81, 46.20%, 15.25%, 17.21%, 15.50%, 3.90%, 2.60%, 6.30%, 4.60%, 1.10, 1.10, 0.89, 0.90, 23.40%, 6.80%, 4.40%, 5.27%, 15.16%, 33.51%, 44.12%, 29.02%, 2.33%
991, TAK, Takeda Pharmaceutical Company Limited, Healthcare, Drug Manufacturers - Specialty & Generic, Japan, 53.88B, 20.59, 56.02, 0.02, 0.01, -, 507.70%, 5.10%, 0.58%, -, -2.60%, -, -, -, -, -, -, -, -, -, -, 2.40%, 0.65%, -3.56%, -12.36%, -6.10%, 1.13%
993, TARO, Taro Pharmaceutical Industries Ltd., Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 2.74B, -, -, 4.99, 1.59, 95.11, -259.30%, -, -12.95%, -155.20%, -15.20%, -16.30%, -22.50%, -24.90%, 2.20, 1.90, 0.00, 0.00, 54.00%, -75.40%, -70.40%, -4.79%, -2.59%, 3.57%, 4.23%, -3.27%, 2.38%
995, TBIO, Translate Bio Inc., Healthcare, Biotechnology, USA, 1.38B, -, -, 8.17, 3.48, 5.24, 63.80%, 60.50%, -, 240.90%, 636.20%, -1.70%, -3.80%, -15.50%, 5.90, 5.90, 0.00, 0.00, -, -8.30%, -7.70%, -21.83%, -24.33%, -1.21%, -13.08%, -2.28%, 6.09%
997, TCDA, Tricida Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 223.68M, -, -, -, 3.75, -, -42.30%, 9.40%, -, 28.60%, -, -67.60%, -173.60%, -, 5.50, 5.50, 1.96, 0.00, -, -, -, -4.75%, -3.96%, -38.70%, -82.84%, -34.61%, 6.67%
999, TCON, TRACON Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 92.38M, -, -, -, 4.57, -, 75.00%, -2.40%, -, 57.90%, -, -63.20%, -111.50%, -, 3.00, 3.00, 0.03, 0.17, -, -, -, -18.07%, -34.24%, -33.74%, 162.17%, -48.46%, 7.83%
1002, TECH, Bio-Techne Corporation, Healthcare, Biotechnology, USA, 15.93B, 54.41, 6.01, 18.79, 10.44, 90.99, 135.60%, 16.28%, 15.00%, 21.80%, 25.10%, 8.90%, 12.50%, 6.30%, 4.10, 3.30, 0.13, 0.14, 67.30%, 24.50%, 21.70%, -4.59%, 11.11%, 37.14%, 56.28%, 30.32%, 3.54%
1004, TENX, Tenax Therapeutics Inc., Healthcare, Biotechnology, USA, 29.19M, -, -, -, 9.29, -, 2.00%, 94.30%, -, -329.80%, -, -480.20%, -681.80%, -, 3.20, 3.20, 0.00, 0.06, -, -, -, 0.00%, -10.96%, 77.27%, 35.42%, 4.84%, 6.51%
1006, TEVA, Teva Pharmaceutical Industries Limited, Healthcare, Drug Manufacturers - Specialty & Generic, Israel, 11.68B, 3.80, -, 0.72, 1.14, -, -297.90%, 5.59%, 5.77%, 10.50%, -8.60%, -7.80%, -36.60%, -9.50%, 1.00, 0.70, 2.23, 2.50, 46.90%, -20.50%, -24.50%, -2.26%, -4.76%, 6.67%, -17.00%, 7.77%, 2.89%
1008, TFX, Teleflex Incorporated, Healthcare, Medical Instruments & Supplies, USA, 18.82B, 26.99, 6.19, 7.41, 5.56, 46.48, -27.60%, 16.75%, 11.00%, -43.10%, 0.50%, 4.10%, 8.60%, 6.90%, 2.70, 1.70, 0.68, 0.70, 52.60%, 14.50%, 11.00%, -3.60%, -0.37%, 7.64%, 10.84%, -2.28%, 2.08%
1010, THC, Tenet Healthcare Corporation, Healthcare, Medical Care Facilities, USA, 7.08B, 12.21, 4.67, 0.40, 57.68, 2.12, 259.80%, 9.88%, 3.98%, 1.00%, 5.80%, 1.50%, -335.80%, 11.20%, 1.40, 1.30, 122.75, 123.86, 83.10%, 10.30%, 2.30%, 12.28%, 26.53%, 105.50%, 207.49%, 67.57%, 3.64%
1012, THTX, Theratechnologies Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 333.00M, -, -, 5.06, -, -, -, -, -, -, -1.80%, -, -, -, -, -, -, -, -, -, -, 0.28%, 0.28%, 49.15%, 95.56%, 40.80%, 4.03%
1014, TLC, Taiwan Liposome Company Ltd., Healthcare, Biotechnology, Taiwan, 246.15M, -, -, 2.41, 0.56, -, 40.90%, -13.50%, -, -, 1.10%, -, -, -, -, -, -, -, -, -, -, 5.22%, 8.33%, 34.48%, 19.14%, 32.05%, 7.62%
1016, TLIS, Talis Biomedical Corporation, Healthcare, Medical Devices, USA, 257.92M, -, -, 23.58, 0.64, -, -445.40%, 52.20%, 47.30%, -204.90%, 180.00%, -, -, 84.00%, 8.40, 8.40, 0.00, 0.00, -, -, -, -19.57%, -43.63%, -, -, -64.96%, 8.02%
1018, TLRY, Tilray Inc., Healthcare, Drug Manufacturers - Specialty & Generic, Canada, 7.68B, -, -, 37.22, 5.23, -, 32.70%, 76.70%, 49.30%, -16.30%, -7.90%, -44.40%, -138.80%, -19.70%, 2.00, 1.70, 0.48, 0.57, 13.20%, -68.80%, -, -10.62%, -34.78%, 123.16%, 69.24%, 101.82%, 8.59%
1020, TMBR, Timber Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 47.49M, -, -, 94.99, 7.63, -, 89.20%, -, -, 84.70%, -4.30%, -110.20%, -654.10%, -266.40%, 6.60, 6.60, 0.00, 0.00, -, -, -, -23.75%, -46.72%, 6.09%, -54.81%, 64.20%, 11.09%
1001, TDOC, Teladoc Health Inc., Healthcare, Health Information Services, USA, 23.02B, -, -, 16.84, 1.45, -, -289.50%, 67.20%, -3.13%, -224.80%, 150.90%, -6.40%, -7.40%, -2.50%, 4.00, 3.70, 0.09, 0.09, 66.00%, -43.20%, -47.90%, -11.87%, -32.59%, -20.99%, -13.49%, -24.69%, 5.11%
1003, TELA, TELA Bio Inc., Healthcare, Medical Devices, USA, 196.07M, -, -, 9.61, 4.75, -, 15.90%, 21.90%, -, 11.00%, 59.50%, -33.50%, -56.50%, -31.70%, 13.30, 12.50, 0.74, 0.74, 61.40%, -, -, 0.15%, -13.75%, -17.63%, -0.07%, -8.64%, 5.00%
1005, TERN, Terns Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 429.89M, -, -, -, 1.37, -, 57.20%, 9.50%, -, 66.00%, -, -, -, -, 23.60, 23.60, 0.00, 0.00, -, -, -, -18.68%, -30.56%, -, -, -6.96%, 8.49%
1007, TFFP, TFF Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 272.36M, -, -, -, 4.13, -, 54.30%, 53.80%, -, -65.60%, -, -54.10%, -56.00%, -, 32.90, 32.90, 0.00, 0.00, -, -, -, -7.26%, -26.88%, -32.89%, 99.06%, -25.91%, 7.42%
1009, TGTX, TG Therapeutics Inc., Healthcare, Biotechnology, USA, 4.77B, -, -, 5302.18, 10.32, -, -23.80%, 40.70%, -, -41.80%, 0.00%, -73.20%, -95.90%, -49.70%, 5.80, 5.80, 0.00, 0.07, 84.70%, -, -, -18.94%, -22.51%, 18.24%, 86.97%, -32.97%, 5.26%
1011, THMO, ThermoGenesis Holdings Inc., Healthcare, Medical Devices, USA, 31.81M, 21.08, -, 3.93, 2.98, -, 22.40%, 126.50%, -, 81.10%, -53.10%, -69.90%, -231.90%, -, 1.60, 1.10, 0.06, 0.70, 5.90%, -, -, 4.98%, -2.49%, 9.60%, -55.52%, 31.10%, 8.38%
1013, TIL, Instil Bio Inc., Healthcare, Biotechnology, USA, 2.28B, -, -, 16512.72, 3.44, -, -478.60%, -10.90%, -, -, -, -, -, 85.30%, 35.40, 35.40, 0.00, 0.00, -, -, -, -6.95%, -, -, -, -32.68%, 10.73%
1015, TLGT, Teligent Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 52.01M, -, -, 1.15, -, -, -214.30%, -, 15.00%, -, 56.80%, -, -, -172.80%, 4.40, 2.90, -, -, -8.20%, -, -, -8.97%, -42.86%, 0.56%, -86.23%, -28.39%, 6.72%
1017, TLMD, SOC Telemed Inc., Healthcare, Medical Care Facilities, USA, 547.80M, -, -, 7.52, 3.12, -, 85.80%, 38.50%, -, -, -12.60%, -, -, -76.00%, 2.70, 2.70, 0.65, 0.65, 33.80%, -, -, -23.18%, -26.29%, -27.01%, -38.84%, -23.47%, 6.90%
1019, TLSA, Tiziana Life Sciences PLC, Healthcare, Biotechnology, United Kingdom, 228.67M, -, -, -, 35.61, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -10.31%, -27.47%, -6.00%, -11.12%, 16.34%, 7.46%
1022, TMDI, Titan Medical Inc., Healthcare, Medical Devices, Canada, 210.29M, -, -, 10.51, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 15.66%, -9.86%, 93.94%, 619.64%, 12.28%, 7.67%
1024, TMO, Thermo Fisher Scientific Inc., Healthcare, Diagnostics & Research, USA, 185.70B, 23.85, 4.66, 5.17, 5.28, 24.07, 73.80%, -11.40%, 5.06%, 198.80%, 59.00%, 12.20%, 24.10%, 12.30%, 2.50, 1.90, 0.53, 0.53, 51.50%, 27.70%, 22.10%, 1.10%, 2.16%, 4.69%, 34.45%, 0.80%, 1.89%
1026, TNXP, Tonix Pharmaceuticals Holding Corp., Healthcare, Biotechnology, USA, 388.50M, -, -, -, 1.93, -, 97.10%, 13.00%, -, 81.00%, -, -62.60%, -67.10%, -, 28.70, 28.70, 0.00, 0.00, -, -, -, 2.61%, -3.28%, 113.77%, 81.54%, 74.81%, 7.66%
1028, TRHC, Tabula Rasa HealthCare Inc., Healthcare, Health Information Services, USA, 1.04B, 105.13, -, 3.44, 11.90, -, -136.00%, 152.15%, 30.00%, -25.40%, 5.40%, -17.60%, -58.30%, -13.90%, 1.40, 1.30, 4.02, 4.13, 30.00%, -22.90%, -28.60%, -7.45%, 10.48%, 23.49%, -19.13%, 0.86%, 4.83%
1030, TRIL, Trillium Therapeutics Inc., Healthcare, Biotechnology, Canada, 822.00M, -, -, 5554.07, 3.12, -, -26.90%, 28.10%, -, -, -, -, -, -, -, -, -, -, -, -, -, -12.13%, -31.82%, -54.17%, 17.55%, -45.82%, 5.99%
1032, TRVN, Trevena Inc., Healthcare, Biotechnology, USA, 287.90M, -, -, 87.24, 2.85, -, 15.20%, 17.90%, -, -3.20%, 122.60%, -30.80%, -36.30%, -28.60%, 8.10, 8.10, 0.00, 0.00, 89.50%, -, -, 1.16%, -22.32%, -25.64%, 33.85%, -18.69%, 7.24%
1034, TTNP, Titan Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 23.79M, -, -, 5.41, 2.28, -, 79.90%, 43.90%, -, 76.50%, -36.40%, -, -, -181.30%, 3.50, 3.50, 0.01, 0.07, 86.80%, -, -, -2.40%, -26.06%, -57.17%, -71.29%, -25.84%, 5.84%
1036, TVTX, Travere Therapeutics Inc., Healthcare, Biotechnology, USA, 906.26M, -, -, 4.58, 2.35, -, -14.80%, 22.60%, -, -129.70%, -0.80%, -32.70%, -75.10%, -41.30%, 6.60, 6.60, 0.60, 0.60, 96.80%, -, -, -38.86%, -50.36%, -33.49%, -3.28%, -44.34%, 6.10%
1038, TWST, Twist Bioscience Corporation, Healthcare, Diagnostics & Research, USA, 5.28B, -, -, 46.73, 8.51, -, 8.90%, 2.60%, -, 8.90%, 61.70%, -22.60%, -25.50%, -41.20%, 15.00, 14.60, 0.00, 0.01, 37.00%, -, -, -21.43%, -25.97%, 7.70%, 182.77%, -24.05%, 8.75%
1040, TXMD, TherapeuticsMD Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 491.50M, -, -, 6.78, -, -, 6.90%, 60.50%, 17.60%, 45.80%, 61.80%, -82.60%, 193.30%, -136.80%, 3.10, 2.90, -, -, 75.20%, -, -, 8.04%, -16.26%, -9.70%, 7.08%, 0.00%, 6.88%
1021, TMCI, Treace Medical Concepts Inc., Healthcare, Medical Devices, USA, 1.29B, -, -, 22.48, -, -, 12.50%, -, -, 38.90%, 44.30%, -, -, 3.60%, -, -, -, -, 78.30%, -1.10%, -8.70%, 10.68%, -, -, -, 27.11%, 10.76%
1023, TMDX, TransMedics Group Inc., Healthcare, Medical Devices, USA, 725.36M, -, -, 28.78, 7.18, -, 50.70%, 46.70%, -, 30.60%, -5.30%, -17.90%, -26.20%, -19.10%, 12.00, 10.90, 0.36, 0.36, 65.90%, -98.70%, -, -11.03%, -28.56%, 76.71%, 85.39%, 28.84%, 7.31%
1025, TNDM, Tandem Diabetes Care Inc., Healthcare, Medical Devices, USA, 5.37B, 137.73, -, 9.90, 17.01, 107.73, -33.20%, 282.72%, -, 67.50%, 44.00%, -3.60%, -7.70%, -1.10%, 6.40, 5.80, 0.89, 0.89, 52.30%, 0.40%, -4.50%, -9.14%, -10.89%, -6.37%, 2.69%, -10.75%, 4.23%
1027, TPTX, Turning Point Therapeutics Inc., Healthcare, Biotechnology, USA, 3.33B, -, -, 66.36, 2.94, -, -28.80%, -33.00%, -, 57.10%, -, -14.20%, -14.60%, -, 46.00, 46.00, 0.00, 0.00, -, -, -, -15.11%, -45.41%, -37.60%, -4.43%, -45.69%, 5.30%
1029, TRIB, Trinity Biotech plc, Healthcare, Diagnostics & Research, Ireland, 66.70M, 9.78, -, 0.65, -, 2.29, 79.30%, -8.57%, 15.00%, 172.10%, 20.80%, -1.90%, -255.60%, 0.70%, 2.80, 1.60, -, -, 47.60%, 3.80%, -2.50%, -8.75%, -45.75%, -19.12%, 148.41%, -17.85%, 8.43%
1031, TRVI, Trevi Therapeutics Inc., Healthcare, Biotechnology, USA, 42.00M, -, -, -, 1.75, -, 20.40%, -9.50%, -, 9.30%, -, -67.70%, -103.20%, -, 7.90, 7.90, 0.58, 0.60, -, -, -, -9.36%, -26.55%, -31.07%, -22.26%, -11.98%, 4.40%
1033, TSHA, Taysha Gene Therapies Inc., Healthcare, Biotechnology, USA, 858.15M, -, -, -, 3.74, -, -6.50%, -11.30%, -, -, -, -, -, -, 12.60, 12.60, 0.00, 0.00, -, -, -, -10.00%, -16.26%, 1.81%, -, -15.22%, 7.74%
1035, TTOO, T2 Biosystems Inc., Healthcare, Diagnostics & Research, USA, 186.09M, -, -, 8.27, -, -, 70.30%, 3.20%, -, 67.00%, 180.00%, -60.60%, -796.60%, -76.70%, 4.30, 3.90, -, -, 0.60%, -, -, -1.42%, -39.30%, 28.70%, 65.61%, 12.10%, 9.61%
1037, TVTY, Tivity Health Inc., Healthcare, Medical Care Facilities, USA, 1.28B, 15.57, -, 3.31, 49.43, -, 20.00%, 10.58%, -5.81%, 132.80%, -32.30%, -, -, 21.30%, 1.40, -, 15.13, 15.41, 50.10%, -, -, 7.51%, 11.44%, 49.46%, 146.01%, 33.74%, 2.94%
1039, TXG, 10x Genomics Inc., Healthcare, Health Information Services, USA, 19.33B, -, -, 58.09, 26.01, -, -571.20%, 61.80%, -, 51.30%, 47.10%, -60.80%, -78.80%, -73.60%, 6.20, 5.90, 0.00, 0.00, 81.80%, -, -, -8.81%, -3.61%, 27.80%, 130.86%, 27.12%, 6.16%
1042, TYME, Tyme Technologies Inc., Healthcare, Biotechnology, USA, 252.21M, -, -, -, 22.00, -, 40.40%, 20.00%, -, 24.30%, -, -120.50%, -188.10%, -, 3.30, 3.30, 0.00, 0.00, -, -, -, -2.53%, -29.68%, 49.51%, 0.00%, 26.23%, 9.68%
1044, UHS, Universal Health Services Inc., Healthcare, Medical Care Facilities, USA, 13.56B, 13.03, 1.78, 1.15, 2.08, 7.10, 20.40%, 12.48%, 7.61%, 48.30%, 6.50%, 7.80%, 16.50%, 10.40%, 1.20, 1.20, 0.54, 0.55, -, 12.10%, 8.60%, 7.43%, 24.81%, 19.80%, 51.38%, 16.09%, 1.99%
1046, UPC, Universe Pharmaceuticals INC, Healthcare, Biotechnology, China, 67.41M, -, -, 2.20, -, -, -, -, -, -28.50%, -5.20%, -, -, -, -, -, -, -, -, -, -, -13.48%, -, -, -, -32.42%, 6.16%
1048, USPH, U.S. Physical Therapy Inc., Healthcare, Medical Care Facilities, USA, 1.53B, 37.93, 3.90, 3.62, 5.42, -, 1.00%, 11.97%, 12.00%, 6.10%, -0.30%, -, -, 17.80%, 0.80, 0.80, 0.06, 0.08, 24.80%, -, -, 1.19%, 0.00%, 8.04%, 56.95%, -3.23%, 2.72%
1050, UTMD, Utah Medical Products Inc., Healthcare, Medical Instruments & Supplies, USA, 313.70M, -, -, 7.43, 2.98, 20.24, -22.10%, -, -, -1.90%, 0.90%, 9.80%, 10.60%, 10.60%, 14.60, 13.30, 0.00, 0.00, 60.70%, 32.70%, 25.30%, -2.49%, -3.47%, -4.50%, -13.84%, 1.67%, 1.71%
1052, VAPO, Vapotherm Inc., Healthcare, Medical Devices, USA, 510.92M, -, -, 3.68, 4.77, -, 21.20%, 2.60%, 4.70%, 39.10%, 69.10%, -23.50%, -39.40%, -, 5.00, 4.10, 0.41, 0.42, 51.10%, -31.70%, -34.60%, -10.09%, -21.57%, -18.20%, -25.72%, -26.36%, 5.30%
1054, VBLT, Vascular Biogenics Ltd., Healthcare, Biotechnology, Israel, 126.19M, -, -, 180.27, 3.32, -, -2.60%, 4.40%, -, -2.60%, 50.00%, -, -, -79.00%, 4.30, 4.30, 0.00, 0.00, 41.80%, -, -, 19.19%, 27.57%, 91.09%, 91.87%, 24.87%, 8.35%
1056, VCNX, Vaccinex Inc., Healthcare, Biotechnology, USA, 70.59M, -, -, 47.06, 79.33, -, 37.90%, 87.70%, -, 41.60%, -, -176.10%, 149.80%, 162.80%, 4.50, 4.50, 1.38, 4.25, 99.90%, -, -, -7.03%, -37.04%, 14.98%, -38.04%, 14.98%, 7.02%
1058, VECT, VectivBio Holding AG, Healthcare, Biotechnology, Switzerland, 534.34M, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -6.88%, -, -, -, -38.51%, 5.22%
1060, VERO, Venus Concept Inc., Healthcare, Medical Devices, Canada, 112.51M, -, -, 1.31, 3.00, -, 51.20%, 43.70%, -, 89.80%, 55.90%, -29.20%, -114.00%, -60.20%, 3.70, 3.00, 2.19, 0.00, 66.60%, -42.50%, -51.50%, 9.68%, -22.73%, -10.92%, -31.08%, 17.92%, 6.18%
1041, TYHT, Shineco Inc., Healthcare, Drug Manufacturers - Specialty & Generic, China, 53.99M, -, -, 3.80, 0.49, -, -804.90%, -, -, -87.50%, -45.90%, -29.90%, -37.60%, -9.80%, 3.90, 3.70, 0.00, 0.04, 16.20%, -, -, -16.95%, 115.76%, 152.87%, 107.68%, 159.90%, 19.05%
1043, UBX, Unity Biotechnology Inc., Healthcare, Biotechnology, USA, 255.58M, -, -, -, 3.03, -, 2.10%, 5.50%, -, 50.70%, -, -50.60%, -87.40%, -, 9.90, 9.90, 0.31, 0.31, -, -, -, -12.16%, -41.13%, -20.71%, -45.23%, -14.50%, 7.22%
1045, UNH, UnitedHealth Group Incorporated, Healthcare, Healthcare Plans, USA, 389.47B, 19.29, 1.86, 1.48, 5.86, 21.23, 11.90%, 14.99%, 12.62%, 44.50%, 9.00%, 8.60%, 25.90%, 16.00%, -, -, 0.56, 0.70, -, 9.20%, 6.40%, 2.58%, 23.09%, 23.63%, 35.12%, 17.46%, 1.49%
1047, URGN, UroGen Pharma Ltd., Healthcare, Biotechnology, USA, 408.96M, -, -, 21.19, 5.12, -, -15.20%, 26.20%, -, 34.70%, -, -89.60%, -107.00%, -135.00%, 5.50, 5.30, 0.00, 0.00, 90.10%, -, -, -12.64%, -13.88%, -13.54%, -24.93%, -2.22%, 7.61%
1049, UTHR, United Therapeutics Corporation, Healthcare, Biotechnology, USA, 8.32B, 12.41, -, 5.52, 2.41, 14.50, 583.80%, 40.00%, -10.88%, -80.50%, 6.40%, 9.10%, 12.30%, 10.90%, 6.70, 6.40, 0.23, 0.00, 92.80%, 23.80%, 26.90%, -8.98%, 8.54%, 37.63%, 57.61%, 22.47%, 3.10%
1051, VACC, Vaccitech plc, Healthcare, Biotechnology, United Kingdom, 503.47M, -, -, 104.45, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, -, 4.82%, -
1053, VBIV, VBI Vaccines Inc., Healthcare, Biotechnology, USA, 836.31M, -, -, 929.24, 4.49, -, 53.80%, 55.20%, -, -49.80%, -25.00%, -28.00%, -34.50%, -23.20%, 6.10, 6.00, 0.09, 0.00, -, -, -, 0.94%, -10.77%, 18.75%, 48.17%, 17.45%, 7.11%
1055, VCEL, Vericel Corporation, Healthcare, Biotechnology, USA, 2.60B, 141.96, -, 19.64, 18.52, 138.77, 127.70%, 623.64%, -, 31.70%, 29.60%, 2.40%, 3.40%, 1.60%, 5.50, 5.00, 0.00, 0.00, 68.50%, 3.20%, 3.20%, -7.56%, 17.29%, 126.36%, 292.91%, 82.97%, 5.24%
1057, VCYT, Veracyte Inc., Healthcare, Biotechnology, USA, 2.66B, -, -, 21.57, 2.54, -, -140.10%, 47.00%, -, -181.00%, 18.00%, -11.90%, -12.70%, -8.40%, 11.10, 10.90, 0.00, 0.00, 66.20%, -55.80%, -52.90%, -20.31%, -37.91%, -23.28%, 56.58%, -20.21%, 7.31%
1059, VEEV, Veeva Systems Inc., Healthcare, Health Information Services, USA, 40.44B, 72.87, 7.54, 25.90, 19.50, -, 31.30%, 16.12%, 14.67%, 72.80%, 27.40%, 13.00%, 16.90%, 16.00%, 3.20, 3.20, 0.00, 0.00, 72.50%, 21.70%, 22.00%, 3.31%, -0.81%, 8.56%, 33.11%, 7.01%, 3.18%
1062, VINC, Vincerx Pharma Inc., Healthcare, Biotechnology, USA, 249.28M, -, -, -, 7.46, -, 22.10%, -6.90%, -, -, -, -, -, -, 1.90, 1.90, 0.00, 0.00, -, -, -, -15.88%, -27.86%, -15.31%, -, -33.62%, 6.27%
1064, VIRI, Virios Therapeutics LLC, Healthcare, Biotechnology, USA, 44.10M, -, -, -, 1.61, -, -294.50%, -, -, -516.20%, -, -83.70%, -113.30%, -, 24.20, 24.20, 0.00, 0.00, -, -, -, -9.64%, -19.85%, -, -, -30.09%, 7.26%
1066, VIVE, Viveve Medical Inc., Healthcare, Medical Devices, USA, 29.29M, -, -, 5.23, 0.86, -, 95.20%, 17.70%, 20.00%, 90.20%, 15.40%, -108.40%, -182.60%, -144.50%, 7.90, 7.20, 0.17, 0.22, 8.90%, -, -, -10.71%, -20.52%, -51.44%, -56.43%, -41.49%, 5.37%
1068, VKTX, Viking Therapeutics Inc., Healthcare, Biotechnology, USA, 412.39M, -, -, -, 1.66, -, -51.90%, -30.10%, 40.00%, -39.60%, -, -16.80%, -17.60%, -, 19.30, 19.30, 0.00, 0.00, -, -, -, -16.29%, -25.67%, -17.61%, -26.71%, -6.93%, 5.16%
1070, VMD, Viemed Healthcare Inc., Healthcare, Medical Devices, USA, 309.10M, -, -, 2.27, 6.80, -, -, -, -, -60.30%, 19.40%, -, -, -, -, -, -, -, -, -, -, -21.11%, -19.90%, -16.20%, -6.24%, 0.64%, 3.52%
1072, VNRX, VolitionRx Limited, Healthcare, Diagnostics & Research, USA, 191.98M, -, -, 14292.03, 5.72, -, -9.40%, 4.40%, -, 15.40%, -, -69.30%, -96.80%, -, 5.80, 5.80, 0.10, 0.13, -, -, -, 6.40%, -16.51%, 4.18%, 13.31%, -10.28%, 6.21%
1074, VRAY, ViewRay Inc., Healthcare, Medical Devices, USA, 975.32M, -, -, 16.73, 5.71, -, 38.10%, 6.10%, 10.00%, 10.60%, 8.40%, -37.50%, -69.10%, -56.60%, 5.10, 4.20, 0.35, 0.35, -2.80%, -, -, 19.27%, 26.18%, 53.52%, 236.00%, 53.93%, 5.21%
1076, VRDN, Viridian Therapeutics Inc., Healthcare, Biotechnology, USA, 148.40M, -, -, 87.30, -, -, -55.30%, 63.60%, -, -9.80%, 87.50%, -151.20%, 658.80%, 181.50%, 7.40, 7.40, -, -, -, -, -, 0.95%, 5.94%, 11.10%, 21.65%, 9.48%, 4.49%
1078, VRNA, Verona Pharma plc, Healthcare, Biotechnology, United Kingdom, 305.71M, -, -, -, 2.06, -, 35.90%, 5.50%, -, 50.00%, -, -, -, -, 14.90, 14.90, 0.03, 0.00, -, -, -, -11.03%, -34.88%, -16.67%, 27.10%, -13.57%, 6.42%
1080, VRTX, Vertex Pharmaceuticals Incorporated, Healthcare, Biotechnology, USA, 53.67B, 16.68, 1.54, 8.37, 6.03, 17.61, 128.00%, 13.72%, 12.90%, 9.00%, 13.80%, 24.30%, 33.20%, 26.40%, 4.40, 4.20, 0.06, 0.00, 88.10%, 47.10%, 43.10%, -1.52%, -0.83%, -4.34%, -27.55%, -11.72%, 1.86%
1061, VERU, Veru Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 702.78M, -, -, 14.06, 4.27, 702.78, -49.80%, -1050.00%, -, -205.30%, 34.30%, -0.50%, -0.70%, -32.00%, 8.30, 7.90, 0.04, 0.08, 75.60%, 9.80%, -1.00%, -4.02%, -38.72%, 192.38%, 136.73%, 2.08%, 7.51%
1063, VIR, Vir Biotechnology Inc., Healthcare, Biotechnology, USA, 5.62B, -, -, 77.38, 8.22, -, 56.50%, 70.20%, 7.00%, -85.50%, -64.90%, -42.50%, -56.90%, -41.40%, 2.80, 2.80, 0.00, 0.00, -, -, -, -12.38%, -37.19%, 47.52%, 22.62%, 56.50%, 6.76%
1065, VIRX, Viracta Therapeutics Inc., Healthcare, Biotechnology, USA, 425.27M, -, -, -, 1.32, -, 42.70%, 62.70%, -, -187.90%, -, -178.50%, -242.30%, -154.90%, 21.10, 21.10, 0.04, 0.04, -, -, -, 7.34%, -28.41%, 110.33%, -23.96%, 49.03%, 10.76%
1067, VIVO, Meridian Bioscience Inc., Healthcare, Diagnostics & Research, USA, 908.67M, 17.90, 0.76, 3.04, 3.21, 20.33, 88.20%, -32.56%, 17.00%, 829.10%, 96.00%, 11.80%, 19.20%, 15.20%, 3.30, 2.10, 0.21, 0.00, 63.60%, 20.50%, 15.40%, 3.85%, -5.89%, 16.89%, 34.28%, 11.08%, 4.53%
1069, VLON, Vallon Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 30.72M, -, -, 307.20, 1.90, -, -38.10%, -, -, -168.80%, -, -128.60%, -218.80%, 435.30%, 5.90, 5.90, 0.01, 0.02, -, -, -, -8.88%, -35.48%, -, -, -46.81%, 7.63%
1071, VNDA, Vanda Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 1.01B, 22.25, -, 3.99, 2.09, 16.71, -79.90%, 29.27%, -, 94.30%, 8.10%, 6.00%, 7.00%, 4.20%, 6.80, 6.80, 0.00, 0.00, 90.40%, 14.90%, 12.50%, 5.99%, -5.60%, 46.08%, 50.94%, 34.63%, 3.50%
1073, VOR, Vor Biopharma Inc., Healthcare, Biotechnology, USA, 762.77M, -, -, -, 1.76, -, -275.00%, -12.70%, -, -444.10%, -, -, -, -, 30.80, 30.80, 0.00, 0.00, -, -, -, -28.88%, -56.04%, -, -, -43.73%, 12.92%
1075, VRCA, Verrica Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 322.94M, -, -, 26.91, 4.67, -, -50.80%, -14.00%, -, 90.70%, -, -38.70%, -74.10%, -, 2.30, 2.30, 0.00, 0.66, -, -, -, -13.38%, -21.37%, 19.15%, -1.92%, -2.17%, 7.58%
1077, VREX, Varex Imaging Corporation, Healthcare, Medical Devices, USA, 998.58M, 20.22, -, 1.38, 2.16, -, -471.60%, 24.72%, 5.00%, 257.50%, 3.30%, -5.10%, -12.70%, -2.30%, 3.60, 1.90, 1.01, 1.01, 27.20%, -2.50%, -8.00%, 6.18%, 4.32%, 50.33%, 33.74%, 50.42%, 4.08%
1079, VRPX, Virpax Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 22.80M, -, -, -, 1.78, -, -31.20%, -, -, -89.40%, -, -, -, -, 5.00, 5.00, 0.10, 0.11, -, -, -, 4.87%, -25.43%, -, -, -34.00%, 7.66%
1082, VTGN, VistaGen Therapeutics Inc., Healthcare, Biotechnology, USA, 379.69M, -, -, 632.82, 2.23, -, 44.20%, -31.80%, -, 52.10%, -, -46.20%, -75.50%, -, 35.20, 35.20, 0.00, 0.00, -, -, -, 7.47%, 7.47%, 225.01%, 486.50%, 33.51%, 8.29%
1084, VTVT, vTv Therapeutics Inc., Healthcare, Biotechnology, USA, 199.51M, -, -, 26.96, -, -, 69.50%, -13.30%, -, 30.90%, 91314.30%, -65.10%, 12.50%, 14.80%, 1.80, 1.80, -, -, -, -, -, -6.82%, -1.60%, 23.00%, -14.58%, 32.26%, 5.79%
1086, VXRT, Vaxart Inc., Healthcare, Biotechnology, USA, 817.97M, -, -, 481.16, 4.33, -, 57.80%, 77.00%, -, -548.60%, -82.80%, -32.50%, -39.80%, -24.60%, 15.10, 15.10, 0.00, 0.00, -, -, -, -28.12%, -12.32%, 3.44%, 147.01%, 15.94%, 11.06%
1088, VYNE, VYNE Therapeutics Inc., Healthcare, Biotechnology, USA, 190.11M, -, -, 8.12, 2.08, -, 36.30%, 48.10%, -, 88.90%, 127.80%, -196.00%, -375.30%, -356.80%, 6.60, 6.30, 0.36, 0.36, 92.60%, -, -, -23.00%, -46.91%, -40.15%, -58.68%, -37.50%, 8.30%
1090, WAT, Waters Corporation, Healthcare, Diagnostics & Research, USA, 19.98B, 29.30, 4.20, 7.96, 86.86, 28.68, -3.30%, 9.27%, 7.77%, 176.50%, 30.90%, 21.70%, -, 35.00%, 2.30, 1.80, 6.94, 7.37, 58.10%, 29.80%, 24.60%, 6.67%, 16.32%, 42.12%, 61.25%, 30.24%, 2.05%
1092, WINT, Windtree Therapeutics Inc., Healthcare, Biotechnology, USA, 47.29M, 6.32, -, -, 0.34, -, 17.30%, 229.41%, -, -6.20%, -, -28.20%, -43.70%, -, 5.30, 5.30, 0.16, 0.19, -, -, -, -20.98%, -64.81%, -72.08%, -75.65%, -65.50%, 8.79%
1094, WST, West Pharmaceutical Services Inc., Healthcare, Medical Instruments & Supplies, USA, 25.45B, 44.62, 2.42, 10.94, 14.04, 98.56, 42.50%, 9.08%, 25.80%, 102.70%, 36.50%, 16.10%, 24.10%, 15.90%, 2.70, 2.10, 0.14, 0.14, 37.50%, 21.30%, 18.20%, 7.07%, 22.80%, 29.09%, 60.85%, 22.66%, 1.89%
1096, XAIR, Beyond Air Inc., Healthcare, Medical Devices, USA, 101.82M, -, -, 203.64, 5.05, -, -130.50%, 13.50%, -, 24.10%, -66.70%, -, -, -79.20%, 8.00, 8.00, 0.26, 0.26, -, -, -, -19.38%, -15.09%, -6.78%, -32.01%, -6.07%, 6.21%
1098, XBIT, XBiotech Inc., Healthcare, Biotechnology, USA, 516.64M, -, -, 14.27, 1.44, -, -102.50%, -, -, -, -61.40%, -3.90%, -4.00%, -4.80%, 120.50, 120.50, 0.00, 0.00, 24.80%, -54.30%, -38.10%, -3.20%, -11.40%, -6.35%, 23.48%, 10.22%, 3.46%
1100, XENE, Xenon Pharmaceuticals Inc., Healthcare, Biotechnology, Canada, 774.63M, -, -, 26.35, 2.53, -, 47.40%, -46.80%, -, -90.40%, -38.00%, -16.20%, -18.30%, -19.60%, 24.60, 24.60, 0.00, 0.00, -, -, -, 0.87%, 3.07%, 62.87%, 34.82%, 20.09%, 5.89%
1081, VSTM, Verastem Inc., Healthcare, Biotechnology, USA, 687.70M, -, -, 8.14, 6.45, -, 77.90%, 25.70%, 1.74%, 75.10%, -80.40%, -25.30%, -38.80%, -38.00%, 10.80, -, 0.19, 0.00, 61.60%, -45.90%, -53.00%, 25.65%, 58.61%, 127.65%, 108.06%, 81.69%, 6.68%
1083, VTRS, Viatris Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 18.30B, 4.12, -, 1.33, 0.86, 11.88, -10.10%, 4.28%, -2.85%, -, 69.10%, -3.80%, -10.10%, -0.40%, 1.20, 0.70, 1.03, 1.14, 36.20%, -4.90%, -12.60%, 14.07%, 3.53%, -10.72%, -10.72%, -18.68%, 2.71%
1085, VVOS, Vivos Therapeutics Inc., Healthcare, Medical Devices, USA, 126.38M, -, -, 9.67, 6.81, -, -7.70%, 20.00%, -, -20.80%, 9.70%, -, -, -66.20%, 2.30, 2.30, 0.01, 0.09, -, -, -, -20.30%, -27.69%, -, -, -8.97%, 5.61%
1087, VYGR, Voyager Therapeutics Inc., Healthcare, Biotechnology, USA, 157.28M, -, -, 0.99, 1.17, -, 181.00%, -1.90%, -, 12.10%, -64.10%, 14.80%, 29.50%, 17.70%, 7.10, 7.10, 0.00, 0.00, -, 16.40%, 24.70%, -13.41%, -28.64%, -49.16%, -64.79%, -40.42%, 7.27%
1089, VYNT, Vyant Bio Inc., Healthcare, Biotechnology, USA, 102.58M, -, -, 22.80, 0.18, -, 11.00%, -, -, -310.50%, -85.70%, -55.50%, -73.00%, -199.60%, 4.70, 4.60, 0.00, 0.00, 33.50%, -, -, -1.86%, -40.77%, 57.02%, 19.42%, 33.21%, 10.74%
1091, WBA, Walgreens Boots Alliance Inc., Healthcare, Pharmaceutical Retailers, USA, 45.85B, 10.14, -, 0.34, 2.16, 18.36, -88.00%, 11.39%, 3.63%, 8.80%, 4.60%, -0.70%, -3.00%, 2.40%, 0.80, 0.60, 0.57, 0.81, 19.90%, -0.50%, -0.50%, -0.14%, 10.05%, 34.78%, 22.64%, 32.05%, 2.35%
1093, WORX, SCWorx Corp., Healthcare, Health Information Services, USA, 16.49M, -, -, 3.17, 2.68, -, 54.70%, -, -, -, 0.00%, -, -, -100.80%, 0.50, 0.30, 0.07, 0.00, 32.60%, -, -, -6.13%, -21.54%, 22.40%, -27.14%, 13.32%, 8.67%
1095, WVE, Wave Life Sciences Ltd., Healthcare, Biotechnology, Singapore, 343.50M, -, -, 21.60, 6.33, -, 33.20%, 16.20%, -, 37.20%, 293.30%, -55.90%, -242.10%, -184.20%, 4.00, 4.00, 0.00, 0.00, -, -, -, 11.58%, -31.80%, -25.73%, -32.81%, -13.09%, 8.07%
1097, XBIO, Xenetic Biosciences Inc., Healthcare, Biotechnology, USA, 16.50M, -, -, 27.50, 1.53, -, 73.10%, 43.90%, -, 18.70%, 100.00%, -83.90%, -95.30%, -90.30%, 13.80, 13.80, 0.00, 0.00, -, -, -, -6.83%, -24.21%, 96.91%, 90.20%, -6.37%, 7.86%
1099, XCUR, Exicure Inc., Healthcare, Biotechnology, USA, 152.20M, -, -, 18.12, 2.93, -, 38.00%, -5.50%, -, -, -89.10%, -38.70%, -57.40%, -32.60%, 5.80, 5.80, 0.33, 0.00, -, -, -, -15.23%, -23.74%, 18.44%, -39.71%, -5.65%, 6.77%
1102, XERS, Xeris Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 215.00M, -, -, 8.02, 4.33, -, 55.60%, 46.90%, -, 66.20%, 355.60%, -48.50%, -275.10%, -69.70%, 5.90, 5.40, 1.97, 0.00, 65.10%, -, -, -19.38%, -42.22%, -31.88%, -39.30%, -36.59%, 7.61%
1104, XGN, Exagen Inc., Healthcare, Diagnostics & Research, USA, 236.69M, -, -, 5.50, 1.82, -, 84.40%, 7.10%, -, -8.60%, 10.40%, -18.40%, -29.40%, -22.00%, 16.40, 16.40, 0.27, 0.27, 61.10%, -36.10%, -40.30%, -15.18%, -27.15%, -2.60%, 22.95%, 7.95%, 7.87%
1106, XNCR, Xencor Inc., Healthcare, Biotechnology, USA, 2.25B, -, -, 18.13, 3.82, -, -363.60%, -27.10%, -, 69.80%, 4.90%, -9.50%, -11.10%, -13.40%, 5.90, 5.90, 0.00, 0.00, -, -67.20%, -51.30%, -13.24%, -20.42%, -6.13%, 27.14%, -11.85%, 4.45%
1108, XOMAO, XOMA Corporation, Healthcare, Biotechnology, USA, -, -, -, -, -, -, -, -, -, -, 6435.80%, -, -, -, -, -, -, -, -, -, -, -1.06%, -, -, -, -1.34%, 0.57%
1110, XTLB, XTL Biopharmaceuticals Ltd., Healthcare, Biotechnology, Israel, 18.22M, -, -, -, 2.89, -, 42.00%, -, -, 118.50%, -, -, -, -, 24.10, 24.10, 0.00, 0.00, -, -, -, -0.83%, 9.64%, 41.78%, 143.48%, 16.51%, 4.85%
1112, XXII, 22nd Century Group Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 769.81M, -, -, 27.59, 12.50, -, 32.70%, 0.00%, -, -20.20%, -4.20%, -36.00%, -41.30%, -47.00%, 5.20, 4.90, 0.00, 0.01, 6.50%, -79.00%, -74.30%, -5.06%, 36.78%, 198.01%, 443.28%, 104.55%, 10.70%
1114, YI, 111 Inc., Healthcare, Health Information Services, China, 812.16M, -, -, 0.56, 20.27, -, 9.20%, 82.90%, -, -16.80%, 64.70%, -17.90%, -113.50%, -80.70%, 1.60, 1.00, 0.00, 0.18, 4.30%, -5.80%, -5.20%, -24.40%, -51.35%, 44.15%, 31.49%, 40.00%, 8.64%
1116, YMTX, Yumanity Therapeutics Inc., Healthcare, Biotechnology, USA, 152.26M, -, -, 14.64, 3.20, -, 6.70%, -54.50%, -, 77.50%, -, -, -, -76.60%, 3.60, 3.60, 0.23, 0.31, -, -, -, -8.94%, -15.73%, -26.76%, -41.30%, -9.53%, 6.04%
1118, ZCMD, Zhongchao Inc., Healthcare, Health Information Services, China, 46.60M, -, -, 2.59, -, -, -, -, -, -16.30%, -26.40%, -, -, -, -, -, -, -, -, -, -, -4.86%, -2.76%, -3.30%, -16.19%, 3.53%, 6.06%
1120, ZGNX, Zogenix Inc., Healthcare, Biotechnology, USA, 995.08M, -, -, 38.13, 3.05, -, 60.00%, 47.00%, 8.80%, -86.40%, 336.20%, -38.60%, -63.00%, -44.40%, 7.80, 7.70, 0.47, 0.47, 95.30%, -, -, -7.87%, -16.23%, -16.75%, -39.75%, -12.21%, 3.85%
1101, XENT, Intersect ENT Inc., Healthcare, Medical Devices, USA, 594.98M, -, -, 6.99, 11.17, -, -61.90%, 27.20%, 7.60%, -12.00%, 22.70%, -38.00%, -103.30%, -51.50%, 2.30, 2.00, 1.23, 1.23, 62.00%, -80.40%, -88.00%, -21.69%, -27.46%, -12.58%, 58.30%, -22.93%, 4.99%
1103, XFOR, X4 Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 224.67M, -, -, 74.89, 1.88, -, 33.20%, 6.90%, -, -133.10%, -, -55.70%, -83.70%, -56.80%, 8.20, 8.20, 0.32, 0.00, -, -, -, 12.03%, -4.04%, 47.98%, 11.24%, 47.74%, 7.79%
1105, XLRN, Acceleron Pharma Inc., Healthcare, Biotechnology, USA, 7.92B, -, -, 70.12, 9.78, -, -22.80%, 31.00%, -, -9.80%, 476.70%, -22.10%, -23.90%, -19.60%, 14.80, 14.80, 0.00, 0.00, -, -, -, 4.33%, -6.60%, 15.07%, 32.44%, 2.31%, 3.37%
1107, XOMA, XOMA Corporation, Healthcare, Biotechnology, USA, 341.56M, -, 10.41, 11.78, 4.05, 29.70, 446.30%, 37.50%, 19.00%, -44.20%, -50.00%, 5.60%, 9.60%, 13.00%, 5.40, 5.40, 0.14, 0.23, -, 40.20%, 20.30%, -20.33%, -20.57%, -9.77%, 42.92%, -33.22%, 5.44%
1109, XRAY, DENTSPLY SIRONA Inc., Healthcare, Medical Instruments & Supplies, USA, 14.51B, 20.87, 3.21, 4.15, 2.97, 28.16, -132.30%, 11.90%, 26.35%, 184.00%, 17.50%, 1.90%, 3.60%, -0.50%, 1.40, 1.00, 0.39, 0.46, 50.60%, 7.60%, 5.00%, 0.97%, 12.08%, 30.40%, 43.85%, 27.81%, 2.16%
1111, XTNT, Xtant Medical Holdings Inc., Healthcare, Medical Devices, USA, 125.71M, -, -, 2.46, 3.56, -, 60.50%, -, 20.00%, 99.80%, -15.50%, -9.90%, 38.80%, -3.30%, 2.00, 1.10, 0.00, 0.50, 64.30%, 1.00%, -8.90%, -24.35%, -64.30%, 22.69%, 18.70%, 22.06%, 8.17%
1113, YCBD, cbdMD Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 172.10M, -, -, 3.70, 1.88, -, 110.90%, 72.70%, -, -161.70%, 25.50%, -32.50%, -45.40%, 15.80%, 5.10, 4.40, 0.01, 0.02, 65.20%, -80.90%, -81.70%, -23.10%, -25.00%, 17.90%, 106.12%, 2.71%, 7.68%
1115, YMAB, Y-mAbs Therapeutics Inc., Healthcare, Biotechnology, USA, 1.61B, -, -, 61.71, 5.95, -, -29.20%, -1.30%, -, 214.30%, -, -33.30%, -38.50%, -113.40%, 15.50, 15.50, 0.00, 0.00, 99.60%, -, -, 20.68%, 0.31%, -18.10%, -6.16%, -27.63%, 6.72%
1117, ZBH, Zimmer Biomet Holdings Inc., Healthcare, Medical Devices, USA, 34.95B, 19.20, 5.49, 4.93, 2.81, 50.17, -112.30%, 11.54%, 11.29%, 138.30%, 3.60%, 2.40%, 4.70%, 0.20%, 2.40, 1.20, 0.61, 0.63, 69.60%, 8.90%, 8.00%, -5.76%, 3.02%, 12.46%, 33.24%, 9.24%, 1.68%
1119, ZEAL, Zealand Pharma A/S, Healthcare, Biotechnology, Denmark, 1.33B, -, -, 3.76, 0.99, -, -14.40%, 9.70%, -, -, 451.30%, -, -, -, -, -, -, -, -, -, -, -7.33%, -8.71%, -14.52%, -14.80%, -14.78%, 2.83%
1122, ZIVO, Zivo Bioscience Inc. Common Stock, Healthcare, Biotechnology, USA, -, -, -, -, -, -, 46.20%, -, -, 15.80%, -, -, 80.20%, -, 0.00, 0.00, -, -, -, -, -, -, -, -, -, -, -
1124, ZNTL, Zentalis Pharmaceuticals Inc., Healthcare, Biotechnology, USA, 2.28B, -, -, -, 8.40, -, -216.70%, -9.80%, -, -164.50%, -, -45.10%, -53.60%, -, 9.30, 9.30, 0.00, 0.00, -, -, -, -6.82%, 33.84%, 21.31%, 6.95%, 7.53%, 6.02%
1126, ZSAN, Zosano Pharma Corporation, Healthcare, Biotechnology, USA, 91.90M, -, -, 183.81, 1.95, -, 78.60%, 18.80%, -, 67.40%, -, -49.40%, -79.90%, -56.20%, 2.00, 2.00, 0.08, 0.22, 30.90%, -, -, -15.19%, -39.85%, 37.93%, -18.37%, 51.77%, 5.95%
1128, ZYME, Zymeworks Inc., Healthcare, Biotechnology, Canada, 1.38B, -, -, 44.03, 4.25, -, 6.30%, 28.20%, 11.00%, -35.70%, -92.80%, -35.20%, -45.40%, -45.80%, 6.20, 6.20, 0.00, 0.00, -, -, -, -5.97%, -15.15%, -35.74%, -18.15%, -33.98%, 5.32%
1130, ZYXI, Zynex Inc., Healthcare, Medical Devices, USA, 528.29M, 19.14, -, 5.94, 9.45, -, -7.10%, 114.86%, -, -123.60%, 58.60%, 8.90%, 11.20%, 15.90%, 6.50, 5.40, 0.01, 0.01, 77.60%, 7.40%, 6.10%, -5.05%, 3.61%, 13.41%, -21.55%, 13.08%, 4.90%
1121, ZIOP, ZIOPHARM Oncology Inc., Healthcare, Biotechnology, USA, 657.40M, -, -, -, 6.20, -, 45.60%, 2.20%, -, -10.00%, -, -53.50%, -61.90%, -, 5.90, 5.90, 0.00, 0.00, -, -, -, -11.88%, -42.21%, 4.11%, 2.70%, 20.63%, 5.81%
1123, ZLAB, Zai Lab Limited, Healthcare, Biotechnology, China, 14.42B, -, -, 294.62, 15.56, -, -14.20%, 32.00%, -, -418.70%, 310.20%, -, -, -25.80%, 11.30, 11.20, 0.00, 0.00, -, -, -, 5.59%, 9.65%, 66.52%, 138.79%, 31.27%, 5.40%
1125, ZOM, Zomedica Corp., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 825.20M, -, -, -, 2.71, -, 75.10%, -, -, 78.10%, -, -17.00%, -19.10%, -, 141.90, 141.80, 0.00, 0.01, -, -, -, -17.65%, -59.22%, 569.86%, 432.66%, 264.27%, 9.01%
1127, ZTS, Zoetis Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 82.93B, 34.90, 3.80, 11.83, 20.54, 64.89, 9.90%, 11.92%, 12.53%, 32.50%, 22.00%, 13.10%, 49.10%, 14.90%, 3.30, 2.50, 1.61, 1.76, 69.60%, 31.20%, 25.30%, 1.24%, 12.04%, 10.29%, 26.75%, 6.76%, 1.68%
1129, ZYNE, Zynerba Pharmaceuticals Inc., Healthcare, Drug Manufacturers - Specialty & Generic, USA, 217.83M, -, -, -, 2.38, -, -26.90%, -16.10%, -, 62.30%, -, -54.00%, -63.30%, -, 8.50, 8.50, 0.00, 0.00, -, -, -, 23.75%, 21.89%, 24.02%, 7.98%, 72.12%, 8.63%
